<SEC-DOCUMENT>0001104659-17-009286.txt : 20170214
<SEC-HEADER>0001104659-17-009286.hdr.sgml : 20170214
<ACCEPTANCE-DATETIME>20170214161951
ACCESSION NUMBER:		0001104659-17-009286
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20170214
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170214
DATE AS OF CHANGE:		20170214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0924

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		17609198

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a17-4436_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">WASHINGTON, D.C. 20549</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt .5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event reported):</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">February&nbsp;14, 2017</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">HOLOGIC,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-36214</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">04-2902449</font></b></p>    </td>   </tr>
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other   jurisdiction<br>   of incorporation)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission<br>   File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(IRS Employer<br>   Identification No.)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="60%" valign="top" style="padding:0in 0in 0in 0in;width:60.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">250   Campus Drive, Marlborough, MA</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">01752</font></b></p>    </td>   </tr>
<tr>
<td width="60%" valign="top" style="padding:0in 0in 0in 0in;width:60.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal   executive offices)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="37%" valign="top" style="padding:0in 0in 0in 0in;width:37.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Zip Code)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(508) 263-2900</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Telephone number, including area code)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligations of any registrant under any of the following provisions:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425) </p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12) </p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">x</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b)) </p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c)) </p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 1.01 <u>Entry into a Material Definitive Agreement</u>.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Merger Agreement</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On February&nbsp;14, 2017, Hologic,&nbsp;Inc. (&#147;<u>Hologic</u>&#148;) and Cynosure,&nbsp;Inc. (&#147;<u>Cynosure</u>&#148;) entered into a definitive Agreement and Plan of Merger, dated as of February&nbsp;14, 2017 (the &#147;<u>Merger Agreement</u>&#148;), by and among Hologic, Cynosure, and Minuteman Merger Sub,&nbsp;Inc. (&#147;<u>Purchaser</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the terms of Merger Agreement, Purchaser will commence an all cash tender offer (the &#147;<u>Offer</u>&#148;) for any (subject to the minimum condition) and all of Cynosure&#146;s outstanding shares of Class&nbsp;A Common Stock, par value $0.001 per share (the &#147;<u>Shares</u>&#148;), at a purchase price of $66.00 per Share (the &#147;<u>Offer Price</u>&#148;), net to the seller in cash, without interest, subject to any required withholding of taxes.&#160; Under the Merger Agreement, Hologic is required to commence the Offer within five business days after the date of the Merger Agreement.&#160; The Offer will remain open for a minimum of 20 business days from the date of commencement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The obligation of Purchaser to purchase Shares tendered in the Offer is subject to customary closing conditions, including (i)&nbsp;Shares having been validly tendered and not withdrawn that represent at least a majority of the total number of Shares then outstanding, (ii)&nbsp;the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, (iii)&nbsp;approval from the German Federal Cartel Office under the German Act Against Restraints of Competition having been obtained, (iv)&nbsp;the absence of injunctions or other legal restraints preventing the consummation of the Offer or the Merger, as defined below, (v)&nbsp;the accuracy of representations and warranties made by Cynosure in the Merger Agreement, (vi)&nbsp;compliance by Cynosure with its covenants in the Merger Agreement, and (vii)&nbsp;other conditions set forth in Annex I to the Merger Agreement.&#160; The consummation of the Offer is not subject to any financing conditions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Following the completion of the Offer, subject to the absence of injunctions or other legal restraints preventing the consummation of the Merger, Purchaser will merge with and into Cynosure, with Cynosure surviving as a wholly owned subsidiary of Hologic (the &#147;<u>Merger</u>&#148;), pursuant to the procedure provided for under Section&nbsp;251(h)&nbsp;of the Delaware General Corporation Law, without any additional stockholder approvals.&#160; The Merger will be effected as soon as practicable following the time of purchase by Purchaser of Shares validly tendered and not withdrawn in the Offer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">At the effective time of the Merger (the &#147;<u>Effective Time</u>&#148;), each issued and outstanding Share (other than Shares owned by (i)&nbsp;Cynosure, Hologic, Purchaser, or any other subsidiary of Hologic, which Shares will be canceled and will cease to exist, (ii)&nbsp;any subsidiary of Cynosure , which Shares will be converted into such number of shares of common stock of the Surviving Corporation so as to maintain relative ownership percentages or (iii)&nbsp;stockholders who validly exercise appraisal rights under Delaware law with respect to such Shares) will be converted into the right to receive an amount in cash equal to the Offer Price, without interest, subject to any required withholding taxes.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_122246_5012"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the terms of the Merger Agreement, as of immediately prior to the Effective Time, (i)&nbsp;each then-outstanding Cynosure stock option will vest in full and be cancelled and converted into a right to receive the Offer Price (less the applicable exercise price) in respect of each Share underlying such stock option, (ii)&nbsp;each then outstanding Cynosure restricted stock unit award will vest and be cancelled and converted into the right to receive the Offer Price in respect of each Share underlying such restricted stock unit award, and (iii)&nbsp;each then-outstanding Cynosure performance stock unit award will vest and be cancelled and converted into the right to receive the Offer Price in respect of the maximum number of Shares underlying such performance stock unit award.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In the Merger Agreement, Cynosure has agreed, among other things, (i)&nbsp;to use commercially reasonable efforts to conduct its business in the ordinary course during the period between the execution of the Merger Agreement and the consummation of the Merger; (ii)&nbsp;subject to certain customary exceptions set forth in the Merger Agreement to permit Cynosure&#146;s board of directors to comply with its fiduciary duties, to recommend that Cynosure&#146;s stockholders accept the Offer and tender their shares pursuant to the Offer; and (iii)&nbsp;not to solicit alternative acquisition proposals and to certain restrictions on its ability to respond to any such proposals.&#160; The Merger Agreement also contains customary representations, warranties and covenants of Cynosure, Hologic and Purchaser.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.05pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Merger Agreement contains customary termination rights for both Hologic and Cynosure, including, among others, for failure to consummate the Offer on or before August&nbsp;14, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Upon termination of the Merger Agreement under specified circumstances, including (i)&nbsp;a termination by Cynosure to enter into an agreement for an alternative transaction that constitutes a &#147;Superior Proposal&#148; (as defined in the Merger Agreement) or (ii)&nbsp;a termination by Hologic due to a change in the Cynosure board&#146;s recommendation, Cynosure has agreed to pay Hologic a termination fee of approximately $57.7 million.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:23.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The foregoing description of the Merger Agreement does not purport to be complete and is qualified in its entirety by reference to the actual terms of the Merger Agreement, a copy of which is attached hereto as Exhibit&nbsp;2.1 and incorporated herein by reference. The Merger Agreement has been included to provide investors with information regarding its terms and is not intended to provide any financial or other factual information about Cynosure or Hologic. In particular, the representations, warranties and covenants contained in the Merger Agreement (i)&nbsp;were made only for purposes of that agreement and as of specific dates, (ii)&nbsp;were solely for the benefit of the parties to the Merger Agreement, (iii)&nbsp;may be subject to limitations agreed upon by the parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the Merger Agreement instead of establishing those matters as facts and (iv)&nbsp;may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors.&#160; Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Merger Agreement, which subsequent information may or may not be fully reflected in public disclosures by Hologic or Cynosure. Accordingly, investors should read the representations and warranties in the Merger Agreement not in isolation but only in conjunction with the other information about Hologic or Cynosure and their respective subsidiaries that the</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_122309_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">respective companies include in reports, statements and other filings they make with the U.S. Securities and Exchange Commission (the &#147;<u>SEC</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 8.01 Other Events</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">On February&nbsp;14, 2017, Hologic and Cynosure issued a joint press release announcing the execution of the Merger Agreement.&#160; Hologic also made an investor presentation concerning the proposed transaction.&#160; Copies of the joint press release and the investor presentation are attached hereto as Exhibits 99.1 and 99.2, respectively. </font>In addition, a transcript of the investor presentation is attached hereto as Exhibit 99.3.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01.&#160; Financial Statements and Exhibits</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 27.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Exhibits</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;<br>   No.</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="88%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:88.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement and Plan of   Merger, dated as of February&nbsp;14, 2017, by and among Hologic,&nbsp;Inc.,   Cynosure,&nbsp;Inc. and Minuteman Merger Sub,&nbsp;Inc.&#134;</font></p>    </td>   </tr>
<tr>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Joint Press Release,   dated February&nbsp;14, 2017.</font></p>    </td>   </tr>
<tr>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investor Presentation   Materials, dated February&nbsp;14, 2017.</font></p>    </td>   </tr>
<tr>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="88%" valign="top" style="padding:0in 0in 0in 0in;width:88.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investor Presentation   Transcript, dated February 14, 2017.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#134; Schedules have been omitted pursuant to Item 601(b)(2)&nbsp;of Regulation S-K. Hologic hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the U.S. Securities and Exchange Commission.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Additional Information and Where to Find It</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The tender offer for the outstanding shares of Cynosure has not yet commenced.&#160; This Current Report on Form&nbsp;8-K &#160;is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares, nor is it a substitute for the tender offer materials that Hologic and its subsidiary will file with the Securities and Exchange Commission (&#147;SEC&#148;).&#160; At the time the tender offer is commenced, Hologic and its subsidiary will file tender offer materials on Schedule TO, and thereafter Cynosure will file a Solicitation/Recommendation Statement on Schedule 14D-9, with the SEC with respect to the tender offer.&#160; THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT WILL CONTAIN IMPORTANT INFORMATION.&#160; HOLDERS OF SHARES OF CYNOSURE COMMON STOCK ARE URGED TO READ THESE DOCUMENTS CAREFULLY WHEN THEY BECOME AVAILABLE (AS EACH MAY&nbsp;BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME) BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT HOLDERS OF SHARES OF CYNOSURE COMMON STOCK SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES.&#160; The Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="PB_4_122457_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">well as the Solicitation/Recommendation Statement, will be made available to all holders of shares of Cynosure common stock at no expense to them. The tender offer materials and the Solicitation/Recommendation Statement will be made available for free at the SEC&#146;s website at www.sec.gov.&#160; Additional copies of the tender offer materials may be obtained for free by contacting Hologic,&nbsp;Inc. at 250 Campus Drive, Marlborough, MA 01752, Attention: Investor Relations.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, Hologic and Cynosure file annual, quarterly and current reports and other information with the SEC.&#160; You may read and copy any reports or other information filed by Hologic or Cynosure at the SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549.&#160; Please call the Commission at 1-800-SEC-0330 for further information on the public reference room.&#160; Hologic&#146;s and Cynosure&#146;s filings with the SEC are also available to the public from commercial document-retrieval services and at the SEC&#146;s website at www.sec.gov.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Forward-Looking Statements</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This document contains forward-looking information that involves risks and uncertainties, including statements about each company&#146;s plans, objectives, expectations and intentions.&#160; Such statements include, without limitation: financial or other information based upon or otherwise incorporating judgments or estimates relating to future performance, events or expectations; each company&#146;s strategies, positioning, resources, capabilities, and expectations for future performance; and each company&#146;s outlook and financial and other guidance.&#160; Any statements that are not statements of historical fact (including statements containing the words &#147;believes,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;expects,&#148; estimates and similar expressions) should also be considered to be forward looking statements.&#160; These forward-looking statements are based upon assumptions made as of this date and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Risks and uncertainties that could adversely affect the either company&#146;s business and prospects, and otherwise cause actual results to differ materially from those anticipated, include without limitation: the possibility that the anticipated benefits from the proposed transaction cannot be fully realized or may take longer to realize than expected; the possibility that costs or difficulties related to the integration of Cynosure&#146;s operations with those of Hologic will be greater than expected; the ability of the combined company to retain and hire key personnel; the ability of the parties to timely and successfully receive required regulatory approvals; the effect of the continuing worldwide macroeconomic uncertainty, including the UK&#146;s decision to leave the European Union, on each company&#146;s business and results of operations; the coverage and reimbursement decisions of third-party payors and the guidelines, recommendations, and studies published by various organizations relating to the use of products and treatments; the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on each company&#146;s business and results of operations; the impact to Hologic&#146;s results of operations from the disposal of its blood screening business to Grifols, and the operational challenges of separating this business unit from Hologic&#146;s molecular diagnostics business; the ability to successfully manage ongoing organizational and strategic changes, including Hologic&#146;s ability to attract,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="PB_5_122514_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">motivate and retain key employees; the impact and anticipated benefits of completed acquisitions and acquisitions Hologic may complete in the future; the ability to consolidate certain of Hologic&#146;s manufacturing and other operations on a timely basis and within budget, without disrupting Hologic&#146;s business and to achieve anticipated cost synergies related to such actions; the development of new competitive technologies and products; regulatory approvals and clearances for products; production schedules for products; the anticipated development of markets in which products are sold into and the success of products in these markets; the anticipated performance and benefits of products; business strategies; estimated asset and liability values; the impact and costs and expenses of any litigation the companies may be subject to now or in the future; compliance with covenants contained in Hologic&#146;s debt agreements; anticipated trends relating to Hologic&#146;s financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations; and Hologic&#146;s capital resources and the adequacy thereof.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The risks included above are not exhaustive.&#160; Other factors that could adversely affect each company&#146;s business and prospects are described in the filings made by the applicable company with the SEC. Hologic and Cynosure expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="PB_6_122533_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='6',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, Hologic,&nbsp;Inc. has duly caused this current report to be signed on its behalf by the undersigned officer hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">HOLOGIC,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   John M. Griffin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">John   M. Griffin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">General   Counsel</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>February&nbsp;14, 2017</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="PB_7_122719_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='7',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;Index</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;<br>   No.</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="87%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:87.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement and Plan of   Merger, dated as of February&nbsp;14, 2017, by and among Hologic,&nbsp;Inc.,   Cynosure,&nbsp;Inc. and Minuteman Merger Sub,&nbsp;Inc.&#134;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Joint Press Release,   dated February&nbsp;14, 2017.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.2</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investor Presentation   Materials, dated February&nbsp;14, 2017.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" color="black" face="Times New Roman" style="color:black;font-size:10.0pt;">99.3 </font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" color="black" face="Times New Roman" style="color:black;font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" color="black" face="Times New Roman" style="color:black;font-size:10.0pt;">Investor Presentation Transcript, dated February 14, 2017.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#134; Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Hologic hereby undertakes to furnish supplemental copies of any of the omitted schedules upon request by the U.S. Securities and Exchange Commission.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="PB_8_122858_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='8',FILE='C:\JMS\109487\17-4436-1\task8278854\4436-1-ba.htm',USER='109487',CD='Feb 15 01:47 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>a17-4436_1ex2d1.htm
<DESCRIPTION>EX-2.1
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;2.1</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">EXECUTION VERSION</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AGREEMENT AND PLAN OF MERGER</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">by and among</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CYNOSURE,&nbsp;INC.,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">MINUTEMAN MERGER SUB,&nbsp;INC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">HOLOGIC,&nbsp;INC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated as of February&nbsp;14, 2017</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TABLE OF CONTENTS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Page</font></b></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;I   The Cash Tender Offer</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Offer</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Actions</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;II   The Merger</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Merger; No Vote of   Stockholders</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effective Time of the   Merger</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Closing</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.4</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effects of the Merger</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.5</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Directors and Officers   of the Surviving Corporation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.6</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conversion of Capital   Stock</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Surrender of   Certificates</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.8</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Stock Plans</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.9</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dissenting Shares</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Withholding Rights</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;III   Representations and Warranties of the Company</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Organization, Standing   and Power</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Capitalization</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.3</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Subsidiaries</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.4</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authority; No Conflict;   Required Filings and Consents</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.5</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">SEC Filings; Financial   Statements; Information Provided</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.6</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Undisclosed   Liabilities</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.7</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Absence of Certain   Changes or Events</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.8</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Taxes</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.9</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Real Property</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.10</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intellectual Property</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.11</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contracts</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">22</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.12</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Litigation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.13</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Environmental Matters</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.14</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employee Benefit Plans</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.15</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Compliance With Laws</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.16</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Permits; Regulatory   Matters</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.17</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Labor Matters</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.18</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Opinion of Financial   Advisor</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.19</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;203 of the   DGCL; Other Anti-Takeover Laws</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.20</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Brokers</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.21</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Insurance</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.22</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Suppliers</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.23</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Product Liability</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;IV   Representations and Warranties of the Parent and the Purchaser</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Organization, Standing   and Power</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Authority; No Conflict;   Required Filings and Consents</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Information Provided</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Operations of the   Purchaser</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.5</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Available Funds</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.6</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ownership of Company   Common Stock</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.7</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Litigation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.8</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Agreements or   Understandings</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.9</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Brokers</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.10</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Independent   Investigation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.11</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Other Company   Representations or Warranties</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.12</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Non-Reliance on Company   Estimates, Projections, Forecasts, Forward-Looking Statements and Business   Plans</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;V   Conduct of Business</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Covenants of the   Company</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">34</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conduct of Business by   the Parent and the Purchaser Pending the Merger</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;VI   Additional Agreements</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No Solicitation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">37</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nasdaq Listing</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.3</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Confidentiality; Access   to Information</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Reasonable Best Efforts</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">41</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Public Disclosure</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.6</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnification</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.7</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notification of Certain   Matters</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">46</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.8</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employee Benefits   Matters</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">46</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.9</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">State Takeover Laws</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.10</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rule&nbsp;16b-3</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.11</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rule&nbsp;14d-10   Matters</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.12</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Control of Operations</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.13</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Security Holder   Litigation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.14</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Director Resignations</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">49</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;VII   Conditions to Merger</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions to Each   Party&#146;s Obligation To Effect the Merger</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;VIII   Termination and Amendment</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Termination</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Effect of Termination</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fees and Expenses</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.4</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amendment</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.5</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Extension; Waiver</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.6</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Procedure for   Termination, Amendment, Extension or Waiver</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">ii<a name="PB_ii_110644_3623"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='ii',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;IX   Defined Terms</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">54</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="90%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:90.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;X   Miscellaneous</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">64</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.1</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Nonsurvival of   Representations and Warranties</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">64</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.2</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notices</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">64</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.3</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Entire Agreement</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.4</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Third Party   Beneficiaries</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.5</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assignment</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.6</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Severability</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.7</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Counterparts and   Signature</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.8</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Interpretation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.9</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Governing Law</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.10</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Remedies; Waiver of   Jury Trial</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">67</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.11</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Submission to   Jurisdiction</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">68</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.12</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Disclosure Schedule</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.13</font></p>    </td>
<td width="79%" valign="top" style="padding:0in 0in 0in 0in;width:79.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Parent Guarantee</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="14%" valign="top" style="padding:0in 0in 0in 0in;width:14.16%;">
<p style="margin:0in 0in .0001pt 38.9pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annex   I</font></p>    </td>
<td width="75%" valign="top" style="padding:0in 0in 0in 0in;width:75.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions of the Offer</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" valign="top" style="padding:0in 0in 0in 0in;width:14.16%;">
<p style="margin:0in 0in .0001pt 38.9pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="75%" valign="top" style="padding:0in 0in 0in 0in;width:75.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="14%" valign="top" style="padding:0in 0in 0in 0in;width:14.16%;">
<p style="margin:0in 0in .0001pt 38.9pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit&nbsp;A</font></p>    </td>
<td width="75%" valign="top" style="padding:0in 0in 0in 0in;width:75.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form&nbsp;of   Certificate of Incorporation of the Surviving Corporation</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">iii<a name="PB_iii_110650_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='iii',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGREEMENT AND PLAN OF MERGER</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THIS AGREEMENT AND PLAN OF MERGER (this &#147;<u>Agreement</u>&#148;), is made and entered into as of this 14th day of February, 2017, by and among Hologic,&nbsp;Inc., a Delaware corporation (the &#147;<u>Parent</u>&#148;), Minuteman Merger Sub,&nbsp;Inc., a Delaware corporation and a wholly owned subsidiary of the Parent (the &#147;<u>Purchaser</u>&#148;), and Cynosure,&nbsp;Inc., a Delaware corporation (the &#147;<u>Company</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">RECITALS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, upon the terms and subject to the conditions set forth in this Agreement, the Purchaser will make a cash tender offer (as it may be extended or amended from time to time as permitted under this Agreement, the &#147;<u>Offer</u>&#148;) to acquire all of the outstanding shares of Company Common Stock (other than shares of Company Common Stock to be cancelled or converted in accordance with Section&nbsp;2.6(b)) for $66.00 per share of Company Common Stock, net to the seller in cash, without interest thereon and subject to Sections 1.1(g)&nbsp;and 2.10 (such price, or any higher price as may be paid in the Offer in accordance with this Agreement, the &#147;<u>Offer Price</u>&#148;);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, upon the terms and subject to the conditions set forth in this Agreement, as soon as practicable following the consummation of the Offer, the Purchaser will, in accordance with Section&nbsp;251(h)&nbsp;of the DGCL, merge with and into the Company, with the Company continuing as the surviving corporation of such merger (the &#147;<u>Merger</u>&#148;) and each share of Company Common Stock issued and outstanding immediately prior to the Effective Time (other than shares of Company Common Stock to be cancelled or converted in accordance with Section&nbsp;2.6(b)&nbsp;and Dissenting Shares) being converted in the Merger into the right to receive the Offer Price (the &#147;<u>Merger Consideration</u>&#148;);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, the Company Board has as of the date hereof unanimously (a)&nbsp;adopted, approved and declared the advisability of this Agreement, the Offer, the Merger and the other transactions contemplated by this Agreement, (b)&nbsp;declared that it is in the best interests of the Company and the stockholders of the Company that the Company enter into this Agreement and consummate the Merger and that the stockholders of the Company tender their shares of Company Common Stock pursuant to the Offer, in each case on the terms and subject to the conditions set forth herein, (c)&nbsp;declared that the terms of the Offer and the Merger are fair to the Company and the Company&#146;s stockholders and (d)&nbsp;resolved to recommend that the Company&#146;s stockholders accept the Offer and tender their shares of Company Common Stock pursuant to the Offer;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, the respective board of directors of the Parent and the Purchaser have approved and declared it advisable for the Parent and the Purchaser to enter into this Agreement and to consummate the Offer, the Merger and the other transactions contemplated by this Agreement, upon the terms and subject to the conditions set forth herein; and</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">WHEREAS, the Merger shall be governed by and effected under Section&nbsp;251(h)&nbsp;of the DGCL and shall be effected as soon as practicable following the consummation of the Offer upon the terms and subject to the conditions set forth in this Agreement;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth herein, the Parent, the Purchaser and the Company, intending to be legally bound, hereby agree as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;I</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE CASH TENDER OFFER</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>The Offer</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Commencement of the Offer; Acceptance of Shares</u>.&#160; Subject to the terms and conditions of this Agreement and provided that the Company has complied in all material respects with its obligations under Section&nbsp;1.1(c)&nbsp;and Section&nbsp;1.2 in each case to the extent necessary for Purchaser to comply with its obligation under this Section&nbsp;1.1, as soon as practicable, and in any event within five (5)&nbsp;Business Days, after the date of this Agreement, the Purchaser shall commence (within the meaning of Rule&nbsp;14d-2 under the Exchange Act) the Offer to purchase any and all outstanding shares of Company Common Stock (other than shares of Company Common Stock to be cancelled or converted in accordance with Section&nbsp;2.6(b)) for a price per share of Company Common Stock equal to the Offer Price.&#160; As promptly as practicable on the later of: (i)&nbsp;the earliest time as of which the Purchaser is permitted under the Exchange Act to accept for payment shares of Company Common Stock validly tendered (and not validly withdrawn) pursuant to the Offer and (ii)&nbsp;the earliest time as of which each of the Offer Conditions shall have been satisfied or waived, the Purchaser shall (and the Parent shall cause the Purchaser to) irrevocably accept for purchase all shares of Company Common Stock validly tendered (and not validly withdrawn) pursuant to the Offer.&#160; The obligation of the Purchaser to accept for payment shares of Company Common Stock validly tendered (and not validly withdrawn) pursuant to the Offer shall be subject only to the satisfaction or waiver of each of the Offer Conditions (and shall not be subject to any other conditions), without limiting the right of the Parent or the Purchaser to terminate, extend or modify the Offer to the extent permitted under the terms of this Agreement.&#160; On the terms and subject to the conditions of the Offer and this Agreement, the Purchaser shall promptly after the Acceptance Time pay, or cause the Paying Agent to pay, for all shares of Company Common Stock validly tendered (and not validly withdrawn) in the Offer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Expiration Date; Extensions and Amendment</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Offer shall initially expire at midnight, Eastern time, at the end of the day that is the 20th Business Day after commencement of the Offer (determined in accordance with Rules&nbsp;14d-1(g)(3)&nbsp;and 14d-2 under the Exchange Act).&#160; Subject to the immediately succeeding sentence, the Parent and the Purchaser expressly reserve the right, in their sole and absolute discretion, to (A)&nbsp;increase the Offer Price, (B)&nbsp;waive any of the Offer Conditions, in whole or in part, at any time and from time to time prior to the Acceptance Time and (C)&nbsp;make other changes in the terms and conditions of the Offer prior to the Acceptance Time to the extent not inconsistent with the terms of this Agreement.&#160; Notwithstanding anything to the contrary contained in this Agreement, neither the Parent nor the Purchaser shall (without the prior written consent of the Company in its sole and absolute discretion):&#160; (1)&nbsp;change the form of consideration payable in the Offer, decrease the Offer Price, increase the Offer Price in</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_110356_7831"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">an increment of less than $0.25 per share or change the Offer so that it is for fewer than all of the outstanding shares of Company Common Stock (other than shares of Company Common Stock to be cancelled or converted in accordance with Section&nbsp;2.6(b)); (2)&nbsp;except pursuant to Section&nbsp;1.1(b)(ii)&nbsp;or Section&nbsp;1.1(f), terminate the Offer or accelerate, extend or otherwise change the expiration date of the Offer; (3)&nbsp;provide any &#147;subsequent offering period&#148; (or any extension thereof) within the meaning of Rule&nbsp;14d-11promulgated under the Exchange Act; (4)&nbsp;amend, change or waive the Minimum Condition or the condition in clause (c)(v)&nbsp;of Annex I; (5)&nbsp;amend, modify or supplement any of the Offer Conditions in any manner that is adverse to holders of shares of Company Common Stock or that would, individually or in the aggregate, reasonably be expected to prevent or delay the consummation of the Offer or prevent, delay or impair the ability of the Parent or the Purchaser to consummate the Offer, the Merger or the other transactions contemplated by this Agreement; (6)&nbsp;amend, modify or supplement any of the terms of the Offer (other than the Offer Conditions) in any manner that is adverse to holders of shares of Company Common Stock or that would, individually or in the aggregate, reasonably be expected to prevent or materially delay the consummation of the Offer or prevent, materially delay or impair the ability of the Parent or the Purchaser to consummate the Offer, the Merger or the other transactions contemplated by this Agreement; or (7)&nbsp;impose any condition to the Offer other than the Offer Conditions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding anything herein to the contrary (but subject to the last sentence of this Section&nbsp;1.1(b)(ii)), the Purchaser shall extend the scheduled expiration date of the Offer:&#160; (A)&nbsp;as required by applicable law (including for any period required by any rule, regulation, interpretation or position of the SEC); (B)&nbsp;in connection with an increase in the consideration to be paid pursuant to the Offer if and only to the extent required to comply with applicable rules&nbsp;and regulations of the SEC; and (C)&nbsp;if at the then scheduled expiration date of the Offer any of the Offer Conditions has not been satisfied (and the Parent or the Purchaser has not waived such condition in accordance with the terms of this Agreement), and without limiting Purchaser&#146;s obligation to further extend the Offer until the earlier of the Outside Date or the termination of this Agreement pursuant to Section&nbsp;8.1, for one or more periods specified by the Purchaser (not in excess of ten (10)&nbsp;Business Days each, or for such longer period as the parties may agree in writing) in order to permit the satisfaction of such conditions to the Offer.&#160; Notwithstanding anything to the contrary herein, Purchaser shall not be required to, and without the Company&#146;s prior written consent shall not, extend the Offer beyond the Outside Date.&#160; Nothing in this Section&nbsp;1.1(b)(ii)&nbsp;shall be deemed to impair, limit or otherwise restrict in any manner the right of the Company, the Parent or the Purchaser to terminate this Agreement pursuant to Section&nbsp;8.1.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Schedule TO and Offer Documents</u>.&#160; On the date of commencement of the Offer, the Parent and the Purchaser shall file with the SEC a Tender Offer Statement on Schedule TO (together with all amendments and supplements thereto, the &#147;<u>Schedule TO</u>&#148;) with respect to the Offer.&#160; The Schedule TO shall contain an offer to purchase (the &#147;<u>Offer to Purchase</u>&#148;) and a form of the related letter of transmittal in customary form (the &#147;<u>Letter of Transmittal</u>&#148;), and ancillary documents and instruments pursuant to which the Offer will be made (collectively, together with any supplements or amendments thereto, the &#147;<u>Offer Documents</u>&#148;).&#160; The Parent and the Purchaser shall cause the Offer Documents (i)&nbsp;to comply as to form in all material respects with the requirements of applicable U.S. federal securities laws and (ii)&nbsp;on the date first filed with the SEC and on the date first published, sent or given to the holders of shares of Company</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_110414_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Common Stock, not to contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except that no covenant is made by the Parent or the Purchaser with respect to information supplied by or on behalf of the Company in writing specifically for inclusion in the Offer Documents.&#160; The Parent and the Purchaser shall take all steps necessary to cause the Offer Documents to be disseminated to holders of shares of Company Common Stock, as and to the extent required by applicable U.S. federal securities laws.&#160; Each of the Parent, the Purchaser and the Company shall promptly correct any information provided by it or on its behalf specifically for inclusion in the Schedule TO or the other Offer Documents if and to the extent that such information shall have become false or misleading in any material respect or as otherwise required by applicable law, and the Parent and the Purchaser shall take all steps necessary to amend or supplement the Schedule TO and, as applicable, the other Offer Documents and to cause the Schedule TO as so amended and supplemented to be filed with the SEC and the other Offer Documents as so amended and supplemented to be disseminated to holders of shares of Company Common Stock, in each case as and to the extent required by applicable U.S. federal securities laws.&#160; Except to the extent related to the Parent or the Purchaser&#146;s response to an Acquisition Proposal, a Trigger Event or a Recommendation Change Notice, the Company and its counsel shall be given reasonable opportunity to review and comment upon the Offer Documents and any amendments thereto prior to the filing thereof with the SEC or dissemination to the holders of shares of Company Common Stock.&#160; Except to the extent related to the Parent or the Purchaser&#146;s response to an Acquisition Proposal, a Trigger Event or a Recommendation Change Notice, the Parent and the Purchaser shall provide the Company and its counsel with a copy of any written comments or telephonic notification of any oral comments the Parent, the Purchaser or their counsel may receive from the SEC with respect to the Offer or any Offer Document promptly after the receipt thereof, shall consult with the Company and its counsel prior to responding to any such comments, and shall provide the Company and its counsel with a copy of any written responses thereto and telephonic notification of any oral responses thereto of the Parent or the Purchaser or their counsel.&#160; Subject to the foregoing, the Parent and the Purchaser shall use reasonable best efforts to respond to any such comments promptly after they are received.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Provision of Information for Schedule 14d-9</u>.&#160; Parent and Purchaser shall promptly supply to the Company in writing, for inclusion in the Schedule 14d-9, all information concerning Parent and the Purchaser required under applicable U.S. federal securities laws to be included in the Schedule 14d-9.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Provisions of Funds by the Parent</u>.&#160; The Parent shall deposit, or shall cause to be deposited, on behalf of the Purchaser, with the Paying Agent, prior to or promptly following the Acceptance Time (but in no event later than the earlier of (i)&nbsp;immediately prior to the Effective Time and (ii)&nbsp;the Business Day during which the Acceptance Time occurs or the immediately following Business Day if the Acceptance Time does not occur on a Business Day), all of the funds necessary to purchase any and all shares of Company Common Stock that the Purchaser becomes obligated to purchase pursuant to the Offer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination of Offer and Return of Tendered Shares</u>.&#160; Unless this Agreement is terminated pursuant to Section&nbsp;8.1, the Purchaser shall not terminate or withdraw the Offer prior to any scheduled expiration date without the prior written consent of the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="PB_4_110426_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-01.htm',USER='107541',CD='Feb 14 12:08 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company in its sole and absolute discretion.&#160; In the event this Agreement is terminated pursuant to Section&nbsp;8.1, the Purchaser shall promptly (and in any event within one (1)&nbsp;Business Day) following such termination terminate the Offer and shall not acquire any shares of Company Common Stock pursuant thereto.&#160; If the Offer is terminated in accordance with this Agreement prior to the Acceptance Time, the Purchaser shall promptly return, or cause any depositary acting on behalf of the Purchaser to return, all tendered shares of Company Common Stock to the tendering stockholders.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustments to Offer Price</u>.&#160; Subject to all limitations set forth in Section&nbsp;5.1 hereof, the Offer Price shall be adjusted to reflect fully the effect of any reclassification, stock split, reverse split, stock dividend (including any dividend or distribution of securities convertible into Company Common Stock), reorganization, recapitalization or other like change with respect to Company Common Stock occurring (or for which a record date is established)&nbsp;after the date hereof and prior to the Acceptance Time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Company Actions</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Approval and Consent</u>.&#160; The Company hereby approves of and consents to the Offer, the Merger and the other transactions contemplated by this Agreement and, subject to Section&nbsp;6.1 below, to the inclusion of the recommendation of the Company Board that the Company&#146;s stockholders accept the Offer and tender their shares of Company Common Stock to Purchaser pursuant to the Offer in the Offer Documents.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Schedule 14D-9</u>.&#160; On the date of the commencement of the Offer, concurrently with the filing of the Schedule TO, the Company shall file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the Offer (together with all amendments and supplements thereto, the &#147;<u>Schedule 14D-9</u>&#148;) that contains the fairness opinion of the Company&#146;s financial advisor referenced in Section&nbsp;3.18 and the notice and other information required by Section&nbsp;262(d)(2)&nbsp;of the DGCL, and disseminate the Schedule 14D-9, to the extent required by Rule&nbsp;14d-9 promulgated under the Exchange Act and any other applicable laws, to the holders of shares of Company Common Stock, including by setting the Stockholder List Date as the record date for the purpose of receiving the notice required by Section&nbsp;262(d)(2)&nbsp;of the DGCL.&#160; Except as permitted pursuant to, and in accordance with, Section&nbsp;6.1 below, the Offer Documents and the Schedule 14D-9 shall contain the recommendation of the Company Board that the Company&#146;s stockholders accept the Offer and tender all of their shares of Company Common Stock to the Purchaser pursuant to the Offer (the &#147;<u>Company Board Recommendation</u>&#148;).&#160; The Company shall cause the Schedule 14D-9 (i)&nbsp;to comply as to form in all material respects with the requirements of applicable U.S. federal securities laws and (ii)&nbsp;on the date first filed with the SEC and on the date first published, sent or given to the holders of shares of Company Common Stock, not to contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, except that no covenant is made by the Company with respect to information supplied by or on behalf of the Parent or the Purchaser in writing specifically for inclusion in the Schedule 14D-9.&#160; Each of the Company, the Parent and the Purchaser shall promptly correct any information provided by it or on its behalf specifically for inclusion in the Schedule 14D-9 if and to the extent that such information shall have become false or misleading in any material respect or as otherwise required by applicable law, and the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="PB_5_110917_8689"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='5',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company shall take all steps necessary to amend or supplement the Schedule 14D-9 and to cause the Schedule 14D-9 as so amended or supplemented to be filed with the SEC and disseminated to the holders of shares of Company Common Stock, in each case as and to the extent required by applicable U.S. federal securities laws.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Sharing of Materials and Information</u>.&#160; Except to the extent related to an Acquisition Proposal, a Trigger Event or a Recommendation Change Notice:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Parent and its counsel shall be given reasonable opportunity to review and comment upon the Schedule 14D-9 and any amendments thereto prior to the filing thereof with the SEC or dissemination to holders of shares of Company Common Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company shall provide the Parent and its counsel with a copy of any written comments or telephonic notification of any oral comments the Company or its counsel may receive from the SEC with respect to the Schedule 14D-9 promptly after the receipt thereof, shall consult with the Parent and its counsel prior to responding to any such comments, and shall provide the Parent and its counsel with a copy of any written responses thereto and telephonic notification of any oral responses thereto of the Company or its counsel.&#160; Subject to the foregoing, the Company shall use its reasonable best efforts to respond to any such comments promptly after they are received.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Provision of Information for Offer Documents</u>.&#160; The Company shall promptly supply to the Parent and the Purchaser in writing, for inclusion in the Offer Documents, all information in its possession or control concerning the Company and the holders of shares of Company Common Stock required under applicable U.S. federal securities laws to be included in the Offer Documents or reasonably requested in connection with any action contemplated by Section&nbsp;1.1(b), including communication of the Offer to the record and beneficial holders of shares of Company Common Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Stockholder Lists</u>.&#160; In connection with the Offer, the Company shall instruct its transfer agent to, and shall use its reasonable best efforts to cause its transfer agent to, promptly furnish to the Purchaser or its designated agent mailing labels containing the names and addresses of the record holders of the shares of Company Common Stock and any available listing containing the names and addresses of beneficial holders of shares of Company Common Stock, in each case, as of the most recent practicable date, and shall furnish to the Purchaser such information and assistance (including updated lists of the record and beneficial holders of shares of Company Common Stock, mailing labels and lists of security positions) as the Purchaser may reasonably request for the purpose of communicating the Offer to the holders of shares of Company Common Stock (the date of the list used by the Purchaser to determine the Persons to whom the Offer Documents and Schedule 14D-9 are first disseminated, the &#147;<u>Stockholder List Date</u>&#148;).&#160; Subject to the requirements of applicable laws and except for such steps as are necessary to disseminate the Offer Documents and any other documents necessary to consummate the Offer, the Merger and the other transactions contemplated by this Agreement, the Parent and the Purchaser shall, until consummation of the Offer, hold in confidence the information contained in any of such labels and lists in accordance with the Confidentiality Agreement, shall use such information only in connection with the Offer, the Merger and the other transactions contemplated by this Agreement and, if this Agreement shall be terminated in accordance with</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="PB_6_110928_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='6',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;8.1, shall destroy all electronic copies of such information and destroy or deliver to the Company all other copies of such information then in their possession or under their control.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;II</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">THE MERGER</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>The Merger; No Vote of Stockholders</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the DGCL, the Purchaser shall merge with and into the Company at the Effective Time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Merger shall be governed by and effected under Section&nbsp;251(h)&nbsp;of the DGCL. The parties shall take all necessary and appropriate actions to cause the Merger to become effective as soon as practicable following the Acceptance Time, without a vote of stockholders of the Company, in accordance with Section&nbsp;251(h)&nbsp;of the DGCL.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effective Time of the Merger</u>.&#160; Upon the terms and subject to the conditions set forth in this Agreement, on the Closing Date as soon as practicable after the Acceptance Time, Parent, Purchaser and the Company shall cause a certificate of merger or other appropriate documents (in any such case, the &#147;<u>Certificate of Merger</u>&#148;) to be duly prepared, executed and acknowledged in accordance with the relevant provisions of the DGCL and filed with the Secretary of State.&#160; The Merger shall become effective upon the due filing of the Certificate of Merger with the Secretary of State or at such subsequent time or date as the Parent and the Company shall, subject to Section&nbsp;2.1(b), agree and specify in the Certificate of Merger (the &#147;<u>Effective Time</u>&#148;).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Closing</u>.&#160; Subject to the satisfaction or waiver (to the extent permitted by law) of the conditions set forth in Article&nbsp;VII, the Closing shall take place at the offices of Wilmer Cutler Pickering Hale and Dorr LLP, 60 State Street, Boston, MA 02109 as soon as practicable following the Acceptance Time, which shall not be later than the Business Day following the day on which the last to be satisfied or waived of the conditions set forth in Article&nbsp;VII (other than those conditions that by their nature are to be satisfied at the Closing, but subject to the fulfillment or waiver of such conditions) shall be satisfied or waived in accordance with this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effects of the Merger</u>.&#160; At the Effective Time (a)&nbsp;the separate existence of the Purchaser shall cease, the Purchaser shall be merged with and into the Company and the Company shall continue as the Surviving Corporation in the Merger and (b)&nbsp;the certificate of incorporation of the Company as in effect immediately prior to the Effective Time shall be amended and restated in its entirety to read as set forth on <u>Exhibit&nbsp;A</u>, until further amended in accordance with the DGCL.&#160; In addition, subject to Section&nbsp;6.6(b)&nbsp;hereof, the Parent shall cause the bylaws of the Surviving Corporation to be amended and restated in their entirety so that, immediately following the Effective Time, they are identical to the bylaws of the Purchaser as in effect immediately prior to the Effective Time, except that all references to the name of the Purchaser therein shall be changed to refer to the name of the Company, and, as so amended and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="PB_7_110941_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='7',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">restated, such bylaws shall be the bylaws of the Surviving Corporation, until further amended in accordance with the DGCL.&#160; The Merger shall have the effects set forth in Section&nbsp;259 of the DGCL.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Directors and Officers of the Surviving Corporation</u>.&#160; The directors of the Purchaser immediately prior to the Effective Time shall be the initial directors of the Surviving Corporation, and the officers of the Company immediately prior to the Effective Time shall be the initial officers of the Surviving Corporation, in each case to hold office in accordance with the term of office set forth in certificate of incorporation and bylaws of the Surviving Corporation and until their successors are duly elected and qualified.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Conversion of Capital Stock</u>.&#160; As of the Effective Time, by virtue of the Merger and without any action on the part of the Company, the Purchaser, the Parent or the holder of any shares of the capital stock of the Company or capital stock of the Purchaser:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Capital Stock of the Purchaser</u>.&#160; Each share of the common stock, par value $0.01&nbsp;per share, of the Purchaser issued and outstanding immediately prior to the Effective Time shall be converted into and become one validly issued, fully paid and nonassessable share of common stock, par value $0.01&nbsp;per share, of the Surviving Corporation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Cancellation of Treasury Stock and Parent-Owned Stock;&#160; Converted Shares</u>.&#160; All shares of Company Common Stock&nbsp;that are held in the treasury of the Company and any shares of Company Common Stock owned by the Parent, the Purchaser or any other Subsidiary of the Parent immediately prior to the Effective Time shall be cancelled and shall cease to exist and no consideration shall be delivered in exchange therefor.&#160; Each share of Company Common Stock that is owned directly by any Subsidiary of the Company shall be converted into such number of shares of common stock of the Surviving Corporation so as to maintain relative ownership percentages.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Merger Consideration for Company Common Stock</u>.&#160; Subject to Section&nbsp;2.7, each share of Company Common Stock&nbsp;issued and outstanding immediately prior to the Effective Time (other than shares to be cancelled or converted in accordance with Section&nbsp;2.6(b)&nbsp;and Dissenting Shares) shall be automatically converted into the right to receive the Merger Consideration.&#160; As of the Effective Time, all such shares of Company Common Stock shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and each holder of a Certificate or Uncertificated Shares shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration pursuant to this Section&nbsp;2.6(c)&nbsp;in accordance with the provisions of Section&nbsp;2.7.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Adjustments to Merger Consideration</u>.&#160; Subject to the limitations set forth in Section&nbsp;5.1 below, the Merger Consideration shall be adjusted to reflect fully the effect of any reclassification, stock split, reverse split, stock dividend (including any dividend or distribution of securities convertible into Company Common Stock), reorganization, recapitalization or other like change with respect to Company Common Stock occurring (or for which a record date is established)&nbsp;after the date hereof and prior to the Effective Time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="PB_8_110954_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='8',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Surrender of Certificates</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Paying Agent</u>.&#160; Prior to the expiration of the Offer, Parent shall engage the Paying Agent.&#160; At, prior to or promptly following the Acceptance Time (but in no event later than the earlier of (i)&nbsp;immediately prior to the Effective Time and (ii)&nbsp;the Business Day during which the Acceptance Time occurs or the immediately following Business Day if the Acceptance Time does not occur on a Business Day), the Parent shall deposit with the Paying Agent, for the benefit of the holders of shares of Company Common Stock outstanding immediately prior to the Effective Time, for payment through the Paying Agent in accordance with this Section&nbsp;2.7, the Payment Fund.&#160; The Payment Fund shall not be used for any other purpose.&#160; The Payment Fund shall be invested by the Paying Agent as directed by the Parent; <u>provided</u>, <u>however</u>, that such investments shall be in obligations of or guaranteed by the United States of America, in commercial paper obligations rated A-1 or P-1 or better by Moody&#146;s Investors Service,&nbsp;Inc. or Standard&nbsp;&amp; Poor&#146;s Corporation, respectively, or in certificates of deposit, bank repurchase agreements or banker&#146;s acceptances of commercial banks with capital exceeding $10 billion (based on the most recent financial statements of such bank which are then publicly available); <u>provided</u>, <u>however</u>, that no gain or loss thereon shall affect the amounts payable hereunder and the Parent shall take all actions necessary to ensure that the Payment Fund includes at all times cash sufficient to satisfy the Parent&#146;s obligation to pay the Merger Consideration under this Agreement.&#160; Any interest and other income resulting from such investments (net of any losses) shall be paid to the Parent pursuant to Section&nbsp;2.7(e).&#160; In the event the Payment Fund is diminished below the level required for the Paying Agent to make prompt cash payments as required under Section&nbsp;2.7(b), including any such diminishment as a result of investment losses, the Parent shall, or shall cause the Surviving Corporation to, immediately deposit additional cash into the Payment Fund in an amount equal to the deficiency in the amount required to make such payments.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Exchange Procedures</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Promptly (and in any event within three (3)&nbsp;Business Days) after the Effective Time, the Parent shall cause the Paying Agent to mail to each holder of record of a Certificate (A)&nbsp;a letter of transmittal in customary form specifying that delivery shall be effected, and risk of loss and title to the Certificates shall pass, only upon delivery of the Certificates (or affidavits of loss in lieu thereof as provided in Section&nbsp;2.7(g)) to the Paying Agent, and (B)&nbsp;instructions for use in effecting the surrender of the Certificates (or affidavits of loss in lieu thereof as provided in Section&nbsp;2.7(g)) in exchange for the Merger Consideration payable with respect thereto.&#160; Upon surrender of a Certificate (or affidavit of loss in lieu thereof as provided in Section&nbsp;2.7(g)) to the Paying Agent in accordance with the terms of such letter of transmittal, duly executed, the holder of such Certificate shall be promptly paid in exchange therefor a cash amount in immediately available funds equal to (1)&nbsp;the number of shares of Company Common Stock formerly represented by such Certificate (or affidavit of loss in lieu thereof as provided in Section&nbsp;2.7(g)) multiplied by (2)&nbsp;the Merger Consideration, and the Certificate so surrendered shall forthwith be cancelled.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>With respect to Uncertificated Shares, the Parent and the Company shall cooperate to establish procedures with the Paying Agent and the holders of Uncertificated Shares to ensure that the Paying Agent will transmit to such holder or its nominees, upon</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="PB_9_111005_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='9',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">surrender of Uncertificated Shares held of record by such holder or its nominees in accordance with customary surrender procedures (including receipt by the Paying Agent of an &#147;agent&#146;s message&#148; in customary form and/or such other evidence, if any, of transfer as the Paying Agent may reasonably request), the Merger Consideration pursuant to and in accordance with the terms of this Agreement, and each such Uncertificated Share shall forthwith be cancelled.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Interest; Transfers; Rights Following the Effective Time</u>.&#160; No interest will be paid or accrued on the cash payable upon the surrender of such Certificates or Uncertificated Shares.&#160; If payment of the Merger Consideration is to be made to a Person other than the Person in whose name the surrendered Certificate is registered, it shall be a condition precedent of payment that (i)&nbsp;the Certificate so surrendered shall be properly endorsed or shall be otherwise in proper form for transfer and (ii)&nbsp;the Person requesting such payment shall have paid any transfer and other similar Taxes required by reason of the payment of the Merger Consideration to a Person other than the registered holder of the Certificate surrendered or shall have established to the satisfaction of the Parent that such Tax either has been paid or is not required to be paid.&#160; Payment of the Merger Consideration with respect to Uncertificated Shares shall only be made to the Person in whose name such Uncertificated Shares are registered.&#160; Until surrendered as contemplated by this Section&nbsp;2.7, each Certificate and all Uncertificated Shares (other than Certificates or Uncertificated Shares representing Dissenting Shares) shall be deemed at any time after the Effective Time to represent only the right to receive upon such surrender the Merger Consideration as contemplated by Section&nbsp;2.6(c), without any interest thereon.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Further Ownership Rights in Company Common Stock</u>.&#160; All Merger Consideration paid upon the surrender of Certificates and cancellation of Uncertificated Shares in accordance with the terms hereof shall be deemed to have been paid in satisfaction of all rights pertaining to the shares of Company Common Stock formerly represented by such Certificates and Uncertificated Shares, and from and after the Effective Time there shall be no further registration of transfers on the stock transfer books of the Surviving Corporation of the shares of Company Common Stock which were outstanding immediately prior to the Effective Time.&#160; If, after the Effective Time, Certificates or Uncertificated Shares are presented to the Surviving Corporation or the Paying Agent for any reason, they shall be cancelled and exchanged as provided in this Article&nbsp;II, subject to Section&nbsp;2.7(e).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination of Payment Fund</u>.&#160; Any portion of the Payment Fund which remains undistributed to the holders of Certificates and Uncertificated Shares for one year after the Effective Time (including all interest and other income received by the Paying Agent in respect of all funds made available to it) shall be delivered to the Parent, upon demand, and any holder of a Certificate or Uncertificated Shares who has not previously complied with this Section&nbsp;2.7 shall be entitled to receive only from the Parent or the Surviving Corporation (subject to abandoned property, escheat and other similar laws) payment of its claim for Merger Consideration, without interest.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Liability</u>.&#160; To the extent permitted by applicable law, none of the Parent, the Purchaser, the Company, the Surviving Corporation or the Paying Agent shall be liable to any holder of shares of Company Common Stock for any amount required to be delivered to a public official pursuant to any applicable abandoned property, escheat or similar law.&#160; If any Certificates or Uncertificated Shares shall not have been surrendered prior to the date</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="PB_10_111016_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='10',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">on which the related Merger Consideration would escheat to or become the property of any governmental authority, any such Merger Consideration shall, to the extent permitted by applicable law, immediately prior to such time become the property of Parent, free and clear of all claims or interest of any Person previously entitled thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Lost Certificates</u>.&#160; If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such Certificate to be lost, stolen or destroyed, and, if reasonably required by the Parent, the posting by such Person of a bond in such reasonable and customary amount as the Parent may direct as indemnity against any claim that may be made against it with respect to such Certificate, the Paying Agent shall pay, in exchange for such lost, stolen or destroyed Certificate, the Merger Consideration to be paid in respect of the shares of Company Common Stock formerly represented thereby pursuant to this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Company Stock Plans</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Effective as of immediately prior to the Effective Time, each then-outstanding and unexercised Company Stock Option shall vest in full and automatically be canceled and converted into the right to receive an amount of cash from the Surviving Corporation equal to the product of (i)&nbsp;the total number of shares of Company Common Stock then underlying such Company Stock Option multiplied by (ii)&nbsp;the excess, if any, of the Merger Consideration over the exercise price per share of such Company Stock Option, without any interest thereon and subject to all applicable withholding.&#160; In the event that the exercise price of any such Company Stock Option is equal to or greater than the Merger Consideration, such Company Stock Option shall be cancelled, without any consideration being payable in respect thereof, and have no further force or effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Effective as of immediately prior to the Effective Time, each Company RSU that is then outstanding and unvested shall vest in full and automatically be canceled and converted into the right to receive an amount of cash from the Surviving Corporation equal to the product of (i)&nbsp;the total number of shares of Company Common Stock then underlying such Company RSU multiplied by (ii)&nbsp;the Merger Consideration, without any interest thereon and subject to all applicable withholding.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Effective as of immediately prior to the Effective Time, each Company PSU that is then-outstanding and unvested shall vest with respect to the maximum number of shares of Company Common Stock that could be earned thereunder and automatically be canceled and converted into the right to receive an amount of cash from the Surviving Corporation equal to the product of (i)&nbsp;the maximum number of shares of Company Common Stock then underlying such Company PSU multiplied by (ii)&nbsp;the Merger Consideration, without any interest thereon and subject to all applicable withholding.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Prior to the Effective Time, the Company shall pass resolutions and take such other actions as are necessary to provide for the treatment of the Company Stock Options, Company RSUs and Company PSUs as contemplated by this Section&nbsp;2.8.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="PB_11_111028_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='11',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Parent shall cause the Surviving Corporation to make the payments contemplated by the foregoing Section&nbsp;2.8(a), Section&nbsp;2.8(b)&nbsp;and Section&nbsp;2.8(c)&nbsp;as promptly as practicable (and in any event within five (5)&nbsp;Business Days) after the Effective Time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As soon as practicable following the execution of this Agreement, the Company shall mail to each Person who is a holder of Company Stock Options, Company RSUs or Company PSUs a letter describing the treatment of and payment for such equity awards pursuant to this Section&nbsp;2.8 and providing instructions for use in obtaining payment therefor.&#160; The Company shall provide Parent with a reasonable opportunity to review the notices described in this Section&nbsp;2.8(f)&nbsp;reasonably in advance of providing said notices and the Company shall consider in good faith any reasonable comments provided by Parent to the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Parent and the Company may agree to treat equity compensation held by Company employees subject to non-U.S. law in a manner other than that contemplated above in this Section&nbsp;2.8 to the extent necessary to take into account applicable non-U.S. law or Tax or employment considerations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Dissenting Shares</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding anything to the contrary contained in this Agreement, Dissenting Shares shall not be converted into or represent the right to receive the Merger Consideration in accordance with Section&nbsp;2.6, but shall be entitled only to such rights as are granted by the DGCL to a holder of Dissenting Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any Dissenting Shares shall lose their status as such (through failure to perfect or otherwise), then, as of the later of the Effective Time or the date of loss of such status, such shares shall thereupon be deemed to have been converted as of the Effective Time into the right to receive the Merger Consideration in accordance with Section&nbsp;2.6, without interest, and shall not thereafter be deemed to be Dissenting Shares.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company shall give the Parent:&#160; (i)&nbsp;prompt notice of any written demand for appraisal received by the Company prior to the Effective Time pursuant to the DGCL, any withdrawal of any such demand and any other demand, notice or instrument delivered to the Company prior to the Effective Time pursuant to the DGCL that relates to such demand; and (ii)&nbsp;the opportunity to participate in and direct all negotiations and proceedings with respect to any such demand, notice or instrument.&#160; The Company shall not settle or pay or make any payment or settlement offer with respect to any such demand, notice or instrument or agree to do any of the foregoing unless the Parent shall have given its written consent to such settlement, payment or settlement or payment offer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Withholding Rights</u>.&#160; Each of the Parent, the Purchaser, the Company, the Surviving Corporation and the Paying Agent shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement to any holder of shares of Company Common Stock or any other recipient of payments hereunder any amounts as it is required to deduct and withhold with respect to the making of such payment under the Code, or any other applicable state, local or foreign Tax law.&#160; To the extent that amounts are so withheld and timely remitted by the Parent, the Purchaser, the Company, the Surviving Corporation or the Paying</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="PB_12_111038_7906"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='12',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agent, as the case may be, to the applicable Governmental Entity, such amounts&nbsp;shall be treated for all purposes of this Agreement as having been paid to the holder or other recipient in respect of which such deduction and withholding was made.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;III</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">REPRESENTATIONS AND WARRANTIES OF THE COMPANY</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company represents and warrants to the Parent and the Purchaser that the statements contained in this Article&nbsp;III are true and correct, except (a)&nbsp;as disclosed in the Company SEC Reports filed with or furnished to the SEC since January&nbsp;1, 2015 and prior to the date of this Agreement and publicly available prior to the date of this Agreement (but excluding any predictive, cautionary or forward looking disclosures contained under the captions &#147;Risk Factors&#148;, &#147;Forward Looking Statements&#148; or any similar predictive, cautionary or forward looking sections) or (b)&nbsp;as set forth in the Company Disclosure Schedule, subject to Section&nbsp;10.12.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Organization, Standing and Power</u>.&#160; The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware.&#160; The Company has all requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted and is duly qualified to do business and, where applicable as a legal concept, is in good standing as a foreign corporation in each jurisdiction in which the character of the properties it owns, operates or leases or the nature of its activities makes such qualification legally required, except for such failures to have such power and authority or to be so qualified or in good standing, individually or in the aggregate, that has not had and would not be reasonably likely to have a Company Material Adverse Effect and would not reasonably be expected to prevent, or materially impair or delay, the ability of the Company to consummate the Offer or the Merger.&#160; The Company has publicly filed correct and complete copies of the Company&#146;s certificate of incorporation and bylaws (and all amendments thereto) as in effect on the date of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Capitalization</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The authorized capital stock of the Company as of the date of this Agreement consists of 61,500,000&nbsp;shares of Company Common Stock and 5,000,000 shares of preferred stock, par value $0.001 per share (the &#147;<u>Company Preferred Stock</u>&#148;).&#160; The Company Common Stock and the Company Preferred Stock are entitled to the rights and privileges set forth in the Company&#146;s certificate of incorporation.&#160; As of the Capitalization Date, (i)&nbsp;23,771,337<b>&nbsp;</b>shares of Company Common Stock were issued and outstanding (not including shares held in treasury), (ii)&nbsp;1,628,586 shares of Company Common Stock were held in treasury, (iii)&nbsp;no shares of Company Preferred Stock were issued or outstanding, (iv)&nbsp;870,477&nbsp;shares of Company Common Stock were underlying outstanding Company Stock Options and the Company Stock Options had a weighted average exercise price of $26.21, (v)&nbsp;420,405<b>&nbsp;</b>shares of Company Common Stock were underlying outstanding Company RSUs, (vi)&nbsp;165,635<b>&nbsp;</b>shares of Company Common Stock were underlying outstanding Company PSUs (assuming applicable performance criteria were deemed satisfied at target performance), and (vii)&nbsp;268,377<b>&nbsp;</b>shares of</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">13<a name="PB_13_111048_3736"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='13',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Common Stock were underlying outstanding Company PSUs (assuming applicable performance criteria were deemed satisfied at maximum performance).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company has made available to the Parent a complete and accurate list, as of the Capitalization Date, of all Company Stock Plans, indicating for each Company Stock Plan, as of such date, the number of shares of Company Common Stock reserved for future issuance under such Company Stock Plan.&#160; The Company has made available to the Parent complete and accurate copies of all (i)&nbsp;Company Stock Plans, (ii)&nbsp;forms of stock option agreements evidencing Company Stock Options, (iii)&nbsp;forms of agreements evidencing Company RSUs and Company PSUs and (iv)&nbsp;forms of agreements evidencing any other equity or equity-linked award or compensation arrangement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except (i)&nbsp;as set forth in Section&nbsp;3.2(a)&nbsp;and for changes since the Capitalization Date resulting from the exercise or settlement of Company Stock Options, Company RSUs or Company PSUs outstanding on such date in accordance with their respective terms, and (ii)&nbsp;grants of equity awards since the date of this Agreement permitted under Section&nbsp;5.1(j), (A)&nbsp;there are no equity securities of any class of the Company, or any security exchangeable into or exercisable for such equity securities, issued, reserved for issuance (other than pursuant to the Company Stock Plans made available to the Parent) or outstanding and (B)&nbsp;there are no options, warrants, equity securities, calls, rights or agreements to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries is bound obligating the Company or any of its Subsidiaries to issue, exchange, transfer, deliver or sell, or cause to be issued, exchanged, transferred, delivered or sold, additional shares of capital stock or other equity interests of the Company or any security or rights convertible into or exchangeable or exercisable for any such shares or other equity interests, or obligating the Company or any of its Subsidiaries to grant, extend, accelerate the vesting of, otherwise modify or amend or enter into any such option, warrant, equity security, call, right or agreement.&#160; The Company does not have any outstanding stock appreciation rights, phantom stock or similar rights or obligations.&#160; Neither the Company nor any of its Subsidiaries nor, to the Company&#146;s Knowledge, any of its Affiliates is a party to or is bound by any agreement with respect to the voting (including proxies)&nbsp;or sale or transfer of any shares of capital stock or other equity interests of the Company.&#160; There are no registration rights, and there is no rights agreement, &#147;poison pill&#148; anti-takeover plan or other similar agreement to which the Company or any of its Subsidiaries is a party or by which it or they are bound with respect to any equity security of any class of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All outstanding shares of Company Common Stock are, and all shares of Company Common Stock subject to issuance as specified in Section&nbsp;3.2(b)&nbsp;above, upon issuance on the terms and conditions specified in the instruments pursuant to which they are issuable, will be, duly authorized, validly issued, fully paid and nonassessable and not subject to or issued in violation of any purchase option, call option, right of first refusal, preemptive right, subscription right or any similar right under any provision of the DGCL, the Company&#146;s certificate of incorporation or bylaws or any agreement to which the Company is a party or is otherwise bound.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">14<a name="PB_14_111059_9621"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='14',FILE='C:\JMS\107541\17-4436-1\task8277066\4436-1-kc-03.htm',USER='107541',CD='Feb 14 12:15 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There are no obligations, contingent or otherwise, of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire, or to register, any shares of Company Common Stock or the capital stock of the Company or any of its Subsidiaries.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Subsidiaries</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.3 of the Company Disclosure Schedule sets forth, as of the date of this Agreement, for each Subsidiary of the Company: (i)&nbsp;its name; (ii)&nbsp;the number and type of its outstanding equity securities and a list of the holders thereof; and (iii)&nbsp;its jurisdiction of organization.&#160; All of the issued and outstanding shares of capital stock of, or other equity securities in, each Subsidiary of the Company (x)&nbsp;have been duly authorized and validly issued and are fully paid and nonassessable and not subject to or issued in violation of any purchase option, call option, right of first refusal, preemptive right, subscription right or any similar right and (y)&nbsp;except as set forth in Section&nbsp;3.3 of the Company Disclosure Schedule, are owned, directly or indirectly, by the Company free and clear of all Liens.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Subsidiary of the Company is an entity duly organized, validly existing and in good standing (to the extent such concepts are applicable)&nbsp;under the laws of the jurisdiction of its incorporation, has all requisite corporate (or similar, in the case of a non-corporate entity) power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted, and is duly qualified to do business and is in good standing as a foreign corporation (to the extent such concepts are applicable)&nbsp;in each jurisdiction where the character of its properties owned, operated or leased or the nature of its activities makes such qualification necessary, except for such failures to be so organized, qualified or in good standing, individually or in the aggregate, that have not had and would not be reasonably likely to have a Company Material Adverse Effect.&#160; The Company has made available to Parent true, correct and complete copies of the certificate of incorporation and bylaws (or comparable organizational documents) of each Subsidiary of the Company (and all amendments thereto) as currently in effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company does not own or control, directly or indirectly, any capital stock of any Person that is not a Subsidiary of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Authority; No Conflict; Required Filings and Consents</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company has all requisite corporate power and authority to enter into this Agreement, perform its obligations hereunder and, assuming that the Merger will be consummated in accordance with Section&nbsp;251(h)&nbsp;of the DGCL, consummate the Merger.&#160; The Company Board, at a meeting duly called and held, by the unanimous vote of all directors, duly adopted resolutions (i)&nbsp;approving the execution and delivery by the Company of this Agreement and declaring the advisability of this Agreement, the Merger, the Offer and the other transactions contemplated by this Agreement, (ii)&nbsp;declaring that it is in the best interests of the Company and the stockholders of the Company that the Company enter into this Agreement and consummate the Merger and that the stockholders of the Company accept the Offer and tender their shares of Company Common Stock pursuant to the Offer, in each case on the terms and subject to the conditions set forth herein, (iii)&nbsp;declaring that the terms of the Offer and the Merger are fair to the Company and the Company&#146;s stockholders, (iv)&nbsp;recommending that the stockholders of the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">15<a name="PB_15_105219_6022"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='15',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company accept the Offer and tender their shares of Company Common Stock to Purchaser pursuant to the Offer and (v)&nbsp;subject to the accuracy of the Parent&#146;s and the Purchaser&#146;s representation and warranty set forth in Section&nbsp;4.6 hereof, approved the Parent, the Purchaser and their respective Affiliates and this Agreement and the transactions contemplated hereby (including the Offer and the Merger) in order to render the restrictions on business combinations set forth in Section&nbsp;203 of the DGCL to be inapplicable to the Parent, the Purchaser and their respective Affiliates and this Agreement and the transactions contemplated hereby (including the Offer and the Merger).&#160; Assuming the accuracy of the representations and warranties of the Parent and the Purchaser in Section&nbsp;4.6 and that the Merger will be consummated in accordance with Section&nbsp;251(h)&nbsp;of the DGCL, the execution and delivery of this Agreement and the consummation of the transactions contemplated by this Agreement by the Company have been duly authorized by all necessary corporate action on the part of the Company.&#160; This Agreement has been duly executed and delivered by the Company and constitutes the valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors&#146; rights and to general equity principles (the &#147;<u>Bankruptcy and Equity Exception</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The execution and delivery of this Agreement by the Company do not, and (assuming that the Merger will be consummated in accordance with Section&nbsp;251(h)&nbsp;of the DGCL) the consummation by the Company of the transactions contemplated by this Agreement shall not, (i)&nbsp;conflict with, or result in any violation or breach of, any provision of the certificate of incorporation or bylaws of the Company or any Subsidiary of the Company, (ii)&nbsp;conflict with, or result in any violation or breach of, or constitute a default (with or without notice or lapse of time, or both) (or give rise to a right of termination, cancellation or acceleration of any obligation or loss of any material benefit) under, or require a consent or waiver under, or result (or, with or without notice or lapse of time, or both, would result) in the creation or imposition of any Lien on any asset, property or right of the Company or any of its Subsidiaries under, any of the terms, conditions or provisions of any Contract to which the Company or any of its Subsidiaries is a party or by which any of them or any of their properties, rights or assets may be bound, or (iii)&nbsp;subject to compliance with the requirements specified in clauses (i)&nbsp;through (v)&nbsp;of Section&nbsp;3.4(c), conflict with or violate any permit, concession, franchise, license, judgment, injunction, order, decree, statute, law, ordinance, rule&nbsp;or regulation applicable to the Company or any of its Subsidiaries or any of its or their respective properties, rights or assets, except in the case of clauses (ii)&nbsp;and (iii)&nbsp;of this Section&nbsp;3.4(b)&nbsp;for any such conflicts, violations, breaches, defaults, terminations, cancellations, accelerations, losses, penalties or Liens, and for any consents or waivers not obtained, that, individually or in the aggregate, have not had and would not be reasonably likely to have a Company Material Adverse Effect and would not reasonably be expected to prevent, or materially impair or delay, the ability of the Company to consummate the Offer&#160; or the Merger (provided that, with respect to clause (ii)&nbsp;only, the existence of a change of control or similar provision in and of itself (and not the consequences of failing to satisfy such provision) shall not be deemed to prevent, or materially impair or delay, the ability of the Company to consummate the Offer or the Merger).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No consent, approval, license, permit, order or authorization of, or registration, declaration, notice or filing with, any Governmental Entity or any stock market or stock exchange on which shares of Company Common Stock are listed for trading is required by</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">16<a name="PB_16_105239_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='16',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">or with respect to the Company or any of its Subsidiaries in connection with the execution and delivery of this Agreement by the Company or the consummation by the Company of the transactions contemplated by this Agreement, except for (i)&nbsp;the pre-merger notification requirements under the HSR Act, and any other applicable Antitrust Laws, (ii)&nbsp;the filing of the Certificate of Merger with the Secretary of State and appropriate corresponding documents with the appropriate authorities of other states in which the Company is qualified as a foreign corporation to transact business, (iii)&nbsp;the filing of the Offer Documents and the Schedule 14D-9 with the SEC in accordance with the Exchange Act, (iv)&nbsp;the filing of such reports, schedules or materials under the Exchange Act as may be required in connection with this Agreement and the transactions contemplated hereby, (v)&nbsp;such consents, approvals, orders, authorizations, registrations, declarations, notices and filings as may be required under applicable state securities laws, the rules&nbsp;and regulations of the Nasdaq Stock Market, and (vi)&nbsp;such other consents, approvals, licenses, permits, orders, authorizations, registrations, declarations, notices and filings which, if not obtained or made, individually or in the aggregate, would not be reasonably likely to have a Company Material Adverse Effect and would not reasonably be expected to prevent, or materially impair or delay, the ability of the Company to consummate the Offer or the Merger.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Assuming the accuracy of the Parent&#146;s and the Purchaser&#146;s representation and warranty set forth in Section&nbsp;4.6 and that the Merger will be consummated in accordance with Section&nbsp;251(h)&nbsp;of the DGCL, no vote of the holders of any class or series of the Company&#146;s capital stock or other securities is necessary for the adoption of this Agreement or for the consummation by the Company of the Merger.&#160; There are no bonds, debentures, notes or other indebtedness of the Company having the right to vote (or convertible into, or exchangeable for, securities having the right to vote) on any matters on which stockholders of the Company may vote.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Compensation Committee of the Company Board, or a committee of the Company Board consisting solely of independent directors (as defined in the Nasdaq Marketplace Rules), has taken, at a duly convened meeting thereof, all such actions as may be required to cause to be exempted under Rule&nbsp;14d-10(d)(2)&nbsp;under the Exchange Act any and all employment compensation, severance and employee benefit agreements and arrangements (including the transactions contemplated hereby) that have been entered into or granted by the Company or any of its Subsidiaries with or to directors, officers, or employees of the Company or any of its Subsidiaries, and to cause such agreements and arrangements to satisfy the non-exclusive safe harbor provisions of Rule&nbsp;14d-10(d)(2)&nbsp;under the Exchange Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>SEC Filings; Financial Statements; Information Provided</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company has filed all registration statements, forms, reports and other documents required to be filed by the Company with the SEC since January&nbsp;1, 2015.&#160; All such registration statements, forms, reports and other documents (including exhibits, all other information incorporated therein and any supplements or amendments thereto and those registration statements, forms, reports and other documents that the Company may file after the date hereof until the Closing)&nbsp;are referred to herein as the &#147;<u>Company SEC Reports</u>.&#148;&#160; The Company SEC Reports (i)&nbsp;were or will be filed on a timely basis, (ii)&nbsp;at the time filed, complied, or will comply when filed, as to form in all material respects with the requirements of the Securities Act and the Exchange Act applicable to such Company SEC Reports and (iii)&nbsp;except</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">17<a name="PB_17_105302_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='17',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">to the extent that information contained in a Company SEC Report has been revised, amended, modified or superseded by a later filed Company SEC Report prior to the date hereof, did not or will not at the time they were or are filed contain any untrue statement of a material fact or omit to state a material fact required to be stated in such Company SEC Reports or necessary in order to make the statements in such Company SEC Reports, in the light of the circumstances under which they were made, not misleading.&#160; The Company has not as of the date hereof received any written comments from the SEC with respect to any of the Company SEC Reports which remain unresolved.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each of the consolidated financial statements (including, in each case, any related notes and schedules)&nbsp;contained or to be contained in the Company SEC Reports at the time filed (i)&nbsp;complied or will comply as to form in all material respects with applicable accounting requirements and the published rules&nbsp;and regulations of the SEC with respect thereto, (ii)&nbsp;were or will be prepared in accordance with GAAP&nbsp;applied on a consistent basis throughout the periods involved (except as may be indicated in the notes to such financial statements or, in the case of unaudited interim financial statements, as permitted by the SEC on Form&nbsp;10-Q under the Exchange Act), and (iii)&nbsp;fairly presented or will fairly present in all material respects the consolidated financial position of the Company and its Subsidiaries as of the dates indicated and the consolidated results of its operations and cash flows for the periods indicated, except that the unaudited interim financial statements were or are subject to normal and recurring year-end audit adjustments.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The information to be supplied by or on behalf of the Company for inclusion in the Schedule TO or the Offer Documents, on the date the Schedule TO is filed with the SEC, on the date of any amendment or supplement thereto and on the date the Offer Documents are first published, sent or given to holders of shares of Company Common Stock, shall not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances in which they shall be made, not misleading.&#160; On the date the Schedule 14D-9 is filed with the SEC, on the date of any amendment or supplement thereto and on the date the Schedule 14D-9 is first published, sent or given to holders of shares of Company Common Stock, the Schedule 14D-9 (a)&nbsp;will comply as to form in all material respects with the requirements of the Exchange Act and (b)&nbsp;will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they are made, not misleading.&#160; Notwithstanding the foregoing provisions of this Section&nbsp;3.5(c), no representation or warranty is made by the Company with respect to information or statements made or incorporated by reference in the Schedule 14D-9 based upon information supplied by the Parent, the Purchaser or any of their respective Representatives expressly for use or incorporation by reference therein.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act.&#160; Each required form, report and document containing financial statements that has been filed with or submitted to the SEC was accompanied by any certifications required to be filed or submitted by the Company&#146;s principal executive officer and principal financial officer pursuant to the Sarbanes-Oxley Act and, at the time of filing or submission of each such certification, any such certification complied in all material respects with the applicable provisions of the Sarbanes-Oxley Act.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">18<a name="PB_18_105331_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='18',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company maintains disclosure controls and procedures required by Rule&nbsp;13a-15 or 15d-15 under the Exchange Act.&#160; Such disclosure controls and procedures are designed to provide reasonable assurance that all information concerning the Company that could have a material effect on the financial statements is made known on a timely basis to the individuals responsible for the preparation of the Company&#146;s filings with the SEC and other public disclosure documents.&#160; The Company has established and maintained a system of internal control over financial reporting (as defined in Rule&nbsp;13a-15 under the Exchange Act).&#160; Such internal controls are designed to provide reasonable assurance regarding the reliability of the Company&#146;s financial reporting and the preparation of Company financial statements for external purposes in accordance with GAAP.&#160; The Company&#146;s principal executive officer and its principal financial officer have disclosed, based on the most recent evaluation of internal control over financial reporting prior to the date of this Agreement, to the Company&#146;s auditors and the audit committee of the Company Board (and made available to Parent a summary of the significant aspects of such disclosure, if any) (i)&nbsp;all known significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting that are reasonably likely to adversely affect in any material respect the Company&#146;s ability to record, process, summarize and report financial information, and (ii)&nbsp;any known fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal control over financial reporting.&#160; The Company is in compliance in all material respects with the applicable listing and other rules&nbsp;and regulations of the Nasdaq Stock Market.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company is not subject to any &#147;Off-Balance Sheet Arrangement&#148; (as defined in Item 303(a)&nbsp;of Regulation S-K under the Securities Act).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Undisclosed Liabilities</u>.&#160; Except (a)&nbsp;as disclosed in the Company Balance Sheet, (b)&nbsp;for performance of obligations in the Ordinary Course of Business under Contracts binding upon the Company or any of its Subsidiaries (other than resulting from any breach or acceleration thereof) made available to Parent prior to the date of this Agreement and (c)&nbsp;for liabilities incurred in the Ordinary Course of Business since the date of the Company Balance Sheet, the Company and its Subsidiaries do not have any liabilities of any nature that, individually or in the aggregate, have had or would be reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Absence of Certain Changes or Events</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Since December&nbsp;31, 2015, there has not been a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From the date of the Company Balance Sheet until the date of this Agreement, except for the transactions contemplated by this Agreement and discussions, negotiations and transactions related hereto, (i)&nbsp;the business of the Company and its Subsidiaries, taken as a whole, has been conducted in the Ordinary Course of Business and (ii)&nbsp;none of the Company or any of its Subsidiaries has taken any action that would have required the consent of the Parent under Section&nbsp;5.1 of this Agreement (other than paragraphs&nbsp;(b), (h)&nbsp;and (j)&nbsp;of Section&nbsp;5.1 and paragraph (o)&nbsp;of Section&nbsp;5.1 as it relates to paragraphs (b), (h)&nbsp;and (j)&nbsp;of Section&nbsp;5.1) had such action or event occurred after the date of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">19<a name="PB_19_105356_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='19',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Taxes</u>.&#160; Except for matters that, individually or in the aggregate, have not had and would not be reasonably likely to have a Company Material Adverse Effect:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and each of its Subsidiaries has filed all Tax Returns that it was required to file, and all such Tax Returns were correct and complete.&#160; The Company and each of its Subsidiaries has paid (or caused to be paid) on a timely basis all Taxes due and owing by the Company and/or its Subsidiaries, other than Taxes that are being contested in good faith through appropriate proceedings and for which the most recent financial statements contained in the Company SEC Reports reflect an adequate reserve in accordance with GAAP.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>As of the date of this Agreement, no examination or audit of any Tax Return, or other action or proceeding in respect of any Tax, of the Company or any of its Subsidiaries by any Governmental Entity is currently in progress or has been proposed in writing, nor has any written adjustment with respect to any Tax Return or written claim for any additional Tax been received from a Governmental Entity by the Company or any of its Subsidiaries that is still in progress.&#160; There are no Liens for Taxes on any of the assets or properties of the Company or any of its Subsidiaries.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and its Subsidiaries have complied with applicable laws for the withholding of Taxes and have timely withheld and paid over to the appropriate Governmental Entity all amounts of Taxes required to be withheld and paid over.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>There is no outstanding waiver or extension of any applicable statute of limitations for the assessment or collection of Taxes from the Company or any of its Subsidiaries.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither the Company nor any of its Subsidiaries&nbsp;has any liability for any Taxes of any Person (other than the Company and its Subsidiaries)&nbsp;(i)&nbsp;under Treasury Regulation Section&nbsp;1.1502-6 (or any similar provision of Tax law in any jurisdiction) or as a transferee or successor, or (ii)&nbsp;pursuant to any Tax sharing or Tax indemnification agreement or other similar agreement (other than pursuant to commercial agreements or arrangements that are not primarily related to Taxes).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No closing agreements, private letter rulings or similar agreements or rulings have been entered into or issued by any Governmental Entity responsible for Taxes within the last five years with respect to the Company or any of its Subsidiaries, and no such agreements or rulings have been applied for by the Company or any of its Subsidiaries that are currently pending.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither the Company nor any of its Subsidiaries has entered into any &#147;listed transaction&#148; within the meaning of Treasury Regulation Section&nbsp;1.6011-4(b)(2).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither the Company nor any of its Subsidiaries constituted a &#147;distributing corporation&#148; or a &#147;controlled corporation&#148; (within the meaning of Section&nbsp;355(a)(1)(A)&nbsp;of the Code) in a distribution of stock intended to qualify for tax-free treatment under Section&nbsp;355 of the Code (or any similar provision of state, local or non-U.S. law) in the two (2)&nbsp;years prior to the date hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">20<a name="PB_20_105426_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='20',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No claim has been made in writing prior to the date of this Agreement by a Governmental Entity in a jurisdiction where the Company does not file Tax Returns that it is or may be subject to taxation by that jurisdiction.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company will not be required to include any item of income in, or to exclude any item of deductions from, taxable income from any taxable period (or portion thereof) ending after the Closing as a result of any (i)&nbsp;change in the method of accounting or (ii)&nbsp;closing agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Real Property</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither the Company nor any of its Subsidiaries owns any real property.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.9(b)&nbsp;of the Company Disclosure Schedule sets forth a complete and accurate list as of the date of this Agreement of all Company Leases&nbsp;and the location of the premises subject thereto.&#160; Except as, individually or in the aggregate, has not had and would not be reasonably likely to have a Company Material Adverse Effect (i)&nbsp;each Company Lease is in full force and effect except to the extent it has previously expired in accordance with its terms, (ii)&nbsp;neither the Company nor any of its Subsidiaries nor, to the Company&#146;s Knowledge, any other party to any Company Lease is in default under any of the Company Leases, (iii)&nbsp;neither the Company nor any of its Subsidiaries has received any written notice regarding any violation or breach or default under any Company Lease that has not been cured and (iv)&nbsp;the Company and its Subsidiaries hold a valid and existing leasehold interest in the real property covered under the Company Leases, free and clear of all Liens.&#160; Neither the Company nor any of its Subsidiaries leases, subleases or licenses any real property to any Person other than the Company and its Subsidiaries.&#160; The Company has made available to the Parent complete and accurate copies of all Company Leases.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Intellectual Property</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.10(a)&nbsp;of the Company Disclosure Schedule sets forth a true, correct and complete list of (i)&nbsp;the current owner of, (ii)&nbsp;the jurisdiction of application/registration for and (iii)&nbsp;the application or registration number for, each item of registered material Company Intellectual Property.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.10(b)&nbsp;of the Company Disclosure Schedule sets forth a true correct and complete list as of the date of this Agreement of&nbsp;all agreements under which the Company or any of its Subsidiaries licenses or sublicenses from any other Person or has licensed or sublicensed to any other Person the right to use any material Company Intellectual Property Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as, individually or in the aggregate, has not had and would not be reasonably likely to have a Company Material Adverse Effect, the Company and its Subsidiaries (i)&nbsp;exclusively own all right, title and interest in and to all Intellectual Property owned or purported to be owned by the Company or any of its Subsidiaries and (ii)&nbsp;hold a valid and enforceable license or sublicense to use all Intellectual Property licensed or sublicensed or purported to be licensed or sublicensed by the Company or any of its Subsidiaries.&#160; Except as, individually or in the aggregate, has not had and would not be reasonably likely to have a</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">21<a name="PB_21_105452_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='21',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Material Adverse Effect, the Company and its Subsidiaries own, or hold a valid and enforceable written license or other right to use, all Intellectual Property used in or held for use in the conduct of the Company&#146;s business as currently conducted.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All issued patents and registrations for trademarks, service marks and copyrights included in the Company Intellectual Property are subsisting and have not expired or been cancelled.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The conduct of the business of the Company and its Subsidiaries, as currently conducted and as conducted in the past three (3)&nbsp;years), does not (and did not) infringe, violate or constitute a misappropriation of any Intellectual Property of any third party, except for such infringements, violations and misappropriations that, individually or in the aggregate, have not had and would not be reasonably likely to have a Company Material Adverse Effect.&#160; There are no claims with respect to the Company Intellectual Property pending as of the date of this Agreement and, to the Company&#146;s Knowledge, between January&nbsp;1, 2014 and the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written claim or notice from any Person (i)&nbsp;alleging any such infringement, violation or misappropriation or (ii)&nbsp;advising that such Person is challenging or threatening to challenge the ownership, use, validity or enforceability of any Company Intellectual Property, except, in each case in clauses (i)&nbsp;and (ii), for any such infringement, violation, misappropriation or challenge that, individually or in the aggregate, has not had and would not be reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and its Subsidiaries have implemented commercially reasonable measures to maintain the confidentiality of the Company Intellectual Property of a nature that the Company intends to keep confidential.&#160; Each employee who is or was involved in the creation or development of any material Company Intellectual Property which is owned or purported to be owned by the Company or any of its Subsidiaries has signed a valid, enforceable agreement containing an assignment of the applicable Intellectual Property to the Company or a Subsidiary of the Company and reasonable confidentiality provisions protecting such Company Intellectual Property which, to the Company&#146;s Knowledge, has not been breached by such Person, except for breaches that, individually or in the aggregate, have not had and would not be reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>To the Company&#146;s Knowledge, no third party is infringing, violating or misappropriating any of the Company Intellectual Property (and no third party has done so in the past three (3)&nbsp;years), except for infringements, violations or misappropriations that, individually or in the aggregate, have not had and would not be reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Contracts</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.11 of the Company Disclosure Schedule sets forth, as of the date of this Agreement, a list of, and the Company has made available to the Parent a true, correct and complete copy of, each Company Material Contract (as amended prior to the date of this Agreement) to which the Company or any of its Subsidiaries is a party as of the date of this</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">22<a name="PB_22_105520_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='22',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Agreement or by which any of them or any of their respective properties, rights or assets are bound.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Company Material Contract is in full force and effect except to the extent it has previously expired in accordance with its terms or where the failure to be in full force and effect, individually or in the aggregate, is not reasonably likely to have a Company Material Adverse Effect.&#160; Neither the Company nor any of its Subsidiaries nor, to the Company&#146;s Knowledge, any other party to any Company Material Contract is in violation of or in default under (nor does there exist any condition which, upon the passage of time or the giving of notice or both, would cause such a violation of or default under)&nbsp;any Company Material Contract, except for violations or defaults that, individually or in the aggregate, are not reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Since January&nbsp;1, 2016, neither the Company nor any of its Subsidiaries has entered into any transaction that would be subject to disclosure pursuant to Item 404 of Regulation S-K that has not been disclosed in the Company SEC Reports.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.12</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Litigation</u>.&#160; As of the date of this Agreement, there is no action, suit, proceeding, claim, arbitration or investigation pending or, to the Company&#146;s Knowledge, threatened against the Company or any of its Subsidiaries, in each case that, individually or in the aggregate, has had or is reasonably likely to have a Company Material Adverse Effect or would reasonably be expected to prevent, or materially impair or delay, the ability of the Company to consummate the Offer or the Merger.&#160; As of the date of this Agreement, there are no judgments, orders or decrees outstanding against the Company or any of its Subsidiaries that, individually or in the aggregate, have had or are reasonably likely to have a Company Material Adverse Effect or would reasonably be expected to prevent, or materially impair or delay, the ability of the Company to consummate the Offer or the Merger.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.13</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Environmental Matters</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except for matters that, individually or in the aggregate, have not had and would not be reasonably likely to have a Company Material Adverse Effect: (i)&nbsp;the Company and each of its Subsidiaries is, and since January&nbsp;1, 2014 has been, in compliance with all applicable Environmental Laws; (ii)&nbsp;the Company and its Subsidiaries have all permits, licenses and other authorizations required under any Environmental Law and the Company and its Subsidiaries are in compliance with such permits, licenses and other authorizations; (iii)&nbsp;as of the date of this Agreement there is no legal proceeding under Environmental Laws that is pending or, to the Company&#146;s Knowledge, threatened against the Company or any of its Subsidiaries or any real property currently or formerly owned, operated or leased by the Company or any of its Subsidiaries; (iv)&nbsp;neither Company nor any of its Subsidiaries has between January&nbsp;1, 2014 and the date hereof received any written notice of or entered into or assumed (by contract or operation of law or otherwise), any obligation, liability, order, settlement, judgment, injunction or decree arising under Environmental Laws; and (v)&nbsp;there has been no Release of Hazardous Substances at any real property currently or formerly owned, leased or used by the Company or any of its Subsidiaries that would reasonably be expected to result in a liability to the Company or any of its Subsidiaries.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">23<a name="PB_23_105543_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='23',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The only representations and warranties of the Company in this Agreement as to any environmental matters or any other obligation or liability with respect to Hazardous Substances or materials of environmental concern are those contained in this Section&nbsp;3.13.&#160; Without limiting the generality of the foregoing, the representations and warranties contained in Sections 3.15 and 3.16 do not relate to environmental matters.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.14</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Benefit Plans</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Section&nbsp;3.14(a)&nbsp;of the Company Disclosure Schedule sets forth a complete and accurate list, as of the date of this Agreement, of all material Company Employee Plans.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>With respect to each Company Employee Plan in effect on the date of this Agreement, the Company has made available to the Parent a complete and accurate copy of (i)&nbsp;such Company Employee Plan, including amendments thereto, (ii)&nbsp;the most recent annual report (Form&nbsp;5500)&nbsp;filed with the IRS, if any, (iii)&nbsp;each trust agreement, group annuity contract and summary plan description, if any, relating to such Company Employee Plan, (iv)&nbsp;the most recent actuarial report, financial statement or valuation report for such Company Employee Plan, if applicable, (v)&nbsp;a current IRS opinion or favorable determination letter, if applicable, and (vi)&nbsp;all material correspondence to or from any Governmental Entity relating to any audit or investigation of such Company Employee Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each Company Employee Plan is being administered in accordance with ERISA, the Code and all other applicable laws and the regulations thereunder and in accordance with its terms, except for failures to so administer such Company Employee Plan as are not, individually or in the aggregate, reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>With respect to the Company Employee Plans, there are no benefit obligations for which contributions have not been made or properly accrued to the extent required by GAAP, except for failures to make such contributions or accruals for contributions as are not, individually or in the aggregate, reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All the Company Employee Plans that are intended to be qualified under Section&nbsp;401(a)&nbsp;of the Code have received determination letters from the IRS to the effect that such Company Employee Plans are qualified and the plans and trusts related thereto are exempt from federal income taxes under Sections 401(a)&nbsp;and 501(a), respectively, of the Code, or are based on prototype or volume submitter documents that have received such letters, and no such determination letter has been revoked and revocation has not been threatened, and, to the Company&#146;s Knowledge, no act or omission has occurred, that would adversely affect its qualification except, in each case, as is not, individually or in the aggregate, reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as would not, individually or in the aggregate, be reasonably likely to have a Company Material Adverse Effect, other than routine claims for benefits, there are no suits, claims, proceedings, actions, governmental audits or investigations that are pending or, to the Company&#146;s Knowledge, threatened against or involving any Company Employee Plan or asserting any rights to or claims for benefits under any Company Employee Plan.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">24<a name="PB_24_105713_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='24',FILE='C:\JMS\C902342\17-4436-1\task8276919\4436-1-kc-05.htm',USER='C902342',CD='Feb 14 11:04 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None of the Company, any of the Company&#146;s Subsidiaries or any of their respective ERISA Affiliates (i)&nbsp;maintains (or has during the past six&nbsp;(6)&nbsp;years maintained) a Company Employee Plan that is (or was) subject to Section&nbsp;412 of the Code or Title IV of ERISA or (ii)&nbsp;is obligated (or was during the past six&nbsp;(6)&nbsp;years obligated) to contribute to a &#147;multiemployer plan&#148; (as defined in Section&nbsp;4001(a)(3)&nbsp;of ERISA).&#160; During the immediately preceding six (6)&nbsp;years, no liability under Section&nbsp;302 or Title&nbsp;IV of ERISA has been incurred by the Company, any of the Company Subsidiaries or any of their respective ERISA Affiliates or their respective predecessors that has not been satisfied in full.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby will (either alone or in conjunction with any other event): (i)&nbsp;entitle any current or former employee, officer, director or individual independent contractor of the Company or any of the Company Subsidiaries to any payment or benefit (or result in the funding of any such payment or benefit) under any Company Employee Plan; (ii)&nbsp;increase the amount of any compensation, equity award or other benefits otherwise payable by the Company or any of the Company Subsidiaries under any Company Employee Plan; (iii)&nbsp;result in the acceleration of the time of payment, funding or vesting of any compensation, equity award or other benefits under any Company Employee Plan; (iv)&nbsp;result in any &#147;excess parachute payment&#148; (within the meaning of Section&nbsp;280G of the Code) becoming due to any current or former employee, officer, director or individual independent contractor of the Company or any of the Company Subsidiaries; or (v)&nbsp;limit or restrict the right of the Company or any of the Company Subsidiaries to merge, amend or terminate any Company Employee Plan in accordance with its terms and applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither the Company nor any of the Company Subsidiaries is a party to, or is otherwise obligated under, any plan, policy, agreement or arrangement that provides for the gross-up or reimbursement of Taxes imposed under Section&nbsp;409A or 4999 of the Code (or any corresponding provisions of state or local law relating to Tax).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>None of the Company Employee Plans promises or provides medical or other welfare benefits to any Person beyond their retirement or other termination of service, except as required by Section&nbsp;4980B of the Code.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All Company Employee Plans maintained pursuant to the laws of a country other than the United States and all plans or arrangements applicable to employees outside the United States that are mandated by applicable law (i)&nbsp;have in all material respects been maintained in accordance with all applicable requirements (including applicable law), (ii)&nbsp;that are intended to qualify for special Tax treatment meet all material requirements for such treatment, and (iii)&nbsp;that are required to be funded and/or book reserved are funded and/or book reserved, as appropriate, in accordance with GAAP and, if required, applicable law, except, in the case of clause&nbsp;(iii), as has not had and would not be reasonably likely to have a Company Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.15</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Compliance With Laws</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and each of its Subsidiaries is, and since January&nbsp;1, 2014 has been, in compliance with, and is not in violation of, any applicable statute, law or regulation</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">25<a name="PB_25_105857_3434"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='25',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with respect to the conduct of its business, or the ownership or operation of its properties or assets, except for failures to comply or violations that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries taken as a whole.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Neither the Company nor any of its Subsidiaries, nor, to the Company&#146;s Knowledge, any of their respective directors, officers, employees, agents or distributors has since January&nbsp;1, 2014 violated or is violating in any material respect any provision of the U.S. Foreign Corrupt Practices Act of 1977, or any other applicable domestic or foreign anti-bribery or anti-corruption law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and its Subsidiaries are in compliance with all applicable export control laws, including those administered by the U.S. Department of Commerce and the U.S. Department of State, and applicable asset control laws, including those administered by the U.S. Department of the Treasury, except for failures to comply that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries taken as a whole.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and its Subsidiaries are in compliance with all applicable Healthcare Laws, except for failures to comply that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries taken as a whole.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.16</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Permits; Regulatory Matters</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company and its Subsidiaries have all authorizations, permits, licenses and franchises from Governmental Entities required to conduct their businesses as now being conducted, including authorizations, permits, licenses and franchises under Healthcare Laws, except for such permits, licenses and franchises the absence of which, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries, taken as a whole (the &#147;<u>Company Permits</u>&#148;).&#160; The Company Permits are in full force and effect, except for any failures to be in full force and effect that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries, taken as a whole.&#160; The Company and each of its Subsidiaries are in compliance with the terms of the Company Permits, except for such failures to comply that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries, taken as a whole.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as would not be material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries is a party to any corporate integrity agreements, monitoring agreements, deferred prosecution agreements, or similar material agreements with or imposed by any Governmental Entity and, to the Company&#146;s Knowledge, no such action is pending as of the date of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except for matters that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries, taken as a whole, since January&nbsp;1, 2014, all reports, documents, claims, permits, adverse event reports, compliance</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">26<a name="PB_26_105925_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='26',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">testing and certifications, warning labels, radiation reports, recordkeeping, notices, registrations and applications required to be filed, maintained or furnished to the FDA or any other Healthcare Regulatory Authority by the Company and its Subsidiaries have been so filed, maintained or furnished, and all such reports, documents, claims, permits, adverse event reports, compliance testing and certifications, warning labels, radiation reports, recordkeeping, notices, registrations and applications were complete and accurate on the date filed (or were corrected in or supplemented by a subsequent filing prior to the date of this Agreement).&#160; Between January&nbsp;1, 2014 and the date of this Agreement, except for matters that have not been and are not reasonably likely to be material to the Company and its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries, nor, to the Company&#146;s Knowledge, any officer or employee of the Company or any of its Subsidiaries, has made an untrue statement of a material fact or a fraudulent statement to the FDA or any other Healthcare Regulatory Authority, failed to disclose a material fact required to be disclosed to the FDA or any other Healthcare Regulatory Authority, or committed an act, made a statement, or failed to make a statement, in each such case, related to the business of the Company or any of its Subsidiaries, that, at the time such disclosure was made, would reasonably be expected to provide a basis for the FDA to invoke its policy respecting &#147;Fraud, Untrue Statements of Material Facts, Bribery, and Illegal Gratuities&#148; set forth in 56 Fed. Reg. 46191 (September&nbsp;10, 1991) or for the FDA or any other Healthcare Regulatory Authority to invoke any similar policy.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Between January&nbsp;1, 2014 and the date of this Agreement (i)&nbsp;neither the Company nor any of its Subsidiaries or, to the Company&#146;s Knowledge, any member of its board of directors or any of its executive officers or managing employees (as such term is defined in 42 U.S.C. &#167; 1320a-5(b)), has been debarred, convicted of any crime or engaged in any conduct for which debarment is mandated or permitted by 21 U.S.C.A &#167; 335a(a)&nbsp;or any similar law or authorized by 21 U.S.C.A &#167; 335a(b)&nbsp;or any similar law, and (ii)&nbsp;neither the Company nor any of its Subsidiaries or, to the Company&#146;s Knowledge, any member of its board of directors or any of its executive officers or managing employees (as such term is defined in 42 U.S.C. &#167; 1320a-5(b)), has been excluded from participation in any federal health care program or convicted of any crime or engaged in any conduct for which such Person could be excluded from participating in any federal health care program under Section&nbsp;1128 of the Social Security Act of 1935.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as available in the public databases of any Healthcare Regulatory Authority prior to the date hereof, between January&nbsp;1, 2014 and the date of this Agreement, neither the Company nor any of its Subsidiary has initiated, conducted or issued, or caused to be initiated, conducted or issued any material recall, field corrective action, market withdrawal or replacement, safety alert, warning, &#147;dear doctor&#148; letter, investigator notice, or other notice or action to wholesalers, distributors, retailers, healthcare professionals or patients relating to an alleged lack of safety, efficacy or regulatory compliance of any Company Product or been required to do so, other than notices and actions that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries, taken as a whole.&#160; Except for notices that, individually or in the aggregate, have not been and are not reasonably likely to be material to the Company and its Subsidiaries, taken as a whole, between January&nbsp;1, 2014 and the date of this Agreement neither the Company nor any of its Subsidiaries has received any written notice from the FDA or any other Healthcare Regulatory Authority regarding (i)&nbsp;any recall, market withdrawal or replacement of any Company Product, (ii)&nbsp;a change in the marketing status or classification, or a material change in the labelling of any such</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">27<a name="PB_27_105949_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='27',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt .3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Products, (iii)&nbsp;a negative change in reimbursement status of </font>a Company Product, (iv)&nbsp;a 510(k)&nbsp;rescission letter, (v)&nbsp;any regulatory action by the FDA or any other Healthcare Regulatory Authority against the Company or any Company Product, including any notice of adverse findings, any regulatory, untitled or warning letters or any mandatory recalls, (vi)&nbsp;any safety alert with respect to a Company Product or (vii)&nbsp;any search warrant, subpoena, civil investigative demand, or similar written communication.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.17</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Labor Matters</u>.&#160; The Company and its Subsidiaries have complied with all applicable laws relating to labor and employment, including those relating to wages, hours, collective bargaining, unemployment compensation, worker&#146;s compensation, equal employment opportunity, age and disability discrimination, immigration control and employee classification, except for such failures to comply that, individually or in the aggregate, are not reasonably likely to have a Company Material Adverse Effect.&#160; Neither the Company nor any of its Subsidiaries is the subject of any proceeding asserting that the Company or any of its Subsidiaries has committed an unfair labor practice or seeking to compel it to bargain with any labor union or labor organization that, individually or in the aggregate, is reasonably likely to have a Company Material Adverse Effect.&#160; There are no pending or, to the Company&#146;s Knowledge, threatened labor strikes, disputes, walkouts, work stoppages, slow-downs or lockouts involving the Company or any of its Subsidiaries that, individually or in the aggregate, are reasonably likely to have a Company Material Adverse Effect, nor have there, to the Company&#146;s Knowledge, been any such strikes, disputes, walkouts, work stoppages, slow-downs or lockouts within the past three (3)&nbsp;years.&#160; Neither the Company nor any of the Company Subsidiaries is a party to, or otherwise bound by, any collective bargaining agreement or other Contract with any labor organization, union or association.&#160; There are no labor unions or other organizations representing, or, to the Company&#146;s Knowledge, purporting to represent or attempting to represent, any employee of the Company or any of its Subsidiaries, nor, to the Company&#146;s Knowledge, has any such action or attempt occurred within the three (3)&nbsp;years prior to the date of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.18</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Opinion of Financial Advisor</u>.&#160; The financial advisor of the Company, Leerink Partners LLC (&#147;<u>Leerink</u>&#148;), has delivered to the Company Board an opinion to the effect that, as of the date of such opinion, and based upon and subject to the various qualifications, assumptions and limitations to be set forth in Leerink&#146;s written opinion, the Offer Price and the Merger Consideration to be received by the holders of Company Common Stock (other than the Excluded Shares, as defined in Leerink&#146;s written opinion) pursuant to the Merger Agreement is fair, from a financial point of view, to such holders.&#160; As soon as practicable following the date hereof, an executed copy of the aforementioned opinion will be made available to Parent for informational purposes only.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.19</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Section&nbsp;203 of the DGCL; Other Anti-Takeover Laws</u>.&#160; Assuming the accuracy of the representations and warranties of the Parent and the Purchaser in Section&nbsp;4.6, the Company Board has taken all actions necessary so that the restrictions contained in Section&nbsp;203 of the DGCL applicable to a &#147;business combination&#148; (as defined in Section&nbsp;203 of the DGCL)&nbsp;shall not apply to the execution, delivery or performance of this Agreement or the consummation of the Offer, the Merger or the other transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">28<a name="PB_28_110107_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='28',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.20</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Brokers</u>.&#160; No agent, broker, investment banker, financial advisor or other firm or Person is or shall be entitled, as a result of any action or agreement of the Company or any of its Subsidiaries, to any broker&#146;s, finder&#146;s, financial advisor&#146;s or other similar fee or commission in connection with any of the transactions contemplated by this Agreement, except as disclosed in Section&nbsp;3.20 of the Company Disclosure Schedule.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.21</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Insurance</u>.&#160; Except as has not had and would not be reasonably likely to, individually or in the aggregate, have a Company Material Adverse Effect, (a)&nbsp;all insurance policies of the Company and its Subsidiaries are in full force and effect, except for any expiration thereof in accordance with the terms thereof, (b)&nbsp;the Company and its Subsidiaries are not in default under any such insurance policy and (c)&nbsp;no written notice of cancelation or termination has been received with respect to any such insurance policy, other than in connection with ordinary renewals.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.22</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Suppliers</u>.&#160; Listed in Section&nbsp;3.22 of the Company Disclosure Schedules are the names of the ten (10)&nbsp;most significant suppliers (by dollar volume of purchases) of the Company (each, a &#147;<u>Significant Supplier</u>&#148;) for the twelve-month period ended December&nbsp;31, 2016 and the approximate amount purchased from each such supplier during such period.&#160; From January&nbsp;1, 2016 through the date of this Agreement, neither the Company nor any of its Subsidiaries has received any written notice or, to the Knowledge of the Company, any other notice from a Significant Supplier that such Significant Supplier has ceased, or will cease, to supply or make available all or substantially all of the products, equipment, goods or services currently supplied to the Company or its Subsidiaries by such Significant Supplier following the date hereof.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.23</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Product Liability</u>.&#160; Except for matters that, individually or in the aggregate, have not had and would not be reasonably likely to have a Company Material Adverse Effect, (a)&nbsp;each product designed, formulated, manufactured or sold by the Company and its Subsidiaries has been done so since January&nbsp;1, 2015 in conformity in all material respects with all applicable product specifications, applicable express and implied warranties and applicable law and (b)&nbsp;neither the Company nor any of its Subsidiaries has received any written notice of any allegation that a product it designed, formulated, manufactured or sold is materially defective or not in conformity in all material respects with the an applicable product specification, applicable express or implied warranties or applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;IV</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">REPRESENTATIONS AND WARRANTIES OF THE PARENT AND THE PURCHASER</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:45.35pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Parent and the Purchaser, jointly and severally, represent and warrant to the Company that the statements contained in this Article&nbsp;IV are true and correct.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Organization, Standing and Power</u>.&#160; Each of the Parent and the Purchaser is a corporation duly organized, validly existing and in good standing (to the extent such concepts are applicable) under the laws of the jurisdiction of its incorporation.&#160; Each of the Parent and the Purchaser has all requisite corporate power and authority to own, lease and operate its properties and assets and to carry on its business as now being conducted, and is duly qualified to do business and, where applicable as a legal concept, is in good standing as a foreign corporation in</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">29<a name="PB_29_110140_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='29',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">each jurisdiction in which the character of the properties it owns, operates or leases or the nature of its activities makes such qualification legally required, except for such failures to have such power and authority or to be so organized, qualified or in good standing, individually or in the aggregate, that have not had and are not reasonably likely to have a Parent Material Adverse Effect.&#160; Parent has delivered or made available to the Company complete and correct copies of the certificate or articles of incorporation and bylaws, or similar organizational documents as amended through the date of this Agreement, of Purchaser and Parent.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Authority; No Conflict; Required Filings and Consents</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Each of the Parent and the Purchaser has all requisite corporate power and authority to enter into this Agreement and, subject to the adoption of this Agreement by the Parent as the sole stockholder of the Purchaser (which shall occur promptly after the execution and delivery of this Agreement), to consummate the transactions contemplated hereby.&#160; The execution and delivery of, and the consummation of the transactions contemplated by, this Agreement by the Parent and the Purchaser have been duly authorized by all necessary corporate action on the part of each of the Parent and the Purchaser, subject to the adoption of this Agreement by the Parent as the sole stockholder of the Purchaser (which shall occur promptly after the execution and delivery of this Agreement).&#160; This Agreement has been duly executed and delivered by each of the Parent and the Purchaser and constitutes the valid and binding obligation of each of the Parent and the Purchaser, enforceable against each of them in accordance with its terms, subject to the Bankruptcy and Equity Exception.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The execution and delivery of this Agreement by each of the Parent and the Purchaser do not, and the consummation by the Parent and the Purchaser of the transactions contemplated by this Agreement shall not, (i)&nbsp;conflict with, or result in any violation or breach of, any provision of the certificate of incorporation, bylaws or other organizational documents of the Parent or the Purchaser, (ii)&nbsp;conflict with, or result in any violation or breach of, or constitute a default (or give rise to a right of termination, cancellation or acceleration of any obligation or loss of any material benefit)&nbsp;under, or require a consent or waiver under, any of the terms, conditions or provisions of any lease, license, contract or other agreement, instrument or obligation to which the Parent or the Purchaser is a party or by which any of them or any of their properties or assets may be bound, or (iii)&nbsp;subject to compliance with the requirements specified in clauses (i), (ii), (iii), (iv)&nbsp;and (v)&nbsp;of Section&nbsp;4.2(c), conflict with or violate any permit, concession, franchise, license, judgment, injunction, order, decree, statute, law, ordinance, rule&nbsp;or regulation applicable to the Parent or the Purchaser or any of its or their respective properties or assets, except in the case of clauses (ii)&nbsp;and (iii)&nbsp;of this Section&nbsp;4.2(b)&nbsp;for any such conflicts, violations, breaches, defaults, terminations, cancellations, accelerations, losses, penalties or Liens, and for any consents or waivers not obtained, that, individually or in the aggregate, have not had and are not reasonably likely to have a Parent Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No consent, approval, license, permit, order or authorization of, or registration, declaration, notice or filing with, any Governmental Entity or any stock market or stock exchange on which shares of common stock of the Parent are listed for trading is required by or with respect to the Parent or the Purchaser in connection with the execution and delivery of this Agreement by the Parent or the Purchaser or the consummation by the Parent or the Purchaser of the transactions contemplated by this Agreement, except for (i)&nbsp;the pre-merger</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">30<a name="PB_30_110200_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='30',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">notification requirements under the HSR Act and any other applicable Antitrust Laws, (ii)&nbsp;the filing of the Certificate of Merger with the Secretary of State and appropriate corresponding documents with the appropriate authorities of other states in which the Company is qualified as a foreign corporation to transact business, (iii)&nbsp;required filings of the Offer Documents and the Schedule 14D-9 under the Exchange Act, (iv)&nbsp;the filing of such reports, schedules or materials under the Exchange Act as may be required in connection with this Agreement and the transactions contemplated hereby, (v)&nbsp;such consents, approvals, orders, authorizations, registrations, declarations, notices and filings as may be required under applicable state securities laws, the rules&nbsp;and regulations of the Nasdaq Stock Market, and (vi)&nbsp;such other consents, approvals, licenses, permits, orders, authorizations, registrations, declarations, notices and filings which, if not obtained or made, are not reasonably likely to have a Parent Material Adverse Effect.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>No vote of the holders of any class or series of the Parent&#146;s capital stock or other securities is necessary for the consummation by the Parent of the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Information Provided</u>.&#160; The information to be supplied by or on behalf of the Parent or the Purchaser for inclusion in the Schedule 14D-9, on the date the Schedule 14D-9 is filed with the SEC, on the date of any amendment or supplement thereto and on the date the Schedule 14D-9 is first published, sent or given to holders of shares of Company Common Stock, shall not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances in which they shall be made, not misleading.&#160; On the date the Schedule TO is filed with the SEC, on the date of any amendment or supplement thereto and on the date the Schedule TO is first published, sent or given to holders of shares of Company Common Stock, the Schedule TO (a)&nbsp;will comply as to form in all material respects with the requirements of the Exchange Act and (b)&nbsp;will not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in light of the circumstances under which they are made, not misleading.&#160; Notwithstanding the foregoing provisions of this Section&nbsp;4.3, no representation or warranty is made by the Parent and the Purchaser with respect to information or statements made or incorporated by reference in the Schedule TO based upon information supplied by the Company or any of its Representatives expressly for use or incorporation by reference therein.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Operations of the Purchaser</u>.&#160; The Purchaser was formed solely for the purpose of engaging in the transactions contemplated by this Agreement and has engaged in no other business activities other than in connection with the transactions contemplated hereby.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Available Funds</u>.&#160; The Parent has, and will at the Acceptance Time and at the Closing have, access to (including under existing credit facilities) all of the funds that are necessary to enable the payment by the Parent or the Purchaser in cash of all amounts required to be paid by the Parent or the Purchaser in connection with the transactions contemplated by this Agreement, including the payment of the Offer Price for each share of Company Common Stock tendered pursuant to the Offer, the payment of the Merger Consideration pursuant to the Merger, the payments owing to holders of Company Stock Options, Company RSUs and Company PSUs under Section&nbsp;2.8 and the payment of all fees and expenses related to or arising out of the transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">31<a name="PB_31_110222_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='31',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Ownership of Company Common Stock</u>.&#160; Neither Parent nor any of its Subsidiaries has been at any time during the period commencing three (3)&nbsp;years prior to the date that the Company Board approved this Agreement through the date hereof, an &#147;interested stockholder&#148; of the Company, as such term is defined in Section&nbsp;203 of the DGCL.&#160; Neither Parent nor the Purchaser own as of the date of this Agreement, and prior to the Acceptance Time will not own, any shares of Company Common Stock.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Litigation</u>.&#160; As of the date of this Agreement, there is no action, suit, proceeding, claim, arbitration or investigation pending and of which the Parent has been notified or, to the Parent&#146;s knowledge, threatened against the Parent or any of its Subsidiaries, in each case that, individually or in the aggregate, is reasonably likely to have a Parent Material Adverse Effect.&#160; As of the date of this Agreement, there are no judgments, orders or decrees outstanding against the Parent or any of its Subsidiaries that, individually or in the aggregate, is reasonably likely to have a Parent Material Adverse Effect.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Other Agreements or Understandings</u>.&#160; There are no written contracts, arrangements or understandings between or among the Parent, the Purchaser, or any other Subsidiary of the Parent, on the one hand, and any member of the board of directors or management of the Company or any of its Subsidiaries, on the other hand.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Brokers</u>.&#160; No agent, broker, investment banker, financial advisor or other firm or Person is or shall be entitled, as a result of any action or agreement of the Parent or any of its Subsidiaries, to any broker&#146;s, finder&#146;s, financial advisor&#146;s or other similar fee or commission in connection with any of the transactions contemplated by this Agreement for which the Company or any of its Subsidiaries would have any obligations or liabilities prior to the Effective Time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Independent Investigation</u>.&#160; Each of the Parent and the Purchaser acknowledges that it has conducted to its satisfaction its own independent investigation and analysis of the business, operations, assets, liabilities, results of operations, condition (financial or otherwise) and prospects of the Company and the Company&#146;s Subsidiaries and that each of the Parent and the Purchaser and its Representatives have received access to certain books and records, facilities, equipment, contracts and other assets of the Company and the Company&#146;s Subsidiaries that it and its Representatives have requested to review for such purpose, and that it and its Representatives have had a full opportunity to meet with the management of the Company and the Company&#146;s Subsidiaries and to discuss the business, operations, assets, liabilities, results of operations, condition (financial or otherwise) and prospects of the Company and the Company&#146;s Subsidiaries.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Other Company Representations or Warranties</u>.&#160; The Parent and the Purchaser hereby acknowledge and agree that, except for the representations and warranties set forth in Article&nbsp;III (in each case as qualified and limited by the Company Disclosure Schedule), (a)&nbsp;none of the Company or any of its Subsidiaries, or any of its or their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Company, has made or is making any express or implied representation or warranty with respect to the Company or any of its Subsidiaries or their respective business or operations, including with respect to any information provided or made available to the Parent, the Purchaser or any of their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Parent, or, except as</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">32<a name="PB_32_110246_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='32',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">otherwise expressly set forth in this Agreement, had or has any duty or obligation to provide any information to the Parent, the Purchaser or any of their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Parent, in connection with this Agreement, the transactions contemplated hereby or otherwise, and (b)&nbsp;to the fullest extent permitted by law, none of the Company or any of its Subsidiaries, or any of its or their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Company, will have or be subject to any liability or indemnification or other obligation of any kind or nature to the Parent, the Purchaser or any of their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Parent, resulting from the delivery, dissemination or any other distribution to the Parent, the Purchaser or any of their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Parent, or the use by the Parent, the Purchaser or any of their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Parent, of any such information provided or made available to any of them by the Company or any of its Subsidiaries, or any of its or their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Company, including any information, documents, estimates, projections, forecasts or other forward-looking information, business plans or other material provided or made available to the Parent, the Purchaser or any of their respective Affiliates, stockholders, or Representatives, or any other Person acting on behalf of the Parent, in &#147;data rooms,&#148; confidential information memoranda, management presentations or otherwise in anticipation or contemplation of the Offer, the Merger or any other transaction contemplated by this Agreement, and (subject to the express representations and warranties of the Company set forth in Article&nbsp;III (in each case as qualified and limited by the Company Disclosure Schedule)) none of the Parent, the Purchaser or any of their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Parent, has relied on any such information (including the accuracy or completeness thereof).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.12</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Non-Reliance on Company Estimates, Projections, Forecasts, Forward-Looking Statements and Business Plans</u>.&#160; In connection with the due diligence investigation of the Company by the Parent and the Purchaser and their respective Representatives, the Parent and the Purchaser and their respective Representatives have received and may continue to receive after the date hereof (including pursuant to Section&nbsp;6.3(b)) from the Company and its Representatives certain estimates, projections, forecasts and other forward-looking information, as well as certain business plan information, regarding the Company and its business and operations.&#160; The Parent and the Purchaser hereby acknowledge that there are uncertainties inherent in attempting to make such estimates, projections, forecasts and other forward-looking statements, as well as in such business plans, with which the Parent and the Purchaser are familiar, that the Parent and the Purchaser are taking full responsibility for making their own evaluation of the adequacy and accuracy of all estimates, projections, forecasts and other forward-looking information, as well as such business plans, so furnished to them (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, forward-looking information or business plans), and that the Parent and the Purchaser will have no claim against the Company or any of its Subsidiaries, or any of their respective Affiliates, stockholders or Representatives, or any other Person acting on behalf of the Company, with respect thereto, in each case without limiting any of the express representations and warranties set forth in this Agreement or the rights and remedies as a result of any inaccuracy in any such representations or warranties.&#160; Accordingly, the Parent and the Purchaser hereby acknowledge and agree that none</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">33<a name="PB_33_110313_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='33',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">of the Company or any of its Subsidiaries, nor any of their respective Affiliates, stockholders or Representatives, nor any other Person acting on behalf of the Company, has made or is making any express or implied representation or warranty with respect to such estimates, projections, forecasts, forward-looking statements or business plans (including the reasonableness of the assumptions underlying such estimates, projections, forecasts, forward-looking statements or business plans), in each case other than the express representations and warranties set forth in this Agreement.&#160; The Parent and the Purchaser each expressly disclaims that it is relying upon or has relied upon any representations or warranties or other statements or omissions that may have been made by the Company or any Person acting on behalf of the Company with respect to the Company other than the representations and warranties set forth in this Agreement.&#160; The Parent and the Purchaser each expressly disclaims any obligation or duty by the Company to make any disclosures of fact not required to be disclosed pursuant to the specific representations and warranties set forth in this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;V</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CONDUCT OF BUSINESS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Covenants of the Company</u>.&#160; Except as otherwise expressly contemplated or required by this Agreement, as required by applicable law or by any Company Material Contract in effect on the date hereof and made available to the Parent, as set forth in Section&nbsp;5.1 of the Company Disclosure Schedule, or with Parent&#146;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed), during the Pre-Closing Period, the Company shall, and shall cause each of its Subsidiaries to, use commercially reasonable efforts to act and carry on its business in the Ordinary Course of Business, to preserve intact its business organization and to preserve satisfactory business relationships with material customers, suppliers, licensors, licensees, distributors, wholesales, lessors and others having material business dealings with the Company.&#160; Without limiting the generality of the foregoing, except as otherwise expressly contemplated or required by this Agreement, as required by applicable law, as set forth in Section&nbsp;5.1 of the Company Disclosure Schedule, or with Parent&#146;s prior written consent (which shall not be unreasonably withheld, conditioned or delayed), during the Pre-Closing Period the Company shall not, and shall not permit any of its Subsidiaries to, directly or indirectly, do any of the following:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;declare, set aside, make or pay any dividends or other distributions (whether in cash, securities or other property)&nbsp;in respect of any of its capital stock (other than dividends and distributions by a direct or indirect wholly owned Subsidiary of the Company to its parent), (ii)&nbsp;split, combine or reclassify any of its capital stock or issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for shares of its capital stock or any of its other securities; or (iii)&nbsp;purchase, redeem or otherwise acquire any shares of its capital stock or any other of its securities or any rights, warrants or options to acquire any such shares or other securities, except, in the case of this clause (iii), for the acquisition of shares of Company Common Stock (A)&nbsp;from holders of Company Stock Options (which are outstanding as of the date of this Agreement) in full or partial payment of the exercise price and in accordance with the terms thereof as they exist on the date of this Agreement, (B)&nbsp;from holders of Company Stock Options, Company RSUs or Company PSUs (in each case which are outstanding as of the date of this Agreement) in full or partial payment of any applicable Taxes</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">34<a name="PB_34_110337_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='34',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-07.htm',USER='107541',CD='Feb 14 12:01 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">payable by such holder upon exercise or settlement thereof, as applicable, to the extent required under the terms thereof as they exist on the date of this Agreement or (C)&nbsp;from former employees, directors and consultants as required by agreements existing as of the date of this Agreement providing for the repurchase of shares at their original issuance price or forfeiture of shares for no consideration in accordance with the terms thereof as they exist on the date of this Agreement, in each case, under this clause (C)&nbsp;in connection with any termination of services to the Company or any of its Subsidiaries;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>except as set forth in Section&nbsp;5.1(j)&nbsp;of the Company Disclosure Schedule, issue, deliver, sell, grant, pledge or otherwise dispose of or subject to any Lien any shares of its capital stock, any other voting securities or any securities convertible into or exchangeable for, or any rights, warrants or options to acquire, any such shares, voting securities or convertible or exchangeable securities, in each case other than the issuance of shares of Company Common Stock upon the exercise of Company Stock Options outstanding on the date of this Agreement and in accordance with the terms thereof as they exist on the date of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>amend the Company&#146;s or any of its Subsidiaries&#146; certificate of incorporation, bylaws or other comparable charter or organizational documents;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>acquire, or cause any acquisition of, any assets, rights or properties (including by&nbsp;merging or consolidating with any business or any corporation, partnership, joint venture, limited liability company, association or other business organization or division thereof), except purchases of inventory and raw materials in the Ordinary Course of Business and for purchases of other assets in an aggregate amount not to exceed $1,000,000;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>sell, lease, license (or sublicense), pledge, mortgage or otherwise dispose of or subject to any Lien any properties, rights or assets of the Company or of any of its Subsidiaries, other than sales of inventory and disposition of obsolete equipment in each case in the Ordinary Course of Business and sales of other assets (other than any Company Intellectual Property) in an aggregate amount not to exceed $500,000;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;adopt any stockholder rights plan, (ii)&nbsp;adopt a plan of complete or partial liquidation, dissolution, recapitalization, restructuring or other reorganization or (iii)&nbsp;subject to Section&nbsp;6.1 and Section&nbsp;8.1(f), merge or consolidate with any Person;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;incur any indebtedness for borrowed money or guarantee any such indebtedness of another Person (other than (x)&nbsp;to the Company or one of its wholly-owned Subsidiaries in the Ordinary Course of Business, (y)&nbsp;letters of credit or similar arrangements issued to or for the benefit of suppliers and manufacturers in the Ordinary Course of Business and (z)&nbsp;short-term borrowings of not more than $1,000,000 in the aggregate, incurred in the Ordinary Course of Business), (ii)&nbsp;issue, sell or amend any debt securities or warrants or other rights to acquire any debt securities of the Company or any of its Subsidiaries, guarantee any debt securities of another Person, enter into any &#147;keep well&#148; or other agreement to maintain any financial statement condition of another Person or enter into any arrangement having the economic effect of any of the foregoing, (iii)&nbsp;make any loans, advances (other than routine advances to employees of the Company and its Subsidiaries in the Ordinary Course of Business)&nbsp;or capital contributions to, or investment in, any other Person, other than any of the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">35<a name="PB_35_105257_5965"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='35',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company&#146;s direct or indirect wholly owned Subsidiaries, or (iv)&nbsp;enter into any hedging agreement or other financial agreement or arrangement designed to protect the Company or its Subsidiaries against fluctuations in exchange rates;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>make any capital expenditures or other expenditures with respect to property, plant or equipment in excess of $2,000,000 in the aggregate for the Company and its Subsidiaries, taken as a whole, other than to the extent included in and in accordance with the Company&#146;s budget for capital expenditures made available to the Parent prior to the date of this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>make any material changes in accounting methods, principles or practices, except insofar as may be required by a change in GAAP;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(j)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>except as required by or in order to comply with any Company Employee Plan in existence on the date hereof, (i)&nbsp; adopt, enter into, terminate or amend in any manner adverse to the Company any employment, consulting, severance, retention, change in control, termination or similar agreement with any of its directors, officers, employees or individual independent contractors, other than entry into at-will offer letters in the Ordinary Course of Business with newly hired employees, which letters do not provide for any severance or change in control benefits (other than participation in the Company Severance Practices as in effect on the date hereof), (ii)&nbsp;hire any new employees or individual independent contractors, other than (A)&nbsp;new hires of non-executive employees or individual independent contractors, in each case, in the Ordinary Course of Business, (B)&nbsp;hiring contemplated in, and in accordance with, the budget made available to the Parent prior to the date of this Agreement or (C)&nbsp;hiring of employees to fill vacancies at total annual compensation substantially similar to their predecessors in the Ordinary Course of Business, (iii)&nbsp;establish, adopt, enter into, amend or terminate any collective bargaining agreement or Company Employee Plan, except for amendments to Company Employee Plans that are welfare plans in the Ordinary Course of Business that do not increase in any material respect the cost to the Company of maintaining such Company Employee Plans and that apply to substantially all employees across-the-board, (iv)&nbsp;increase the compensation or benefits of, or pay or award any bonus or other incentive compensation to, any director, officer, employee or individual independent contractor (except for salary increases in the Ordinary Course of Business in connection with promotions made in the Ordinary Course of Business and except, in the case of individual independent contractors, for rate increases in the Ordinary Course of Business), (v)&nbsp;take any action to accelerate any payment or benefit, the vesting of any payment or benefit or the funding of any payment or benefit, payable or to become payable to any of its directors, officers, employees or individual independent contractors, (vi)&nbsp;grant to any of its directors, officers, employees or individual independent contractors any increase in severance or termination pay, (vii)&nbsp;grant any stock options, restricted stock units, stock appreciation rights, stock-based or stock-related awards, performance units or restricted stock, or (viii)&nbsp;terminate the employment of any employee or individual independent contractor whose total annual compensation exceeds $200,000, other than for cause;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(k)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>(i)&nbsp;enter into any Contract that, if in effect on the date hereof, would have been a Company Material Contract, (ii)&nbsp;terminate any Company Material Contract, except as a result of a material breach or a material default by the counterparty thereto or as a result of the expiration of such Company Material Contract in accordance with its terms as in effect on the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">36<a name="PB_36_105321_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='36',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">date of this Agreement, (iii)&nbsp;amend or modify in a manner that is materially adverse to the Company and its Subsidiaries, taken as a whole, any Company Material Contract or (iv)&nbsp;waive any material term of, or waive any material default under, or release, settle or compromise any material claim against the Company or any of its Subsidiaries under, or any material liability or obligation owing to the Company or any of its Subsidiaries under, any Company Material Contract;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(l)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>knowingly relinquish, abandon or permit to lapse any of its rights in any material registered Intellectual Property;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(m)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>except as permitted by and in accordance with Section&nbsp;6.13, settle any action, suit, proceeding, claim, arbitration or investigation, other than the settlement of any action, suit, proceeding, claim, arbitration or investigation (but not a criminal proceeding) for an amount not in excess of the amount reserved with respect to such matter in the Company Balance Sheet included in the Company SEC Reports filed prior to the date hereof or that requires payments by the Company (net of insurance proceeds received) in an amount not to exceed, individually or in the aggregate, $1,000,000, and in each case does not involve any admission of wrongdoing or injunctive or other equitable relief;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(n)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>make, revoke or change any material Tax election, adopt or change any accounting method for Tax purposes that has a material effect on Taxes, extend the statute of limitations (or file any extension request) relating to material Taxes with any Governmental Entity, amend any material Tax Return, or settle or compromise any material Tax liability; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(o)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>authorize any of, or commit or agree, in writing or otherwise, to take any of, the foregoing actions.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Conduct of Business by the Parent and the Purchaser Pending the Merger</u>. &#160;Except as otherwise expressly contemplated or permitted by this Agreement or as required by applicable law, during the Pre-Closing Period, (a)&nbsp;neither the Parent nor the Purchaser shall, directly or indirectly, without the prior consent of the Company (not to be unreasonably withheld, delayed or conditioned), take or cause to be taken any action that would be reasonably expected to materially delay, impair or prevent the consummation of the transactions contemplated by this Agreement and (b)&nbsp;the Purchaser shall not engage in any activity of any nature except for activities related to or in furtherance of the Offer, the Merger and the other transactions contemplated by this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;VI</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ADDITIONAL AGREEMENTS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Solicitation</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Solicitation or Negotiation</u>.&#160; Except as set forth in this Section&nbsp;6.1, until the Specified Time, neither the Company nor any of its Subsidiaries shall, and the Company shall cause its directors, officers and senior management not to and shall use reasonable efforts to cause its other Representatives not to, directly or indirectly:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">37<a name="PB_37_105341_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='37',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>solicit, initiate or knowingly facilitate or knowingly encourage any inquiries or the making of any proposal or offer that constitutes, or would reasonably be expected to lead to, any Acquisition Proposal;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>provide any non-public information concerning the Company or any of its Subsidiaries to any Person or group who has made or would reasonably be expected to make any Acquisition Proposal or for the purpose of encouraging or facilitating any Acquisition Proposal;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>amend or grant a waiver or release under any standstill or similar agreement with respect to any Company Common Stock (other than for Parent or its Affiliate), except under the circumstances permitted under this Section&nbsp;6.1(a); or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>enter into, continue or otherwise participate in any discussions or negotiations regarding any Acquisition Proposal.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding the foregoing or anything to the contrary set forth in this Agreement, subject to compliance with Section&nbsp;6.1(c), if at any time prior to the Acceptance Time, (i)&nbsp;the Company has received after the date of this Agreement a written Acquisition Proposal that did not result from a material breach of this Section&nbsp;6.1, and (ii)&nbsp;the Company Board determines in good faith, after consultation with its financial advisor and outside legal counsel, that such Acquisition Proposal constitutes or could reasonably be expected to result in a Superior Proposal (the Person making such Acquisition Proposal, a &#147;<u>Qualified Person</u>&#148;) and that the failure to take such action described in clause (A)&nbsp;or clause (B)&nbsp;below would be reasonably likely to be inconsistent with the Company Board&#146;s fiduciary duties under applicable law, then the Company may (A)&nbsp;furnish non-public information with respect to the Company and its Subsidiaries to such Qualified Person (and the Representatives of such Qualified Person), pursuant to a confidentiality agreement not materially less restrictive with respect to the confidentiality and non-use obligations of the Qualified Person than the Confidentiality Agreement (<u>provided</u>, that&nbsp;the Company shall substantially concurrently provide to Parent, in accordance with the terms of the Confidentiality Agreement, any non-public written information and any other material non-public information concerning the Company and its Subsidiaries that is provided to (or given access to) such Qualified Person and which was not previously provided or made available to Parent), (B)&nbsp;engage in discussions or negotiations (including solicitation of revised Acquisition Proposals)&nbsp;with any such Qualified Person (and the Representatives of such Qualified Person) regarding any such Acquisition Proposal and (C)&nbsp;amend, or grant a waiver or release under, any standstill or similar agreement with respect to any Company Common Stock with any Qualified Person.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Change in Recommendation or Alternative Acquisition Agreement</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Prior to the earlier of the Acceptance Time or the termination of this Agreement in accordance its terms, the Company Board shall not, except as set forth in this Section&nbsp;6.1, (x)&nbsp;fail to include the Company Board Recommendation in the Schedule 14D-9,(y)&nbsp;withhold, withdraw or modify or publicly propose to withhold, withdraw or modify, in a manner adverse to the Parent or the Purchaser, the Company Board Recommendation or (z)&nbsp;approve, endorse or recommend, or publicly propose to approve, endorse, declare the advisability of or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">38<a name="PB_38_105356_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='38',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">recommend, any Acquisition Proposal (any action described in clauses (x),&#160; (y)&nbsp;or (z), a &#147;<u>Company Board Recommendation Change</u>&#148;);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Prior to the earlier of the Effective Time or the termination of this Agreement in accordance its terms, the Company shall not, and shall not permit any of its Subsidiaries to, enter into any letter of intent, memorandum of understanding, agreement in principle, acquisition agreement, merger agreement or similar agreement (an &#147;<u>Alternative Acquisition Agreement</u>&#148;)&nbsp;providing for a transaction contemplated by any Acquisition Proposal (other than a confidentiality agreement referred to in Section&nbsp;6.1(a)&nbsp;entered into in the circumstances referred to in Section&nbsp;6.1(a)).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding the foregoing or anything to the contrary set forth in this Agreement (including the provisions of this Section&nbsp;6.1), at any time prior to the Acceptance Time, the Company Board may (A)&nbsp;effect a Company Board Recommendation Change in response to a Superior Proposal concurrently with causing the Company to terminate this Agreement pursuant to and in accordance with Section&nbsp;8.1(f)&nbsp;in order to enter into a definitive agreement providing for such Superior Proposal or (B)&nbsp;effect a Company Board Recommendation Change (other than pursuant to clause (z)&nbsp;of the definition thereof) in response to an Intervening Event if (in the case of either clause (A)&nbsp;or (B): (i)&nbsp;the Company Board shall have determined in good faith (after consultation with outside counsel) that the failure to effect a Company Board Recommendation Change would be reasonably likely to be inconsistent with its fiduciary duties under applicable law; (ii)&nbsp;the Company has notified the Parent in writing at least four (4)&nbsp;Business Day prior to taking such action that it intends to effect a Company Board Recommendation Change, describing in reasonable detail the reasons for such Company Board Recommendation Change (a &#147;<u>Recommendation Change Notice</u>&#148;) (it being understood that the Recommendation Change Notice shall not, in and of itself, constitute a Company Board Recommendation Change or a Trigger Event for purposes of this Agreement so long as such notice clearly states that it is not a Company Board Recommendation Change and that the Company Board is not changing the Company Board Recommendation); (iii)&nbsp;if requested by the Parent, the Company shall have made available and instructed its Representatives to discuss and negotiate with the Parent&#146;s Representatives any proposed modifications to the terms and conditions of this Agreement (in a manner that would obviate the need to effect such Company Board Recommendation Change) during the four (4)&nbsp;Business Day period following delivery by the Company to the Parent of such Recommendation Change Notice; and (iv)&nbsp;at the end of such four (4)&nbsp;Business Day period, the Company Board shall have determined in good faith (after consultation with outside counsel), after giving effect to the terms of any revised offer by the Parent, that the failure to effect a Company Board Recommendation Change would still be reasonably likely to be inconsistent with its fiduciary duties under applicable law and, with respect to a Company Board Recommendation Change in response to a Superior Proposal, the Company Board has determined in good faith (after consultation with financial advisor and outside counsel) that such initial or revised (as applicable) Superior Proposal continues to constitute a Superior Proposal; <u>provided</u> that, if there are any material amendments, revisions or changes to the terms of any such Superior Proposal (including any revision to the amount, form or mix of consideration the Company&#146;s stockholders would receive as a result of the Superior Proposal, whether or not material), the Company shall notify the Parent of each such amendment, revision or change in compliance with Section&nbsp;6.1(c)&nbsp;and the applicable four (4)&nbsp;Business Day period described above shall be extended until at least two (2)&nbsp;Business Days after</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">39<a name="PB_39_105410_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='39',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the time that the Parent receives notification from the Company of each such amendment, revision or change and the Company Board shall not make a Company Board Recommendation Change prior to the end of any such period as so extended and compliance with the other requirements described above during such period as so extended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notices to the Parent</u>.&#160; The Company shall promptly (and in any event within one (1)&nbsp;Business Day) advise the Parent orally and in writing of the Company&#146;s receipt of any Acquisition Proposal, including the material terms and conditions of any such Acquisition Proposal and the identity of the Person making any such Acquisition Proposal.&#160; Thereafter, the Company shall keep Parent reasonably informed on a reasonably prompt basis of any material developments with respect to any such Acquisition Proposal, including any material changes to the terms thereof.&#160; The Company shall promptly (and, in any event, within one (1)&nbsp;Business Day) provide Parent with copies of all written requests, proposals or offers, including proposed agreements, and oral summaries of any material oral requests, proposals or offers, received by or made to the Company&#160; from any Person or group making an Acquisition Proposal.&#160; The Company shall not enter into any confidentiality agreement subsequent to the date hereof which prohibits the Company from providing to Parent the information required to be provided to Parent pursuant to this Section&nbsp;6.1(c).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Certain Permitted Disclosure</u>.&#160; Notwithstanding anything to the contrary in this Agreement, nothing contained in this Agreement&nbsp;shall prohibit the Company or the Company Board from (i)&nbsp;taking and disclosing to its stockholders a position with respect to a tender offer contemplated by Rule&nbsp;14d-9 or Rule&nbsp;14e-2 promulgated under the Exchange Act, or from issuing a &#147;stop, look and listen&#148; statement pending disclosure of its position thereunder (any &#147;stop, look and listen&#148; communication, in and of itself, shall not be deemed to constitute a Company Board Recommendation Change), or (ii)&nbsp;making any disclosure to the Company&#146;s stockholders if, in the good faith judgment of the Company Board, after consultation with outside counsel, failure to so disclose would be reasonably likely to be inconsistent with its fiduciary duties under applicable law; <u>provided</u> that this Section&nbsp;6.1(d)&nbsp;shall not permit the Company Board of Directors to make a Company Board Recommendation Change except to the extent expressly permitted by, and in accordance with, Section&nbsp;6.1(b).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Cessation of Ongoing Discussions</u>.&#160; The Company shall, and shall cause its Representatives to, except with respect to the Parent and the Purchaser, (i)&nbsp;cease immediately all discussions and negotiations that commenced prior to the date of this Agreement regarding any proposal that constitutes, or could reasonably be expected to lead to, an Acquisition Proposal, (ii)&nbsp;request the prompt return or destruction of all confidential or non-public information previously furnished to any Person within the last twelve (12) months for the purpose of evaluating a possible Acquisition Proposal and (iii)&nbsp;terminate access to any physical or electronic data rooms relating to a possible Acquisition Proposal; <u>provided</u>, <u>however</u>, that the foregoing shall not in any way limit or modify any of the Company&#146;s rights under the other provisions of this Section&nbsp;6.1.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Nasdaq Listing</u>.&#160; The Company shall use its commercially reasonable efforts to continue the listing of the Company Common Stock on the Nasdaq Stock Market until the Effective Time.&#160; Each of the parties hereto agrees to cooperate with the other parties hereto and to use its reasonable best efforts to take or cause to be taken, all actions necessary to delist the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">40<a name="PB_40_105422_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='40',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Common Stock from the Nasdaq Stock Market as promptly as possible following the Effective Time and the deregistration of the Company Common Stock under the Exchange Act as promptly as practicable after such delisting.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Confidentiality; Access to Information</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as expressly modified herein, the Confidentiality Agreement shall continue in full force and effect in accordance with its terms.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>During the Pre-Closing Period, notwithstanding anything in the Confidentiality Agreement to the contrary, the Company shall (and shall cause each of its Subsidiaries to)&nbsp;afford to the Parent and the Parent&#146;s Representatives, reasonable access, upon reasonable notice, during normal business hours and in a manner that does not unreasonably disrupt or interfere with business operations, to all of its employees (subject to this Section&nbsp;6.3(b)), properties, books, contracts and records as the Parent shall reasonably request, and, during such period, the Company shall (and shall cause each of its Subsidiaries to)&nbsp;furnish promptly to the Parent (i)&nbsp;a copy of each report, schedule, registration statement and other document filed or received by it during such period pursuant to the requirements of federal or state securities laws and (ii)&nbsp;all other information concerning its employees (subject to this Section&nbsp;6.3(b)), business, properties and assets as the Parent may reasonably request; <u>provided</u>, <u>however</u>, that the Company shall not be required to permit any inspection or other access, or to disclose any information, (A)&nbsp;to the extent related to an Acquisition Proposal or a Trigger Event (except as otherwise required by the terms of this Agreement), or (B)&nbsp;that in the reasonable judgment of the Company (after consultation with outside legal counsel) would: (1)&nbsp;violate any legal requirement or contract (including confidentiality provisions thereof), or (2)&nbsp;jeopardize protections afforded the Company under the attorney-client privilege or the attorney work product doctrine (so long as in connection with this clause (B)&nbsp;the Company has used commercially reasonable efforts to make appropriate substitute arrangements to permit reasonable disclosure, to the extent permitted by applicable law and practicable under the circumstances); <u>provided</u>  <u>further</u>, that the Company shall not be required to provide access to its employees (other than senior management) other than pursuant to a reasonable integration plan that has been agreed in good faith by the Company and the Parent or as otherwise reasonably approved by the Company; <u>provided</u>  <u>further</u> that the Company shall only be required to provide access to its senior management (other than the Chief Executive Officer of the Company) following reasonable advance notice from Parent to the Chief Executive Officer of the Company.&#160; Any such information shall be subject to the Confidentiality Agreement.&#160; Notwithstanding anything in the Confidentiality Agreement to the contrary, during the Pre-Closing Period, subject to compliance with applicable law, Parent and its Representatives shall be permitted to contact or communicate with any of the licensors, customers or suppliers of the Company or any of its Subsidiaries after providing notice to the Company it being understood that nothing herein shall restrict Parent&#146;s ability to contact or interact with any such persons for reasons other than related to this Agreement and the transactions contemplated hereby.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Reasonable Best Efforts</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to the terms hereof, including Section&nbsp;6.1, Section&nbsp;6.4(b), Section&nbsp;6.4(c)&nbsp;and Section&nbsp;6.4(d), each party hereto shall each use its reasonable best efforts to:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">41<a name="PB_41_105434_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='41',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>take, or cause to be taken, all actions, and do, or cause to be done, and to assist and cooperate with the other parties hereto in doing, all things necessary, proper or advisable to consummate and make effective the transactions contemplated hereby as promptly as practicable;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as promptly as practicable, obtain any consents, licenses, permits, waivers, approvals, authorizations, or orders required to be obtained by such party (or any of its Subsidiaries) from any Governmental Entity or third party in connection with the authorization, execution and delivery of this Agreement and the consummation of the transactions contemplated hereby; <u>provided, however</u>, that in no event shall the Parent, the Purchaser, the Company or any of their respective Subsidiaries be required to pay any monies (except for filings or similar fees) or (except, in the case of the Parent or the Purchaser, as contemplated by, and subject to, Section&nbsp;6.4(d)) agree to any material undertaking in connection with any of the foregoing;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>as promptly as practicable, make all necessary filings, and thereafter make any other required submissions, with respect to this Agreement, the Offer and the Merger required under (A)&nbsp;the Exchange Act, and any other applicable federal or state securities laws, (B)&nbsp;the HSR Act, any other applicable Antitrust Laws and any related governmental request thereunder and (C)&nbsp;any other applicable law;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>contest and resist any action, including any administrative or judicial action, and seek to have vacated, lifted, reversed or overturned any decree, judgment, injunction or other order (whether temporary, preliminary or permanent) (a &#147;<u>Restrictive Order</u>&#148;) which has the effect of prohibiting consummation of the Offer or making the Merger illegal or otherwise prohibiting consummation of the Offer, the Merger or the other transactions contemplated by this Agreement; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>execute or deliver any additional instruments necessary to consummate the transactions contemplated by, and to fully carry out the purposes of, this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The parties hereto shall cooperate with each other in connection with the making of all such filings and submissions contemplated by the foregoing clauses (ii)&nbsp;or (iii), including providing copies of all such documents to the non-filing Person and its advisors prior to filing and, if requested, accepting reasonable additions, deletions or changes suggested in connection therewith.&#160; Each party hereto shall use its reasonable best efforts to furnish to each other all information required for any application or other filing to be made pursuant to any applicable law in connection with the transactions contemplated by this Agreement.&#160; Notwithstanding the foregoing, each party may, as each determines is reasonably necessary, designate competitively sensitive material provided to the other pursuant to this Section&nbsp;6.4 as &#147;Outside Counsel Only.&#148; Such materials and the information contained therein shall be given only to the outside legal counsel of the recipient and will not be disclosed by such outside counsel to directors, officers or employees of the recipient unless express permission is obtained in advance from the source of the materials (Parent or Company, as the case may be) or its legal counsel.&#160; For the avoidance of doubt, nothing contained in this Section&nbsp;6.4(a)&nbsp;shall limit any obligation under any other provision in this Section&nbsp;6.4.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">42<a name="PB_42_105543_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='42',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Without limiting the generality of anything contained in this Section&nbsp;6.4, each of the Parent and the Company shall as soon as reasonably practicable and in any event within ten (10)&nbsp;Business Days following the date of this Agreement, if required, make an appropriate filing of a Notification and Report Form&nbsp;pursuant to the HSR Act (including seeking early termination of the waiting period under the HSR Act) with respect to the transactions contemplated by this Agreement. None of the Parent, the Purchaser or the Company shall commit to or agree with any Governmental Entity to stay, toll or extend any applicable waiting period under the HSR Act or other applicable Antitrust Laws or enter into a timing agreement with any Governmental Entity, without the prior written consent of the other parties.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to the terms hereof, and without limiting the Parent&#146;s obligations under Section&nbsp;6.4(d), the parties hereto shall, and shall cause each of their respective Subsidiaries to, cooperate and use their respective reasonable best efforts to obtain any government clearances or approvals required for the Closing under any Antitrust Law, to respond to any government requests for information under any Antitrust Law, to cause any waiting periods under any applicable Antitrust Laws to expire or be terminated, and to contest and resist any action, including any legislative, administrative or judicial action, and to have vacated, lifted, reversed or overturned any Restrictive Order.&#160; The parties hereto shall consult and cooperate with one another, and consider in good faith the views of one another, in connection with, and provide to the other parties in advance, any analyses, appearances, presentations, memoranda, briefs, arguments, opinions and proposals made or submitted by or on behalf of any party hereto in connection with proceedings under or relating to any Antitrust Law.&#160; To the extent permitted by law or Governmental Entities reviewing the transactions contemplated by this Agreement, the parties will provide each other the opportunity to participate in meetings and other substantive conversations with any such Governmental Entities.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Notwithstanding anything to the contrary in this Agreement, the Parent shall propose, negotiate, offer to commit and effect (and if such offer is accepted, commit to and effect), by consent decree, hold separate order or otherwise, the sale, divestiture or disposition of such assets or businesses of the Parent or, effective as of the Effective Time, the Surviving Corporation, or their respective Subsidiaries, or otherwise offer to take or offer to commit to take any action which it is capable of taking and if the offer is accepted, take or commit to take such action that limits its freedom of action with respect to, or its ability to retain, any of the businesses, services or assets of the Parent, the Surviving Corporation or their respective Subsidiaries, in order to avoid the entry of, or to effect the dissolution of, any Restrictive Order, which would have the effect of preventing or delaying the Acceptance Time beyond the Outside Date; <u>provided</u>, <u>however</u>, that neither the Parent nor any of its Subsidiaries shall be required to take any of the actions under this Section&nbsp;6.4(d)&nbsp;or any other provision of Section&nbsp;6.4 that would reasonably be expected to have, either individually or in the aggregate, a material adverse effect on the Parent, the Company, or any of their respective Subsidiaries.&#160; For the purposes of this provision, a material adverse effect shall be measured relative to the size of the Company and its Subsidiaries taken as a whole, regardless of whether such actions are imposed on, or affect, the Parent, the Company, or any of their respective Subsidiaries.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For the avoidance of doubt, subject to Section&nbsp;6.4(d), the Parent shall take any and all actions necessary in order to ensure that (i)&nbsp;no requirement for a waiver, consent, approval or termination of applicable waiting periods of the Federal Trade Commission, the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">43<a name="PB_43_105552_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='43',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Antitrust Division of the Department of Justice, any State Attorney General or other Governmental Entity and (ii)&nbsp;no decree, judgment, injunction, temporary restraining order or any other order in any suit or proceeding, in each case pursuant to any Antitrust Law, would preclude consummation of the Offer or the Merger by the Outside Date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Public Disclosure</u>.&#160; Except as may be required by law or stock market regulations, (a)&nbsp;the press release announcing the execution of this Agreement shall be issued only in such form as shall be mutually agreed upon by the Company and the Parent and (b)&nbsp;the Parent and the Company shall use their respective commercially reasonable efforts to consult with the other party before issuing any other press release or otherwise making any public statement with respect to the Offer, the Merger or this Agreement that is not limited to previously approved statements; <u>provided</u>, <u>however</u>, that these restrictions shall not apply to any Company communications (or the Parent&#146;s or the Purchaser&#146;s response thereto) in connection with an Acquisition Proposal, a Trigger Event or a Recommendation Change Notice.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Indemnification</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From and after the Acceptance Time, each of the Parent and, from and after the Effective Time, the Surviving Corporation shall, jointly and severally, indemnify and hold harmless each Indemnified Party against all claims, losses, liabilities, damages, judgments, fines and reasonable fees, costs and expenses, including attorneys&#146; fees and disbursements, incurred in connection with any claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of or pertaining to the fact that the Indemnified Party is or was an officer, director, manager, employee or agent of the Company or any of its Subsidiaries or, while a director, manager or officer of the Company or any of its Subsidiaries, is or was serving at the request of the Company or one of its Subsidiaries as an officer, director, manager, employee or agent of another Person, in respect of acts or omissions occurring or alleged to have occurred at or prior to the Effective Time, whether asserted or claimed prior to, at or after the Effective Time, in each case to the fullest extent that the Company would have been permitted to do so under applicable law.&#160; Each Indemnified Party will be entitled to advancement of expenses (including attorneys&#146; fees) incurred in the defense of any such claim, action, suit, proceeding or investigation from each of the Parent and the Surviving Corporation (without duplication) within ten (10)&nbsp;Business Days of receipt by the Parent from the Indemnified Party of a request therefor; <u>provided</u> that any Indemnified Party to whom expenses are to be advanced provides prior to any receipt of such advances an undertaking, to the extent required by the DGCL or other applicable law, to repay such advances if it is determined by a final determination of a court of competent jurisdiction (which determination is not subject to appeal) that such Indemnified Party is not entitled to indemnification under applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From the Effective Time through the six-year anniversary of the date on which the Effective Time occurs, the certificate of incorporation and bylaws of the Surviving Corporation shall contain, and the Parent shall cause the certificate of incorporation and bylaws of the Surviving Corporation to so contain, provisions no less favorable with respect to indemnification, advancement of expenses and exculpation of present and former directors and officers of the Company and its Subsidiaries in respect of acts or omissions occurring or alleged</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">44<a name="PB_44_105605_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='44',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-09.htm',USER='107541',CD='Feb 14 12:03 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">to have occurred at or prior to the Effective Time than are set forth in the certificate of incorporation and bylaws of the Company as in effect on the date of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Subject to this Section&nbsp;6.6(c), the Surviving Corporation shall either (i)&nbsp;maintain, and the Parent shall cause the Surviving Corporation to maintain, at no expense to the beneficiaries, in effect for six (6)&nbsp;years from the Effective Time the Current D&amp;O Insurance with respect to matters existing or occurring at or prior to the Effective Time (including the transactions contemplated by this Agreement), so long as the annual premium therefor would not exceed the Maximum Premium, or (ii)&nbsp;purchase a Reporting Tail Endorsement and maintain such endorsement in full force and effect for its full term;.&#160; Subject to this Section&nbsp;6.6(c), if the Company&#146;s or the Surviving Corporation&#146;s existing insurance contemplated by the prior sentence expires, is terminated or canceled during such six-year period or exceeds the Maximum Premium, the Surviving Corporation shall obtain, and the Parent shall cause the Surviving Corporation to obtain, as much directors&#146; and officers&#146; liability insurance as can be obtained for the remainder of such period for an annualized premium not in excess of the Maximum Premium, on terms and conditions no less advantageous, in the aggregate, to the Indemnified Parties than the Current D&amp;O Insurance.&#160; Notwithstanding anything to the contrary in this Agreement, the Company may, and the Company shall if requested by Parent, prior to the Acceptance Time, purchase a Reporting Tail Endorsement (after reasonable consultation with the Parent), provided that the Company does not pay or commit to pay, in the aggregate, more than the Maximum Premium for such Reporting Tail Endorsement without discussing in good faith with the Parent the Company&#146;s discussions with its insurers, the quoted cost and reasons therefor and considering in good faith any alternatives that the Parent may suggest to the Company in lieu of obtaining such Reporting Tail Endorsement.&#160; If a Reporting Tail Endorsement has been purchased by the Company prior to the Acceptance Time, the Parent shall cause such Reporting Tail Endorsement to be maintained in full force and effect for its full term and cause all obligations thereunder to be honored by the Surviving Corporation and, in such case, the Parent&#146;s and the Surviving Corporation&#146;s obligations under this Section&nbsp;6.6(c)&nbsp;shall be deemed satisfied.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In the event the Parent or the Surviving Corporation or any of their respective successors or assigns (i)&nbsp;consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii)&nbsp;transfers all or substantially all of its properties and assets to any Person, then, and in each such case, proper provision shall be made so that the successors and assigns of the Parent or the Surviving Corporation, as the case may be, shall expressly assume (or assume by operation of law) and succeed to the obligations set forth in this Section&nbsp;6.6.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any Indemnified Party makes any claim for indemnification or advancement of expenses under this Section&nbsp;6.6 that is denied by the Parent and/or the Company or the Surviving Corporation, and a court of competent jurisdiction determines that the Indemnified Party is entitled to such indemnification or advancement of expenses, then the Parent, the Company or the Surviving Corporation shall pay the Indemnified Party&#146;s costs and expenses, including reasonable legal fees and expenses, incurred by the Indemnified Party in connection with pursuing his or her claims to the fullest extent permitted by law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The provisions of this Section&nbsp;6.6 are intended to be in addition to the rights otherwise available to any Indemnified Party by law, charter, statute, bylaw or agreement,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">45<a name="PB_45_105758_8523"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='45',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and shall operate for the benefit of, and shall be enforceable by, each of the Indemnified Parties and their heirs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.7</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Notification of Certain Matters</u>.&#160; Prior to the Specified Time, the Parent shall give prompt notice to the Company, and the Company shall give prompt notice to the Parent, of (a)&nbsp;the occurrence, or failure to occur, of any event, which occurrence or failure to occur is reasonably likely to cause any representation or warranty of such Person (or, in case of the Parent&#146;s obligation to provide notice, any representation or warranty of the Purchaser) contained in this Agreement to be untrue or inaccurate (i)&nbsp;in the case of any representation or warranty of the Company, in any manner that would result in the failure of the condition set forth in clause (c)(ii)&nbsp;of <u>Annex I</u> or (ii)&nbsp;in the case of any representation or warranty of the Parent or the Purchaser, in any material respect, in each case at any time from and after the date of this Agreement until the Specified Time or (b)&nbsp;any material breach by such Person (or, in case of the Parent&#146;s obligation to provide notice, any material breach by the Purchaser) of any covenant or agreement set forth in this Agreement.&#160; The delivery of any notice pursuant to this Section&nbsp;6.7 shall not affect or be deemed to modify any representation or warranty in this Agreement or the conditions to the obligations of the parties to consummate the transactions contemplated by this Agreement or the remedies available to the parties hereunder.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.8</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Employee Benefits Matters</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From and after the Effective Time, the Parent shall, and shall cause the Company (including the Surviving Corporation) to, carry out all employer responsibilities under all Company Employee Plans in accordance with their terms as in effect immediately before the Effective Time.&#160; For a period of one year following the Effective Time, the Parent shall provide, or shall cause to be provided, to each Company Employee (i)&nbsp;a base salary, commission opportunities, annual bonus opportunities and the value of annual equity awards no less favorable in the aggregate than the total compensation package (including base salary, commission opportunities, annual bonus opportunities and value of annual equity awards) provided to such Company Employee immediately before the Effective Time and (ii)&nbsp;other employee benefits that are substantially comparable, in the aggregate, to the other benefits provided to such Company Employee immediately before the Effective Time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>For all purposes (including purposes of vesting, eligibility to participate and level of benefits) under the New Plans, each Company Employee shall, subject to applicable law and applicable tax qualification requirements, be credited with his or her years of service with the Company and its Subsidiaries and their respective predecessors before the Effective Time, to the same extent as such Company Employee was entitled, before the Effective Time, to credit for such service under any similar Company Employee Plan in which such Company Employee participated or was eligible to participate immediately prior to the Effective Time; <u>provided</u> that the foregoing shall not apply to the extent that its application would result in a duplication of benefits or for purposes of benefit accrual under any defined benefit plan.&#160; In addition, and without limiting the generality of the foregoing, (i)&nbsp;each Company Employee shall be immediately eligible to participate, without any waiting time, in any and all New Plans to the extent coverage under such New Plan is of the same type as the Company Employee Plan in which such Company Employee participated immediately before the Effective Time (such plans, collectively, the &#147;<u>Old Plans</u>&#148;), and (ii)(A)&nbsp;for purposes of each New Plan providing medical,</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">46<a name="PB_46_105813_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='46',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">dental, pharmaceutical or vision benefits to any Company Employee, the Parent shall use commercially reasonable efforts to cause all pre-existing condition exclusions and actively-at-work requirements of such New Plan to be waived for such Company Employee and his or her covered dependents, unless such conditions would not have been waived under the Old Plan of the Company or its Subsidiaries in which such Company Employee participated immediately prior to the Effective Time and (B)&nbsp;the Parent shall use commercially reasonable efforts to cause any eligible expenses incurred by such employee and his or her covered dependents during the portion of the plan year of the Old Plan ending on the date such employee&#146;s participation in the corresponding New Plan begins to be taken into account under such New Plan for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such employee and his or her covered dependents for the applicable plan year as if such amounts had been paid in accordance with such New Plan.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>If any Company Employee (who is not otherwise a party to an employment agreement providing for severance benefits) whose employment is terminated on or prior to the first anniversary of the Effective Time under circumstances under which such Company Employee would have received severance benefits under the Company Severance Practices, the Parent will cause the Surviving Corporation to provide that such Company Employee shall be entitled to severance benefits from the Surviving Corporation that are equal to the severance benefits that would have been paid under the Company Severance Practices as in existence on the date of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>From and after the Effective Time, the Parent shall cause the Surviving Corporation and its Subsidiaries to assume in accordance with their terms, all contracts, agreements, arrangements, policies, plans and commitments of the Company and the Subsidiaries of the Company as in effect immediately prior to the Acceptance Time that are applicable to any current or former employees or directors of the Company or any Subsidiary of the Company.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The provisions of Sections&nbsp;6.8(a)&nbsp;through 6.8(c)&nbsp;shall not apply to persons employed by the Company or any of its Subsidiaries outside the United States, it being agreed that such persons shall be treated in accordance with applicable law and the terms of any contracts covering them.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>At the request of the Parent made at least five (5)&nbsp;Business Days prior to the Closing Date, the Company shall take all steps necessary to terminate the Cynosure,&nbsp;Inc. 401(k)&nbsp;Plan and any and all of the Company Employee Plans that are intended to be qualified within the meaning of Sections 401(a)&nbsp;and 401(k)&nbsp;of the Code (such plans, the &#147;<u>Company 401(k)&nbsp;Plans</u>&#148;), with such termination to be effective as of the day immediately prior to the Closing Date and reflected in the resolutions of the Company Board (the form and substance of which resolutions shall be subject to the prior review and approval of the Parent).&#160; In connection with the termination of the Company 401(k)&nbsp;Plans, the Parent shall use commercially reasonable efforts to permit each Company Employee to make rollover contributions of &#147;eligible rollover distributions&#148; (within the meaning Section&nbsp;401(a)(31) of the Code), in an amount equal to the full account balance distributed or distributable to such Company Employee from each Company 401(k)&nbsp;Plan, including, subject to vendor&#146;s capabilities and procedures, notes evidencing any</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">47<a name="PB_47_105829_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='47',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">outstanding loans, from such Company 401(k)&nbsp;Plan to a Parent 401(k)&nbsp;plan that is qualified within the meaning of Sections 401(a)&nbsp;and 401(k)&nbsp;of the Code.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Without limiting Section&nbsp;10.4, nothing in this Agreement shall confer upon any Company Employee any right to continue in the employ or service of the Parent, the Surviving Corporation or any Affiliate of the Parent, or shall interfere with or restrict in any way the rights of the Parent, the Surviving Corporation or any Affiliate of Parent to discharge or terminate the services of any Company Employee at any time for any reason whatsoever, with or without cause.&#160; Nothing in this Section&nbsp;6.8 shall (i)&nbsp;be deemed or construed to be an amendment or other modification of any Company Employee Plan or employee benefit plan of the Parent or any of its Affiliates, or (ii)&nbsp;create any third-party rights in any current or former service provider of the Company or its Affiliates (or any beneficiaries or dependents thereof).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.9</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>State Takeover Laws</u>.&#160; If any &#147;fair price,&#148; &#147;business combination&#148; or &#147;control share acquisition&#148; statute or other similar anti-takeover statute or regulation (collectively, an &#147;<u>Anti-Takeover Law</u>&#148;) is or may become applicable to any of the transactions contemplated by this Agreement, the Company, the Company Board, Parent and Purchaser, as applicable, each shall use its respective reasonable best efforts to (a)&nbsp;take such actions as are reasonably necessary so that the transactions contemplated hereunder may be consummated as promptly as practicable on the terms contemplated hereby and (b)&nbsp;otherwise take all such actions as are necessary to eliminate the effects of any such statute or regulation on such transactions; <u>provided</u> that, the Parent and the Purchaser shall only be required to take any action pursuant to this Section&nbsp;6.9 if they have received written notice from the Company regarding the applicability of such Anti-Takeover Law and the Company has requested in such written notice that the Parent and the Purchaser take specified actions to render such Antitakeover Law inapplicable.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.10</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Rule&nbsp;16b-3</u>.&#160; Prior to the Effective Time, the Company shall take all reasonable steps as may be required to cause any dispositions of Company equity securities (including derivative securities) pursuant to the transactions contemplated by this Agreement by each individual who is a director or officer of the Company and who would otherwise be subject to Rule&nbsp;16b-3 promulgated under the Exchange Act to be exempt under such rule&nbsp;to the extent permitted by applicable law.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.11</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Rule&nbsp;14d-10 Matters</u>.&#160; Notwithstanding anything herein to the contrary, the Company shall not, from and after the date hereof and until the Specified Time, enter into, establish, amend or modify any plan, program, agreement or arrangement pursuant to which compensation is paid or payable, or pursuant to which benefits are provided, in each case, to any current or former director, manager, officer, employee or independent contractor of the Company, unless prior to such entry into, establishment, amendment or modification, the compensation committee of the Company Board (each member of which the Company Board determined is an &#147;independent director&#148; within the meaning of the applicable Nasdaq Marketplace Rules&nbsp;and shall be an &#147;independent director&#148; in accordance with the requirements of Rule&nbsp;14d-10(d)(2)&nbsp;under the Exchange Act at the time of any such action) shall have taken all such steps as may reasonably be necessary to (a)&nbsp;approve as an &#147;employment compensation, severance or other employee benefit arrangement&#148; within the meaning of Rule&nbsp;14d-10(d)(1)&nbsp;under the Exchange Act each such plan, program or arrangement, and (b)&nbsp;satisfy the requirements of the non-exclusive safe harbor under Rule&nbsp;14d-10(d)(2)&nbsp;under the Exchange Act</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">48<a name="PB_48_105842_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='48',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with respect to such plan, program, agreement or arrangement; <u>provided</u> that nothing in this Section&nbsp;6.11 shall be construed to permit the Company to take any action that is expressly prohibited by the terms of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.12</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Control of Operations</u>.&#160; Without in any way limiting any party&#146;s rights or obligations under this Agreement, (a)&nbsp;nothing contained in this Agreement shall give the Parent or the Purchaser, directly or indirectly, the right to control or direct the Company&#146;s operations prior to the Acceptance Time and (b)&nbsp;prior to the Acceptance Time, the Company shall exercise, subject to the terms and conditions of this Agreement, complete control and supervision over its and its Subsidiaries&#146; operations.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.13</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Security Holder Litigation</u>.&#160; In the event that any litigation related to this Agreement, the Offer, the Merger or the other transactions contemplated hereby is brought by any stockholder of the Company or any holder of the Company&#146;s other securities against the Company and/or its directors or officers, the Company shall promptly notify Parent of such litigation and shall keep Parent reasonably informed with respect to the status thereof.&#160; Notwithstanding anything to the contrary herein (but subject to the following sentence), the Company shall have the right to control the defense of any litigation related to this Agreement, the Offer, the Merger or the other transactions contemplated by this Agreement brought by any stockholder of the Company or any holder of the Company&#146;s other securities against the Company and/or its directors or officers, provided that the Company shall give the Parent the opportunity to participate, at the Parent&#146;s expense, in the defense of any such litigation and the Company shall give due consideration to the Parent&#146;s advice with respect to such litigation.&#160; Notwithstanding anything to the contrary contained in this Agreement, the Company shall not settle or enter into any negotiations or agreement with respect to the settlement of any such litigation without the prior written consent of Parent (which consent shall not be unreasonably conditioned, withheld or delayed (provided that Parent shall not withhold its consent if the settlement involves (a)&nbsp;solely the payment of an aggregate amount not to exceed $350,000 and supplemental disclosure (provided that the Parent shall be given reasonable opportunity to review and comment on any supplemental disclosure and the Company shall consider in good faith any reasonable changes thereto proposed by Parent) , (b)&nbsp;no admission of wrongdoing or liability, (c)&nbsp;no injunctive or similar relief, (d)&nbsp;a complete and unconditional release of all defendants in respect of all disclosure claims then pending relating to this Agreement, the Offer, the Merger or the other transactions contemplated hereby and (e)&nbsp;the withdrawal or dismissal of all claims and actions then pending relating to this Agreement, the Offer, the Merger or the other transactions contemplated hereby)).&#160; Each of the Parent and the Company shall notify the other promptly of the commencement of any such stockholder litigation of which it has received notice.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.14</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Director Resignations</u>.&#160; Prior to the then-scheduled expiration of the Offer, the Company shall use its reasonable best efforts to cause to be delivered to Parent resignations executed by each director of the Company in office as of immediately prior to the Effective Time and effective upon the Effective Time (resigning from all directorships with the Company and its Subsidiaries).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">49<a name="PB_49_105853_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='49',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;VII</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CONDITIONS TO MERGER</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Conditions to Each Party&#146;s Obligation To Effect the Merger</u>.&#160; The respective obligations of each party hereto to effect the Merger shall be subject to the satisfaction on or prior to the Closing Date of the following conditions:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Completion of the Offer</u>.&#160; The Parent or the Purchaser shall have irrevocably accepted for purchase all shares of Company Common Stock validly tendered (and not validly withdrawn) pursuant to the Offer.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>No Injunctions</u>.&#160; No Governmental Entity of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any order, executive order, temporary restraining order, stay, decree, judgment or injunction (preliminary or permanent)&nbsp;or statute, rule&nbsp;or regulation which is in effect and which has the effect of making the Merger illegal or otherwise prohibiting consummation of the Merger.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;VIII</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TERMINATION AND AMENDMENT</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.1</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Termination</u>.&#160; This Agreement may be terminated and the Offer and the Merger may be abandoned (with respect to Sections&nbsp;8.1(b)&nbsp;through 8.1(i), by written notice by the terminating party to the other party) (with any termination by the Parent also being an effective termination by the Purchaser):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by mutual written consent of the Parent and the Company at any time prior to the Acceptance Time;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by either the Parent or the Company at any time prior to the Acceptance Time if the Acceptance Time shall not have occurred on or before 11:59 p.m., Eastern Time, on the Outside Date (provided that the right to terminate this Agreement pursuant to this Section&nbsp;8.1(b)&nbsp;shall not be available to any party hereto if the failure of such party (or, in the case of the Parent, Purchaser) to fulfill any obligation under this Agreement has been a principal cause of or resulted in the failure of the Acceptance Time to occur on or before the Outside Date);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by either the Parent or the Company at any time prior to the Acceptance Time if a Governmental Entity of competent jurisdiction shall have issued a nonappealable final order, decree or ruling or taken any other nonappealable final action, in each case having the effect of permanently restraining, enjoining or otherwise prohibiting the acceptance for payment of, and payment for, shares of Company Common Stock pursuant to the Offer or consummation of the Merger; <u>provided</u>, <u>however</u>, that a party hereto shall not be permitted to terminate this Agreement pursuant to this Section&nbsp;8.1(c)&nbsp;if the failure of such party (or, in the case of the Parent, Purchaser) to fulfill any obligation under this Agreement has been a principal cause of or resulted in the issuance of any such order, decree, ruling or the taking of such other action;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">50<a name="PB_50_105907_7906"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='50',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Parent or the Company if the Offer (as it may have been extended pursuant to Section&nbsp;1.1(b)) expires as a result of the non-satisfaction of the Minimum Condition, without the Purchaser having accepted for payment any shares of Company Common Stock validly tendered (and not validly withdrawn) pursuant to the Offer; <u>provided</u>, <u>however</u>, that a party hereto shall not be permitted to terminate this Agreement pursuant to this Section&nbsp;8.1(d)&nbsp;if the failure of such party (or, in the case of the Parent, Purchaser) to fulfill any obligation under this Agreement has been a principal cause of or resulted in the non-satisfaction of the Minimum Condition;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Parent, prior to the Acceptance Time, if:&#160; (i)&nbsp;the Company Board shall have failed to recommend that the Company&#146;s stockholders accept the Offer and tender their shares of Company Common Stock to Purchaser pursuant to the Offer in the Schedule 14D-9 (or the Schedule 14D-9 at any point fails to include such recommendation); (ii)&nbsp;the Company Board shall have effected a Company Board Recommendation Change; or (iii)&nbsp;a tender offer or exchange offer for outstanding shares of Company Common Stock shall have been commenced (other than by the Parent or an Affiliate of the Parent) and the Company Board shall have recommended that the stockholders of the Company tender their shares in such tender or exchange offer or, within ten (10)&nbsp;Business Days after the commencement of such tender or exchange offer, the Company Board shall have failed to recommend against acceptance of such offer (each of clauses (i)&nbsp;through (iii), a &#147;<u>Trigger Event</u>&#148;);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Company, at any time prior to the Acceptance Time, in order to effect a Change of Recommendation and enter into a definitive agreement providing for a Superior Proposal; provided that (i)&nbsp;the Company has complied in all material respects with the terms of Section&nbsp;6.1(b)&nbsp;with respect to such Superior Proposal and (ii)&nbsp;immediately prior (and as a condition) to the termination of this Agreement, the Company pays the Parent the Termination Fee contemplated by Section&nbsp;8.3(b)(ii);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Parent, prior to the Acceptance Time, if there has been a breach of, inaccuracy in or failure to perform any of the Company&#146;s representations, warranties, covenants or agreements set forth in this Agreement, which breach, inaccuracy or failure to perform (i)&nbsp;would cause any of the conditions set forth in clauses (c)(ii)&nbsp;or (c)(iii)&nbsp;of <u>Annex I</u> not to be satisfied, and (ii)&nbsp;is not capable of being cured by the Outside Date or, if capable of being cured by the Outside Date, shall not have been cured within twenty (20) Business Days following receipt by the Company of written notice of such breach, inaccuracy or failure to perform from the Parent; <u>provided</u> that neither the Parent nor the Purchaser is then in material breach of any of its representations, warranties or covenants under this Agreement;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Company, prior to the Acceptance Time, if there has been a breach of, inaccuracy in or failure to perform any of the Parent&#146;s or the Purchaser&#146;s representations, warranties, covenants or agreements set forth in this Agreement, which breach, inaccuracy or failure to perform (i)&nbsp;shall have had or would reasonably likely to have, individually or in the aggregate, a Parent Material Adverse Effect and (ii)&nbsp;is not capable of being cured by the Outside Date or, if capable of being cured by the Outside Date, shall not have been cured within twenty (20) Business Days following receipt by the Parent of written notice of such breach, inaccuracy or failure to perform from the Company; <u>provided</u> that the Company is not then in material breach of any of its representations, warranties or covenants under this Agreement; or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">51<a name="PB_51_105922_3736"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='51',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Company (A)&nbsp;if the Purchaser shall have failed to commence (within the meaning of Rule&nbsp;14d-2 under the Exchange Act) the Offer within the time period specified in Section&nbsp;1.1(a); <u>provided</u> that the Company is not then in material breach of Section&nbsp;1.1(c)&nbsp;or Section&nbsp;1.2 or (B)&nbsp;if the Purchaser shall have failed to irrevocably accept for purchase all shares of Company Common Stock validly tendered (and not validly withdrawn) within two (2)&nbsp;Business Days of the expiration of the Offer (as it may be extended) and as of such expiration, all of the Offer Conditions have been satisfied or waived.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.2</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Effect of Termination</u>.&#160; In the event of termination of this Agreement as provided in Section&nbsp;8.1, this Agreement shall immediately become void and there shall be no liability or obligation on the part of the Parent, the Company, the Purchaser or their respective Representatives, stockholders or Affiliates (except as provided in Section&nbsp;8.3(d)); <u>provided</u> that, subject to Section&nbsp;8.3(d), (a)&nbsp;any such termination shall not relieve any party hereto from liability for fraud or any Willful Breach and (b)&nbsp;the provisions of Section&nbsp;6.3(a)&nbsp;(Confidentiality), this Section&nbsp;8.2 (Effect of Termination), Section&nbsp;8.3 (Fees and Expenses), Article&nbsp;IX (Defined Terms)&nbsp;and Article&nbsp;X (Miscellaneous)&nbsp;of this Agreement and the Confidentiality Agreement shall remain in full force and effect and survive any termination of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.3</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Fees and Expenses</u>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Except as set forth in this Section&nbsp;8.3, all fees and expenses incurred in connection with this Agreement and the transactions contemplated hereby shall be paid by the party incurring such fees and expenses, whether or not the Offer or the Merger is consummated.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The Company shall pay the Parent the Termination Fee in the event that this Agreement is terminated:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Parent pursuant to Section&nbsp;8.1(e);</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by the Company pursuant to Section&nbsp;8.1(f); or</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>by either the Parent or the Company pursuant to Section&nbsp;8.1(b)&nbsp;or Section&nbsp;8.1(d)&nbsp;or the Parent pursuant to Section&nbsp;8.1(g)&nbsp;(arising from a breach of the Company&#146;s covenants or agreements set forth in this Agreement), if (A)&nbsp;before the date of such termination, an Acquisition Proposal shall have been publicly announced and not irrevocably withdrawn at least two (2)&nbsp;Business Days prior to the earlier of the date of such termination, the Outside Date and the-then scheduled expiration date of the Offer and (B)&nbsp;within 12 months after the date of such termination, any Acquisition Proposal is consummated or a definitive agreement with respect to any Acquisition Proposal is entered into and such Acquisition Proposal is thereafter consummated;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">provided</font></u>, <u>however</u>, that, for purposes of Section&nbsp;8.3(b)(iii), all references to &#147;20%&#148; and &#147;80%&#148; in the definition of &#147;Acquisition Proposal&#148; shall be deemed to be references to &#147;50%&#148;.&#160; Any fee due under Section&nbsp;8.3(b)(i)&nbsp;shall be paid by or on behalf of the Company to the Parent by wire transfer of same-day funds within two (2)&nbsp;Business Days after the date of termination of this Agreement.&#160; Any fee due under Section&nbsp;8.3(b)(ii)&nbsp;shall be paid by or on behalf of the Company to the Parent by wire transfer of same-day funds prior to or simultaneously with (and as a condition to the effectiveness of) such termination.&#160; Any fee due under Section&nbsp;8.3(b)(iii)&nbsp;shall</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">52<a name="PB_52_105939_9621"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='52',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">be paid by or on behalf of the Company to the Parent by wire transfer of same-day funds within one (1)&nbsp;Business Day after the date any transaction referenced in clause (B)&nbsp;of Section&nbsp;8.3(b)(iii)&nbsp;is consummated.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In no event shall the Company be required to pay the Termination Fee on more than one occasion, whether or not the Termination Fee may be payable under more than one provision of this Agreement at the same or at different times and the occurrence of different events.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The agreements contained in this Section&nbsp;8.3 are an integral part of the transactions contemplated by this Agreement, and the parties hereto would not enter into this Agreement absent such agreement.&#160; Notwithstanding Section&nbsp;8.2 or any other provision of this Agreement, other than in the case of any Willful Breach of Section&nbsp;1.2, Section&nbsp;6.1 or Section&nbsp;6.4, payment of the fees described in this Section&nbsp;8.3 shall constitute the sole and exclusive remedy of the Parent and the Purchaser in connection with any termination of this Agreement in the circumstances in which such fees became payable.&#160; Other than in the case of any Willful Breach of Section&nbsp;1.2, Section&nbsp;6.1 or Section&nbsp;6.4, in the event that the Parent shall receive the Termination Fee, the receipt of such fee shall be deemed to be liquidated damages for any and all losses or damages suffered or incurred by the Parent, the Purchaser, any of their respective Affiliates or any other Person in connection with this Agreement (and the termination hereof), the transactions contemplated hereby (and the abandonment thereof) or any matter forming the basis for such termination, and none of the Parent, the Purchaser, any of their respective Affiliates or any other Person shall be entitled to bring or maintain any other claim, action or proceeding against the Company or any of its Affiliates or any Representative of the Company or any of its Affiliates arising out of this Agreement, any of the transactions contemplated hereby or any matters forming the basis for such termination.&#160; If the Company fails promptly to pay the Termination Fee when due and payable pursuant to this Agreement and, in order to obtain such payment, the Parent commences an action or other proceeding that results in an award against the Company for such fee, the Company shall pay interest on the amount of such fee from the date such payment was required to be made until the date of payment at the prime lending rate as published in <i>The Wall Street Journal</i> in effect on the date such payment was required to be made.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.4</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Amendment</u>.&#160; This Agreement may be amended by the Company, the Parent and Purchaser to the extent permitted by law; <u>provided</u> that following the Acceptance Time, this Agreement may not be amended in any manner that causes the Merger Consideration to differ from the Offer Price.&#160; This Agreement may not be amended except by an instrument in writing signed on behalf of each of the parties hereto.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.5</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Extension; Waiver</u>. &#160;At any time prior to the Effective Time, the parties hereto may, to the extent legally allowed, (a)&nbsp;extend the time for the performance of any of the obligations or other acts of the other parties hereto, (b)&nbsp;waive any inaccuracies in the representations and warranties contained herein or in any document delivered pursuant hereto and (c)&nbsp;waive compliance with any of the agreements or conditions contained herein.&#160; Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party.&#160; Such extension or waiver shall not apply to any time for performance, inaccuracy in any representation or warranty, or noncompliance with any agreement or condition, as the case may be, other than that which is</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">53<a name="PB_53_105953_8715"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='53',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">specified in the extension or waiver.&#160; The failure of any party hereto to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of such rights.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.6</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><u>Procedure for Termination, Amendment, Extension or Waiver</u>.&#160; A termination of this Agreement pursuant to Section&nbsp;8.1 shall, in order to be effective, require action by the respective Board of Directors of the applicable parties.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;IX</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DEFINED TERMS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following capitalized terms shall have the respective meanings set forth below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">&#147;<u>Acceptance Time</u>&#148; means the time at which </font>the Purchaser irrevocably accepts for purchase all shares of Company Common Stock validly tendered (and not validly withdrawn) pursuant to the Offer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Acquisition Proposal</u>&#148; means (a)&nbsp;any proposal or offer for a merger, consolidation, dissolution, recapitalization, share exchange, tender offer or other business combination involving the Company and its Subsidiaries (other than mergers, consolidations, recapitalizations, share exchanges, tender offers or other business combinations that if consummated would result in the holders of the outstanding shares of Company Common Stock immediately prior to such transaction owning more than 80% of the equity securities of the Company, or any successor or acquiring entity, immediately thereafter), (b)&nbsp;any proposal for the issuance by the Company of 20% or more of its equity securities or (c)&nbsp;any proposal or offer to acquire in any manner, directly or indirectly, 20% or more of the equity securities or consolidated total assets of the Company and its Subsidiaries, in each case other than the transactions contemplated by this Agreement or any offer or proposal by Parent or any Subsidiary of Parent.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Affiliate</u>&#148; when used with respect to any Person, means any other Person who is an &#147;affiliate&#148; of that first Person within the meaning of Rule&nbsp;405 promulgated under the Securities Act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Agreement</u>&#148; has the meaning set forth in the preamble.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Alternative Acquisition Agreement</u>&#148; has the meaning set forth in Section&nbsp;6.1(b)(ii).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Anti-Takeover Law</u>&#148; has the meaning set forth in Section&nbsp;6.9.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Antitrust Laws</u>&#148; means the HSR Act, the Sherman Act, the Clayton Act, the Federal Trade Commission Act, and any other applicable federal, state or foreign law, regulation or decree designed to prohibit, restrict or regulate actions for the purpose or effect of monopolization or restraint of trade.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Bankruptcy and Equity Exception</u>&#148; has the meaning set forth in Section&nbsp;3.4(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">54<a name="PB_54_110010_563"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='54',FILE='C:\JMS\107541\17-4436-1\task8277046\4436-1-kc-11.htm',USER='107541',CD='Feb 14 12:04 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Business Day</u>&#148; means any day, other than a Saturday, Sunday and any day which is a legal holiday under the laws of the State of New York or a day on which banking institutions located in New York, New York are permitted or required by law, executive order or governmental decree to remain closed.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Capitalization Date</u>&#148; means the close of business on February&nbsp;10, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Certificate</u>&#148; means a certificate that immediately prior to the Effective Time represents any shares of Company Common Stock.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Certificate of Merger</u>&#148; has the meaning set forth in Section&nbsp;2.2.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Closing</u>&#148; means the closing of the Merger.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Closing Date</u>&#148; means the date on which the Closing occurs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Code</u>&#148; means the Internal Revenue Code of 1986, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company</u>&#148; has the meaning set forth in the preamble.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Balance Sheet</u>&#148; means the consolidated unaudited balance sheet of the Company as of September&nbsp;30, 2016, as included in the Company SEC Reports filed prior to the date hereof.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Board</u>&#148; means the Board of Directors of the Company (together with any duly constituted and authorized committee thereof).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Board Recommendation</u>&#148; has the meaning set forth in Section&nbsp;1.2(b).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Board Recommendation Change</u>&#148; has the meaning set forth in Section&nbsp;6.1(b)(i).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Common Stock</u>&#148; means the Class&nbsp;A Common Stock, par value $0.001 per share, of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Disclosure Schedule</u>&#148; means the disclosure schedule delivered by the Company to the Parent and the Purchaser concurrently with the execution of this Agreement and dated as of the date of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Employee Plans</u>&#148; means any &#147;employee pension benefit plan&#148; (as defined in Section&nbsp;3(2)&nbsp;of ERISA), any &#147;employee welfare benefit plan&#148; (as defined in Section&nbsp;3(1)&nbsp;of ERISA) (in each case, whether or not such plan is subject to ERISA), and any other plan, policy, agreement or arrangement relating to insurance coverage, severance benefits, retention benefits, change in control benefits, employment, fringe benefits, supplemental benefits, disability benefits, deferred compensation, bonuses, stock options, stock purchase, phantom stock, stock appreciation or other forms of incentive compensation or post-retirement compensation, for the benefit of, or relating to, any current or former employee of the Company or any of its</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">55<a name="PB_55_105449_4535"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='55',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Subsidiaries and as to which the Company or any Subsidiary has any liability, but excludes any plan, agreement or arrangement required to be maintained by non-U.S. law.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Employees</u>&#148; means each employee of the Company and its Subsidiaries.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Intellectual Property</u>&#148; means any Intellectual Property owned or licensed, or purported to be owned or licensed, by the Company or any of its Subsidiaries.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Leases</u>&#148; means the leases, subleases or licenses pursuant to which the Company or any of its Subsidiaries leases, subleases or licenses from third parties any real property.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Material Adverse Effect</u>&#148; means any effect, change, event, occurrence or development that is materially adverse to the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole; <u>provided</u>, <u>however</u>, that no effect, change, event, occurrence or development resulting from, arising out of, attributable to, or related to any of the following shall be deemed to be or constitute a &#147;Company Material Adverse Effect,&#148; and no effect, change, event, occurrence or development resulting from, arising out of, attributable to, or related to any of the following shall be taken into account when determining whether a &#147;Company Material Adverse Effect&#148; has occurred or may, would or could occur: (a)&nbsp;general economic conditions (or changes in such conditions) in the United States or any other country or region in the world, or conditions in the global economy generally; (b)&nbsp;conditions (or changes in such conditions) in the securities markets, credit markets, currency markets or other financial markets in the United States or any other country or region in the world, including (i)&nbsp;changes in interest rates in the United States or any other country or region in the world and changes in exchange rates for the currencies of any countries and (ii)&nbsp;any suspension of trading in securities (whether equity, debt, derivative or hybrid securities) generally on any securities exchange or over-the-counter market operating in the United States or any other country or region in the world; (c)&nbsp;conditions (or changes in such conditions) in the industries in which the Company and its Subsidiaries conduct business; (d)&nbsp;political conditions (or changes in such conditions) in the United States or any other country or region in the world or acts of war, sabotage or terrorism (including any escalation or general worsening of any such acts of war, sabotage or terrorism) in the United States or any other country or region in the world; (e)&nbsp;earthquakes, hurricanes, tsunamis, tornadoes, floods, mudslides, wild fires or other natural disasters, weather conditions and other force majeure events in the United States or any other country or region in the world; (f)&nbsp;the announcement of this Agreement or the pendency or consummation of the transactions contemplated hereby, including the identity of the Parent (provided that this clause (f)&nbsp;shall not apply to any representation or warranty in Section&nbsp;3.4 and Section&nbsp;3.14(h)); (g)&nbsp;any actions taken or failure to take action, in each case, to which the Parent has approved, consented to or requested in each case in writing; or the taking of any action required by this Agreement (other than any action required by the first sentence of Section&nbsp;5.1), or the failure to take any action prohibited by this Agreement; (h)&nbsp;changes in law or other legal or regulatory conditions (including rules, regulations and administrative policies of the FDA), or the interpretation thereof, or changes in GAAP or other accounting standards (or the interpretation thereof); (i)&nbsp;any product candidate of the Company or any of its Subsidiaries, including any change, event, circumstance or development relating to the use or sale of any such product candidate, the suspension, rejection, refusal of, request to refile or any delay in obtaining</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">56<a name="PB_56_105515_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='56',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">or making any regulatory application or filing relating to any such product candidate, any other negative actions, requests, recommendations or decisions of the FDA or any other Governmental Entity relating to any such product candidate, any other regulatory development affecting any such product candidate, or the failure to conduct successful clinical trials on a timely basis for any such product candidate; (j)&nbsp;any product or product candidate of any Person (other than the Company and its Subsidiaries), including the entry into the market of any product competitive with any product or product candidate of the Company or any of its Subsidiaries; (k)&nbsp;any fees or expenses incurred in connection with the transactions contemplated by this Agreement; (l)&nbsp;changes in the Company&#146;s stock price or the trading volume of the Company&#146;s stock, or any failure by the Company to meet any public estimates or expectations of the Company&#146;s revenue, earnings or other financial performance or results of operations for any period, or any failure by the Company or any of its Subsidiaries to meet any internal budgets, plans or forecasts of its revenues, earnings or other financial performance or results of operations (but not, in each case, the underlying cause of such changes or failures, unless such changes or failures would otherwise be excepted from this definition); or (m)&nbsp;any legal proceedings made or brought by any of the current or former stockholders of the Company (on their own behalf or on behalf of the Company) against the Company, the Purchaser, the Parent or any of their directors or officers arising out of the Offer, the Merger or in connection with any other transactions contemplated by this Agreement; <u>provided</u> that that with respect to the exceptions set forth in clauses (a), (b), (c), (d), (e)&nbsp;and (h), if any such effect, change, event, occurrence or development has had a disproportionate adverse impact on the Company relative to other companies of comparable size to the Company operating in the industry in which the Company operates, then the incremental impact of such event shall be taken into account for the purpose of determining whether a &#147;Company Material Adverse Effect&#148; has occurred or may, would or could occur.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Material Contract</u>&#148; means any Contract to which the Company or one of its Subsidiaries is a party or by which any of them or any of their respective properties, rights or assets are bound that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; would be required to be filed by the Company as a &#147;material contract&#148; pursuant to Item 601(b)(10)&nbsp;of Regulation S-K under the Securities Act;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (i)&nbsp;prohibits or otherwise restricts, in any material respect, the Company or any of its Subsidiaries from freely engaging in any business anywhere in the world;&#160; (ii)&nbsp;requires the Company to conduct any business on a &#147;most favored nations&#148; basis with any third party or (iii)&nbsp;provides for &#147;exclusivity&#148; or any similar requirement in favor of a third party;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; provides for or governs the formation, creation, operation, management or control of any partnership, joint venture or similar arrangement;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; constitutes a license by the Company of any material Company Intellectual Property to any third party (other than as ancillary to a sale of products to customers) or a license pursuant to which the Company has rights to use any Intellectual Property (other than generally commercially available, off-the-shelf software programs) that is material to the Company and its Subsidiaries, taken as a whole;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">57<a name="PB_57_105541_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='57',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; constitutes a customer, manufacturing, supply, distribution or marketing agreement that provides for payment obligations by or to the Company of at least $1,000,000 or more in the past twelve (12) months or in any prospective twelve (12) month period;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; pursuant to which the Company has continuing guarantee, &#147;earn-out&#148; or other contingent payment obligations (other than indemnification or performance guarantee obligations provided for in the Ordinary Course of Business), in each case that would reasonably be expected to result in payments in excess of $1,000,000;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; constitutes a settlement, conciliation or similar agreement (A)&nbsp;that is with any Governmental Entity, (B)&nbsp;pursuant to which the Company is obligated after the date of this Agreement to pay consideration to a Governmental Entity or (C)&nbsp;that would otherwise limit the operation of the Company in any material respect after the Closing;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any Contract pursuant to which any indebtedness for borrowed money of the Company is outstanding with respect to a principal amount in excess of $1,000,000; and</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; was entered into after January&nbsp;1, 2014 and provides for the acquisition or disposition, directly or indirectly (by merger or otherwise), of a business, capital stock, other equity interests or all or substantially all the assets of another Person.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Permits</u>&#148; has the meaning set forth in Section&nbsp;3.16.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Preferred Stock</u>&#148; has the meaning set forth in Section&nbsp;3.2(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Product</u>&#148; means all &#147;drugs&#148; and &#147;devices&#148; (as those terms are defined in Section&nbsp;201 of the FDCA) and other products subject to the FDCA or any similar law in any foreign jurisdiction that are being researched, tested, developed, commercialized, manufactured, sold or distributed by or on behalf of the Company or any of its Subsidiaries.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company PSUs</u>&#148; mean any performance-based share units with respect to shares of Company Common Stock granted under any Company Stock Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company RSUs</u>&#148; mean restricted stock units with respect to shares of Company Common Stock granted under any Company Stock Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company SEC Reports</u>&#148; has the meaning set forth in Section&nbsp;3.5(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Severance Practices</u>&#148; means the Company&#146;s severance practices set forth in Section&nbsp;6.8(c)&nbsp;of the Company Disclosure Schedule.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Stock Option</u>&#148; means each option to purchase shares of Company Common Stock granted pursuant to any Company Stock Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company Stock Plan</u>&#148; means the Company&#146;s Amended and Restated 2005&nbsp;Stock Incentive Plan and the Company&#146;s 2004&nbsp;Stock Option Plan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">58<a name="PB_58_105805_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='58',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Company&#146;s Knowledge</u>&#148; or &#147;<u>Knowledge of the Company</u>&#148; means the actual knowledge as of the date hereof of the individuals identified in Section&nbsp;10.1 of the Company Disclosure Schedule, after reasonable inquiry of the employee with primary responsibility for the applicable subject matter.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Confidentiality Agreement</u>&#148; means the confidentiality agreement, dated as of January&nbsp;23, 2017, between the Company and the Parent.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Contract</u>&#148; means, with respect to any Person, any contract, lease, license, indenture, note, bond, agreement, concession, franchise or other legally binding instrument to which such Person or its Subsidiaries is a party or by which any of their respective properties, rights or assets is bound.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Current D&amp;O Insurance</u>&#148; means the directors&#146; and officers&#146; liability insurance policies maintained by the Company as of the date of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>DGCL</u>&#148; means the General Corporation Law of the State of Delaware.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Dissenting Shares</u>&#148; means shares of Company Common Stock issued and outstanding immediately prior to the Effective Time that are held by a holder who is entitled to demand and properly demands appraisal rights of such shares pursuant to, and who is complying in all respects with, the provisions of Section&nbsp;262 of the DGCL (until such time as such holder effectively withdraws, fails to perfect or otherwise loses such holder&#146;s appraisal rights under the DGCL with respect to such shares, at which time such shares shall cease to be Dissenting Shares).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Effective Time</u>&#148; has the meaning set forth in Section&nbsp;2.2.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>EMA</u>&#148; means European Medicines Agency.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Environmental Law</u>&#148; means any applicable law, regulation, order, decree or permit requirement of any governmental jurisdiction relating to:&#160; (a)&nbsp;the protection, investigation or restoration of the environment, human health and safety, or natural resources, (b)&nbsp;the handling, use, storage, treatment, transport, disposal, release or threatened release of any Hazardous Substance or (c)&nbsp;noise, odor or wetlands protection.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>ERISA</u>&#148; means the Employee Retirement Income Security Act of 1974, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>ERISA Affiliate</u>&#148; means any entity which is a member of (a)&nbsp;a controlled group of corporations (as defined in Section&nbsp;414(b)&nbsp;of the Code), (b)&nbsp;a group of trades or businesses under common control (as defined in Section&nbsp;414(c)&nbsp;of the Code) or (c)&nbsp;an affiliated service group (as defined under Section&nbsp;414(m)&nbsp;of the Code or the regulations under Section&nbsp;414(o)&nbsp;of the Code), any of which includes or included the Company or any of its Subsidiaries.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Exchange Act</u>&#148; means the Securities Exchange Act of 1934, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>FDA</u>&#148; means the U.S. Food and Drug Administration.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">59<a name="PB_59_105848_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='59',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>FDCA</u>&#148; means U.S. Food, Drug, and Cosmetic Act of 1938, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>GAAP</u>&#148; means United States generally accepted accounting principles.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Governmental Entity</u>&#148; means any foreign or domestic court, arbitrational tribunal, administrative agency or commission or other governmental or regulatory authority, agency or instrumentality, or any self-regulatory body or organization having authority or jurisdiction over the activities of any party or any Subsidiary of any party.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Hazardous Substance</u>&#148; means:&#160; (a)&nbsp;any substance that is regulated or which falls within the definition of a &#147;hazardous substance,&#148; &#147;hazardous waste&#148; or &#147;hazardous material&#148; pursuant to any Environmental Law or (b)&nbsp;any petroleum product or by-product, asbestos-containing material, polychlorinated biphenyls, radioactive materials or radon.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Healthcare Laws</u>&#148; means (a)&nbsp;the FDCA (including all applicable registration and listing requirements set forth in Section&nbsp;510 of the FDCA (21 U.S.C.A &#167; 360) and 21 C.F.R. Part&nbsp;807)&#894; (b)&nbsp;federal Medicare and Medicaid statutes (Title XVIII and Title XIX of the Social Security Act)&#894; (c)&nbsp;Patient Protection and Affordable Care Act&#894; (d)&nbsp;the Physician Payments Sunshine Act&#894; (e)&nbsp;the federal Anti-Kickback Statute (42 U.S.C.A &#167; 1320a7b(b)), Stark Law (42 U.S.C.A &#167; 1395nn), False Claims Act (31 U.S.C.A &#167; 3729 et seq.), Health Insurance Portability and Accountability Act of 1996 (42 U.S.C.A &#167; 1320d et seq.) (HIPAA), as amended by the Health Information Technology for Economic and Clinical Health Act, and any comparable federal, state, provincial or local laws&#894; (f)&nbsp;state or provincial device licensing, disclosure and reporting requirements&#894; (g)&nbsp;the Federal Trade Commission Act; and (h)&nbsp;any comparable foreign laws for any of the foregoing, in each case as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Healthcare Regulatory Authority</u>&#148; means any federal, national, foreign or multinational governmental health regulatory agency or authority with jurisdiction over (a)&nbsp;the research, development, marketing, labeling, sale, distribution, use, handling and control, safety, efficacy, reliability, manufacturing, approval, licensing of any drug or medical device, (b)&nbsp;federal healthcare programs under which such products are purchased or (c)&nbsp;the protection of personal health information.&#160; References in this Agreement to Healthcare Regulatory Authority shall be deemed to include the EMA and the FDA, the Centers for Medicare&nbsp;&amp; Medicaid Services, the U.S. Department of Justice, the U.S. Department of Health and Human Services, Office of Civil Rights, and the Federal Trade Commission and their equivalent foreign entities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>HSR Act</u>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Indemnified Party</u>&#148; means each Person who is now, or has been at any time prior to the date hereof, or who becomes prior to the Effective Time a director, manager or officer of the Company or any of its Subsidiaries.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Intellectual Property</u>&#148; means (a)&nbsp;patents, patent applications, inventions and invention disclosures, and all related continuations, continuations-in-part, divisionals, reissues, re-examinations, substitutions and extensions thereof, (b)&nbsp;trademarks, service marks, trade dress, logos, trade names, corporate names,&nbsp;Internet domain names, design rights and other source identifiers, together with the goodwill symbolized by any of the foregoing, (c)&nbsp;copyrightable</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">60<a name="PB_60_105908_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='60',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">works and copyrights, (d)&nbsp;trade secrets, know-how, processes, ideas, formulae, models, schematics, technology, computer software programs, computer applications and methodologies, (e)&nbsp;other tangible or intangible proprietary or confidential information and materials, (f)&nbsp;all rights in the foregoing and in other similar intangible assets, and (g)&nbsp;all applications and registrations for the foregoing.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Intervening Event</u>&#148; means any material event, development or occurrence that was not known to the Company Board as of the date hereof and becomes known to the Company Board after the date hereof and prior to the Acceptance Time; <u>provided</u>, <u>however</u>, that in no event shall the receipt, existence or terms of an Acquisition Proposal or any matter relating thereto or consequences thereof constitute or be deemed to be an Intervening Event.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Leerink</u>&#148; has the meaning set forth in Section&nbsp;3.18.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Letter of Transmittal</u>&#148; has the meaning set forth in Section&nbsp;1.1(c).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Lien</u>&#148; means any mortgage, security interest, pledge, lien, charge or encumbrance, other than (a)&nbsp;mechanics&#146;, carriers&#146;, workmen&#146;s, warehousemen&#146;s, repairmen&#146;s or other statutory liens arising in the Ordinary Course of Business, (b)&nbsp;liens for Taxes, assessments and other governmental charges and levies that are not due and payable or that are being contested in good faith by appropriate proceedings, (c)&nbsp;liens arising from actions of the Parent or the Purchaser (including in connection with any financing), (d)&nbsp;liens, defects or irregularities in title, easements, rights-of-way, covenants, restrictions, and other, similar matters of record that are, in each case, shown in public records, (e)&nbsp;liens on goods in transit incurred pursuant to documentary letters of credit, in each case arising in the Ordinary Course of Business, (f)&nbsp;liens arising under applicable securities laws, (g)&nbsp;non-exclusive licenses of Company Intellectual Property granted by the Company to its customers in connection with the sale of products in the Ordinary Course of Business and (h)&nbsp; zoning, building and other similar codes and regulations relating to real property.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Maximum Premium</u>&#148; means an amount equal to 300% of the last annual premium paid prior to the Effective Time for the Current D&amp;O Insurance.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Merger</u>&#148; has the meaning set forth in the Recitals.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Merger Consideration</u>&#148; has the meaning set forth in the Recitals.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Minimum Condition</u>&#148; has the meaning set forth in <u>Annex I</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>New Plans</u>&#148; means employee benefit plans of the Parent and its Subsidiaries providing benefits to any Company Employees after the Effective Time.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Offer</u>&#148; has the meaning set forth in the Recitals.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Offer Conditions</u>&#148; means the conditions of the Offer set forth on <u>Annex I</u>.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Offer Documents</u>&#148; has the meaning set forth in Section&nbsp;1.1(c).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">61<a name="PB_61_105930_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='61',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Offer Price</u>&#148; has the meaning set forth in the Recitals.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Offer to Purchase</u>&#148; has the meaning set forth in Section&nbsp;1.1(c).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Old Plans</u>&#148; has the meaning set forth in Section&nbsp;6.8(b).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Ordinary Course of Business</u>&#148; means the ordinary course of business consistent in all material respects with past practice.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Outside Date</u>&#148; means August&nbsp;14, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Parent</u>&#148; has the meaning set forth in the preamble.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Parent Material Adverse Effect</u>&#148; means any change, event or development that would reasonably be expected to prevent, or materially impair or delay, the ability of the Parent or the Purchaser to consummate the Offer or the Merger.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">&#147;<u>Paying Agent</u>&#148; means American Stock Transfer&nbsp;&amp; Trust Company, LLC or another bank or trust company mutually acceptable to the Parent and the Company, which shall be engaged by Parent </font>to act as a depositary agent for the holders of shares of Company Common Stock tendered in the Offer and as paying agent for the payment of the Merger Consideration to the holders of shares of Company Common Stock outstanding immediately prior to the Effective Time.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Payment Fund</u>&#148; means cash in an amount sufficient to make payment of the Merger Consideration pursuant to Section&nbsp;2.6(c)&nbsp;in exchange for all of the outstanding shares of Company Common Stock (other than shares of Company Common Stock cancelled or converted in accordance with Section&nbsp;2.6(b)).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Person</u>&#148; means any individual, corporation, partnership, limited liability company, joint venture, association, trust, Governmental Entity, unincorporated organization or other entity.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Pre-Closing Period</u>&#148; means the period commencing on the date of this Agreement and ending at the Effective Time.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Purchaser</u>&#148; has the meaning set forth in the preamble.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Qualified Person</u>&#148; has the meaning set forth in Section&nbsp;6.1(a).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Recommendation Change Notice</u>&#148; has the meaning set forth in Section&nbsp;6.1(b)(iii).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Release</u>&#148; means any actual or threatened release, spill, emission, leaking, injection, pouring, deposit, disposal, discharge, dispersal, leaching or migration into or through the indoor or outdoor environment.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Reporting Tail Endorsement</u>&#148; means a six (6)&nbsp;year extended reporting period endorsement with respect to the Current D&amp;O Insurance, on terms and conditions providing coverage retentions, limits and other material terms substantially equivalent to the Current D&amp;O Insurance.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">62<a name="PB_62_110006_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='62',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Representatives</u>&#148; means, with respect to any Person, such Person&#146;s directors, managers, officers, employees, investment bankers, attorneys, accountants and other advisors or representatives.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Restrictive Order</u>&#148; has the meaning set forth in Section&nbsp;6.4(a)(iv).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Sarbanes-Oxley Act</u>&#148; means the Sarbanes-Oxley Act of 2002, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Schedule 14D-9</u>&#148; has the meaning set forth in Section&nbsp;1.2(b).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Schedule TO</u>&#148; has the meaning set forth in Section&nbsp;1.1(c).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>SEC</u>&#148; means the United States Securities and Exchange Commission.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Secretary of State</u>&#148; means the Secretary of State of the State of Delaware.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Securities Act</u>&#148; means the Securities Act of 1933, as amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Significant Supplier</u>&#148; has the meaning set forth in Section&nbsp;3.22.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Specified Time</u>&#148; means the earlier of (a)&nbsp;time at which this Agreement is terminated in accordance with the terms hereof and (b)&nbsp;the Acceptance Time.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Stockholder List Date</u>&#148; has the meaning set forth in Section&nbsp;1.2(e).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Subsidiary</u>&#148; means, with respect to any Person, another Person (a)&nbsp;of which such first Person owns or controls, directly or indirectly, securities or other ownership interests representing (i)&nbsp;more than 50% of the voting power of all outstanding stock or ownership interests of such second Person or (ii)&nbsp;the right to receive more than 50% of the net assets available for distribution to the holders of outstanding stock or ownership interests upon a liquidation or dissolution, (b)&nbsp;of which the power to vote or direct voting of sufficient voting securities, other voting rights or voting partner interests to elect a majority of the board of directors or other governing body or persons performing similar functions is directly or indirectly held by such Person, or (c)&nbsp;of which such first Person is a general partner or managing member.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Superior Proposal</u>&#148; means any <i>bona fide</i> written proposal made by a third party after the date of this Agreement to acquire more than 50% of the equity securities or consolidated total assets of the Company and its Subsidiaries, pursuant to a tender or exchange offer, a merger, a consolidation, business combination or recapitalization or a sale of its assets, (a)&nbsp;on terms which the Company Board determines in its good faith judgment to be more favorable to the holders of Company Common Stock than the transactions contemplated by this Agreement (after consultation with its financial and legal advisors), taking into account all the terms and conditions of such proposal and this Agreement (including any written, binding offer by the Parent to amend the terms of this Agreement) that the Company Board determines to be relevant and (b)&nbsp;which the Company Board determines to be reasonably capable of being completed on the terms proposed, taking into account all financial, regulatory, legal and other aspects of such proposal that the Company Board determines to be relevant; <u>provided</u>, that such proposal was not solicited, encouraged or negotiated in material breach of Section&nbsp;6.1, and that any proposal</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">63<a name="PB_63_110042_7608"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='63',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">that was solicited, encouraged or negotiated in material breach of Section&nbsp;6.1 shall not be deemed a Superior Proposal.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Surviving Corporation</u>&#148; means the Company following the Merger.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Tax Returns</u>&#148; means all reports, returns, forms, or statements required to be filed with a Governmental Entity with respect to Taxes.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Taxes</u>&#148; means all taxes or other similar assessments or liabilities in the nature of a tax, including income, gross receipts, ad valorem, premium, value-added, excise, real property, personal property, sales, use, services, transfer, withholding, employment, payroll and franchise taxes imposed by the United States of America or any state, local or foreign government, or any agency thereof, or other political subdivision of the United States or any such government, and any interest, fines, penalties, or additions to tax imposed or assessed with respect thereto.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Termination Fee</u>&#148; means a termination fee of $57,715,052.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Trigger Event</u>&#148; has the meaning set forth in Section&nbsp;8.1(e).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Uncertificated Shares</u>&#148; means uncertificated shares that immediately prior to the Effective Time represented any shares of Company Common Stock.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;<u>Willful Breach</u>&#148; means a material breach of any covenant or agreement set forth in this Agreement that is a consequence of an act, or failure to act, undertaken by the breaching party with the knowledge that the taking of such act, or failure to act, would result in such breach.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">ARTICLE&nbsp;X</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">MISCELLANEOUS</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.1&#160;&#160;&#160; <u>Nonsurvival of Representations and Warranties</u></font>.&#160; None of the representations and warranties in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Effective Time.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.2&#160;&#160;&#160; <u>Notices</u></font>.&#160; All notices and other communications hereunder shall be in writing and shall be deemed duly delivered (i)&nbsp;four (4)&nbsp;Business Days after being sent by registered or certified mail, return receipt requested, postage prepaid, (ii)&nbsp;one Business Day after being sent for next Business Day delivery, fees prepaid, via a reputable nationwide overnight courier service, or (iii)&nbsp;on the date of confirmation of receipt (or, the first Business Day following such receipt if the date of such receipt is not a Business Day)&nbsp;of transmission by facsimile or electronic mail, in each case to the intended recipient as set forth below:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">64<a name="PB_64_110107_8146"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='64',FILE='C:\JMS\C902308\17-4436-1\task8276925\4436-1-kc-13.htm',USER='C902308',CD='Feb 14 11:01 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="86%" style="border-collapse:collapse;margin-left:.5in;">
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">if to the Parent   or the Purchaser, to:</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hologic,&nbsp;Inc.</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">250 Campus Drive</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Marlborough, MA</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn: John M. Griffin</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E-mail:   john.griffin@hologic.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile: +1-508-263-6133</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy (which   shall not constitute notice) to:</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Wachtell, Lipton,   Rosen&nbsp;&amp; Katz</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">51 West 52nd Street</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">New York, NY 10019</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn:</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adam O. Emmerich</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Benjamin M. Roth</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Victor Goldfeld</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E-mail:</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">aoemmerich@wlrk.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">bmroth@wlrk.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">vgoldfeld@wlrk.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile:</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;+1-212 403-2000</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">if to the   Company, to:</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cynosure,&nbsp;Inc.</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5 Carlisle Road,</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Westford, MA 01886</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn:</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael R. Davin</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E-mail: </font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">mdavin@cynosure.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile: </font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">+978-367-8716</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with a copy (which   shall not constitute notice) to:</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Wilmer   Cutler Pickering Hale and Dorr LLP</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">60   State Street</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Boston,   Massachusetts 02109</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attn:</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hal   J. Leibowitz,&nbsp;Esq.</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jason   L. Kropp,&nbsp;Esq.</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Andrew   R. Bonnes,&nbsp;Esq.</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E-mail:</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">hal.leibowitz@wilmerhale.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">jason.kropp@wilmerhale.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">andrew.bonnes@wilmerhale.com</font></p>    </td>   </tr>
<tr>
<td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.38%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.74%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="top" style="padding:0in 0in 0in 0in;width:9.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facsimile:   </font></p>    </td>
<td width="68%" valign="top" style="padding:0in 0in 0in 0in;width:68.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">+1   617 526 5000</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any party hereto may change the address to which notices and other communications hereunder are to be delivered by giving the other parties hereto notice in the manner herein set forth.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">65<a name="PB_65_111050_9843"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='65',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.3&#160;&#160;&#160; <u>Entire Agreement</u></font>.&#160; This Agreement (including the Schedules and Exhibits hereto and the documents and instruments referred to herein) constitutes the entire agreement among the parties hereto and supersedes any prior understandings, agreements or representations by or among the parties hereto, or between the Company and the Purchaser or between the Company and the Parent, written or oral, with respect to the subject matter hereof, and the parties hereto specifically disclaim reliance on any such prior understandings, agreements or representations to the extent not embodied in this Agreement.&#160; Notwithstanding the foregoing, the Confidentiality Agreement shall remain in effect in accordance with its terms.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.4&#160;&#160;&#160; <u>Third Party Beneficiaries</u></font>.&#160; This Agreement is not intended to, and shall not, confer upon any other Person any rights or remedies hereunder, except (a)&nbsp;as set forth in or contemplated by the terms and provisions of Section&nbsp;6.6 (with respect to which the Indemnified Parties shall be third party beneficiaries), and (b)&nbsp;from and after the Acceptance Time and Effective Time (as applicable), the rights of holders of shares of Company Common Stock, Company Stock Options, Company RSUs and Company PSUs to receive the consideration in each case in accordance with the terms and subject to the conditions set forth in Articles I and II.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.5&#160;&#160;&#160; <u>Assignment</u></font>.&#160; Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned or delegated, in whole or in part, by operation of law or otherwise by any of the parties hereto without the prior written consent of the other parties, and any such assignment without such prior written consent shall be null and void; <u>provided</u>, that, notwithstanding the foregoing, the Parent and the Purchaser may transfer or assign all or any part of their respective rights, in whole or in part, under this Agreement or under any related agreement, document or instrument to any lender (or any administrative or collateral agent on behalf of itself and such lender(s)) as collateral security (it being understood that such transfer or assignment shall not relieve the Parent and the Purchaser of their respective obligations hereunder or enlarge, alter or change any obligation of any other party hereto).&#160; Subject to the preceding sentence, this Agreement shall be binding upon, inure to the benefit of, and be enforceable by, the parties hereto and their respective successors and permitted assigns.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.6&#160;&#160;&#160; <u>Severability</u></font>.&#160; Any term or provision (or part thereof) of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions (or parts thereof) hereof or the validity or enforceability of the offending term or provision (or part thereof) in any other situation or in any other jurisdiction.&#160; If the final judgment of a court of competent jurisdiction declares that any term or provision (or part thereof) hereof is invalid or unenforceable, the court making such determination shall have the power to limit the term or provision (or part thereof), to delete specific words or phrases, or to replace any invalid or unenforceable term or provision (or part thereof) with a term or provision (or part thereof) that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision (or part thereof), and this Agreement shall be enforceable as so modified.&#160; In the event such court does not exercise the power granted to it in the prior sentence, the parties hereto shall replace such invalid or unenforceable term or provision (or part thereof) with a valid and enforceable term or provision (or part thereof) that will achieve, to the extent possible, the economic, business and other purposes of such invalid or unenforceable term (or part thereof).</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">66<a name="PB_66_111113_7091"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='66',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.7&#160;&#160;&#160; <u>Counterparts and Signature</u></font>.&#160; This Agreement may be executed in two or more counterparts (including by facsimile or by an electronic scan (including by portable document format (.pdf)) delivered by electronic mail), each of which shall be deemed an original but all of which together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each of the parties hereto and delivered to the other parties, it being understood that all parties need not sign the same counterpart.&#160; This Agreement may be executed and delivered by facsimile or by an electronic scan (including by portable document format (.pdf)) delivered by electronic mail.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.8&#160;&#160;&#160; <u>Interpretation</u></font>.&#160; Except where expressly stated otherwise in this Agreement, the following rules&nbsp;of interpretation apply to this Agreement:&#160; (a)&nbsp;&#147;include&#148;, &#147;includes&#148; and &#147;including&#148; are not limiting; (b)&nbsp;&#147;hereof&#148;, &#147;hereto&#148;, &#147;hereby&#148;, &#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this Agreement refer to this Agreement as a whole and not to any particular provision of this Agreement; (c)&nbsp;&#147;date hereof&#148; refers to the date set forth in the initial caption of this Agreement; (d)&nbsp;&#147;extent&#148; in the phrase &#147;to the extent&#148; means the degree to which a subject or other thing extends, and such phrase does not mean simply &#147;if&#148;; (e)&nbsp;descriptive headings, the table of defined terms and the table of contents are inserted for convenience only and do not affect in any way the meaning or interpretation of this Agreement; (f)&nbsp;definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms; (g)&nbsp;references to a Person are also to its permitted successors and assigns; (h)&nbsp;references to an &#147;Article&#148;, &#147;Section&#148;, &#147;Recital&#148;, &#147;preamble&#148;, &#147;Annex&#148;, &#147;Exhibit&#148; or &#147;Schedule&#148; refer to an Article, Section, Recital or preamble of, or an Annex, Exhibit&nbsp;or Schedule to, this Agreement; (i)&nbsp;references to &#147;$&#148; or otherwise to dollar amounts refer to the lawful currency of the United States; (j)&nbsp;references to a federal, state, local or foreign statute or law include any rules, regulations and delegated legislation issued thereunder; (k)&nbsp;references to a communication by a regulatory agency include a communication by the staff of such regulatory agency and (l)&nbsp;references to &#147;made available&#148; mean made available through an electronic data room, through EDGAR or otherwise at least four (4)&nbsp;hours prior to the execution of this Agreement.&#160; The language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent, and no rule&nbsp;of strict construction shall be applied against any party hereto.&#160; No summary of this Agreement prepared by any party shall affect the meaning or interpretation of this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.9&#160;&#160;&#160; <u>Governing Law</u></font>.&#160; This Agreement shall be governed by and construed in accordance with the internal laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule&nbsp;(whether of the State of Delaware or any other jurisdiction)&nbsp;that would cause the application of laws of any jurisdictions other than those of the State of Delaware.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.10&#160; <u>Remedies; Waiver of Jury Trial</u></font>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except as otherwise provided herein, any and all remedies herein expressly conferred upon a Person will be deemed cumulative with and not exclusive of any other remedy conferred hereby, or by law or equity upon such Person, and the exercise by a Person of any one remedy will not preclude the exercise of any other remedy.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">67<a name="PB_67_111137_455"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='67',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Irreparable damage would occur in the event that any provision of this Agreement were not performed in accordance with its specific terms or were otherwise breached, as money damages or other legal remedies would not be an adequate remedy for any such damages.&#160; Accordingly, in the event of any breach or threatened breach by the Company, on the one hand, or the Parent and/or the Purchaser, on the other hand, of any of their respective covenants or obligations set forth in this Agreement, the Company, on the one hand, and the Parent and the Purchaser, on the other hand, shall be entitled to an injunction or injunctions to prevent or restrain breaches or threatened breaches of this Agreement, by the other (as applicable), and to specifically enforce the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of the other under this Agreement, in each case without posting a bond or other security.&#160; No party hereto shall raise any objections to the availability of the equitable remedy of specific performance to prevent or restrain breaches or threatened breaches of this Agreement, or to specifically enforce the terms and provisions of this Agreement to prevent breaches or threatened breaches of, or to enforce compliance with, the covenants and obligations of the parties under this Agreement.&#160; Time shall be of the essence for purposes of this Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY&nbsp;ARISE UNDER THIS AGREEMENT IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY&nbsp;HAVE TO A TRIAL BY JURY IN ANY LITIGATION ARISING OUT OF, RELATING TO OR IN CONNECTION WITH THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY,&nbsp;INCLUDING THE OFFER AND THE MERGER.&#160; EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I)&nbsp;NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT,&nbsp;IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II)&nbsp;EACH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATION OF THIS WAIVER, (III)&nbsp;EACH PARTY MAKES THIS WAIVER VOLUNTARILY, AND (IV)&nbsp;EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.11&#160; <u>Submission to Jurisdiction</u></font>.&#160; Each of the parties hereto (a)&nbsp;consents to submit itself to the exclusive personal jurisdiction of the Court of Chancery of the State of Delaware, New Castle County, or, if that court does not have jurisdiction, a federal court sitting in the State of Delaware in any action or proceeding arising out of or relating to this Agreement or any of the transactions contemplated by this Agreement, (b)&nbsp;agrees that all claims in respect of such action or proceeding shall be heard and determined in any such court, (c)&nbsp;agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such court, and (d)&nbsp;agrees not to bring any action or proceeding arising out of or relating to this Agreement or any of the transaction contemplated by this Agreement in any other court.&#160; Each of the parties hereto waives any defense of inconvenient forum to the maintenance of any action or proceeding so brought and waives any bond, surety or other security that might be required of any other Person with respect thereto.&#160; Any party hereto may make service on another party by sending or delivering a copy of the process to the party to be served at the address and in the</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">68<a name="PB_68_111201_4141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='68',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 9.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">manner provided for the giving of notices in Section&nbsp;10.2.&#160; Nothing in this Section&nbsp;10.11, however, shall affect the right of any Person to serve legal process in any other manner permitted by law.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.12&#160; <u>Disclosure Schedule</u></font>.&#160; The Company Disclosure Schedule shall be arranged in Sections corresponding to the numbered sections contained in this Agreement, and the disclosure in any section shall qualify (a)&nbsp;the corresponding section of this Agreement and (b)&nbsp;the other sections of this Agreement, to the extent that it is reasonably apparent from a reading of such disclosure that it also qualifies or applies to such other sections; provided that no disclosure in any Section&nbsp;of the Company Disclosure Schedule shall modify or qualify any provision of Section&nbsp;5.1 unless such disclosure is expressly included in Section&nbsp;5.1 of the Company Disclosure Schedule.&#160; The inclusion of any information in the Company Disclosure Schedule shall not be deemed to be an admission or acknowledgment, in and of itself, that such information is required by the terms hereof to be disclosed, is material, has resulted in or would result in a Company Material Adverse Effect or is outside the Ordinary Course of Business.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 9.0pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.13&#160; <u>Parent Guarantee</u></font>.&#160; The Parent agrees to take all action necessary to cause the Purchaser or, after the Effective Time, the Surviving Corporation, as applicable, to perform all of its agreements, covenants and obligations under this Agreement.&#160; The Parent unconditionally guarantees to the Company the full and complete performance by the Purchaser of its obligations under this Agreement and shall be liable for any breach of any representation, warranty, covenant or obligation of the Purchaser under this Agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">[Remainder of Page&nbsp;Intentionally Left Blank.]</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">69<a name="PB_69_111234_8627"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='69',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Parent, the Purchaser and the Company have executed this Agreement as of the date set forth in the initial caption of this Agreement.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">HOLOGIC,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ John   M. Griffin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: John M. Griffin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: General Counsel</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">MINUTEMAN MERGER   SUB,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ John M. Griffin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: John M. Griffin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: President</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CYNOSURE,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Michael R. Davin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: Michael R. Davin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="5%" valign="top" style="padding:0in 0in 0in 0in;width:5.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title: Chairman, President   and CEO</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">[Signature Page&nbsp;to Merger Agreement]</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">ANNEX I</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conditions of the Offer</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">All terms defined in the Agreement and Plan of Merger (the &#147;Agreement&#148;) of which this Annex I is a part and used in this Annex I shall have the meanings assigned to such terms in the Agreement.</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Notwithstanding any other provisions of the Offer or the Agreement, the Purchaser shall not be required (and the Parent shall not be required to cause the Purchaser) to irrevocably accept for purchase or, subject to any applicable rules&nbsp;and regulations of the SEC, including Rule&nbsp;14e-1(c)&nbsp;under the Exchange Act, to pay for any shares of Company Common Stock validly tendered pursuant to the Offer (and not validly withdrawn), and may terminate or amend the Offer in accordance with (and to the extent permitted by) the terms of the Agreement, and may postpone the acceptance of, or payment for, any shares of Company Common Stock in accordance with (and to the extent permitted by) the terms of the Agreement, if:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; immediately prior to the-then scheduled expiration of the Offer, the number of shares of Company Common Stock validly tendered and not validly withdrawn, together with any shares of Company Common Stock beneficially owned by the Parent or any Subsidiary of the Parent, does not equal at least one share more than half of all shares of Company Common Stock then outstanding (the &#147;<u>Minimum Condition</u>&#148;);</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; immediately prior to the-then scheduled expiration of the Offer, any waiting period (and any extensions thereof) and any approvals or clearances applicable to the Offer or the consummation of the Merger under the HSR Act and the German Act Against Restraints of Competition of 1958, as amended, shall not have expired, or been terminated or obtained, as applicable; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any of the following shall exist:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; any Governmental Entity of competent jurisdiction shall have enacted, issued, promulgated, enforced or entered any order, executive order, temporary restraining order, stay, decree, judgment or injunction (preliminary or permanent) or statute, rule&nbsp;or regulation which has the effect of prohibiting the consummation of the Offer or making the Merger illegal or otherwise prohibiting consummation of the Offer or the Merger;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (A)&nbsp;the representations and warranties of the Company contained in Section&nbsp;3.7(a)&nbsp;shall not be true and correct in all respects as of the expiration of the Offer as though made on and as of the expiration of the Offer (except that representations and warranties that by their terms speak specifically as of the date of this Agreement or another date, in which case as of such date); (B)&nbsp;the representations and warranties of the Company contained in the third sentence of Section&nbsp;3.2(a)&nbsp;and in the first and second sentences of Section&nbsp;3.2(c)&nbsp;shall not be true and correct in all respects as of the expiration of the Offer as though made on and as of such date (except that representations and warranties that by their terms speak specifically as of the date of this Agreement or another date, in which case as of such date), except for any <i>de minimis</i> exceptions; (C)&nbsp;the representations and warranties of the Company set forth in the first sentence of Section&nbsp;3.1 and in Section&nbsp;3.4(a), Section&nbsp;3.4(e), Section&nbsp;3.19 and Section&nbsp;3.20 shall</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">not be true and correct in all material respects as of the expiration of the Offer as though made on and as of the expiration of the Offer (except that representations and warranties that by their terms speak specifically as of the date of this Agreement or another date, in which case as of such date); and (D)&nbsp;all the other representations and warranties of the Company set forth in this Agreement shall not be true and correct as of the expiration of the Offer (without giving effect to any qualification as to materiality or Company Material Adverse Effect contained therein) as though made on and as of the expiration of the Offer (except that representations and warranties that by their terms speak specifically as of the date of this Agreement or another date, in which case as of such date), except where any failures of any such representations and warranties to be true and correct (without giving effect to any qualification as to materiality or Company Material Adverse Effect contained therein) have not had and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect</font>.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Company shall have failed to perform or comply with in all material respects its covenants and obligations required to be performed or complied with by it under the Agreement at or prior to the expiration of the Offer;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Parent and the Purchaser shall not have received a certificate executed by the Company&#146;s Chief Executive Officer and Chief Financial Officer, dated the expiration date of the Offer, confirming on behalf of the Company that the conditions set forth in clauses (c)(ii)&nbsp;and (c)(iii)&nbsp;of this <u>Annex I</u> have been duly satisfied; or</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; the Agreement shall have been validly terminated in accordance with Article&nbsp;VIII of the Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The foregoing conditions shall be in addition to, and not a limitation of, the rights and obligations of the Parent and the Purchaser to extend, terminate or modify the Offer pursuant to the terms of the Agreement.&#160; The foregoing conditions may be waived by the Parent or the Purchaser in whole or in part at any time and from time to time in their sole and absolute discretion (except for the Minimum Condition), subject to the terms of the Agreement and the applicable rules&nbsp;and regulations of the SEC.&#160; The failure by the Parent or the Purchaser at any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right and each such right shall be deemed an ongoing right which may be asserted at any time and from time to time.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Annex I &#150; Page 2</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt 3.0in;text-align:right;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">EXHIBIT&nbsp;A</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Form&nbsp;of Certificate of Incorporation<br>  <u>of the Surviving Corporation</u></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">AMENDED AND RESTATED</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CERTIFICATE OF INCORPORATION</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><br> OF</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><br> CYNOSURE,&nbsp;INC.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;I</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The name of the corporation is Cynosure,&nbsp;Inc. (the &#147;<u>Corporation</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;II</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The address, including street, number, city, and county, of the registered office of the Corporation in the State of Delaware is c/o the Corporation Trust Company, Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, State of Delaware 19801; and the name of the registered agent of the Corporation in the State of Delaware at such address is the Corporation Trust Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;III</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purpose of the Corporation shall be to engage in any lawful act or activity for which corporations may be organized and incorporated under the General Corporation Law of the State of Delaware (the &#147;<u>General Corporation Law of Delaware</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;IV</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Corporation shall be authorized to issue 1,000 shares of capital stock, all of which 1,000 shares shall be shares of common stock, par value $0.01 per share (the &#147;<u>Common Stock</u>&#148;).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Except as otherwise provided by law, the Common Stock shall have the exclusive right to vote for the election of directors and for all other purposes.&#160; Each share of the Common Stock shall have one vote and the Common Stock shall vote together as a single class.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;V</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Any one or more directors may be removed, with or without cause, by the vote or written consent of the holders of a majority of the issued and outstanding shares of capital stock of the Corporation entitled to be voted in the election of directors.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 1</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;VI</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In furtherance and not in limitation of the powers conferred upon it by the laws of the State of Delaware, the Board of Directors shall have the power to adopt, amend, alter or repeal the Corporation&#146;s By-laws. The affirmative vote of a majority of the directors present at any regular or special meeting of the Board of Directors at which a quorum is present shall be required to adopt, amend, alter or repeal the Corporation&#146;s By-laws. The Corporation&#146;s By-laws also may be adopted, amended, altered or repealed by the affirmative vote of the holders of at least 75% of the voting power of the capital stock issued and outstanding and entitled to vote thereon, voting together as a single class, in addition to any other vote required by this Certificate of Incorporation. Notwithstanding any other provisions of this Certificate of Incorporation or the By-laws of the Corporation, and notwithstanding the fact that a lesser percentage may be specified by law, but in addition to any vote of the holders of any class or series of the stock of this Corporation required by law or by this Certificate of Incorporation, the affirmative vote of the holders of at least 75% of the voting power of the capital stock issued and outstanding and entitled to vote thereon, voting together as a single class, shall be required to amend or repeal, or to adopt any provision inconsistent with, this Article&nbsp;VI, in each case whether directly or indirectly, whether by amendment, merger, consolidation or otherwise.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;VII</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Meetings of the stockholders shall be held at such place, within or without the State of Delaware as may be designated by, or in the manner provided in, the By-Laws or, if not so designated, at the registered office of the Corporation in the State of Delaware.&#160; Elections of directors need not be by written ballot unless and to the extent that the By-Laws so provide.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;VIII</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Except as otherwise provided herein and subject to the provisions of Section&nbsp;6.6 of the Agreement and Plan of Merger, dated February&nbsp;14, 2017, among the Corporation, Hologic,&nbsp;Inc. and Minuteman Merger Sub,&nbsp;Inc., the Corporation reserves the right to amend, alter, change or repeal any provision contained in this Certificate of Incorporation, in the manner now or hereafter prescribed by statute and this Certificate of Incorporation, and all rights conferred upon stockholders herein are granted subject to this reservation; provided, however, that notwithstanding any provision of law that might otherwise permit a lesser vote or no vote, but in addition to any vote of the holders of any class or series of stock of this Corporation required by law, this Certificate of Incorporation may include any provision requiring for any corporate action the vote of a larger portion of the stock or of any class or series thereof, or of any other securities having voting power, or a larger number of the directors, than is required by the General Corporation Law of Delaware, and such provision requiring such greater vote shall not be altered, amended or repealed except by such greater vote.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;IX</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Except to the extent that the General Corporation Law of Delaware prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty, no director of the</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 2</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\rcheney\17-4436-1\task8278093\4436-1-kc-15.htm',USER='rcheney',CD='Feb 14 09:55 2017' -->


<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporation shall be personally liable to the Corporation or its stockholders for monetary damages for any breach of fiduciary duty as a director, notwithstanding any provision of law imposing such liability. No amendment to or repeal of this provision shall apply to or have any effect on the liability or alleged liability of any director of the Corporation for or with respect to any acts or omissions of such director occurring prior to such amendment or repeal. If the General Corporation Law of Delaware is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the General Corporation Law of Delaware, as so amended.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;X</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Corporation shall provide indemnification as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.&nbsp;<u>Actions, Suits and Proceedings Other than by or in the Right of the Corporation</u>. The Corporation shall indemnify each person who was or is a party or threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the Corporation) by reason of the fact that he or she is or was, or has agreed to become, a director or officer of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (including any employee benefit plan) (all such persons being referred to hereafter as an &#147;Indemnitee&#148;), or by reason of any action alleged to have been taken or omitted in such capacity or in any other capacity while serving as a director, officer, partner, employee or trustee, against all expenses (including attorneys&#146; fees), liability, loss, judgments, fines, ERISA taxes or penalties and amounts paid in settlement actually</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 3</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">and reasonably incurred by or on behalf of Indemnitee in connection with such action, suit or proceeding and any appeal therefrom, if Indemnitee acted in good faith and in a manner which Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The termination of any action, suit or proceeding by judgment, order, settlement, conviction or upon a plea of&nbsp;<u>nolo</u>&nbsp;<u>contendere</u>&nbsp;or its equivalent, shall not, of itself, create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in, or not opposed to, the best interests of the Corporation, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his or her conduct was unlawful.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.&nbsp;<u>Actions or Suits by or in the Right of the Corporation</u>. The Corporation shall indemnify any Indemnitee who was or is a party to or threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the Corporation to procure a judgment in its favor by reason of the fact that Indemnitee is or was, or has agreed to become, a director or officer of the Corporation, or is or was serving, or has agreed to serve, at the request of the Corporation, as a director, officer, partner, employee or trustee of, or in a similar capacity with, another corporation, partnership, joint venture, trust or other enterprise (including any employee benefit plan), or by reason of any action alleged to have been taken or omitted in such capacity or in any other capacity while serving as a director, officer, partner, employee or trustee, against all expenses (including attorneys&#146; fees) and, to the extent permitted by law, amounts paid in settlement actually and reasonably incurred by or on behalf of Indemnitee in connection with such action, suit or proceeding and any appeal therefrom, if Indemnitee acted in good faith and in a manner which Indemnitee reasonably believed to be in, or not opposed to, the best interests of</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 4</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">the Corporation, except that no indemnification shall be made under this Section&nbsp;2 in respect of any claim, issue or matter as to which Indemnitee shall have been adjudged to be liable to the Corporation, unless, and only to the extent, that the Court of Chancery of Delaware or the court in which such action or suit was brought shall determine upon application that, despite the adjudication of such liability but in view of all the circumstances of the case,&nbsp;Indemnitee is fairly and reasonably entitled to indemnity for such expenses (including attorneys&#146; fees) which the Court of Chancery of Delaware or such other court shall deem proper.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.&nbsp;<u>Indemnification for Expenses of Successful Party</u>. Notwithstanding any other provisions of this Article&nbsp;X, to the extent that an Indemnitee has been successful, on the merits or otherwise, in defense of any action, suit or proceeding referred to in Sections&nbsp;1 and 2 of this Article&nbsp;X, or in defense of any claim, issue or matter therein, or on appeal from any such action, suit or proceeding,&nbsp;Indemnitee shall be indemnified against all expenses (including attorneys&#146; fees) actually and reasonably incurred by or on behalf of Indemnitee in connection therewith.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.&nbsp;<u>Notification and Defense of Claim</u>. As a condition precedent to an Indemnitee&#146;s right to be indemnified, such Indemnitee must notify the Corporation in writing as soon as practicable of any action, suit, proceeding or investigation involving such Indemnitee for which indemnity will or could be sought. With respect to any action, suit, proceeding or investigation of which the Corporation is so notified, the Corporation will be entitled to participate therein at its own expense and/or to assume the defense thereof at its own expense, with legal counsel reasonably acceptable to Indemnitee. After notice from the Corporation to Indemnitee of its election so to assume such defense, the Corporation shall not be liable to Indemnitee for any legal or other expenses subsequently incurred by Indemnitee in connection with such action, suit, proceeding or investigation, other than as provided below in this Section&nbsp;4. Indemnitee shall have the right to</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 5</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">employ his or her own counsel in connection with such action, suit, proceeding or investigation, but the fees and expenses of such counsel incurred after notice from the Corporation of its assumption of the defense thereof shall be at the expense of Indemnitee unless (i)&nbsp;the employment of counsel by Indemnitee has been authorized by the Corporation, (ii)&nbsp;counsel to Indemnitee shall have reasonably concluded that there may be a conflict of interest or position on any significant issue between the Corporation and Indemnitee in the conduct of the defense of such action, suit, proceeding or investigation or (iii)&nbsp;the Corporation shall not in fact have employed counsel to assume the defense of such action, suit, proceeding or investigation, in each of which cases the fees and expenses of counsel for Indemnitee shall be at the expense of the Corporation, except as otherwise expressly provided by this Article&nbsp;X. The Corporation shall not be entitled, without the consent of Indemnitee, to assume the defense of any claim brought by or in the right of the Corporation or as to which counsel for Indemnitee shall have reasonably made the conclusion provided for in clause&nbsp;(ii)&nbsp;above. The Corporation shall not be required to indemnify Indemnitee under this Article&nbsp;X for any amounts paid in settlement of any action, suit, proceeding or investigation effected without its written consent. The Corporation shall not settle any action, suit, proceeding or investigation in any manner which would impose any penalty or limitation on Indemnitee without Indemnitee&#146;s written consent. Neither the Corporation nor Indemnitee will unreasonably withhold or delay its consent to any proposed settlement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.&nbsp;<u>Advance of Expenses</u>. Subject to the provisions of Section&nbsp;6 of this Article&nbsp;X, in the event of any threatened or pending action, suit, proceeding or investigation of which the Corporation receives notice under this Article&nbsp;X, any expenses (including attorneys&#146; fees) incurred by or on behalf of Indemnitee in defending an action, suit, proceeding or investigation or any appeal therefrom shall be paid by the Corporation in advance of the final disposition of</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 6</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">such matter;&nbsp;<u>provided</u>, however, that if the General Corporation Law of Delaware requires, an advancement of expenses incurred by an Indemnitee in his or her capacity as a director or officer (and not in any other capacity in which service was or is rendered by such Indemnitee, including, without limitation, service to an employee benefit plan) the payment of such expenses incurred by or on behalf of Indemnitee in advance of the final disposition of such matter shall be made only upon receipt of an undertaking by or on behalf of Indemnitee to repay all amounts so advanced in the event that it shall ultimately be determined by final judicial decision from which there is no further right to appeal that Indemnitee is not entitled to be indemnified by the Corporation as authorized in this Article&nbsp;X; and further provided that no such advancement of expenses shall be made under this Article&nbsp;X if it is determined (in the manner described in Section&nbsp;6) that (i)&nbsp;Indemnitee did not act in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the Corporation, or (ii)&nbsp;with respect to any criminal action or proceeding,&nbsp;Indemnitee had reasonable cause to believe his or her conduct was unlawful. Such undertaking shall be accepted without reference to the financial ability of Indemnitee to make such repayment.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.&nbsp;<u>Procedure for Indemnification and Advancement</u>. In order to obtain indemnification or advancement of expenses pursuant to Section&nbsp;1, 2, 3 or 5 of this Article&nbsp;X, an Indemnitee shall submit to the Corporation a written request. Any such advancement of expenses shall be made promptly, and in any event within 60&nbsp;days after receipt by the Corporation of the written request of Indemnitee, unless (i)&nbsp;the Corporation has assumed the defense pursuant to Section&nbsp;4 of this Article&nbsp;X (and none of the circumstances described in Section&nbsp;4 of this Article&nbsp;X that would nonetheless entitle the Indemnitee to indemnification for the fees and expenses of separate counsel have occurred) or (ii)&nbsp;the Corporation determines within such&nbsp;60-day&nbsp;period that</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 7</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnitee did not meet the applicable standard of conduct set forth in Section&nbsp;1, 2 or 5 of this Article&nbsp;X, as the case may be. Any such indemnification, unless ordered by a court, shall be made with respect to requests under Section&nbsp;1 or 2 only as authorized in the specific case upon a determination by the Corporation that the indemnification of Indemnitee is proper because Indemnitee has met the applicable standard of conduct set forth in Section&nbsp;1 or 2, as the case may be. Such determination shall be made in each instance (a)&nbsp;by a majority vote of the directors of the Corporation consisting of persons who are not at that time parties to the action, suit or proceeding in question (&#147;disinterested directors&#148;), whether or not a quorum, (b)&nbsp;by a committee of disinterested directors designated by majority vote of disinterested directors, whether or not a quorum, (c)&nbsp;if there are no disinterested directors, or if the disinterested directors so direct, by independent legal counsel (who may, to the extent permitted by law, be regular legal counsel to the Corporation) in a written opinion, or (d)&nbsp;by the stockholders of the Corporation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7.&nbsp;<u>Remedies</u>. The right to indemnification or advancement of expenses as granted by this Article&nbsp;X shall be enforceable by Indemnitee in any court of competent jurisdiction. Neither the failure of the Corporation to have made a determination prior to the commencement of such action that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Corporation pursuant to Section&nbsp;6 of this Article&nbsp;X that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. In any suit brought by the Indemnitee to enforce a right to indemnification, or brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the burden of proving that the Indemnitee is not entitled to be indemnified, or to such advancement of expenses, under this Article&nbsp;X or otherwise shall be on the Corporation.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 8</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indemnitee&#146;s expenses (including attorneys&#146; fees) reasonably incurred in connection with successfully establishing Indemnitee&#146;s right to indemnification, in whole or in part, in any such proceeding shall also be indemnified by the Corporation. Notwithstanding the foregoing, in (i)&nbsp;any suit brought by the Indemnitee to enforce a right to indemnification hereunder (but not in a suit brought by the Corporation to recover an advancement of expenses) it shall be a defense that, and (ii)&nbsp;in any suit brought by the Corporation to recover an advancement of expenses pursuant to the terms of an undertaking, the Corporation shall be entitled to recover such expenses upon a final adjudication that, the Indemnitee has not met any applicable standard for indemnification set forth in the General Corporation Law of Delaware.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8.&nbsp;<u>Limitations</u>. Notwithstanding anything to the contrary in this Article, except as set forth in Section&nbsp;7 of this Article&nbsp;X, the Corporation shall not indemnify an Indemnitee pursuant to this Article&nbsp;X in connection with a proceeding (or part thereof) initiated by such Indemnitee unless the initiation thereof was approved by the Board of Directors of the Corporation. Notwithstanding anything to the contrary in this Article&nbsp;X, the Corporation shall not indemnify an Indemnitee to the extent such Indemnitee is reimbursed from the proceeds of insurance, and in the event the Corporation makes any indemnification payments to an Indemnitee and such Indemnitee is subsequently reimbursed from the proceeds of insurance, such Indemnitee shall promptly refund indemnification payments to the Corporation to the extent of such insurance reimbursement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.&nbsp;<u>Subsequent Amendment</u>. No amendment, termination or repeal of this Article&nbsp;X or of the relevant provisions of the General Corporation Law of Delaware or any other applicable laws shall adversely affect or diminish in any way the rights of any Indemnitee to indemnification under the provisions hereof with respect to any action, suit, proceeding or investigation arising</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 9</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">out of or relating to any actions, transactions or facts occurring prior to the final adoption of such amendment, termination or repeal.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.&nbsp;<u>Other Rights</u>. The indemnification and advancement of expenses provided by this Article&nbsp;X shall not be deemed exclusive of any other rights to which an Indemnitee seeking indemnification or advancement of expenses may be entitled under any law (common or statutory), agreement or vote of stockholders or disinterested directors or otherwise, both as to action in Indemnitee&#146;s official capacity and as to action in any other capacity while holding office for the Corporation, and shall continue as to an Indemnitee who has ceased to be a director or officer, and shall inure to the benefit of the estate, heirs, executors and administrators of Indemnitee. Nothing contained in this Article&nbsp;X shall be deemed to prohibit, and the Corporation is specifically authorized to enter into, agreements with officers and directors providing indemnification rights and procedures different from those set forth in this Article&nbsp;X. In addition, the Corporation may, to the extent authorized from time to time by its Board of Directors, grant indemnification rights to other employees or agents of the Corporation or other persons serving the Corporation and such rights may be equivalent to, or greater or less than, those set forth in this Article&nbsp;X.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.&nbsp;<u>Partial Indemnification</u>. If an Indemnitee is entitled under any provision of this Article&nbsp;X to indemnification by the Corporation for some or a portion of the expenses (including attorneys&#146; fees), judgments, fines or amounts paid in settlement actually and reasonably incurred by or on behalf of Indemnitee in connection with any action, suit, proceeding or investigation and any appeal therefrom but not, however, for the total amount thereof, the Corporation shall nevertheless indemnify Indemnitee for the portion of such expenses (including attorneys&#146; fees), judgments, fines or amounts paid in settlement to which Indemnitee is entitled.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 10</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12.&nbsp;<u>Insurance</u>. The Corporation may purchase and maintain insurance, at its expense, to protect itself and any director, officer, employee or agent of the Corporation or another corporation, partnership, joint venture, trust or other enterprise (including any employee benefit plan) against any expense, liability or loss incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify such person against such expense, liability or loss under the General Corporation Law of Delaware.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13.&nbsp;<u>Savings Clause</u>. If this Article&nbsp;or any portion hereof shall be invalidated on any ground by any court of competent jurisdiction, then the Corporation shall nevertheless indemnify each Indemnitee as to any expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlement in connection with any action, suit, proceeding or investigation, whether civil, criminal or administrative, including an action by or in the right of the Corporation, to the fullest extent permitted by any applicable portion of this Article&nbsp;that shall not have been invalidated and to the fullest extent permitted by applicable law.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14.&nbsp;<u>Definitions</u>. Terms used herein and defined in Section&nbsp;145(h)&nbsp;and Section&nbsp;145(i)&nbsp;of the General Corporation Law of Delaware shall have the respective meanings assigned to such terms in such Section&nbsp;145(h)&nbsp;and Section&nbsp;145(i).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;XI</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stockholders of the Corporation may not take any action by written consent in lieu of a meeting. Notwithstanding any other provisions of this Certificate of Incorporation or the By-laws of the Corporation, and notwithstanding the fact that a lesser percentage may be specified by law, but in addition to any vote of the holders of any class or series of the stock of this Corporation required by law or by this Certificate of Incorporation, the affirmative vote of the holders of at least 75% of the voting power of the capital stock issued and outstanding and entitled to vote thereon, voting together as a single class, shall be required to amend or repeal, or to adopt any provision inconsistent with, this Article&nbsp;XI, in each case whether directly or indirectly, whether by amendment, merger, consolidation or otherwise.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 11</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ARTICLE&nbsp;XII</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Special meetings of stockholders for any purpose or purposes may be called at any time only by the Board of Directors. Business transacted at any special meeting of stockholders shall be limited to matters relating to the purpose or purposes stated in the notice of meeting. Notwithstanding any other provision of this Certificate of Incorporation or the&nbsp;By-laws&nbsp;of the Corporation, and notwithstanding the fact that a lesser percentage may be specified by law, but in addition to any vote of the holders of any class or series of the stock of this Corporation required by law or by this Certificate of Incorporation, the affirmative vote of the holders of at least 75% of the voting power of the capital stock issued and outstanding and entitled to vote thereon, voting together as a single class, shall be required to amend or repeal, or to adopt any provision inconsistent with, this Article&nbsp;XII, in each case whether directly or indirectly, whether by amendment, merger, consolidation or otherwise.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exhibit A &#150; Page 12</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\107541\17-4436-1\task8277102\4436-1-kc-17.htm',USER='107541',CD='Feb 14 12:42 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>a17-4436_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;Expands Hologic&#146;s Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate &#151;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;Accelerates Hologic&#146;s Top- and Bottom-Line Growth Rates and is Immediately Accretive to Non-GAAP Earnings per Share &#151;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">MARLBOROUGH, Mass. and WESTFORD, Mass. (February&nbsp;14, 2017) &#151; Hologic,&nbsp;Inc. (Nasdaq: HOLX), a leader in women&#146;s health, and Cynosure,&nbsp;Inc. (Nasdaq: CYNO), a leader in medical aesthetics systems and technologies, announced today they have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an equity value of approximately $1.65 billion and an enterprise value of $1.44 billion net of cash.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The transaction, which has been approved unanimously by the boards of directors of both companies, would extend Hologic&#146;s scientific and commercial capabilities into one of the fastest-growing segments in medical technology, while expanding Cynosure&#146;s customer reach and addressable market.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;Acquiring Cynosure will accelerate our transformation into a higher-growth company by leveraging our core women&#146;s health expertise and OB/GYN channel leadership into an adjacent, cash-pay segment that is expanding at a low double-digit rate,&#148; said Steve MacMillan, Hologic&#146;s Chairman, President and Chief Executive Officer (CEO).&#160; &#147;We had identified medical aesthetics as an attractive and complementary growth opportunity through our strategic planning process, and are pleased to have agreed to acquire Cynosure, the best-in-class company in the space.&#160; Together, we can strengthen our shared focus on innovation, market-leading products with demonstrated clinical benefits, and strong customer relationships. &#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cynosure has a broad portfolio of more than 20 products across major categories including non-invasive body contouring, hair removal, skin revitalization and women&#146;s health.&#160; Cynosure sells its products through a combination of direct sales and distributors in over 130 countries.&#160; The company has a history of organic innovation, most recently with the introduction of SculpSure</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font>, the world&#146;s first FDA-cleared laser treatment for non-invasive body contouring.&#160; Cynosure also markets MonaLisa Touch<font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font>, a novel CO<font size="1" style="font-size:6.5pt;position:relative;top:1.0pt;">2</font>&#160;laser for women&#146;s health.&#160; Cynosure, which reported revenues of $433.5 million in 2016, has posted 28 consecutive quarters of year-over-year top-line growth.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;We are thrilled at the prospect of becoming part of Hologic through a transaction that provides excellent value for all of our stakeholders,&#148; said Michael Davin, Cynosure&#146;s Chairman, President and CEO.&#160; &#147;Strategically, this deal enables Cynosure to further capitalize on growth opportunities in the core and non-core aesthetic market, rapidly strengthens our position in women&#146;s health &#151; where Hologic has a leading commercial presence &#151; and accelerates our R&amp;D initiatives.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Benefits of the Transaction</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Provides Hologic entry into large, fast-growing medical aesthetics segment.</b>&#160; The medical aesthetics segment exceeds $2 billion globally and is expected to grow at a low-double-digit rate over the next several years, making it one of the fastest-growing segments in the medical technology industry.&#160; Growth is being driven by physicians&#146; desire to increase their cash-based procedures, and by increasing interest in aesthetics and lifestyle health from an aging population.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Leading medical aesthetics platform complements Hologic&#146;s strong position in the OB/GYN and women&#146;s health channels.&#160; </b>Cynosure has a broad product portfolio built from a legacy of innovation, and has begun to capitalize on the fast-growing areas of non-invasive fat body contouring and women&#146;s health.&#160; Approximately 60 percent of Cynosure&#146;s business is derived from physicians outside the traditional areas of plastic surgery and dermatology, with a significant focus on the OB/GYN channel.&#160; Cynosure&#146;s products provide a strong complement to Hologic&#146;s leadership positions and existing products in this channel, and together the companies can further capitalize on the trend toward minimally and non-invasive surgical procedures.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Accelerates top- and bottom-line growth rates.</b>&#160; This transaction, coupled with the recently completed blood screening divestiture, continues Hologic&#146;s transformation into a higher growth company.&#160; Hologic estimates that together, the transactions will enable the Company to accelerate pro-forma revenue growth by roughly 150 basis points, and increase non-GAAP earnings per share (EPS) at a solid double-digit rate, over the next several years.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">1<a name="PB_1_194334_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='1',FILE='C:\JMS\C902314\17-4436-1\task8278171\4436-1-mm-01.htm',USER='C902314',CD='Feb 14 21:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Delivers attractive financial benefits.</b>&#160; The transaction is expected to be fully funded with cash on hand, including proceeds from the recently completed blood screening divestiture.&#160; Hologic estimates the deal will provide a high-single-digit return on invested capital (ROIC) by year five, exceeding the Company&#146;s cost of capital.&#160; The transaction is expected to be dilutive to GAAP earnings per share.&#160; On a non-GAAP basis, however, Hologic forecasts the deal will be immediately accretive, adding approximately $0.03 to $0.05 to the Company&#146;s non-GAAP EPS in the balance of fiscal 2017, adding approximately $0.13 to $0.15 in non-GAAP EPS in fiscal 2018, and becoming increasingly accretive in fiscal 2019 and beyond.&#160; Hologic expects to realize annualized cost synergies of approximately $25 million by the third year after the close.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Transaction Details and Advisers</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Under the terms of the agreement, a subsidiary of Hologic will commence a tender offer to purchase any and all of the outstanding shares of Cynosure common stock for $66.00 per share in cash.&#160; The completion of the tender offer is subject to customary terms and closing conditions, including Cynosure stockholders tendering a majority of Cynosure&#146;s outstanding shares, and receipt of specified regulatory approvals.&#160; Following the successful completion of the tender offer, the agreement provides that Cynosure will merge with a subsidiary of Hologic and become a wholly-owned subsidiary of Hologic, and all remaining outstanding shares of Cynosure will receive the same consideration paid to other stockholders in the tender offer.&#160; Following the completion of the transaction, Cynosure shares will be delisted from NASDAQ.&#160; The tender offer is expected to be completed in late March&nbsp;or April&nbsp;of 2017, subject to the satisfaction or waiver of the offer conditions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Morgan Stanley&nbsp;&amp; Co. LLC is serving as financial adviser to Hologic, and Wachtell, Lipton, Rosen&nbsp;&amp; Katz is serving as legal adviser.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Leerink Partners LLC is serving as financial adviser to Cynosure, and Wilmer Cutler Pickering Hale and Dorr LLP is serving as legal adviser.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Conference Call and Webcast</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hologic&#146;s management will host a conference call at 8:30 a.m.&nbsp;ET today to discuss this transaction.&#160; Approximately 10 minutes before the call, dial 877-591-4951 (U.S. and Canada) or 719-325-4796 (international) and enter access code 473536.&#160; A replay will be available starting two hours after the call ends through March&nbsp;9, 2017 at 888-203-1112 (U.S. and Canada) or 719-457-0820 (international), access code 473536, pin 9876.&#160; The Company will also provide a live webcast of the call at http://investors.hologic.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Hologic,&nbsp;Inc.</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hologic,&nbsp;Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products.&nbsp; The Company&#146;s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health.&nbsp; With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.&nbsp; For more information on Hologic, visit www.hologic.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Hologic and The Science of Sure are trademarks and/or registered trademarks of Hologic,&nbsp;Inc. and/or its subsidiaries in the United States and/or other countries.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Cynosure</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cynosure develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women&#146;s health.&#160; The Company also markets radiofrequency (RF) energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology.&#160; Cynosure&#146;s product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers, intense pulsed light and RF technology.&#160; Cynosure sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, France,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_194408_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\C902314\17-4436-1\task8278171\4436-1-mm-01.htm',USER='C902314',CD='Feb 14 21:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 120 other countries.&#160; For corporate or product information, visit Cynosure&#146;s website at www.cynosure.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Non-GAAP Financial Measures</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This press release discusses non-GAAP diluted EPS, which is a non-GAAP financial measure.&#160; Hologic defines its non-GAAP EPS presented in this press release to exclude transaction costs, the amortization of intangible assets and purchase accounting effects related to recording inventory, fixed assets and deferred revenue to fair value, among other items, as well as potential charges for integration costs including retention, and the related income taxes related to such adjustments.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Non-GAAP diluted EPS adjusts for specified items that may be non-cash, or can be highly variable or difficult to predict.&#160; In the context of forward-looking statements, the non-GAAP financial measures facilitate period-to-period comparisons by excluding the effects of events that have occurred in the past or may occur in the future and have accounting consequences that can mask underlying operational trends, such as acquisitions, restructurings, debt extinguishment and impairments.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This non-GAAP financial measure should be considered supplemental to, and not a substitute for, financial information prepared in accordance with GAAP.&#160; Because non-GAAP financial measures exclude the effect of items that will increase or decrease the Company&#146;s reported results of operations, management encourages investors to review the Company&#146;s consolidated financial statements and publicly filed reports in their entirety.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Future GAAP EPS may be affected by changes in ongoing assumptions and judgments, and may also be affected by non-recurring, unusual or unanticipated charges, expenses or gains, which are excluded in the calculation of the Company&#146;s non-GAAP EPS forecast as described in this press release.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">When Hologic provides its expectations for non-GAAP EPS on a forward-looking basis, a reconciliation of the differences between this non-GAAP expectation and the corresponding GAAP measure (GAAP EPS) is not available without unreasonable effort because Hologic has not estimated the fair value of the assets and liabilities expected to be acquired in the transaction.&#160; Nor has the Company determined the fair value of acquired intangible assets and related annual amortization expense that would be required in order to provide the corresponding GAAP measure.&#160; The variability of the items that have not yet been determined may have a significant, and potentially unpredictable, impact on Hologic&#146;s future GAAP results.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Additional Information and Where to Find It</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The tender offer for the outstanding shares of Cynosure referenced in this document has not yet commenced.&#160; This document is for informational purposes only and is neither an offer to purchase nor a solicitation of an offer to sell shares, nor is it a substitute for the tender offer materials that Hologic and its subsidiary will file with the Securities and Exchange Commission (&#147;SEC&#148;).&#160; At the time the tender offer is commenced, Hologic and its subsidiary will file tender offer materials on Schedule TO, and thereafter Cynosure will file a Solicitation/Recommendation Statement on Schedule 14D-9, with the SEC with respect to the tender offer.&#160; THE TENDER OFFER MATERIALS (INCLUDING AN OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT WILL CONTAIN IMPORTANT INFORMATION.&#160; HOLDERS OF SHARES OF CYNOSURE COMMON STOCK ARE URGED TO READ THESE DOCUMENTS CAREFULLY WHEN THEY BECOME AVAILABLE (AS EACH MAY&nbsp;BE AMENDED OR SUPPLEMENTED FROM TIME TO TIME) BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION THAT HOLDERS OF SHARES OF CYNOSURE COMMON STOCK SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES.&#160; The Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, will be made available to all holders of shares of Cynosure common stock at no expense to them. The tender offer materials and the Solicitation/Recommendation Statement will be made available for free at the SEC&#146;s website at www.sec.gov.&#160; Additional copies of the tender offer materials may be obtained for free by contacting Hologic,&nbsp;Inc. at 250 Campus Drive, Marlborough, MA 01752, Attention: Investor Relations.&#160; In addition to the Offer to Purchase, the related Letter of Transmittal and certain other tender offer documents, as well as the Solicitation/Recommendation Statement, Hologic and Cynosure file annual, quarterly and current reports and other information with the SEC.&#160; You may read and copy any reports or other information filed by Hologic or Cynosure at the SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549.&#160; Please call the Commission at 1-800-SEC-0330 for further information on the public reference room.&#160; Hologic&#146;s and Cynosure&#146;s filings with the SEC are also available to the public from commercial document-retrieval services and at the SEC&#146;s website at www.sec.gov.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_194441_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\C902314\17-4436-1\task8278171\4436-1-mm-01.htm',USER='C902314',CD='Feb 14 21:55 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Forward-Looking Statements</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This news release contains forward-looking information that involves risks and uncertainties, including statements about each company&#146;s plans, objectives, expectations and intentions.&#160; Such statements include, without limitation: financial or other information based upon or otherwise incorporating judgments or estimates relating to future performance, events or expectations; each company&#146;s strategies, positioning, resources, capabilities, and expectations for future performance; and each company&#146;s outlook and financial and other guidance. &#160;Any statements that are not statements of historical fact (including statements containing the words &#147;believes,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;expects,&#148; estimates and similar expressions) should also be considered to be forward-looking statements. These forward-looking statements are based upon assumptions made as of this date and are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Risks and uncertainties that could adversely affect the either company&#146;s business and prospects, and otherwise cause actual results to differ materially from those anticipated, include without limitation: the possibility that the anticipated benefits from the proposed transaction cannot be fully realized or may take longer to realize than expected; the possibility that costs or difficulties related to the integration of Cynosure&#146;s operations with those of Hologic will be greater than expected; the ability of the combined company to retain and hire key personnel; the ability of the parties to timely and successfully receive required regulatory approvals; the effect of the continuing worldwide macroeconomic uncertainty, including the UK&#146;s decision to leave the European Union, on each company&#146;s business and results of operations; the coverage and reimbursement decisions of third-party payors and the guidelines, recommendations, and studies published by various organizations relating to the use of products and treatments; the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on each company&#146;s business and results of operations; the impact to Hologic&#146;s results of operations from the disposal of its blood screening business to Grifols, and the operational challenges of separating this business unit from Hologic&#146;s molecular diagnostics business; the ability to successfully manage ongoing organizational and strategic changes, including Hologic&#146;s ability to attract, motivate and retain key employees; the impact and anticipated benefits of completed acquisitions and acquisitions Hologic may complete in the future; the ability to consolidate certain of Hologic&#146;s manufacturing and other operations on a timely basis and within budget, without disrupting Hologic&#146;s business and to achieve anticipated cost synergies related to such actions; the development of new competitive technologies and products; regulatory approvals and clearances for products; production schedules for products; the anticipated development of markets in which products are sold into and the success of products in these markets; the anticipated performance and benefits of products; business strategies; estimated asset and liability values; the impact and costs and expenses of any litigation the companies may be subject to now or in the future; compliance with covenants contained in Hologic&#146;s debt agreements; anticipated trends relating to Hologic&#146;s financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations; and Hologic&#146;s capital resources and the adequacy thereof.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The risks included above are not exhaustive.&#160; Other factors that could adversely affect each company&#146;s business and prospects are described in the filings made by the applicable company with the SEC. Hologic and Cynosure expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any change in events, conditions or circumstances on which any such statements are based.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Contact</font></u></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Hologic</font></u></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Michael Watts</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vice President,&nbsp;Investor Relations and Corporate Communications</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(858) 410-8588</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Cynosure</font></u></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Scott Solomon</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Senior Vice President</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sharon Merrill Associates</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(617) 542-5300</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CYNO@investorrelations.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="PB_4_194516_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\C902314\17-4436-1\task8278171\4436-1-mm-01.htm',USER='C902314',CD='Feb 14 21:55 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>a17-4436_1ex99d2.htm
<DESCRIPTION>EX-99.2
<TEXT>


<html>
<head>



  </head>
<body link="blue" lang="EN-US">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.2</font></b></p>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">1 Acquisition   of Cynosure February 14, 2017</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi001.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">2 This news   release contains forward-looking information that involves risks and   uncertainties, including statements about each company&#146;s plans, objectives,   expectations and intentions. Such statements include, without limitation:   financial or other information based upon or otherwise incorporating   judgments or estimates relating to future performance, events or   expectations; each company&#146;s strategies, positioning, resources, capabilities,   and expectations for future performance; and each company&#146;s outlook and   financial and other guidance. These forward-looking statements are based upon   assumptions made as of this date and are subject to known and unknown risks   and uncertainties that could cause actual results to differ materially from   those anticipated. Risks and uncertainties that could adversely affect the   either company&#146;s business and prospects, and otherwise cause actual results   to differ materially from those anticipated, include without limitation: the   possibility that the anticipated benefits from the proposed transaction   cannot be fully realized or may take longer to realize than expected; the   possibility that costs or difficulties related to the integration of Cynosure&#146;s   operations with those of Hologic will be greater than expected; the ability   of the combined company to retain and hire key personnel; the ability of the   parties to timely and successfully receive required regulatory approvals; the   effect of the continuing worldwide macroeconomic uncertainty, including the   UK&#146;s decision to leave the European Union, on each company&#146;s business and   results of operations; the coverage and reimbursement decisions of   third-party payors and the guidelines, recommendations, and studies published   by various organizations relating to the use of products and treatments; the   uncertainty of the impact of cost containment efforts and federal healthcare   reform legislation on each company&#146;s business and results of operations; the   impact to Hologic&#146;s results of operations from the disposal of its blood   screening business to Grifols, and the operational challenges of separating   this business unit from Hologic&#146;s molecular diagnostics business; the ability   to successfully manage ongoing organizational and strategic changes,   including Hologic&#146;s ability to attract, motivate and retain key employees;   the impact and anticipated benefits of completed acquisitions and   acquisitions Hologic may complete in the future; the ability to consolidate   certain of Hologic&#146;s manufacturing and other operations on a timely basis and   within budget, without disrupting Hologic&#146;s business and to achieve   anticipated cost synergies related to such actions; the development of new   competitive technologies and products; regulatory approvals and clearances   for products; production schedules for products; the anticipated development   of markets in which products are sold into and the success of products in   these markets; the anticipated performance and benefits of products; business   strategies; estimated asset and liability values; the impact and costs and   expenses of any litigation the companies may be subject to now or in the   future; compliance with covenants contained in Hologic&#146;s debt agreements;   anticipated trends relating to Hologic&#146;s financial condition or results of   operations, including the impact of interest rate and foreign currency   exchange fluctuations; and Hologic&#146;s capital resources and the adequacy   thereof. The risks included above are not exhaustive. Other factors that   could adversely affect each company&#146;s business and prospects are described in   the filings made by the applicable company with the SEC. Hologic and Cynosure   expressly disclaim any obligation or undertaking to release publicly any   updates or revisions to any such statements presented herein to reflect any   change in expectations or any change in events, conditions or circumstances   on which any such statements are based. Hologic, Aptima, Aptima Combo 2,   Genius, Horizon, MyoSure, NovaSure, Panther, Selenia, The Science of Sure,   ThinPrep and Tigris are trademarks and/or registered trademarks of Hologic,   Inc. and/or its subsidiaries in the United States and/or other countries.   Cynosure, SculpSure, Cellulaze, Precision TX, PicoSure, SmartSkin and   associated logos are trademarks and/or registered trademarks of Cynosure,   Inc. Forward-Looking Statements</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi002.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">3 The tender   offer for the outstanding shares of Cynosure referenced in this document has   not yet commenced. This document is for informational purposes only and is   neither an offer to purchase nor a solicitation of an offer to sell shares,   nor is it a substitute for the tender offer materials that Hologic and its   subsidiary will file with the Securities and Exchange Commission (&#147;SEC&#148;). At   the time the tender offer is commenced, Hologic and its subsidiary will file   tender offer materials on Schedule TO, and thereafter Cynosure will file a   Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC with   respect to the tender offer. THE TENDER OFFER MATERIALS (INCLUDING AN OFFER   TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND CERTAIN OTHER TENDER OFFER   DOCUMENTS) AND THE SOLICITATION/RECOMMENDATION STATEMENT WILL CONTAIN   IMPORTANT INFORMATION. HOLDERS OF SHARES OF Cynosure E COMMON STOCK ARE URGED   TO READ THESE DOCUMENTS CAREFULLY WHEN THEY BECOME AVAILABLE (AS EACH MAY BE   AMENDED OR SUPPLEMENTED FROM TIME TO TIME) BECAUSE THEY WILL CONTAIN   IMPORTANT INFORMATION THAT HOLDERS OF SHARES OF Cynosure COMMON STOCK SHOULD   CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR SHARES. The   Offer to Purchase, the related Letter of Transmittal and certain other tender   offer documents, as well as the Solicitation/Recommendation Statement, will   be made available to all holders of shares of Cynosure common stock at no   expense to them. The tender offer materials and the   Solicitation/Recommendation Statement will be made available for free at the   SEC&#146;s website at www.sec.gov. Additional copies of the tender offer materials   may be obtained for free by contacting Hologic, Inc. at 250 Campus Drive,   Marlborough, MA 01752, Attention: Investor Relations. In addition to the   Offer to Purchase, the related Letter of Transmittal and certain other tender   offer documents, as well as the Solicitation/Recommendation Statement,   Hologic and Cynosure file annual, quarterly and current reports and other   information with the SEC. You may read and copy any reports or other   information filed by Hologic or Cynosure at the SEC public reference room at   100 F Street, N.E., Washington, D.C. 20549. Please call the Commission at   1-800-SEC-0330 for further information on the public reference room.   Hologic&#146;s and Cynosure&#146;s filings with the SEC are also available to the   public from commercial document-retrieval services and at the SEC's website   at www.sec.gov. Additional Information and Where to Find It</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi003.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">4 Hologic has   presented the following non-GAAP financial measures in this presentation:   constant currency revenues; non-GAAP gross profit; non-GAAP gross margin;   non-GAAP operating expenses; non-GAAP income from operations; non-GAAP   operating margin; non-GAAP interest expense; non-GAAP pre-tax income;   non-GAAP net margin; non-GAAP net income; non-GAAP diluted EPS; and adjusted   EBITDA. Constant currency presentations show reported current period   operating results as if the foreign exchange rates remain the same as those   in effect in the comparable prior year period. The Company defines its   non-GAAP net income, EPS, and other non-GAAP financial measures to exclude, as   applicable: (i) the amortization of intangible assets and impairment of   goodwill and intangible assets; (ii) additional depreciation expense from   acquired fixed assets and accelerated depreciation related to consolidation   and closure of facilities ; (iii) non-cash interest expense related to   amortization of the debt discount from the equity conversion option of the   convertible notes; (iv) restructuring and divestiture charges and facility   closure and consolidation charges; (v) debt extinguishment losses and related   transaction costs; (vi) the unrealized (gains) losses on the mark-to-market   of forward foreign currency contracts for which the Company has not elected   hedge accounting; (vii) litigation settlement charges (benefits); (viii)   other-than-temporary impairment losses on investments and realized gains and   (losses) resulting from the sale of investments; (ix) other one-time,   non-recurring, unusual or infrequent charges, expenses or gains that may not   be indicative of the Company's core business results as detailed in our   reconciliations of such adjustments; and (x) income taxes related to such   adjustments. The Company defines adjusted EBITDA as its non-GAAP net income   excluding the impact of net interest expense, income taxes, and depreciation   and amortization expense included in its non-GAAP net income. The Company   defines ROIC as its non-GAAP net operating profit after tax on a trailing   twelve month basis divided by the sum of average net debt and average   stockholders&#146; equity as of the beginning and end of the period. These   non-GAAP financial measures should be considered supplemental to, and not a   substitute for, financial information prepared in accordance with GAAP. The   company&#146;s definition of these non-GAAP measures may differ from similarly   titled measures used by others. The non-GAAP financial measures used in this   presentation adjust for specified items that can be highly variable or   difficult to predict. The Company generally uses these non-GAAP financial   measures to facilitate management&#146;s financial and operational   decision-making, including evaluation of Hologic&#146;s historical operating   results, comparison to competitors&#146; operating results and determination of   management incentive compensation. These non-GAAP financial measures reflect   an additional way of viewing aspects of the company&#146;s operations that, when   viewed with GAAP results and the reconciliations to corresponding GAAP   financial measures, may provide a more complete understanding of factors and   trends affecting Hologic&#146;s business. Because non-GAAP financial measures   exclude the effect of items that will increase or decrease the company&#146;s   reported results of operations, management strongly encourages investors to   review the company&#146;s consolidated financial statements and publicly filed reports   in their entirety. A reconciliation of the non-GAAP financial measures to the   most directly comparable GAAP financial measures is included in the tables   accompanying this presentation. Non-GAAP Financial Measures</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi004.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">5 Acquiring Cynosure,   a leader in medical aesthetic systems and technologies, for $66.00/share or   enterprise value of $1.44 billion Benefits Provides Hologic entry into $2+   billion adjacent market with expected double-digit growth Non-Invasive body   contouring is the fastest growing segment Complements Hologic&#146;s strong   position in the OB/GYN and women&#146;s health channels 60% of Cynosure&#146;s business   is outside of traditional dermatologists and plastic surgeons Broadens   R&amp;D portfolio and expands into emerging technologies Accelerates top- and   bottom-line growth rates Delivers compelling financial benefits Immediately   accretive to Hologic&#146;s non-GAAP EPS High-single-digit ROIC by year 5   Transaction expected to be fully funded with cash on hand Transaction   expected to close late March or April of 2017 Transaction Highlights /   Strategic Rationale</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi005.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Cynosure is a   premium and unique asset in the aesthetics space &#150; with high growth,   leadership brands, and broadest portfolio among peers #1 overall market share   leader with key positions in fastest growing categories 60% of Cynosure&#146;s   business is &#147;non-core&#148; or outside of dermatologists and plastic surgeons   Founded in 1991; located in Westford, MA 6 Business Overview Geographic Split   (2016) Market Segments North America: 68% Rest of World: 32% 2013 &#150; 2016   CAGR: 24% Historical Revenue ($MM) Direct sales in 12 countries International   distribution spans 120 countries A Market Leader Body Contouring Skin   Revitalization/Tattoo Hair Removal Women&#146;s Health $226 $292 $340 $434 $- $100   $200 $300 $400 $500 2013 2014 2015 2016</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi006.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">7 Body   Contouring Additional Technologies Non-Invasive Fat Body Contouring Cellulite   Reduction SculpSure Diode Laser Skin Tightening Assisted Liposuction   Cellulaze Pellefirm RF Body Precision TX MIS face and neck SmartLipo MIS   Laser Women&#146;s Health Mona Lisa Touch Fractional CO2 laser Tattoo &amp;   Pigmented Lesions Hair Removal and Other Skin Devices Skin Resurfacing   PicoSure Picosecond laser Vectus Elite Apogee Emerge Cynergy Pellefirm RF Wrinkles   PinPointe Foot Laser RevLite, Medlite, Apogee Q-switched laser SmartSkin   Note: MIS refers to Minimally Invasive Surgery Portfolio ~82% Products, ~18%   Services / Consumables / Other</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi007.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">Preference for   non-invasive procedures that avoid anesthesia, surgery and downtime Aging   population Rising obesity rates Cadence of improved innovation and   demonstrated clinical results driving demand Availability of disposable   income for cosmetic procedures Changing dynamic for doctors, leading to a focus   on patient self / cash-pay procedures to diversify from reimbursement risk   Aesthetics Sector Overview 11% CAGR +8% +6% +18% Global Sector Size and   Growth Key Segment Drivers 8 $2.2B $3.4B Body Contouring is the   Fastest-Growing Non-Invasive Aesthetic Category Source: Company quarterly   earnings estimates and investor presentations, &#147;MarketsandMarkets&#148; Report   Medical Aesthetics Markets Global Forecast to 2020; Internal estimates $0.4   $0.6 $0.7 $1.0 $1.6 $0.3 $0.3 $0.4 $0.4 $0.5 $0.8 $0.9 $1.0 $0.8 $1.4 $0.0   $0.5 $1.0 $1.5 $2.0 $2.5 $3.0 $3.5 2013 2014 2015 2016E - 2020 Skin Devices   Liposuction Devices Non Invasive Body Contouring and Skin Tightening</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi008.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">9 Financial   Overview Financing Timing Purchase price of $66.00 per share in cash for all   outstanding Cynosure shares, representing a total enterprise value of   approximately $1.44 billion Financial Impact Consideration Expected to be   immediately accretive to non-GAAP EPS $0.03 - $0.05 for the remainder of FY17   $0.13 - $0.15 in FY18 Expected cost synergies of approximately $25 million by   year three following the close Expected high-single-digit ROIC by year five   Expected to accelerate top and bottom line growth rates Fully funded with   cash on hand, including proceeds from the recently completed blood screening   divestiture Pro-forma net leverage ratio expected to be approximately 3.1x   Subject to completion of tender offer, including regulatory approvals   Expected to close in late March or April of 2017</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi009.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">10 Acquisition   of Cynosure February 14, 2017</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="830" height="623" src="g44361moi010.gif" alt="GRAPHIC"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105924\17-4436-1\task8277845\4436-1-mo.htm',USER='105924',CD='Feb 14 19:47 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>a17-4436_1ex99d3.htm
<DESCRIPTION>EX-99.3
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.3</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Edited Transcript for Investor Call <br> Hologic,&nbsp;Inc. to Acquire Cynosure,&nbsp;Inc.<br> February&nbsp;14, 2017, 8:30AM EST</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CORPORATE&#160; PARTICIPANTS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mike Watts </font></b>Hologic,&nbsp;Inc. - VP,&nbsp;IR&nbsp;&amp; Corporate <br> Communications <b>Steve MacMillan </b>Hologic,&nbsp;Inc. - Chairman, <br> President&nbsp;&amp; CEO <b>Robert McMahon </b>Hologic,&nbsp;Inc. - CFO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONFERENCE&#160; CALL&#160; PARTICIPANTS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mitchell Petersen </font></b>Barclays Capital - Analyst <br>  <b>Jon Block </b>Stifel Nicolaus - Analyst <br>  <b>Isaac Ro </b>Goldman Sachs - Analyst <br>  <b>Vijay Kumar </b>Evercore ISI - Analyst <br>  <b>Mike Matson&#160; </b>Needham &nbsp;&amp; Co. - Analyst <br>  <b>Raj Denhoy&#160; </b>Jefferies&nbsp;&amp; Co. - Analyst <br>  <b>David Lewis </b>Morgan Stanley - Analyst <br>  <b>Laura Sand </b>Piper Jaffray - Analyst <br>  <b>Patrick Donnelly </b>JPMorgan Chase - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PRESENTATION</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Good morning and welcome to the Hologic conference call. My name is Kayla and I am your operator for today&#146;s call. Today&#146;s conference is being recorded. (Operator Instructions). I would now like to introduce Mike Watts to begin the call. Please go ahead.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mike Watts </font></b>- Hologic,&nbsp;Inc. - VP,&nbsp;IR&nbsp;&amp; Corporate Communications</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thank you, Kayla. Good morning and thanks for joining us to discuss Hologic&#146;s acquisition of Cynosure. With me today are Steve MacMillan, the Company&#146;s Chairman, President and Chief Executive Officer and Bob McMahon, our Chief Financial Officer. Steve has some prepared remarks, then we will have a question-and-answer session. We will wrap up the call in about 30 minutes.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our press release announcing the transaction is available now in the Investors section of our website. We&#146;ve also posted a short slide deck on the deal there and will post our prepared remarks shortly after we deliver them. Finally, a replay of the call will be archived on our website through March&nbsp;9.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Before we begin,&nbsp;I&#146;d like to inform you that certain statements we make during this call will be forward-looking. These statements&#160; involve known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed or implied. Such factors include those referenced in the Safe Harbor statement that&#146;s included in our press release and in our filings with the SEC.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Also, during this call, we will be discussing certain non-GAAP financial measures. When we discuss Hologic&#146;s expectations for non-GAAP EPS, a reconciliation of the differences between this non-GAAP expectation and the corresponding measure of GAAP&#160; EPS is not available without unreasonable effort because we have not estimated the fair value of the assets and liabilities expected to be acquired in the transaction and because we</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-01.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">have not determined the fair value of acquired intangible assets and related annual amortization expense that would be required in order to provide the corresponding GAAP measure. More information about non-GAAP measures can be found in our press release.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_015758_7503"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-01.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Please note that the tender offer in connection with Hologic&#146;s proposed acquisition of Cynosure has not yet commenced and our communication is neither an offer to purchase nor a solicitation of an offer to sell any Cynosure securities. Cynosure shareholders are urged to read the tender offer statement and solicitation recommendation statement to be filed with the SEC when they become available because they will contain important information about the proposed transaction. Now I would like to turn the call over to Steve MacMillan, Hologic&#146;s CEO.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thank you, Mike and good morning, everyone. Thanks for joining us on short notice for a brief call. We are very excited to talk to you today about our agreement to acquire Cynosure, a leader in medical aesthetic systems and technologies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We think this is an excellent transaction for the Company and our shareholders as it provides strong strategic and financial benefits. We are paying $66 per share in cash, which equates to a total enterprise value of approximately $1.44 billion.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We expect the transaction to close in late March&nbsp;or April&nbsp;of this year pending acceptance of the tender offer by a majority of Cynosure shareholders and receipt of regulatory approvals in the US.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In my remarks today,&nbsp;I will touch on four key reasons we think this is a good deal for Hologic and our shareholders. First, it provides&#160; access to a large and rapidly growing market segment. Second, by acquiring the leader in this space, we will leverage our commercial channels in women&#146;s health while simultaneously&#160; expanding Cynosure&#146;s opportunities. Third, it accelerates our top and bottom-line growth rates and fourth, it provides compelling financial benefits.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">But before diving into these points, we would like to discuss some of the history behind today&#146;s announcement. Let me begin by providing a little background on how the acquisition came about. This deal checks many of the boxes that we have discussed related to M&amp;A. It&#146;s additive to our top and bottom-line growth rates; it provides good economic returns as measured by return on invested capital and it&#146;s immediately accretive to EPS on a non-GAAP basis.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">It also adds a completely new growth platform to our business while leveraging our scientific and commercial strengths. And while it is a larger deal than we expected at this point, the unique nature of Cynosure prompted us to act.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">To provide some context, we had identified the medical&#160; aesthetic&#160; space as an attractive adjacency in our strategic planning process last summer. Even at that time, Cynosure rose to the top of the list of potential targets and I will explain why in a moment.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I met Mike Davin, Cynosure&#146;s CEO, for the first time in November, but didn&#146;t have any expectation that we could pursue a transaction right away, but then two things happened, both of which were a little serendipitous. First, we sold our blood screening business to Grifols for $1.85 billion, which significantly increased our financial flexibility and our ability to consider a deal of this size.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Second, we believe Cynosure received an unsolicited inbound offer from another company, which caused them to reach out to us. We were pleased to receive that call and were able to jump quickly into the process since we had studied the market and done much of the work previously.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I wanted to provide this history to illustrate that the timing and outcome of business development activity is always hard to predict and sometimes you have to get a little lucky along the way. In this case, we are happy&#160; that we did.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Now I&#146;d like to return to the four points that underscore why we believe this is a great transaction for Hologic and our shareholders. First, it provides access to a large growing opportunity. As we show on slide 8 of the presentations posted on our website, global sales of medical aesthetic products exceeded $2 billion in 2016 and are projected to grow low double digits for the next several years.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Within this segment,&nbsp;I want to highlight body contouring, which is the largest and fastest-growing area and it&#146;s also where Cynosure&#146;s SculpSure product, the world&#146;s first FDA-cleared laser treatment for noninvasive body contouring, has made an immediate&#160; positive impact.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-01.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The growth in the overall aesthetics field is being driven by a number of demographic and customer trends. In terms of demographics, we have an aging population in the Western world coupled with rising obesity rates. While many baby boomers and Gen Xers have the disposable income needed for aesthetic procedures, they also have a strong preference for noninvasive methods that avoid anesthesia, surgery and downtime. And technology in this space has evolved rapidly to meet that need.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Even in developing markets, such as China and Brazil with younger populations, there is a rising middle and upper class, who are increasingly concerned about their health and appearance.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">And in terms of the customer base, many physicians, including many of our current customers, are looking for new ways to supplement their income and diversify their practices away from declining insurance reimbursement toward more cash pay procedures.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The second point I want to make is that by acquiring a leader in medical aesthetics, we will leverage our commercial channels in women&#146;s health, especially our broad coverage of OB/GYNs, while simultaneously&#160; expanding&#160; Cynosure&#146;s market.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As I mentioned earlier, we believe Cynosure is the best-in-class player in the space and a unique asset. Not only are they the market leader, they have the broadest portfolio of differentiated products in key categories, including body contouring, hair removal, skin revitalization and women&#146;s health.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company has a proven track record of organic innovation, most recently with the development and commercialization of SculpSure. At the same time, the Company has used business development smartly to add to its portfolio. For example, Cynosure is the exclusive distributor for the MonaLisa Touch device, a novel CO2 laser for vaginal rejuvenation.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">You can clearly see the value of Cynosure&#146;s products by looking at their sales performance&#160; over time. The Company has posted 28 consecutive quarters of year-over-year revenue growth, an impressive track record. Most recently, Mike and his team reported 2016 revenue of $434 million with fourth-quarter growth of 19% compared to the prior-year period.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Beyond the numbers, Cynosure is a company that is like Hologic in many ways. We both sell differentiated market-leading products that are backed by strong clinical data. We both enjoy strong consultative relationships with our professional customers and help build their businesses through direct patient outreach. And we are both focused on driving recurring revenue from our large installed base of instruments.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cynosure is also unique in that its customer base complements&#160; ours like no other company in the space. Currently, 60% of Cynosure&#146;s business is generated from what they call non-core customers, meaning outside the traditional areas of dermatologists and plastic surgeons.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A large portion of these sales are to OB/GYNs and we see opportunities to drive growth of SculpSure and the MonaLisa Touch device with these customers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">But Cynosure&#146;s penetration into these key channels is still quite low and represent a significant growth opportunity as the number of minimally and non-invasive surgical procedures continues to grow. Obviously, this is an area where we have a strong position with our diagnostics and surgical sales teams and we can help build awareness and demand.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The third reason we think this is a good deal for Hologic and our shareholders is that it increases our top and bottom-line growth rates. We mentioned earlier that the medical aesthetic segment as a whole is growing at a low double-digit pace and Cynosure has been exceeding this rate. So the acquisition of Cynosure coupled with the recent divestiture of the blood screening business accelerates our transformation into a higher growth company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Specifically, we forecast that these transactions will add roughly 150 basis points to our revenue growth rate and enable us to increase EPS at a solid double-digit rate over our five-year strategic planning horizon.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-01.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Finally, the fourth reason we are excited about this deal is that it provides compelling financial benefits. We intend to fully fund the Cynosure acquisition with cash on hand, including proceeds from the recently completed blood screening divestiture.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In terms of earnings, the deal is expected&#160; to be immediately accretive. Assuming the transaction closes as expected, it will add approximately $0.03 to $0.05 to the Company&#146;s non-GAAP EPS in just the balance of fiscal 2017, add approximately $0.13 to $0.15 in fiscal 2018 and become increasingly accretive in fiscal 2019 and beyond.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contributing to this accretion, Hologic expects to realize annualized cost synergies of approximately $25 million by year three following the close. </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">And finally, the deal provides a solid high single digit return on invested capital by year five. This exceeds our weighted average cost of capital and we believe there is opportunity to enhance this further.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I would also point out that based on our estimates, the transaction yields a net present value of over $0.5 billion and a low double-digit internal rate of return.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Before we open the call up for questions, let me mention that, from a balance sheet perspective, we expect our leverage ratio net debt to EBITDA to be roughly 3 times following the transaction. We are comfortable&#160; with this level of leverage and believe that with our strong cash flows, we still have the ability to pursue smaller acquisitions, retire our convertible notes and buy back stock in the future.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">So in summary, we are very pleased to announce today a transaction that accelerates Hologic&#146;s transformation into a higher growth company and further strengthens our unique position in women&#146;s health. Within a few months, we have exited a declining business for a very healthy valuation and use the proceeds to effectively self-fund the acquisition of the best-in-class player in a large adjacent market segment that is growing at a low double-digit rate.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Combining Cynosure with Hologic provides unique opportunities to leverage our commercial channels in women&#146;s health while simultaneously expanding&#160; Cynosure&#146;s reach. And we are generating compelling financial benefits, including higher top and bottom-line growth rates, solid ROIC and immediate accretion.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Now we&#146;d be happy to take a few questions. In the interest of time, please ask only one question then return to the queue. Operator, we are ready to begin.</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">QUESTIONS AND ANSWERS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thank you. (Operator Instructions) Jack Meehan, Barclays.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mitchell Petersen </font></b>- Barclays Capital - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is actually Mitchell Petersen filling in for Jack this morning. I was hoping you could expand on some of the potential synergies within your distribution channel, specifically in OB/GYN and just wondering if you have an opportunity to leverage your existing salesforce in the surgical business. Thanks.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sure. I think, Mitchell, first and foremost, obviously, the Cynosure team has been doing an amazing job building that business, growing immensely. By the same token, if you wound back the clock, a product like MonaLisa Touch that they have is something that we probably could do a nice job</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-01.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">with as well. So I think what we will look to is using our salesforce to generate leads and awareness in the initial stages and really help to turbocharge a product like that. Obviously, our surgical force has a huge amount of people. We&#146;ve got over 150 people in that salesforce and that will be an obvious thing.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We also expect to be able to do what we&#146;ve done with things like Genius 3D mammography using our GYN salesforces, both diagnostics and surgical, just to increase awareness for some of our other divisional&#160; products.&#160; So whether they are selling directly or just generating&#160; leads, we see as a great opportunity to drive awareness and help really build the top-line synergies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Robert McMahon </font></b>- Hologic,&nbsp;Inc. - CFO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Just to follow up on what Steve talked about, the $25 million of synergies that Steve referenced are really around the G&amp;A areas of procurement, so things like public company costs, procurement and those types of areas are where we expect to see the synergies that we referenced.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Jon Block, Stifel.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Jon Block </font></b>- Stifel Nicolaus - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Capital versus recurring,&#160; Steve,&nbsp;I think Cyno is currently roughly 80% capital, 20% consumable, but SculpSure growth should take that recurring to maybe 30% or so in the coming years. So maybe just your thoughts on how that trends over time and MonaLisa Touch has been a very big product for them. Can you actually go back to the drawing board and mate that with a consumable component, which is Hologic&#146;s strong point? Thanks, guys.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Great question, Jon. I think as you touched on, with especially the incredible uptake of SculpSure and the business model there, all of what the Cynosure team has been driving towards is much higher recurring revenue, which is very nice obviously on the gross margin line and very good on the business model side. So I think we see it going more to razor/razor blade and you can imagine they&#146;ve also been thinking about that same model for the future.&#160; So I think what we can absolutely bank on is the model going forward will be a little less capital, more recurring revenue. That will continue to build over time and ultimately, is it even a 50/50? I can tell you it could easily be that in a number of years down the road and whether MonaLisa &#151; the way to think about it probably&#160; is on the future, it will be a thought process in everything that&#146;s developed and ultimately, it will be a combination&#160; of both capital and recurring revenue.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Isaac Ro, Goldman Sachs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Isaac Ro </font></b>- Goldman Sachs - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Really appreciate all the detail you gave us on the financials and the financial logic for the transaction. I am interested in the strategic aspect of it, specifically with regard to the fact that, prior to this deal, you guys were really a very significant diagnostics company. You had a respectable surgical and medical imaging business. This changes the equation. You are more of a consumer-facing company now.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-01.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Can you give us a sense of, over the next several years, what does this mean for Hologic? Should we think of you guys as a company&#160; that aspires to be a more diversified medical device company or was this really more of a one-off opportunity where you got a great franchise, right time, right place and as we think about the long term, we could see a scenario where you cut it back towards your core in terms of future deals?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sure,&nbsp;Isaac. Good question. I think the way you ought to think about us is probably four key legs going forward and really the way we looked at this is it started out as an extension of our surgical and medical device business. And we have brought in a lot of great consumer marketers into our organization, but I think, at the end of the day, what this really is is we are broadening and diversifying, but still in a very focused area. So I would not expect in the next few years by any stretch that we would go into any additional areas.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Part&nbsp;of the way we think about this is it now provides a fourth leg for those tuck-ins that the other divisions can be looking at, but we view it as very focused and yet having a little bit of diversification within that focus.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Robert McMahon </font></b>- Hologic,&nbsp;Inc. - CFO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I was going to say, yes,&nbsp;I think one of the things &#151; again, to build on what Steve said in his prepared remarks &#151; that&#146;s unique about this, the Cynosure company, is the level of penetration and the level of sales that they have in what they call their non-core markets, which are actually our core markets. And so I think that there is a great synergy there in terms of being able to have that lead generation and so forth, which is probably unique relative to anyone else in the space.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Vijay Kumar, Evercore.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Vijay Kumar </font></b>- Evercore&#160; ISI - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Congratulations on the deal and maybe just on overall market, Steve or maybe Bob, we had two large deals. Obviously, you have the Allergan deal announced and I&#146;m just curious how &#151; are you competing directly against Allergan and how do you see the competitive dynamics changing? And on the synergy front,&nbsp;I think high single digit ROIC by year five,&nbsp;I think my back-of-the-envelope math,&nbsp;I&#146;m getting 1000 bps of synergies by year five. Does it seem a reasonable assumption for you guys? Thank you.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sure,&nbsp;I will start on the first one. Obviously, we will be competing in the same space as the other guys given the announcement yesterday. I think we feel very good about the overall market opportunity. I think that what fascinates us most about this space is &#151; and Mike Davin actually said it really well on his earnings call I think last week or so &#151; they are probably in the first inning and he said of a doubleheader&#160; in terms of where there true market penetration can go. So even if there&#146;s two players in the space, there is a lot of growth. These markets are so underpenetrated and yet there&#146;s proven products.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I would also tell you we feel really good and of course, we believe we&#146;ve got by far the superior asset. We love SculpSure itself and think it brings some incredibly compelling opportunities, plus the broader line of the full product. So we will be &#151; it&#146;s been a consolidating market over time and this probably makes it even a little more consolidated.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-01.htm',USER='109487',CD='Feb 15 01:58 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Robert McMahon </font></b>- Hologic,&nbsp;Inc. - CFO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Steve, let me just add. I think one of the things &#151; certainly Allergan is a very formidable competitor, but when you look at the businesses that we have currently, we compete against big people all the time, whether that be in our mammography business or our diagnostics business and even in the surgical business, we compete against much larger folks and I think we do pretty well and I think we are going to do pretty well here as well.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mike Matson, Needham&nbsp;&amp; Co.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mike Matson </font></b>- Needham &nbsp;&amp; Co. - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Just given you have a fairly sizable exposure to capital equipment before this deal, and now you are getting into the aesthetics area. So I guess just wanted to ask about to what degree economic sensitivity factored into your decision here and I understand that this is a large market with a lot of growth potential, but how cyclical do you think this market is and how do you think it would weather an economic downturn?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sure, Mike. There is always going to be a little bit of sensitivity to an economic downturn with capital. I would say from the capital standpoint, a lot of this is increasingly razor/razor blade, so it&#146;s capital with disposables. I think we like that model and I will probably shift it. It&#146;s got a lot of parallels in those senses really. It&#146;s a business you know well in terms of Stryker&#146;s med-surg business that&#146;s a combination of both capital and disposables and has done really well over time. So I think we feel very good about that. There&#146;s always a little bit.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I think the other way we look at it is there may be some sensitivity to economic downturns. There&#146;s also, however &#151; we are not at the whim of reimbursement issues and what we are seeing and I think is going to continue on a macro trend around the world, people far more willing to pay for these kinds of procedures and as they get more minimally invasive, they also get a little more economical for the patients and it almost becomes a recurring kind of procedure instead of a one-off in their life. They can suddenly tap into the marketplace on multiple occasions over time. So we really like where that model is going.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Raj Denhoy,&#160; Jefferies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Raj Denhoy </font></b>- Jefferies&nbsp;&amp; Co. - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Just maybe a quick question on your growth outlook for the Company. I think the Company has been growing Cynosure north of 20% for the last couple of years. I think the analyst community has the Company growing low double digits, 10%, 11% this year in 2017. When you think about that five-year horizon where you come up with that return on invested capital calculation, what do you assume for growth for this company&#160; as you guys take control of it?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Robert McMahon </font></b>- Hologic,&nbsp;Inc. - CFO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">When we look at the market, the market we are expecting to grow low double digits and we expect to gain share in the market.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-03.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">David Lewis, Morgan Stanley.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="PB_9_015824_1010"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='9',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-03.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">David Lewis </font></b>- Morgan Stanley - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Steve, as long as I can remember, the aesthetic companies have talked about penetrating the obstetrical market with limited success. So can you help us understand what percent of Cynosure&#146;s products actually are sold to OB/GYN today and then how important is MonaLisa to this five-year deal model? If you are going to shift that growth rate 150 basis points for Hologic, how much of this five-year credit growth model is tied up in MonaLisa?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sure. I think we are not going to give, David, the exact breakout of their business into the OB/GYN, but just say it&#146;s a nice and emerging area for them. We do think we can turbocharge it.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I think MonaLisa is a very nice piece of the model. It&#146;s not a compelling part of the model. At the end of the day, we&#146;ve also seen their pipeline and they&#146;ve got a pretty cool pipeline coming that we feel really, really good about. So it will really play plus they&#146;ve got obviously tremendous momentum already with SculpSure. So MonaLisa we think is a very nice piece of it, but it&#146;s not absolutely critical to the model.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Robert McMahon </font></b>- Hologic,&nbsp;Inc. - CFO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I think the other thing, David, that Steve mentioned that I think is important to clarify is that that 150 basis points is a combination of not only the Cynosure acquisition on a pro forma basis, but also the blood screening divestiture. So both of those things translating from a declining business, what we thought was a declining business, into a growth business is how we get to that 150 basis points.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mike Watts </font></b>- Hologic,&nbsp;Inc. - VP,&nbsp;IR&nbsp;&amp; Corporate Communications</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kayla,&nbsp;I think we have time for maybe one or possibly two more questions.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bill Quirk, Piper Jaffray.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Laura Sand </font></b>- Piper Jaffray - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This is Laura Sand on for Bill Quirk. I appreciate all the color you&#146;ve provided. Could we expect for future deals to see you go around existing channels slightly in terms of distribution?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Can you clarify the question, Laura? I think I got it, but I want to make sure.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Laura Sand </font></b>- Piper Jaffray - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Yes, for future acquisitions, would you consider companies that are outside of your existing&#160; sales channels?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-03.htm',USER='109487',CD='Feb 15 01:58 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Steve MacMillan </font></b>- Hologic,&nbsp;Inc. - Chairman, President&nbsp;&amp; CEO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">It&#146;s doubtful for a while. I think this really is a one-off here at this point in time, both on size and scope of deal and I think from this point forward, we will get right back to what would be really supplemental acquisitions for what are now really our four key businesses and I think that would be effectively what you should expect is much more leveraging our existing channels.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Mike Watts </font></b>- Hologic,&nbsp;Inc. - VP,&nbsp;IR&nbsp;&amp; Corporate Communications</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We will take one more.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Tycho Peterson, JPMorgan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Patrick Donnelly </font></b>- JPMorgan Chase - Analyst</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">It&#146;s Patrick Donnelly in for Tycho. You mentioned the deal came up quickly. Obviously, you were looking at other options for the blood screening proceeds. Can you maybe talk about how this compares to those other options, whether it&#146;s paying down the convert, other debt, smaller M&amp;A and related to filling that $0.34 annual EPS gap&#160; that the blood screening business left?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Robert McMahon </font></b>- Hologic,&nbsp;Inc. - CFO</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Yes, obviously, what we want to do is grow the business and when we look at this, we think that this compares very well and is actually superior to those other options on a long-term basis. Certainly, we could have, if we had used all those for a share repurchase, that would have actually levered us up, would have filled some of the gap maybe quicker, but this actually has an opportunity to truly grow not only revenue, but also earnings and so forth.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">And coupled with that, our cash flow was such and our leverage is such that we still feel that we can do those, so it&#146;s not an either/or; it&#146;s really an opportunity to buy a premier asset and a premier company&#160; to join Hologic and really drive our growth.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Operator</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Thank you. That is all the time we have for questions today. This now concludes Hologic's first-quarter fiscal 2017 earnings call. Have a good evening.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109487\17-4436-1\task8278862\4436-1-mq-03.htm',USER='109487',CD='Feb 15 01:58 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g44361moi001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi001.gif
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MS
M
M
M
M
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M*Y-4\($&TIVRF",  C+\UR2D:$/^=*4L9KA>\P$;B (E)B).]7Y6!RF>B"?
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M]EDJ%(G<R076^7(WX =$.A&?P 821T /)6.=A %ML%>D"$Q;%G8F 0@7"*'
MN0)J\)X540I^H .MJ5]1<)<-P0?^9;=@+* &2/5/?F #B42;KS8$WE@0QF6G
M#="4:BATPUA='@ &$781' 4%1<1>NX@!<7!'K7" 0Y<(=B00JT!A'S !43"F
M)9*(\=5Y)"%T+#D!@%D0@*!WA,=I#P ":F!\&T$)YTA/P+4"$7F@71=?"QH2
MED #"Y8!4$ ),.D0H: &SZA?&. &$&$)"*A?#I !5& )U_H0H- %8&6G!90!
M<CJ&&D"IQVD0C["MLL5WB2"E#6$*%@A;IC8#6E=HD# $OH@#5& & @4"*J4&
MD?J.>JEEMCH23:>EGU80H% #I[=A0^<(^@H1IA '.@6%3H<$%?JFUA1K);$*
M.;9?N"?^J!MQ"*.FG,JVK/'7!??9 "K@!\.)$:O0!FVHI71U!#TZJ6ZV@3,J
M$*E@H]P:!>ZX$:PPB5<7 6J05*2 4RO@@AFP C? J>?J(0OEJ JV?B$A= -:
ML0/!"F00GY^% 51PM!5T@-KF64C8:I5Y6L_Z$89P@1D[4C< @R'!"5#0F?*Y
MJPEQ>3)[ ]LI$A58:]/U61V@" BQE+'%C 2QC@Z)4ENF!CV*$:RP!F!UE U
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M<(%:2J"":@B%FFU2V[4?T096J0:. #L046=@3!"08.&Q%<RQ=PB<0#E+DEX
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M 4!X0K(HA3A@@5\$,WW#"!TC/\AHOK98!=NY"RH#@34@1K%8A408 LIXQ84
M@;LRB5+^, +IL;,(F($VZ(1<'(E5F(0UH %W.CR/0"QM.T8OV4.*B GBZ(@.
M((-?.PM24(/'B\<&N(%*B\:2C!5%5 E#3*]XHPE9$PE'4$)+&I$,0 )%",>O
M,(5"$ (,>*[J4 %_;$!N7(EG0KHAV,=;<4,^D,6O4$@J\)[JT"^J XM)L+Y:
MT1T9  -("+^P8 50( 0H4 %]?$@>H3"H6*RYJ$B*2,+L(,@V  6$E A3  0A
MN$8#R0"\,\F\C)]F.Z\4?+6ZI!AMK)XV\+IEZ8 C((1/B$.18 5+V ,AF$B:
M<  -B(-7,BG+88-.X(3-["M.Z,S.Y$S/W,S1%$W/[ 1+.,W^T>0KTN0#K\(2
M#-"!-J"$ QR)5B"%0HB"D<L.3(F"K30)/P#)W8R #A""-3B$4&"%:FL%59@$
M/^""%:BI$N$ZBA!&<U$)4ZG-PAO+E6@ "I@!,GB$FQ0)4/ #(IC"+IP *A!/
MO63/#T')CD"S(5R+@[(+2:R(U -,",$ &8""/9B$4#"%Z6N%53 %3W"$-CB"
M%>"(4FR-3%G/@(.S#EB!"5V!$%@!%KC0"54!"K50#*70#YU0"PT!&0#1#Q4"
M,-#- IDV$#B"-7 $3RB%5:"95F %4R %2_ #*J"!\T01(0!#KUB%-<B H^R(
M"=" &D "-0"$1^ $V3$=TNF$23C^A#:( B%8@0I((4^93DOC/<1)2XH NN[[
MF-S!%.)4@T3HA%)(A1E-A1L%!"J8 5X34P[$BQN0S_;$4PUY&IQQ&=.J(U:S
MJL6,2_YAT AY" D= BH @S6(@SAP S7X B@0 A7@ (>4$PB @J7,L2D:0"]I
MC4#SE88HIP@9U8Y*F ^ A#AXRG6T$$S) !#0@2A8U$9M S8  RH8 A;H@&,J
MQ>MH"3$CBU0  \H8$.G4N0O8@ ]@ ;"1@:EIJ0[  (Z0BT*ULXVS&<1SB*R(
M@"^E"$[@U&7)(<O2 !"X 2B8U3UH S+H@B.@ 6B=4VCI/-G*TWF=D4F(2:WH
M/S6[H?7^$DPPA0).S,,NI#+ 2:&"3:&KP];B\[XCJ,<<"X+O$:ASZ3Q*8(4U
MB,S#@,01X0B#32$J0S9\K;BP2(4ND%/IC)!Q4AA;VTYP?8 .6(.' KU2&1%N
M54M_\Y0!X5C*B%@4$;8X$%1Z!5KG>,^.R%?D0*U:TITO^-G]8+@N,E0ZA3.*
MB0 D:-BB<]IS^2(Q2T!=V<? 40TBM3,6D->S2 4R*$QN$KJ5K4%(],9#@!L\
M_#J<,(1[[0BP15@L<0@,6 /:#-J^Y3>Z742_S)L_Y=>E_1:2O=J;#;$)B )-
M#<J_ -O$70A!D@A6X(/@K YS!!\+BESLTX&$2PM5:(/'NUO^J'W:6E11$RE3
M,B#&QE&GJIV(5@ $P+63APP:$L$ ,N GO^5=H57"H.G3M]O7EDD(]BJ)5%@#
M3)/<D&R #3"#];Q/H5S>SI"Q5C"$&GC7Z860$9F ([C3L&B%0I !2+Q4:D5/
M(DB$5X)!M(3=V"T$F]5>Q'&-#%"#W>W=^U4.>[6+HLV,(MRQQ^C7$"P$[*VJ
M^%6(&2 $P]6S^(U:A_@ 8)T(3D "OF-@F44K-7!<L^ $*#C;"D8A&=@#WU27
MT .+1]"!_*P.(HVC#S! _'5AYIC&MOM>M/B;C,F?L."$*-@6V C8%):3F82"
M0/P*+/3@A.%3S[ (4U #VBWBUXC^ "%(!+Y-BU38 QD@UB9&/&)]C A0 3+X
MWJC@)"H#HK#PA"A8&3K17.W5V#>$RQ=V8Z^ B^P5',%="UU"8>/U"E7P@QO@
M"#DFCH_M83?\ _LU"764W%'-7@6!O]B%A",@/?,M$=9 "!# X.;@A"\  11>
M7C*-@!4  TNHMBI!6DUK7XM0!3Y0GZ7KW%%CB,GL HY\XUANBYCS(?X=C+]!
M+CS^BD]8 Q9P)S].V($97MQIPQ58@Q_-8^G%XAQ"8HQ(!3_H 0JL#*^-9,OZ
M@"B8A#8>"U: !"X @79A"4V^DCC"%!8P TM08(G@%%9K &\3BTF(@IPC$&".
MY(;K3AW^*(1TEN5]AF-%VLYJS"5P.R/[! M.4(,9N.+#\ A0Q5CO5(,9%@E#
M]I15OI5F%@E2B ,=B$Y>N<X2P905Z )(T.<PC 0P\.5VH>BMBP -$((X\(21
M#B$-8&>:+8E[/ (-R#A(QEA,N8$VR&!^!FJP&%I1M66WL"$X"V"OZ(0VN $K
M8="L6)A?B0 /$ (^>,NS(.+O*53#P(U%Q@A2\(,CJ)R;(9/P<8U@$[8;4(-L
M[I!6X(3'[( KWED[:1AAJX$N2 01-@DPKC6&&#2Q0(5#B(),=@ &F.L>=JM0
M+15AZX$]@.6@ANRR$#G;F(V%**>#F+G!6(/<&9%^@>J!@>K^I/Z*4C $+I"!
M: W7EOE4T+:UX10",PA/M1@4KL;&;&5M@QD1\\$.RDZ8SO-JD4B%25 #(8AK
MU;"5@6EEK;@L&>""0B %;1Z,5("$X?X "@3D7DF0E;Z!+@ $Y"27#3!L@1*2
MWCZ(34N+QER#(N@ ZR:1NR60P[X9#%"!*""$GX[L^RX)3[B!GU *_O8)JH;H
MLFB%.#"!G_  _SYP#V *-8!IDF@%3SB$+[#2"PBQ@/F+<(KJU\B>">" &CB"
M-H@$^P8+N3D*_S9Q$^^ $T=P%3?QF>+O&Z!CC"B%1T!0&L#I%.JM. JG:66(
M#%B!$TV$EVX54["$-]4!%4#MWE;^\JM3"*C6'0KX@!M @C;0IP:_")U(\11O
M<:/H "00<:\P!4K8@R>X 6AMY86Q-=#&<(3 @ ^@ 2H !"''[SDGBU:8!$FX
M\T>8A#V?!$C8<S^'A$C@!"L/BU*0!#SG<S^?A$CX\SY_A%(>BU6@!$-H@RXH
M@AE0 0_0@ S8] S@= W0@ Y@ 2DG@SU0!%*0T<SH!$A@]3YO=%=O=4!7]#O?
M<SR7!$7']3ZW=4C0<U>']3Z'!$3O<TL@9)Q8!5)P!#X@@R.X@17H@ [P=$Z/
M]E ' 1LH@BYH@T/H!%>JEU9(!4N@]"] @F;W &CW] OX=$[O !"0 2*@@C8
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M D*S'L<HV\U[T^Y*&W]ZW6O"A12=M<<?6*)&TVA'?_7[*[^__]X4!\  _HV
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M=A_A$WOA?/;-(9'W%1?&TSQ CQ.! K@!*ZC!$"0]$23]$81"__8/U+KB2:^
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M/]OKGKP@,#[C_>MV:B#C?B"4!+P13&LMV1 1%("!0J@B#15 B@)DX A3<(R
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M-8"!##]BA21TD) )+*P3:J "&!RQ"(T=S8I8_,H$QA(*-U#!"XH817!!:Z
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MLH8@:T#@]5SV!2T?U%5A]9?R]53S<CGW%3GQXD1O=6 )EC!B$DY%=#L-,ZO
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MO4" 4RN[61M5.J$+O%NTX<,1QOO^MC.!$KP@O+*;"M2@%!1AN+. O9W;M[C
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M#R")!. !C:B)QV@6=#B,$/ );?4)?, '?B 'DJ 6CB '?A '?&",KI (9R@
M(6 SI. 'T,@'<IAD2F"$ Z $8E$(J^B%1N (IZ(*D\ %[FB$7X",^3@6K" #
M<&B$:X!TCF  5OB-LHAD2."):A 6JM"/1I@ ;0 AA$"&0&C^ =NHCQ>I%8E@
MCQ80!%THA-SU"87@!FK0!H1@";W6"IS@!VO0!@)8$*H "I\0DY(Q&QH!"J#P
M.Z'P"3LYA*JPDZ/P"9_""I90"&V0!FP0!X?P"6M5"CLI$$:3"J,0!P9@A![
M"3MY&*P0DSN9@X$Q"H<0!VH0!X30"=W5E#$)*::0"&ZP!GQ "5;4%?,H!VK
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MCM"<9U@ "0 ";1"FP>EUI& !7G@(K,"%/TB*)>(%]BB) W  8!"1$3", F
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M"GS@D:M8AN6: &,++&!0B?9ZMTLJJT1 G"EH  D@H8<+*:Y0"?:H 8GK,B$
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M)1%6$&HV O% T#+[DK'^[B$T\PTD=^.%;*ZV #<0141(4;O0JHD!:3@4*Y"
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M7__[YW___?]_  Q  1Q  BQ  SQ !$Q !5Q !FQ !WQ "(Q "9Q "JQ "[Q
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I^[-TG6N%-YAPYI]^(8=IG8-WZO^_D\\Y@I;^[+^_ @6ZD/[^*0X( #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g44361moi002.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi002.gif
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M^??X^O[^_LS,S
M
M
M
M
M
M
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M4M;94"3^,5"9P ABQL2'HHS.P="@4RI@Z$QN^.DFHU&J6>4->T[2R!$/)."
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M3I "B*DMCQ1XH DG$ ,S[,D,(R#4%D5P@D<11!!&$,$#3-@!'M#A@)/@ PK
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M0)D*$40$UM0 'LSAI0>Q&$3MI38C/-6C5.*!EJA I49)*0$2,),DIFHL-SE
M"<FJ0P.FA,8.U%4!'=C#'#+Z,PI84B"1L$*ST!J!-'!-#]I*0 ?HH-*_SH!P
M:F"36QD L3I\P*,_FT#GTLF7=XE@:S-+[<S2)@@1&$M6;'+^ :3LJ:8)#"L!
M6:!# UIUS=UN,5"3.(1MK20'D1U!LPUP*Z/X1<;A-F"K#WV6VCJZ)@8TRKI5
M:M>=2AHOA^B!L+UJDUH+8@6WRLI8#KAA+(7%Q4E(@@E$2\ -&#&00M@V2D']
M )4:(((_(55*-TC>>]O$HE;YZ4U834B."/P!'I!A#_83:R3?2M8M*+<!_U7
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M "LQ (E ,C! V?L+:,0U,IL(TGK8TQ[W<"+&\G% >!=P@B CPBB1+D*,[LN
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MZ1;B&P3^SE)A#NWE;XJWD SD20!NL\"X-!"%[8G0 @2D)8DC<KP[#<  ;BM
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M>%0 DP#/X=73(N0AA)5Z8?"4T0;SL2?1(@1 ^$4!=5WWQP5>" 4%'BQ-<L$
M05E F5O^'.C$P6Z]?:%03T$*.22111IY))))*KDDDTGBE%%"#_&TUAU'X3'
M!D^8]46+&2'2$0>30*%22G=!(4D%%SCQ1 4:W%$ !E[X,604 SCAA 8$\*1!
M=AD]N1(''!2PYGM@+#>))(OLAL<DB(3AQ08#_ $&1Q+^U=(D850P$J,/E67
M101ZN9\3N,4$B9@8?$?@3Q]ZIL&,4+A401@2ZK2@$Y'B@4%+!8'Q$R*(8,4!
MK),(U%2C6$%Q'!BB&@G)'4]8P!:0E%[%:*+"8G35AY&\Y\0=D;1J51A1+)7<
M5^K=F4$!:4VR$2228" 2EDZ8%88&&_@9A;!_0'(!>7A$4N#^!9)L4"P&*!TX
MR2.01/&5C)*T2&Q&7EVY@;T$M"=DG"E9X,<%5<H:)Z!^>D&QL3)1915ZHTG2
MU5?_B07&NQ:@VB*5N\WYQZ,;$."'RUX)6]6K/Z+ZQ%="=H;8CP,C3:ZY*>9K
M\I@9+0))U8B0>M9HJ)8\B410!8GC)!F&\02L6KV,]AVXWJM!F$$21V7*T!V8
M$*J05 #&U)-8(*NG*SG1Z'YFX7&'S5Y@$)-P$R?]GWNR3K(!!Y'@\044;2YB
MP=]XW$6>$Q?<:,' FCIK((+(8>62 :9A- F>AJ):=4;?<26Q%T8%F2'-DR!-
MD[\#)>L'YT\X44$&;W+U!08@MPC^!0>48EW !LVVS8&]9S6Y/??=>__]]A)S
MEZG*4U*50117KOD$C#=F! DD@?K^U6X[Z?W?$T^ (0D>3DS+:)"@4(#\L6\1
M!@N Y$CFF8.1)W]>2 B!L@44I5C "5  3\$\E;",Q.0A<_+49("C@9?YK@(<
M4,Y>*C"[Q57&*A5P%9YPQS!:V<H+!,@?%*#PAZ-,(A(6B$AEA.6'!&7D#PVA
M%<O\()C+7,!90EK$$X3S+PX@9A*4PL_[=E,5;O4$.NQR F(@HZ8G&" V7^&
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M=W69C2JB%VC13:5VD"3TZ(X6Y ((9=1G_U =3,\ZYAFI$[G;E"G#4-S=@;=
M4P&M_>US?Q%A8$P/_P TSR7:6"05L*,(XI)<+^)#+!9PH[XO'$3LA2M^&&%/
M^">2LBF184WGU1V$091!RQ>XW_B-RB(@A%K0!XO-5_]Y'_BQ6-[,B?XU74]
MPO?]0; \0B2UWX;]RA_ 7[!8103^^4%K^,$=O!$>1,3+T(=KH,H?5$0(,LP=
M_$H1E># K& 8#(P&%HFCQ)& >5])?,BDA(NQD%/_940DW(%(M. =/$(1+@*Y
M@8WG0(L-&DMK>" )NL;Y-8IPN"#/P$\8?$$DO<^<C. 62D(-3LF' (T?N. C
MA(&'M&$7F@15605/<" /$L@B1$4/;N$2@D&WK.$?O(Q#R!U7N* )E@T1LLK
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M!10,0!0M'?W1YT&XQ,E\@5\HH7Y^ :H4I,,X@6G,B8]!0428!WT^1Q38E9=
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M[VS#*&3^K3CF$C ^LDL))SJHPERP2W\89#W< TG_;E7T-"KU(\8&PB:M)96
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M@(<!> 4,*Q(:EOUP8#9G147L60V&.RH>="YED(I%Q 8J,$^!2/!2+!R642Z
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MAH$GC L/&L# S%#UA U8P DD"0,&,J !UCGD"9EZ! ?\< <G](\#%%G@!31
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M? (Y)94R#, KBD/T8P XY05R)C P)7PFOHI9R'#Z3P/VRQDN(Q4)#0B D@;
MXP5@R<;_(8L##(1B%.;( 2]<RXB 9.<0A?.I!J:2 S3,"J/">2U*E9,@8"@C
M%*ZTRPL8$WLJ?(*Z!/ $0I+D#MW^\\,>.YH\BW"@?WF99!%I&B20@A 2,_."
M "S@!SR0DZ<%N<, "A &?J:Q4!4\H@46\80[M-4 4<B  $X81(I. @K]:YA-
M,>B%*)B0E$3=@$4ALD=*@O&%-E7-'80XQ4E@31(5" ,8OGC.QN4F8U$XW 8J
MY@<#((*-?G!;)[WPPML9( QX<*E%N.>'*,36"0/P0L;@8@ OW*$"&<1)1]G6
M5B@H%PJ+L( '-4#)"GAA@1N A $LD%PW+F*F?@C#][(WW"]D[ MX* !OWD)=
MK.)175C= +C^=0%$0%>Y3Z!N%/SP!+_ND5A12,W92H@'T> A"F;D ,&@AH>R
ME=>,D'+^ FUC2^# ?K)^*<G M?"(X+>V]0F;HB0$%['"_UY@$5A[FFJ&AC0,
MX.$.9<,# ?+GA)V=N,*XO*4% EN!+PQ6)9+ \1_"$  G\%95&@ D%(;BD+/M
MRP)?@"TBOE" ._QA ,OD@ 4&> %3[0P,2-Y809Q@ 017H%D:P ,4H/:$ 7SA
M"P/00 IK-=QJ9O</0 YB!MR2&B@48)>UTAFIX(:',%P =Y/@P #  (:#*9<D
M0].9%_R0@?1ZN='IU9C.!KF!#:#&TADX')J+1Y3S49F!\"-MH(VE6S ,@%XY
MV_(Y_9J! D0AKLL4S7\Q -P,/ W-;C:6C^\ O:=! 0\(O/+^'2"\+S!O+@,5
M%@TBX.R%\GI!B;JN $E#&^,$?X$ 6:YUEV\)YOJ9"LE?F'(D*D" 123Z"1B0
M! :<L$L66F"0>#Q7*,$ MZTNL[QW"$,&I[9G[6)2N9@R9D7&&P8"R+B]>/BN
MFS]8 8(,350>%)BUE7>4 CS3#[^=YXGINT&,HXIU%P"#$J$P7S]F[<2AA@)I
M*5;/;5,<X\_<,Q&]0  J6@"K3O S!G*-.PW<%0J0/+:VQAO*.X0R##KV QLA
MH0$"*+N;:_75$RKPKP3&;\84T=QRPC" J+K53Q!&1'"5':H*&$#0Q2J !J@X
MKH7< 0H$^,,\"]+AR*K$"\R5A /^GVN_F<Z8((NH>@'D_ 1!([>YNL0#@C6V
M.DD,]>_\5?-HPW#VXNY]V3.SF 9K%84,)F]]'^35(J#P\<)_$:X&"%8&WDAO
M1A.L GU7FF(O(+*%M#GB#9^$[:F;934OH@!. $.0H4!@KG @NSRI:Q2:..[Z
M3D)S$1437*\<!=1D:FC(ROH7H@#T[P9ESVU[FP$(LF _#. )8/@YS53X:'*R
MO707^][K*E8!@#D;YC. 3G$+5UF?&9.+PDNGWR.;@/D]/"J(>?.*36$=?3,(
MVMN_XNF6.R  :=(+[5.>H%&NC,,O"\ D/X $=LN\WNNPGRNN)XBX$X0+21"W
M#1J3BR#^+PQZA MD&]LK" V8-8/HOQ;+ '?Y@_XKOF8R@+=SP)#XKC)J/GJR
M *XXB/V#+;O[@ZT)"KC:NQ13":P9/,%CKA8#0@XH'4A 0IZ!&@,(0 F"-(*
M(*'8&1=:,'OY+CQXA(SQ@B_PPJ^9-?;I$SRXLB\H.))(&IT!&"V4/CG; &\3
MQ)^3H][[ RM3F?T#HPMXA.#SPM=[B(,))RO*I''+@"EC"-A1.?C9&):;A :B
M,C/I,$E(/\7"/3#*($=:JV/IJ/W;0].*.'NKB.NBNTP!*TC4F/-!A!J# O,#
M.B8K"%UDO0)8L2<(H# (H"\(/^;8,'PI@%-ANY0I@ S8L[C^0QS/,@#2$AD
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M\GH)(CT)L/*1^;!KXJL/C4V,__*K[A CQG"+ZWT5C*5O\%B$^@EP G>/J],
M0)&/)EJ,XD'P[!"O1T&,2*BP>DFM!*^.!NT>]M!P'0%Q !'Q#2]QR2!QW\ H
MB6F,4 '^U-+@)*<"C-)"C&<IC!DW:IK1%PD'B\];#'[BI(;0KL7($X<^ED<C
M#$GP+X-8EI*0UQU_$YB6J,X@VIT]ER2WF )2L)"H<- AH7H2#"(7&8K8V2V4
M$R]?&B4_#!"\'DNKR09?C!VJ,YX-E>-)GD7KDBA'<=:X@QP/<\ZH\2]8\=9
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MM7T<=K0Z3M.(]_?/9Y:S8> Y' )&@BH72!7YZDEJ+U#ZE@1I,#TU@($G=DY
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MB+5JD0CFWG$/ Z%,/#\=;=$QKH9O2FSOY8)!WO %&H$D>+0D8DIE0MTFYPB
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M'42 !6F06D?0X'[=N[5\P;E\# &LN5FY2NKD$6#ME4"01!3HH_J/F;K1!@$
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M%U1! %9'$D8D8XER>%%P-RS!EH8!C+:1$8G9CT#T!^K$$W<R$'Y BX QDG_
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MP_(3R.<3@"LQ .(DHT*S(X7TO8B!I++ABC!8J!!$G"^ E8]((ZX0%9[R [&
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MNDA0<;9M&6<AC" I<!=YLUN+\C+\Z*,8<1ZG\.[&;BDO\@*G\84PF1S;I*/
M\MHX#5%[8QSV\SR/"U97<OGA ([^:'2;P.&,<,</][DXJ_&8$&_DZER-TXQ@
M8O5:#^:)UCG02R=$P "0P .V4FA88:T":!ILLHSQC!6^-AGKL41)N"<WHC#0
M ^USAB%HR0#00Q/^D"]+A"7J$SU!:7>>@B$.L_?2TQ(#L ]R![U^>B:$\G>7
MP8 O(@ W!B3K<90!X"&8$4CJBXUP+R>YT22&\@Z7LA[[.#KK8:H/!CW0@PM;
M82TP#8#_HN+FF/8_@ \,**UJ%[6R$-2/YI&97P@UA46!^$.6OU2N4BZ%>FP-
M9:W &#%-<L..N/@@VH *P  #2#^.@\6\V225GZ 7ZPB"(VCJ^[,&U,&/EGF3
MDO:P9*O^8Z2^24=ZT%LO00&])X9V6BGW=:-X#7@$\QLUUMHJ0AOZY=* \FJ/
M]_8BP0OPS) C^U!3ZC.0A0*]U "]Y?J7/Z@0ZSD5AZ\/^UC0T/LQA&(MS-NU
ME+U<=&<1CNLN)S  #"@]D* [P0-&V(B+YO.#H4>3:F>M!@'XDI\2 @A!MVAY
MH[#[TT5WNB@TP9LP<]$X(8-VV0P D[HR-SJ+>:>^)!'4^:*-U@>]!3N8#3CY
M]K >D&&M.RE\Y9(?OG_^WB']50I=UAH.L;">K-G[Y4I^IA*4"2H *N&[>W^2
M[9\4;(G#D'&C^1J.[E^.V@.("Q?N3-J P4"& 03 _,EPP<+^A3]^,"SZ<B&#
M!0M^O 2H8-'/I$480(;D %$#(B@""H"9-,F/ 0%1OA# : '/I# "+X1QZ?,G
MT*!"AQ(M:O0HTDE/+B#Z4T##'P-_<E80"651!2^/G Q Y(3BGPM>[EB ! 6#
MI P5_N I<"=,!3R0.&CP4P#/(B<$@6HP@*<AAT5^*MSY4L$/H@Q?##:U  6/
M "^+,OX)8P#1'0%@$%6P@ B,@45P\42BB^AI1:D<,BS",R#*Q#^1G%R E,&)
M4J@&O$#R(K6OQ )AHEP0S $1T$49PD@"C6B# 3\POUC&@TB@))>(#( Q^P4F
MXK@O+V]@?6? V J0HGA6_L3R'T3^'$CFC#RW..%)4?\X(6#]PF-5$0<)@)%\
M 84? EP%A06+:!#88&%XL594&_@41F2+<( !(A:T](0&/D%BP1>3>''!)&"@
M))(3B PPWQV711&=@R@=-@D>:P'XB!=0^*0!:X-Y@>$7?S#8%$+*W2')A)!H
ML%9;88!1%B2"6<"!)!Q (0E,=\3X1U1^@(;7:J=ID!I@D8#Q1';U>?''A'\X
M>!R4&/P!27F08/#$)!Q86 &'=Q3@QU)-$1"B2U#4-J:&:+F4%FX<^,>9%S"%
M\8BBD/@D5DB$.9'!(W@<=\$3C]PAGDN"W@')$YYIH(&FB0Z 5P8<_#' $W^
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MK7+-S1,8F80Y#3=U[D8.[<*$1&5-66YTB'"HB]<V;4@8$FM5;?09V1>0C5Q
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M$]5%C(@8Y]S*E4 !KL!%C]R( RF&F?7:BQ0.LE@ ]SZS:)X-T- @5T4*S&3
M!0[&$[ '0PS E9R*$UB$!J!/-W*  - 6_!((-*:=09#-9133M,0%1W"O<Z6%
M2S7A/?TS.V].="56-6-J/57 1@.;VT+%O$Q/!H#?24>").>K)I].]$US0>#&
M4HAM<5C^QEP)@*U<!AJ1#5/@%:YUKD,@'6&XSBG3U;L, #?%#O[*VHQ(!@$
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M/?RB6))C *3#3B:!1GYW8*0/1*%24&1S>Y(W %FN3A!8(KY <7W).- #3)Z
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M\D;)J\8>RSN6!E!8X-''GK65YL(C0S%5QR:_#'/,\4("QA->N"QSQ2WFS//
M^/4,--"(>/&$6$$?C32\BX2A:-(F(Q+%$V T_3$D8>BK,,U/9.9TUUZ3)@G%
MR>$L[W3"B=WL:6:#)MW :]/;&LAAQVVQ)!F?1G5ID8B=\-MP:P<??%_'&\D?
M5$L2W-Z#)TPWSY'D/9K?93=..-\5WVU:V#QC/AKD!Z+F^>*BU\L!M;]YAD<%
M(_4+Q@;[+9(!1)\=E;)H8)0L7 9X"OS%$_7ZH0'68&\PK :4#[ST)'@8#R\B
M.#6\01@5DZ2\!J&/!KR-DD2_R$#^RU,7AN5AD-TS)!I4(/UG453& 1BC!_S'
MZD!#49EIU"]_O6A?0 :W!K*')I_20(M\G@&>\$33OIPYKT.CB=\! 96!14!A
M+>^K(+_:A8&GZ(0#\N.79%[W%;958'>A&5*&0L.!] 4L//5*'0%!$XEI4:]B
M8+@ @,('K[8PT#3K6I@7  :&"AS/-!S+TU(048$=22\,%QCB(BSPO[[M"P\%
MN /EG*"2#'[,<AY[!-/HQ45Y!= T40#8#.G%0KA5P'T(Y-]HD%B[T"PM?SJY
M  5C%HFKF<8/%2"@HV8310L*<B[4PDH8.,(8#AC$"WBXPP"@>) P%,  7YB(
M$S@ B3O^;" L=H-"(OWPKT(>1#*RJ:+R-ND%2$!BA!_A@,CDLHA_T4\^3XD$
M8_PGB2_$)@H:N)-GO) 2__T0"D=BF2(GP;+Z,&8#LL,#*J'%QJKP<49@L,@3
MCD,_#70F$N&)RI.B@#C&9" *)W&F!J(0A4=XX0N;E!ZT-OF%[H0!GC(9 !0F
M<I)Y:L!]?W""!IQ@HS\4X G_M!!$N)D>7A)/$EY0D2<UL &#Y!*B$.$(1/'D
M!U<VY!%/F!)!!N"%(+(,H  :*0-M:1$H1(**++LF2EYC@)I$P7D"\"0;\:#!
M* @ )Y P9IHDV$M=W;.D@:FF!J2W&(J6])\Y001!CPD6#=S^+ ,"X  BABK!
M16!Q$E3! P4GTBE/9L )?G!"!M)W!PYR("?KU,!1Z_.%E#9JD^M;T0\Y$$5)
M5#-Z91$K21%A5OH5U:WNNRJBUI<!E_[!E>O[#U#).I<H;""=97Q"1E:R@;'.
M* IQ?<M*P*#5#6SR"9#HYU8T= &0^@&<>B5L1!ZZUM=N17IIA*M<K_I)*G73
M "J,A$*Q8X"OW$&R4+!H!KS 30$$[Q'&--</G1"%\15W+O <4FN/*@D,;,"L
M[M-K9J_9TV4:A+D:L"Q$S(E<ZIZ3<EE=;1E)&LM>MH=6JXWD4Q9;7EJ%(7SK
M;*=M.1 %-@XR:6EDZ@ P\ 679#?^,P;8P'U:@H<P*#? !H#"%RHPTP-_P0($
MH!\!IA2% 3AAQ!P0 '"E9H%KCA")[1-(4"[0N@"$P6"1H6145".9,#RAB5>Z
M@ $8,P .>*$ U)K*[?K(0LF 03)^<%31#%"SQDPB U#@XR+N4 $OA($R3+G
M$U3C30X$  Q;9FANAORD"CS9 $_\L5=(4N&^-#3+%TJKL+"<R3@+"Z(EP=T?
M!@#C#)ADG+U!WX5T? '<?($I&9R))"3SA9'YX= CLTD*[0@)O.KD*(\*0P V
M$$0G;,\N',# ?RX$!B] V0\[K:'KJ!*L/VQ9JU6\4'&V>Q!'-L3(@[%1Q,+
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M5!1@T>$$%< YQ?>!-^H%(WB 5%)).J%=TJ&,TI>0-@&#,660+'$2W#>0.9B
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M&S)4D"S)R74P?@@0 !-% Y@+!\%@@ 3%PG@-B"X(:/C$MX4P.EKL-PO^N,.
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M62-H00W:D3 (S0]^"-P7E#@0]9U,8 <YGV&(-;_/H$9R'K'^0'CRB!8OQ&T
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M IRZ&_:FW(H"*D\-ELU\/ P.1\B1]C()]+8/(BG))D(V7P HS#K71MEKAS+
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MH@2=2VH,/&@1)#&/HCRW0Z,@W$B)QGC)B#B@K"0B#/@*5UF$P"FJL/3)"^"
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M/OQMB_Z-"T=EBYP=78=XVX.:ULEM8+D@8.;-">RU8*O!8-R]7KE88#@38;?
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M%E%&3/&,A*1I278H'?F"+\A*5;6IRP&?$;V J98$&!J()Y . 1"7V@:K -'
MU^,=]E#JF( A/  G#@"#^G3L%YG^;MR1G$_BY5YA'B?@"# "'7I*K K*@ #A
M  %0)P, )PSX,YJ^(0\)#H0J[$L=4;[,K@7'Z]QBDLWP._W!*L@8B+A)[0M*
M:1(T;TF&!):*2=F6ZO<+EH098J((;ZU&SR>POR< 2[I.D:*(@O^#WM8* TZL
MO0G/B,Z& F8]<<+H<!LO$9:X@[FN#@8R2B\0SON$9O@>"!!O#QBZL/*T *X3
M51]O[+Z,\HY (N9AD3D$OA)YP+Y(C+=^@MQ9!,HVB S@#Y VZ3^% @&XH@'
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M7(9 0'"Y5,  &$ &M\Q9I$2E>L&Q5(523-=M6<![B,[ZQ,I/D" ;O:*#/,8
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M,%)#342B+#1";T %/:! _^Y@)NZ,+;KB"TK$/ C0 /Q@Q1!C _R@_7(%*_Y
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MK[J=A;I]","2"857K20*5 4WC:+^ CIU +PL<CK%/ [B,QGB<<" '%?L!)W
MR'AULI/D#U*#7TC:KVM$*"J@  RD (;M^9P&6.B#= _3/%![8\8Z0A!:H>\
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M(<+4)#E5<(<7872$X"21.,44&!7@$<5_!_GA1X&3+()'&&#^U 0B1/UY<=2
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M6)]$030&"9Y YH(AK6" DGQ%+X..(N_A@2%Z!SFL)(#7QBB<&!%S<:5_)AW
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MK(="['$0(T9Q73=AL95,+\%E"^$% L 6/$<=JS-,=[0ZYK$LJ)>C?U9J$"H
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MM!OA\@0@ 0G""@9?]19"RSQ')3^"Y"DN)RPIRW?G(6#?<P$@44D_U'6@Y:W
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M._P:8!)U21@9J"1MQ'U#B(,# CE2%6M.@#-=<;S%EQ:-Z05_#32 .!DSB_G
MJU'_,TA; Z&'?6 <0TMDET(UPE>S9@#2C7PDI19CY2+23TU_ ( EHSX-.CL
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ME 7VXH83/P@BV4U5&\$P++ O.SCMUJ "7%5^1*&/SF^(R'1F+JP5! -1P,,
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MG <K&('$$Y1WGD(")8*(",P%UA4ID(%H9CLB0 ;J^).@6. +DP#9Q53R,(5
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M\F MW24IC?&\QA'T1"@\97H6,,Y]U%J!X3"S>A;/0-[^]<<_QJ=Y<(2$!@:
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M$1!Z$<\;@.78I;^0)?HQE7R9K2?2">RB3 HLE_U3ODS"">?0 (&(@OU@C-T
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M].6+ 423(%GXLH'#I$D8H" RX.>/ 2A_\!3XXT3#I M>)E8(HT$#(H)WP%1
M>*?"HHR0%OJ)."E,S8R3-J#,Z*=DAB<9OU3 $Y%#T3L&F$H\ZH<#AXYX&GJ1
M..D/(C]/"/C)*+6JQPM/8M[!(S6G4T0:E K=< '/HJ1?+$B:!,; (@PK_Q"X
M$S/,GPM9">*).PGKI(Y^HE0 ZR?,(@M@$AK $^9@6$00H0C^S8BHPA,_1_%
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M '[<4=@?!42!AP4U7?#%1!=L\(<7$R+B121U83!94XI1:, ?D&DU"13?:4!
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MII5FP F*$0H[DT.T8Y8&#'1)"!DG"LPF/M&.1'IE4AP4!M(LXG= -(U=5.)
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M+VJ !4 9G9V.!<#2$US2QO5+>8B)G505'GH5RE3*;(20(WJ!2X0*T>362%F
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M&<;<ZWOF4 $X 5,@1*=^P1,4@ Z5RR14!$T@Q)6X!$8827!PFX\)Q9+LQ&:
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MPTE:^F)4'Q_(W1YF;_@KWZ(*'E!N#KE,0EAG#CU!T=U(!6CQ2V[)1&BC-A7
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M!J @D(YC90-.B(0%@'*!1_S!(A*[DJ8-!@6-!P4I(^EXS?] @)\7W M+OX
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M5SS=B 8/XP*,$FJ2A3NFPI0YP$/^]^AA)DH \F@!W=?/I% I^'*0(,B5\:(
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MM@Y=@ -C*@A#,,2P/$,CQTCH]P++.4/X.JCIU<7GWUPCC5YPDAXNK$CK64F
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M!1N<!-4%#BWRQ 5EH4;2!19$P8$%&=R&1P9&]L>8DA4X,<D=&%R@@1\*(6*
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MV!DB"7#&9'&@;-F:G1\(4#43C5!(0A( 'O87!G>Y:2#+\<*+T )%* 3@#E"
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M5I!7935DE0UA#:'2>^=W&PX8 &@:,,!/(&& # #M<*8;@%9R>Q+[F;!;=QB
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M00-6%BWQ-GJR'W.G)0&7)$/V%QA0,+^D4@EU'5EA$+0F9;5V$OB2(=+R"$X
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MTSS\([W^2=,RQ<X%;=2E=2TXY@>/X%90\"W$V[O[5Z;$LE7RQ210H+36AM6
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M2BL54%#>1<76_;MG(2O(IG0IM7-$W@VS4*"116MM$<G:4=#;FTT8:D*R43
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M8'"5'V'<)';TO*S@@3]O- ]N=,.V8B$%1*/,3V(,D!:-I)%:&>  ,2]$-C!
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MBX2%DT3T Z7(B+2IR( V D4W"0Q47$56;,4 O Y7C$7V88]%E,5($PY;S,5
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M,I*TL.60ULKY&:0X(%Q#%Y?87(:H6D,KHB1QUI#AC2<1I<UM%R<HS/S#"]=
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M,' _>'4"8H^W*+EWO(^'(*O0XZU7CTA6VRBS6"7\XLI>]Y/#:&8WAXG >8R
M[B)@VY!CB\BL@J[20)1*^0+@UJ#:>: +<(V00E=HC74S?%7IB(Q73QHO"!3X
M.U?=59/$U;\75I9T)YNLJJ6,<(P*JA2S^';NGA6,>%]7OV4_".C..@DP.'@L
MRP@PT&S^2:"I X/RPGJAVS&L.S!<U\ C6<X*I<L)8L0*X7 0.7N$A>=NDA@
MF*65:/X"8G-(\S!EFKC=2^HZCS?VDW"(F3FP6\>-RCD/ _B6.T=7*9F.O2
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M*]$17 DJG?YJE?+I3%F& +F( BEQQ B3C7EP=GUBSXTICY(O1S;5Y"3%5V@
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M0@M@)B%Z"&4EAB<;-0A,"@4# 2>3-HPEZ 5/ 423.!B(0M$ ))%@#"P2^6<
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MQ"Z+N  &VK*;_MA*5QSARQ>@0"\-6& G!% 5!C"P 05-PIO1S!+-(FD!_&1
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M*O GF+:E.!K S%'%]=C # 8^9T3^B#SIZ1]Y,JT"7K"B5SNR,P-D($%>0\0
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MP$  8(HIMF*<(LDMQJZZDF@@[ 4]>L(F'VVDKF<@@@-F'B,RM$<2AK$C-
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M8ES Y1D+ #/8*S?P,"Y:HEL$@(#[ E(F9(GRI$W>:\>\@S!B-H6?IW@.Q8
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MSR[*^,&,X6/^, R.^5$$)UI(E'J/45&L99QF(SX?H:CBU&%G-<ZDJ+67/Z
M"1\>IG[B3!0)EQ+B0ZKB/SVV[_W^PM[[O_R0!" B19I$L* D2 431I*4L*'#
MAPD7<4 $$2(DA 4A#30(Z5%#2 P?'BSHY8O#1Q@K9O0(,>2DCBIC3HJ4LF'(
MD0YQ9DQYT*4DEAE=$M0YE*/"@4)]@B3X)(PD/P;P# 7ZDFI0@Q^%8LWZ\>-&
MF4NU)@P9R>HDHB(Q+C4J<RA&1!S^1/I285'"BV.OGN6Z4Z1#C0U1\HV)-R9#
MM%-E"C3HQX+4BCW9$J2YU6U(/T[$5@3<MK/GSZ!#BQY-NK3ITZA3@W[D1S5J
M/S5=RYY-6[47"Q@L/-%<N[?OWY(XX+9@\K?QXS'!&.# 6S8BBLBC2Y].O;KU
MZ]BS:Y_^_N>.G^;;PP/W@^>/^/.A%^&)C;Z]^_?PX\N?3[^^_?OX\^O?S[^_
M__\ !BC@@ 06:."!"":HX((,-NC@@Q!&*.&$%%9HX8489JCAAAQVZ.&'((8H
MXH@DEFCBB2BFJ.**++;HXHLPQBCCC#36:..-..:HXXX\]NCCCT &*>201!9I
MY)%()JGDDDPVZ>234$8IY9145FGEE5AFJ>667';IY9=@ABGFF&26:>:9:*:I
MYIILMNGFFW#&*>><=-9IYYUXYJGGGGSVZ>>?@ 8JZ*"$%FKHH8@FJNBBC#;J
MZ*.01BKII)16:NFEF&:JZ::<=NKIIZ"&*NJHI)9JZJFHIJK^ZJJLMNKJJ[#&
M*NNLM-9JZZVXYJKKKKSVZNNOP 8K[+#$%FOLL<@FJ^RRS#;K[+/0QB<)> =^
M%>VU8'KQF(.20 $=MN!RN8BU#2)";;CHIJONNBJ&8=Z#DGQA%[OT/GG'MP[>
M,6^]_/;K[[\0_K&O@[ !;+"07[0&;Q3X'NSPPQ!'?-Y"$9HE\<4O:AL3(V6@
MX4A"=I1AQU![E,$$$V7L$5+)=F@E22!G,+&$%G98Q0@<5RS!Q!F",/1(&V<<
M0I C=6C!1!-H"#T)(78H/9:W&$<-H[DQ 6)""TY/TH0'5TRBR!4F@$ ""2"8
MT 0CDXCAP1(-.2+&"B&,'4()2Q#^4I =.HP]=MEE2'*(#"6,' @0<9,00@@R
MT $)'&@(\A#5,DD2!A1.26WYB8%<G?45(%P!21,AL'"%'46W  (3CZC-A$]E
MA&#V'"'+X $0:/-A^@YKV#%'$R64 ,??)NS!R XAY("&'7 ,@7@@@<QA-VE?
M: !&!F!<;KV%8+Q;42 EP)!U$YW;88()+=^]0@ESJ)Y0("N8T$9"@,@0PAF1
M+.'!$(H8) 8(21 B _FMR\'S)C$\$(A!$N0:RA<:!A'O3 (*3KB>!"6$!P8V
M)',LV,,A-GB()70.?*L;"_B:P#DF)*1U0/A80O8'!$"T(' -.<09 .$_]/W
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%2@$! #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g44361moi003.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi003.gif
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M^O[^_LS,S
M
M
M
M
M
M
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M%YNFNZO!'+^I0,,"N;&K XV"I$0""BB0@KL#HT#N"JX*%$@/(-CI6B 1K+M
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M:^9PK04TH *!DZ"(\M,(#V'0=0,!8R,6!+M@R6Y)+X 8#","1@6=\76#9-G
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M:K>7M B9 [,YAR0)ZQ:="&$(YH1.65IV;26?I1B0*9  :(IT9$H0MSDY C&
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ML-<J$&S*.D]Y! 7!7:,E$"JLK8B O0Y@.Y =V1# SHK,U.?G@Y$M 1$ V1-
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MH5<G$AU0^DT4P8&23\<+&'@$![B.';L'7IYW^'O@[W"!"W#^  ,7\/Q[PV
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MW,,  _"".^#+N(L"U+R ?U/,TQ,ZG41+2? "I01-E].[SBS*]A3-ANC)G^0
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M?C#MQ=\[M;R*&<_S298?['LD36<M?O&_V[VQP)W[<??UD_Z^5=W"H@C%N:N
M!CP@ A.HP 4RL($.E$0',  %#60 ?0]<($,.\),+<K"#'OP@"!'XB"=0)(0F
M/"$*4ZC"%;*PA2Y\(0P+^(@O/,$+%HQA2AX1!3!L#8<^_"$0UQ4)+S0KB$8\
M(A*3J,0E,K&)3GPB%*,HQ2E2L8I6O"(6LZC%+7*QBU[\(AC#*,8$1F(H"BPC
MWXHH0QO.#8TH! ,'PC#"#MP0)5=KH!\D!<4[_ 0,^S&)(C8C+Y5$8BM]&-,!
M[< !1"+^4!&7TA@'.-42M!GP$,WBXTKZH$<<)H0E8"@()1&8D![:L6)L_-M)
M"MF2/D3R):JT9'5:<D>7V,%,[7K$I3S7 9LT4'<K =<LP2 [E!RN+']422C'
M>,5'7&"3!E3$T)J4F&=R8'\:\,,CHAG"0QB@ _$Y0!3J:!([E(J#7EA(%)^@
M@0<Y4UX<4$179OF%;K7%@-G<@"T/V)XHR&5(+GD"+PL8!@LP1%PIB0(&@&B'
M>JKD";?I ",/.% "@D\#\.* WS00S%LA\ST;;$D8"A.& XC3))ZA*$LXL*9V
M?<$ 4 A)!MJ)P#[LA243.F9^-+,2#MQ&)"V!J#)=T@<_J*K^<QJJRF/N%31-
M4DP23"79'?S(%Z9V*JI&.XDB5-6OJH#!#I!@IH?PXZ^VA4&8D^*JA.SE1VW"
MS%Y?N$,LJU*E@<U5:8\(@Y@.X:<JC2BK4COKO<AJUL?DT0ZD)*J$AEB UE#P
M-<H+ W[BU!J2D/ YRC,K5PX1!CE6##]!FQU1'P$).YA5(51%DB8Y"XFH[H=U
MG^RA7#V4G[I*A*CQD@@8PH"^PO(ECP]3Y^PZXMH[1&)?,S3 3U;;U</M!)L4
MT^Q?_>7;6&I6CI' JR#!E]O*!0NS);GL:YB#@:RYU&Y:!6P8,.(C[O@5?8K(
M[>_..]$G&'1297V-1?KP,Y+L:[G^\M+L:Z [5?^BA'75S5Q1SQHUDK5UN''U
MFP7H2+WMMH_"5:'/744#V=F:M3URY!@8#  &?P5L91W UJ3X.$R_A%->F]UJ
M8)$$'/UB*PQ_)"IQ@6( RT8ULDC1K754M8'YN/:J?MMPIZ@:I7\9X G]>C%@
MTQK<S3[FD]H%<A1VK#3,5J4U*TOQ<A\RIJPB>78'<(P&G!#5^%H9,A(.*C*_
M,AP.N&5-&XA"'PP0E?:8RP*WP<R49G).#EA@)! :SF0@Q %PFI0V/?%#GM]C
M@"A PL]@0.<7,@#5NVA@QWYPCP8.,!(P; <# _@H&"YRSN' Y2::^DI8-O">
M"RQ'-%'^&, &)K(=34DD QG0P%'R;($[2<(.P0DU5D[5Z8"^"-BYYL  %FD
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M'DX&%"+^00$7?1#@)[7':PR9(L3A%Y 4L,$+\$E$JKSA8WA!+)T,\MFB'V3
M?(!@^DE96BP$.OJ+&DE"!DQ&!DC2"#W'0#15;F"3%X3$2(Q?;@U ]<T%UWW2
M'1#4I\5)+K9BGAU"%&3 F=@(% P+-/U$* *A'?A?25A$61  63Q!C?@)ZVP@
M25S::-E<.WZ(0WS:'72 <4"3-R7==>6BKRF"8OA%04SA!$V*GT'07CP"!1+
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M(.9M,,;^J[Z<9@C+;FQA66"+<#+39=),'F6 L9*$D'IF!B#/7-D<:6(J#F*
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M]3,[ 2+1E%VTQ6Q A%MP5%/WAD:EMF,L]4P[Q$@[+1F28+PA"84PMBU%B;G
MC)RQQJIXA<L5-5\K@J_15*R!R(7,FT5=' ?(J5K_D6V[TU<@X&[3Q[R1TU)$
M'FQ(1<6US7N<\U>D5QR)H@,KMTW^I-I'9T1$&49J_ 1>;QM93$A1:%17W%:%
MT]12U%!&\(1+FJY%*<17/-1/ .4-2@5C'T(<00)JT$A302PD<DH'_ Q/&*-6
MBVR'9Z^?-8_5' XDQ$])OI^+"$R\/$:^4'G?6M#"7'FG! Q&1 ('. JOU$O
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M0<VW1/*>%6Q$0=(_QMW#!'M(Q>4ET-A=^Q?(E (-?L/0EW 8XS"I1-UWT"&
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M1[)#_,*7A8=\.S&P''9NAL*A?'GT*$Q+16$@:>B0DJ-T*%XXVN'X**67 XJ
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MA"NYRBQ-:$BR^(&&AE1B 9QGR]:0RD]L:AM+[+"_ 7AL(5#X"]*^4 !(?ND
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M9ZWU^XS@'K%32&BOI93%P(';=H@")(1IO<NB(J"P2O$LEJ!A8F9?!G !+5_
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MDB/5*JP=NAW64RRZ4N>N \F,F2E=77"O&(5X$*UXM_$]IQB&C/*I)ES6!$_
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MI&8//PJU/N:,8B74C$*A$.(+"",*E.<_V*\A^M%N' (2;&0AD*M):&4A[*.
M<M$+3+/55.+IF,8.@.XC-BLAS.+^*OZ"YCQ&);QR/,L3-9\N+EG2.62*?#@B
M^W+K"1[I)\( 4%82U1:B>W(C;QZ!%P<"9!"DX 3G\:*HNV@2W4[+#I*)'TF#
M0.7B!C4OR,BQ\R12..)3-3[R$#@(,.]@?5SI<])G7@C +BZSF=P.8H@BF<
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M(C!!T<<%=ARP&0:2<-"!=4]L(,D=!R@2!0:18-"!'WYD$.%T$7*PE1_4^5&
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M:AAQ$]-2-H)BT3-=P;4R<1$?&G;0\I>%(@M?$^0=I@+ *MCA)N_34S_3= /
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MG3+@(+;_8OMB2:IN8\DU"P1HJ ,,9 0C2$UU*LJYKRALCBCLSCT@DHPBFV@
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M /5R A,L0 O)@$\")45YC0)DE,A@"$7(@.-CP<VY P*8%U5:0>'S B\0GC[
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M 0 5FHC38HG;Z "S(1*K@;A#N(Z!X0"<5 1(^ H!0XR"Z1C=,+>A@(L+>*<
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M</E;2B'^%K3X2JT:H="  I6*6W+35)WH"L4J$,&P1-D &N$ZUPNHB VP7SO
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MBB&))%K^.7H%\ ?.5_2N54/Q L  OSODX?<D5M0YF"O=D26#A @G:I5@C Q
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M$P,I\T,RZ_E-V8#FHAP T"&<.9G*5"5$D>  5R+#)2\4!Q)0:.9:"')19UY
M-1IHB6\2LY@,P)4H["G 01!B)-\P%:/GBD04MJ,6SD*F0L(1UP#*"1&:L!8
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M$RI&M.\1'<V)Q="[:]K*_=C0LJS^?!34DAT\/!9M#X5>>Q00&RPY^4=B/?E
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M!= IAE/^').25H1VA+^#S AI (0D278&;.C X<*!/H\.7-CPD,.A/@0P/-P
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M^7ID@=$L[%I.T(FT1A@UY!C@3R-9T:KL8*-_;80@%\! CS;PGO&4=0.1Z,,
M#E COT#PF@4DR4;I(S.!<L21BN  %/Q@HPZ,IB<$J)$%-#N4 5B@1[Y,RA>\
M8)XN'N?^84_X;(WZU!7"EA5W:"M 6=9%E0,88 !,NL-J>Q2%J5*M@?/"V59N
MRLU9*@(, M@LX>ZHD&E=YR/4"=%!O@?2H:TP*E**R4P(4B #$  GGE3-HT +
M/W2Q% I.2V0+06> G2C3/CW"@&)XMBRM%5*$FJV1?4;"@3W!)549^$FZ-'F
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M!);0U["'.4$Z8919Q2S$ZCM<S X$8%;'4LEJT/E!@6 P][U99$^08O>)4LL
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M,N(.G:":0<<)<#5KML(D/;//X*)$H* T?(4 )B\)N;ECE- "WH+RU*Q0DJT
M)J]J: @A])8#X)-^H((@X!,U7L8>^4G!["EJ+@#*TF@T'H$OBXA/< (, ( #
M@#G=;&[,ZJ*++T/?=H5\K&0EP-/%G"8_.NU3_L/'J@8-7T*.L@1TYD^M1^WF
M<B-5,$#^Y%8B- KF+   =T3G[!9L+]8&TYP NK4%X A@$*MF(S+$J^5ZZ"!E
MU,Q$)#: .UPLNPW# +@"F_"P((KH 3MFK_@ZPA0#NZ,[:ZS)"2+C^N108,PB
MYE2E#Y200)70?XR2)9JG]LRN55^"&@MOKZH&1%BF )3PUV;B6XP[.01++[S
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MLVW#NI&\&(!R1Q&D2(.]?+X0J8.&N)</V9EZ%V;#@B45I0W,<'"4RAPV,.3
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M@SD)_).!$N\^,;:-ER;J-@S@T3L#Z$]/+)SA1Q@DPAYNR&R@:0<,9, H&-
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MRO(0'3!:C$(5USE:]111G(9AEV$]<T)2&]I&7H17E%=T]50JIC,:(89TAU
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MC-PS>ETO8<]1F4\(26T)A!D=M<$LU18&$C>J@2J/0,,?Q '^%0-V?O#C.%L
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MO%*60;J &L3,^/.@ RB+#BB9K. .*.@(G],-YKF# 9!, W@2\_FW,T*-I#J
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MJWF@#N3?I_H2XK2V^$V>:1&2"2&2EBB0LYX1<+JXAV2-AIN32\D*2*@^WM4
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M01\-* G^O1& -4'>*2\+3LV*#8#57'<DZ;D+MB+5KK\D68DK)F%XD9*2'AR
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M,37 #0/^/[X8P((^9*MII$B,XZ /"N_8X)$O K6@1DGF@DL#DOPPP(Z2)-'
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MKXL\H@]NZ$PFP^;,A9:B;A,WD0/:(S'^)P/D R4V+I(Z@+5.C7$DHP\8 B&
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M3@,W7D01"@ 22PLN(,1G/')3CA PK *HPD T1L@ 4/(VH$S^@ APT:B",Y[
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M#05 :O#(DR(6W'$;&,1!PEIJIHUU@456.9&!)$[\QY83BGUAER*'%) !909
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M[F16L9K^$2 ,D8"0(EB&$@+TP29P:A>#3G6(-6)'5B4;S"<+8)'W<" 2BMB
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M!X),A'S^-Y48!IK2@=-<Y0YSJ2S0P,"1L/A.PFQ#V07XAITG7)M[11S,$PP
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M/KB!5M%Y#K-"",B#\U=Y;]%-P!<5$Q@6W><^3!1^E)>"D: 0/CA_K*%^]\>
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MTP%_N9!"AE\&<!IWD%I7\03; 8J2.8KIH8,:=15V$S)@('6,ESE#<FWF]B'
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MZ4%SN4T\IE6M:V5K6]WZ5KC&-5J*\)I<[7I7O.95KWOE:U\C80>JLK4Z]>H
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MA+^@#(<P" -AT[\X4#(M'P6IG7TA2I$P4$EY@DS)"4@I%;- B^1@B&2ISS#
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M_\( &J2/"]$(%=V,#E!# A*,,-   BJ 0_&AYW&\FI@*II"4[% ,JR.3%CO
MQ?2(6<$ LX6"62DB".L ;"& 490S#N$/G FY[QP ;,F60/$ACO /!Z4,X3@A
MZ 2VGK(51!PP^.F.@_V7W%S8<@29J0A.'8Q8,NV(2$'.I"!,K.TR_UJ1?M&7
M]@I9IV.*A"A9I] U1)G9I074X.C:>VD7QK@,S'JV\/24N;@0-*S2F'DD]A +
MIG4"2R79K"D.P(D"F_"17JU2@#E9N>T;I?T/R<B5;2&+J219Q: :P4C+L2F:
MKQP-E@#-QGE,SJ"V"R"  $$4\./^$5[K2S!PPL:Q$6ORWJ'T R\4I$.BJ2[M
M,7*B7CUIB$Z)R9I-W0N@#[VI+!BQ$W_QVGV1%Q5QR-[-@-G]H0'0V<;PCPG-
MQ/\(&X=M*N)"BC,[%CZ$OOCXBV>CS0AYVH0M-;<!C42R@\2$13&5V&:I6)(L
M7UE5G^$=TXX5D?"DMCL@QB<05HG"#OHPH-OUX>Q &HJ[F,2,X)K0&%V)B$NI
MLYL]MR49C+K[2N4#G9=SEE";&B;3L1Y3V@'T"/)9W=$-&AW, )V0C1*[@(W;
M -T8RSNCRLO8G%+J@Y]0+(!#%K;]B/*!$C 8M=G #D6P 'P%G$=;8.#]FU8;
MP#564YW^.!V3<+QY=0Q67 J6Z(LKL0![M9_@.X^&N3CLB 3RB8_XF0^<60[R
MX)BX90EC?6!7]IIF&UG.?<E$:@M]<1:@LN72#0[MX,XO,,75G5 EA@1J<PP8
MK%.)6F.L1>4?&M[<?8W@4%9!0N28[)O@$Q$$L<9 .=&O2;ZLF1=DD8A2L51C
M]8C3(8AXO@O*[1M19<7H]68^>@E<@0H2M<1GCHQ&-@L@2<P"J G,>3EEH9Z5
M$Z35\BE6=I'Z'=9=4Y%(<2.;:!C$FTFZ/0@7,J;-44!N_F:T& V)PHSQR,18
M44P[>V;1H" GT=5RCD 520F+=I#&$!&25(HCP9H)M3,]R17^(@O'NAJN<C0]
M#AB %WY:T"@)N46RWM#+_'AI.PD,1!Z)9(:1XNR(B0B)3DD.U!L+94$+)ON/
M\K7&D#F$)'2""<%<);D#C\L,F8U@FA4 "0EAM2E:U),SF*59FT!J,GV.WNF#
MY,B*0HL"#),1E^" 9/N"B#-&+X"O2A$1*7N6.8843#$/9!D1F_25G;"5]EV<
MV4@.I2#*3"6 SCZ4S1 +N"@.Z4 <J;X*-Z-%J@&1DA@/_ZCD@%,,0E'A(W$"
M/T@)RH"+_^HSDYA'X>#(#  EET#N*!B * /<X8UJ>@LK+EILOJUDD[@YH@@#
MV5#LS6"(&LH)Q.G5Q)"/#IB-LX7^$:PF1/PPO>#CX\# Z]1PW1].;$@1Y^!+
MCCX8D8 #XVE.'F^=U\3\1>G(UNI O9?T9MR5#08=23]8;H?)E%+F@)44D9F@
M$;+6 )\H,U'A6[4H&4*<ZOWV0I+H'>$LRH*S""QSMKLVB)NDS1;3M#$K1(]X
M@@%XE!HVV*M@D)<<C7MCQ0C/$)O4P?*&DW,QH\\ \D2.F;3 &!3Q:(HX%M-;
MN7?6@)M,2"B9MV2+&9PHB,(A)\"T2"3ILSJI0_@ GX90S.?SEY(Y#SU!%-18
M-TPQ#!7!\7&98,F 47NTCD:;4-0P;U9\BOHEL^'JBPV(@N^P;*?@$9S<"C;Z
MFL#( ![^\9@+H:4Q.216 XG'L[5C12B) +>!2._-P9?8:!:K@12ZGHQ'89S#
MB#I/[X,V&2-L.4D^=%'X"8.%6 _8.'7X,$0G8 FJHZ0<LFSUTK/8(# &VH]L
M\8_UT-E[@9V^L!=+.3=I21@A2AB.@9W $!E1H;H?WPY[3**M@(),A\Y.6O?H
M(;!M L](_PYVU5.?4A@.D/0EVXZ*D8R^N*#N=A@&QPQLD14W%%L#:HGIA!$B
M:;;)^77,:!8V]2F@P5?<Z8-($5M=@Q3^@$$] AIE%>!]@8P*3IS5@6QG.81-
M[_32T/7-6/<2Z_6_RG1<41%HCP15IR7JV!?86':-B:]97W;^QKF@J\GU75=6
M/>Z;9*]X, IU^M@X6@K;@S=X.\-IU'SZHK6PBJFK6'?Y&GE6HV[U_-.8"VKN
MH\",\S$Q7O</BH>1-OK:*"@DCIRHM7?Y.ZG$*$ I915Y-2JB>\/Y_6(3"X.(
M^.A.3R<G?3&O?N%YA_B"\ZD? 9R95)P,;+F7>7TXA<$8XE2(-M>8&@'#_6 /
M$7MU2*#T@<@ #9B:N!^P>7W.QY?\V*\8G$X<Z[D1@*\3$<&6NK<*;($)Y:(I
M:*$DA7J6XY<(:?&JXJ\C@0(Q<+JDM# D.+8C%7,NH4)^KD(AY3>D:XN6[8>4
M:6HNF,J*>?)1[4(APS(K/FJM\(?^EO>/?A22I)<C?DA1C2<[I^DO?[B=ED<L
M78" !$D204F0(A5,* GAPD<*"49ZQ)#A0X$)!SXD:#%C0HH<'7(,&;&C1X,4
M2X;L"++@2I40%7%P\A E2YJ/,(9Y\NB1!ID*6[($^I'BHR@:,'(\F'#GTI"0
MA"Y$"E$A38A0)3&]:%.H%PQ9K?Z\2E!BRI$9S69<2?/I4K$IW\*-*W<NW;IV
M[^+-JW<OW[X<#V' <,@O8;@\PR3T8@"*7449+/29&TD#XL*6+V/._#?#!3^6
M_6#($'IP9D@<#MC1K#JSEPVK7\..+7LV[=JV^4+J0_IV7D4M#_61.E=W7=^\
MCR//&XG^^&5%=_JX[>O'<_+J&A59SZY]._?NWK^##R]^//GRYL^CC]TR4DFH
M.]\_?&0\\WJJ3Y^Z95\P$E*E<(4+AUE$9(4D7W3Z7323@A %N-13)]6&4%55
MB31?811V1!]'"++T4X$6XK>35)%8&)]"_D%4$H<%0:((ADMA%]>*,E;5XHMW
M-6C9C9*=.!5>\NV8GI!4V1%C0G9T@-$7&63P!4%^;)"!$RU]<<$%&%R00600
M@7&!!1?H),DA=]CEQY8*]8%!:@0Y41E!45P9)Q@AA=&!0SSY=,@&U*44AD\$
MZ<EG2HJX25<D'<29 1CMP7FE%QPI\@233DIBAP881#'0'8'^8;"!D4\\*DD8
M&F0 !5106'FE$XHHLL%NL('QA"104$J0'8-U4.A;8'!VP92$@?%G2%%$L=<=
M@A)49WM09*#!G)5>"@5"BG2  0?(/H+JEZ$Z$2>69$;2E951 .4'!QAT@-TC
MDFJP)ABDDBMFM=<NM8$%NG)DAP6>IG3'8&W6]42M";5JP9I\'9*:LIB9*8D7
MQ?;5JJ!.@/$(!V?2=8@&%V \I,<I'0)91V$88(&F!X#QA05W/(+N'5(F],2]
M8="\4A\&1-$'& ?(^@0'=G4@;$%A '"!0Y%@FM &&-!,,[()W6' 8%%++>H!
M1H;DQ05(/0(&UG1BD&-*D%S 01C^L180:D$<6 !&'XH-7%"W=H!A0!@A1Q'&
M!8]"88$77GP!$A@"="")'P= 80?,#RU-\Q<'.'%XQZLQ.YFL8UV0&@9J[[I8
M'V'L&R1<G\-EQ\%X-=D1& 5<4)+*=GAQ@!^'7)#XWI)PH,$='&P@U>-N>U$
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MO)"!0QR 3)4LR/8P$H4Y)2TA?C  +F-%D4KVH7I@(-,A#' L2FV@ _"4I_X
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MK&.9Y+ !..$)!,!4LPB9@0=O@%=(]5M[S54X#MB7;0DD@!,:6RM]1>%Q034
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M"&.C1V7+18GDA69G!F?/A6)CULDQ1%FG%?'IXG0P!&AWM8Q0T-#\6!$95EP
MZD/8 0:(=H&4\GYH#7GM"6V !OO^C(4&((_9J%7"S'9A\)6HD(D.I87_5.TJ
M]HF7' !>%M<!D!=YE:/BD!==7@;'OC5?R"1WDIG<B+2E7$4!3;:8?,$=EF5?
M./?0](Y,IL03!)W'<"?P\<0LJY7-:088B;;I* 0FW06!\P6KQL9RAP0S4@2#
MV^-Z)T9V:\!@*$9VIQX&DM<X:0!-3_5^4,6"W(CON=+.C!5#'.9"5 0(W7-!
MQDB.O,A30";%\9,8U9E(?'B&E 6+C 6]H/BRHIF_&*!S((5'J,B.^ M$/DI
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M0SP V;+>%N" 5CCG!$(G"Y5OEP3^.MEV2^/5SIDN84Q(.J"G.DKL E$- %(
MMP%Z:OGS%M" T0KXH;_S!ZK^L7)!HF,'USY8$=L)IM(W/*&//"$UBHV7FC(
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M))#Z!&TQ*46".B ]AND1LL;7+NL+'J*6L&)>,@IA@U9HAY9H@S571JE$JH,
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,N/;JZZ_ !MM30  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g44361moi004.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi004.gif
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M_LS,S
M
M
M
M
M
M
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M 16,X861> 0<=M !8U+ !F40V!52X((4--**<N#F QS@ #2I*8)SFZ%"[J:
M<DK* 7C^&$@A2*F #MP@5#]\7CHI<"8()#,00$O"^]KY  C8+%^/:\,-NLG.
M!WPS#1_$@PN::8-@KB&7*@@"FR"1!)#.81 W.!,%DJ [0"1A!,;LP [DD$(]
M%.$$O413"JKPHC/&)8W?XMF2*/>Z-R(.@V6@@+221($RQ.X0%&C8CH* OEN=
M *$->40,0 6!CQUD=HX4"!%"U8%%K %I#SO((D00JB PC:L0?5WH))!*+&ZU
M?\$\9?_JBI!A*>EAB(AJ AH AR%4%5LCB&L<E"HM!1S@ RL:R!J6=  5S.$$
MCL56D$JV"*HJ2;,W:*./&G: @$+B"@]8*J[:&(FYJ6^>D[+^00R7M(6!R"%5
M";!!$285T$=*(;7JHH#S"#*'#C26J0H;B".,T(#C,D"D!&F#Q!X0URLX[0 =
M4,3K[JJ *W"WM$5K@W%[Y0"6%F0-$UC7NA1P J_ZU"V&BX'(E@2!? K$J 51
M%+8T-:D&U'8@4'W:") 4O,&%E2 !7E(*L/F0?4[J2O7B+8,CT0:5,:!+<!"J
MTD#G--']3W(*^$ $3_DM"0#B$8YP1"-2G.)M#0+$#SN$O9@T8 44&%NF%$@@
MHCJI'-U*!;H[ZP%Y7*57+6"XV>2DNM:U ]U=BV)M:,"H?(RM)!#$8C@L(D'N
MEELA)^ &LIH"J/PS*8I!8@I(PQ'^MAZ@OT*,P,A"==_G+-<Q"40@SE,@"!R$
M1]V"7"%4(MYNRL:')-H*1 X1,'*_&*FZ/T@ 5 VP<_V0I((1OU<MD4*2$8X6
M*AM 2'!PW%L F12#*UPAI1VKI4 2O*0'! $.<2B"4/W'$/J5\B)C"%4#DNNJ
M)6%N:<C"H78746/VCGAKI$(H[![!B#FTKU\Y7IV 78""<J;@VBG(\T!>#*X8
MS]C706A#')+0-P5$ *N1,$*''S %!Y4A7:W^F)!#>04Y% E;-R (%X0Z@BNL
M00O%SM] E)P 93$B!1WN@(#DH 7))>"U\=3R0&JH !L 0G(42)!6)<6 .4A!
M4P&=PZ3^3U"&.8P!LT@:04_%G*0')"$.<TA#^YAD7T:@? %)N! AXI "21U@
M HFL<*M91I K@"K0&)R9J"20@@Z8.!*+0 $KVRU1E3E U:T%E0OF0(A"Y,&P
M2M+;I=>21B05P1&< U>>!'>XYUV+ 5K(T"/*4+\$ 'G5_+2Q%F0%B;$^+7,*
MF0//$E $@\1!"UM O.(3']>-+TE0 IE#N>5G$$ $, &($LC'GZ8_#(8.:F.[
M0=4FS:3.(R1T2#J8OPX YFW#>""(^/8"]OZZW3XMN8^0 @HFT !QV3:36)]L
MSR(;"4*PU7U%DU*H3I#(0'3 :5_.4+"558@@C  "$4BN0/[^?,">NE;B N&R
M#1QQ5P8HC! 8/\3<?ABQE"<2$-^>UVE10($&G%,@MK:QJ2(!B/KABR" D (Q
M4 1C\#E[UFK5!6B. PG<-2UZ\ B%0 <0PFD*P&;*94#1ETU*IP!<0!"/L ,H
M$ 170'1CQQ9IIP"%EP>C]@&L\D_1(Q"  #]+XE8%$07,$RRL!GD#@2K@8GH'
M<5N38F4%L0,=IBYI%0EY,&G:%@E2 BJK<A#<5X'VA81U%VT"P3^3HGJV C<-
M@7I9*"H(T'IU\GJK]FV>0Q! :&/ZXPB$D ?/$C3@,EQ"]BU+>(5DI5V10 <\
MHTD%L04#R 7S@4'!UEN,$ AYL"W^\W9N X%EKP4ML04)FZ< >29T7T92O)4A
MZ%<L?M9IJO,(;8B' N%@\@*#HQ8#:3 (G^8()M0&/--G11<J(K" W,4 6#<0
M;^1I!)&$>)5T/8,%>L F*%:";U%VA"<0BA,J1? (A@,S9< \VC<0>U!W&\9J
M1Y5_1_8Z6K #01 $VLB-4K @J=(O1]5^OG*$LU6!7H4%HG*$3 AO=C<HY =7
M^^,KMG( #A $EJ8QFL( #@ !_NB/QH0XW&9C>A-[FG)4?U _"[!_+3,]<C!.
MP'.- C%O"\ C!'&,"I!Q D%G%=AX<3-]EL2$@- &23!?YH9NYRA/T*(I-A )
M&98LCW#^CN*"9<J2AK2(.SBY!CSS 8AP$(Y0" \9 T+5@>VH61'@ DD !X2P
MB@7FB@,1A4C'@)JBD001,I-B!+C3"(TP0>/% !89B:UV D$P!B<FC&X!:H47
M"8< ;Q48!RX8:I$0B0@$(_,5:C(V.071?Z'B/(^@ J2U>A_019-&,8+86*,(
M8";Y 7* !WA0(6,@94A"- 7!@TNR WG F(UI0$NR80,1.CC2 *!I)A!  3M0
M20\1.A$0!UJTFJO94\)"AI$0>T&8ES*H &E0$(2 !K@D >AC9'*H,@] ? *!
M!4Y(0.=( :Z9$"!I18"P!9'T (L6*HH(0^D#?I% 3S/PFOW^HP<J\'=9MR0_
MU(S TP$GD#;E.6,)  $0=0AK, 0IP)N?]2U$&0EE )G[M0 3$ 1T$#M"UY&;
MN"11N8'44A"#4)L2X#8(*@(-H#)$Z7RUHB00$ /A9)8F""IIZ9)"Y4<'.1!&
M "H#M#XGH"FFE& )X'L#D9!Q:%>^XBR,4&P?BH9<$*-<H)D*D%9S:&/L-"9B
M@C0.\(Q,PS'\2";\&&=G.'!<A09X, =S@ =-]$01,5=\%4>2LP#>-BF<"8,R
MN "WB45C8"\&LP!:8F,*\)M#]Y\924!$T&%4N1 $1S&+D 3P(S$*8"8J,YVM
M)4/664,)D)U:]313D'[?B3R1P)'^2'( !X  B*HD"-  Q(<&(B \*1.F2S*?
MD+ %0M-8!\!N?G* _EET1R>+CYB7DY8 "*!ZJV>B>' _Q[4 -A"E%#H6F5:,
M6*29:O:"<1DJ<RD[ R:.],%J)BH0*&IC?.F7!V.H@1D)G^># ]$&Z_@\RT./
MHG*API)>T&HK"X!U;U5B>341O/(MN;H0 TFE /9M5\I_"CE<6X T$1 #2= &
M<S"E9-JI3]DSQLDZR3DKE*4LD/0K%' #53 '%-A*B]@L><J2]!&)O+DD-D ?
M<Z,L8P J#" "*( ":%.>%NL",U(&0O4 2+D&>!!_>5D%*0"=O<( 6TIAP$F"
MFO>I@N;^6%9HKKA:L3)KL6FE"&5P _#)+Y5Y8*_:%<0HK8"@5#0#E\WH:U,H
M3#*8 -KFJZ*:HAB4!"X0 U$; U0;!-7"BJ$2 UIV5BKS,']0FTIBJJKB25Q0
M,*;*+PD0;5":$6O+$ -9H[!'KK09*OLG/J&R V49"84PI<$'G.YE=$M"E>H8
M;P7!GGE@1H)89AGRDDPR!24D$'&@,K1VI^Y3L$@R _3!N**B!=2Y *65(?W9
MHRFFE2U&NO2!""+S+3'P@ +!"!\ *F*G7'HP!D&  J.ZL (1NL(9"43P.R$V
M4G=U #M@$*PV!2G&""J&8CAI0I P""09 Q*@KNC6LV/QLWW^B#=PF0?E=G\#
M,;A,DEQWN22_&@G6B&2P<[[G*Q!1%ZW8Q BV=YB1@)%0$S;<&#9L*:Z/Y +2
M&3;\*S4@]G]7"$L8H9ETU1!O^S"*,%X*4*XQZ+3]"<!8RGF2I3+J::94F88<
MF%\+X  3$ ,)M)SIIBD+1A!H(+F)Q(C6Z7<%)Q"$0&@69E_G& -%HY=+PI P
M>+BZDX;X1!"%,#[!DS4_J0=MT 9\%R)L.: 8>GL>R%U(%PG<-;P-I+^P$CN,
M0 >#4#NO$T)Q4 :?TSU?8F,-<+34*Q:9AH*RLX$OHUP]UVI()@<.EP)L(HK=
MU;3"^A Z^2LW@ =%$TUED )( [?^3(AR"B ""0([R]0WV5(M>O@RI&,0&+G
M1KJ+ RS X!I ^*N6Z,G M;E_N4:X\QHJY3-O#Z"RD1"%5'D(QS?(^7(([9,
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MZA-P S35Z6/A"(JP"$2]-(Q@]F</0G@PQ'/PN%^E]B431G)?$=TS!VN0!FV
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M8=)0N(%ES>E24ZO#$]K8AR-60%:,="0DH1" 4YTGCUT HWMP: @H<-,)VS1
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MYZ[,Q&L4ZXBH@((!#% @ *,@<4@/%8"EBT*A"S/@A1*KKPD$J ,KNV!<]&[
M"7?-'@?(8X OU,&OHES4ZJJK20-]+!$.3@0&O. (+[0) Z6BZNH^Y.8\^PN'
M:G:S'3A 3,D*9 ,<>$2,^_ %8=&S9 H>\"$K#(75U0&-L[O8>=-KB$/9@91?
M@*]\]]R$^E8@01QX,#O[L$">6L 07.1#(CB @0ICL0F<NH!Z66S>&5DM$F$>
M"*5B"T@*VJ&*'AY ID>V5O35BLT$A8(CNM<'&M?AQA[S HL:^4M_#NJ.)>,
M 6R<XG7^(UK%-+;Q6@U1 )PV@0,<O9<%0 V% 7BA#Q'TD%Z_T+4IA?O/!JH
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M*9EI9RF)I]6T7^Y)6-V/1 :<T,R\^;QI!HHH H@YRQFA3=*_.QJ9)B@ J=(
M$OLE*-@ 87&" M@ ]/*8V0,C65DO#1"5 H""[M( '2.(1X,$*G&]:CFV*)&]
M%%2NGON3)]B?@9B^D$FX DB3<1&5=(LEEZH#6@D])VA &#LC%1LX\XB1VK*
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MGFJ"I5]]>@+WKC9\:BY6!-\*A[0W 5"O61\CY.6:-0DV"D)%?CT@VAX ZRN
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M'/51 !_^*M9HVT6Y1:*!;(\D<E5,8$S71%!V#* 7?Q(VM<%+4 B@5XQ/-%$
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MU05]R$U;;1R!992U*MJ[J</#\9$(XG)E^\553;R66Q>B_O8%)(!%TG !%UB
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M"&%0V(YA+&"H"P1 -F"Z:$9_= $2@D%$!H'4;6[U&J!T@3O81. 3AHHP*&&
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MUGC;4J3MUIB/>1"'>; =8]#$+[K$WCE! -B43:1MD2Z*4 >43"N&19<'5%4
MRVR.;\ S,*]=$DH-X)WNH)*2FH32!B+7TD*L0Y_0[%"SWZ#^9EXLF^8T%A0$
M5"((E?A<"XJ 9@#LC$7O%<+,-0%LL:CT30MN'WBL2!\PY^'LA)DNLDS'3?%6
MT>V0,X7]6R@!"O&4-%QDW2,$[6NIST*L"!]4@ "H1D/,!:4,*E<$&+:U$%%
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MYX#^%(V21@/J"S1J9:4"50/ P"7TD3*2A[DJ(% "P%G M  <9C6>P*Z6+)^
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M74BPV:CX CPQA#T&$1DW9V4TI*)]Q2P^I+Z2!0#"L0)2'3G^+"2F; 4HOB
MFH!'A#0#:'3A70=NM^,)W.0\BO8ED @^8DI3*D(#!,"MJ==UM&9+@0+'O\)O
M\@-CO]%Z#>#BS$5M+/HG+BZ^CHJ+VKI\*@(>O3$ G& TM\17B<2HOF?LH5$
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MRGW0-S<; D]1<WK1%N #WX1NP0(@'23V#+GQ3&GF"VX@.0O)JU@.@H%IVH$
M0@=)XXQ'93N=^[*_B_.#FEUHXS6$ Q:@90$(<!ZK++N3MA%T!38P' $T(>06
MI3-/2 Y-2-&Y"6T6)$!S'+NU]U@ XODC;F\B3,EH8#F.L0-G9*+(50G@LA9P
M5 42>A$/4?DJR1+ O9[@U7=W093^1!)L3W+_!)I6H Z.,4125#@7[)B&1(XP
MA%*: &$^-$$T(WFA :*J4UJ!KPN%=02)^F!9[Y D [89R;E.)MG;J <ECA0_
ME4:'_O&0'PJG!KQDKN]\' J35HP^RFC2 @E6YE)'11')%";Z<E<70$'7Q%5>
MM6,2LG\^5SZR40#&0S5V-@!2@GLGX0A.4  5>"]7I %/P1$R)Q/FQQ%N966C
MX1/-1T@CL5*\%$(\QB7H$U]V<$T7Q &"Q190L&.F]P2HEP&4HE,L2#I]H!\Y
MQ"4M1A-<94H+XA#-0W\;(&Q*0Q((@7SSX16)T 0- 7X>(@!(4AU-\1>($A&)
M\ 5Y]@C^&+ N%F W7B  =9 (!9 !&'(2CF1\56$(^P0?PV%*[&('L;47"'$!
MEZ0:)Z)57?(?3J W .@5>9@!0+4HD"(6%Q$52X$R=]4W&3 ?PR<2@N4>_L1S
M.#%24  XHP$@B0 )[O&%CZ 3'>,M@%$ ?/ $ _!<"](' O"')($!72 4=1!8
MIN<$.J%6C] EAD  C)B"#&-;B(@DIG<0%D A%]$BTJ@TIM$'B'%Z,D=E678N
M .((JV@5!- $C] $!&!U=@%^XL$1?0!;CP-_:>$03-(1CK !2_& CF11)$$0
M/,517S  UP$>T>@$/ 5D.Y9&F#<\#T@D?>$6%\ ' Y!6&B#^&)(1;0C":>GG
M%,=#B47!,(]@C9% 2)_B!%18'H+5&Q6 (5O!$% 1;6\1D6E%A3ZH*M((?MJQ
M&,$&3!I0 (N';7Q47M>W&UQE .'A+Z8X'E7A2"C!%E_@?R#I!5[@'F#P-^,Q
M$!906")9$4Y@>TR12F^2E1E A^:B-U5C$#91B^[127N86"52$Z:$A?!7)<<'
M2Q<0$;P!?\[7!TXP &K)8WU5 1Q ?&!0)KD$'H&R*V#  >3('(VR;*\Q:2+9
M!:#38A<I%.NA$M6G3$RQD:\'6QD06"M$($9Q/='6%'; D9<Y80P"A0]9 1$E
M&X2T :L'&'UIBK#9=QI0'<L4&L?^=Y,=>2@E,@!W463V<88(@A.)$$(E60 <
ML'!+&6"0XE4\63509EHW<P$\]@0%8!.R=AJYYW82Z1Z AQ<O^'^CEVF00A(&
M40<"X!,:,  4T@4 4!"N)5\HL2^>.!*65B><6(L+@@$$D)"04BNKE@%%^060
M1$)>P"6V2!T5HE77MQ9V 2%"T207@)&4PIR()V]?\2XQZ1Z4,55/08UG*5^4
MZ$\HF9-LMR",>1 3M &2=&#, A>/\!*#Z! >2CH<4! /RA06@#T=]$<"^@48
M&A$X@3I501&/(H^?B"VC\T\*&3V:1R2F\9!KET)?P"B!YI &82.114)'=6@H
MBFG)$9+^A,0C1>H$4>H;S7<\GV8035JD@;$:>E%'-?D%U:>>X"<0>E%4 9.=
MV'*3N\$4^9*,(6&*!M$$8=*$7_&4AX8H'* >*$E"EP%^H\-W<-$%S<FC/5D3
MI",ZI(.67T$G"<I.+OF6.9J&%!9<8UIHQ[D!!-4'8A$6^J$7$V@ ?W4B?_E_
MGU07Y3,<$%(7;&D0#$&94&"9;9$2CA-E;>%\J'F/>H$95AH2E%DC36H(1W4!
M?\$6== >'& '6U@ENYI !,"C9S%Z4<&CBTDM'"5!?8&%>GJ76K$1=K$9G-8W
M5FI??5$7ZT(SM!5-1=:2H>$2I9I9KU<9))$($[1H.,$;@]C^DEBJ'XS")+@7
M6W$Z>G-S(NL)*8"G%TC$E4,HDO)U29R8%$-R82'IGU_QL4+$$<6A+[Z4AH<:
M5A>P&CJ%K $;B-IQF9S(%N&*-V3E!090'&-X=KC%,^4A&+::D*<)&!SK3E5J
M6BI:=06@$W?Q/"^;+VRF.+OG+-+8-CFJ(-@3J\NZ%FE56[^#0H)U3J2H.,KF
M-6Z8$M&VGP91-0XKI0_%JVWZD#TH$BN'+H%I?%]  %]PI,\B$]:8$1[Y!)"
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M XF#@":.P&C0T 620X=]FF30\!%,EYE0'$6RTW&#A9V1('6QX^@)1PY\G&1
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MEJI#P43'^S"QQ$"])^"C+O&6K12]]EFN]O1 1#J(T<G%W3F( .M%D-@--!*
M6RF $6%)^=3-A5Q&#N50/C"07Y([RW!/0S@2)PBLJC*.P5R3HQ"C0S$$JN24
M6P&/\HC^$H: B67; !SAP3YP AUMI2/I,Y!02-,1"IQ(!"WA"ABA$0Z8'\9#
M$4C4"^F"C$*!!/I:MH+X4$-A&\-Q @[8$(O8F5]JG4*L0U7)R#*U+HX"$14=
M4>YX/MXYTVS2G*,PH.'@)]!1"B4=#:Y T\ J"RB@""A=O<Z+(R_EGR^@RL)P
MB8V0$ONXC(QLG9?04HNH YD0TS3I COY4$@ 12<8'#[0,/#P H6K"$]!HSB1
M.XX*K$10B#5ETB1Y"3024O 8$8N0DLW G^XP#]_0P")," L8J<_@BA1Q52_P
M@G5"%"CH GF*C+8(5)>0$W[Z"$75"V35$B>])D^)B2G50U+^)8D#B:8D*8N0
M@B$?G=&0<!,)S$@'T=' <@29T,"/" G>L0R;64.8R(JT$8\S"0]=VHH9/10\
M-55\A0CHV F#51+T8#PY$0TBM1)DI1$Y7=A5S4@KY2BIV K$\! 9_26J'$5/
M<26/4I)+A8SN@%)0M"+?&(K'VU>'T$<.,%FH\5%$/;VTX<%VO3Y Q=C1T(D@
MO93T.-&,7#U>E%;QX9*+[9='5<C"D8M7M2YUE5BGU5G&>5GILC/?<,]$@%H_
MB1$=U8\.#5NQ)24PP !Y(L2Q35L5XSVU7=NI*B00;%NY-9:[2M3SB8NY91:S
MP-LO0[#NX)2\74;N"MP5TR7<(=S^9-PSQ%U<QFU<QWU<9UDR)X(+R$7<R#O<
MRD6/<,H>8<U<L?4QO+&VRBT^NAV18G%(M?1<9[DAU566R./;U@VERXU=VJU=
MV[W=8ME:W$W;):7=K26ZW36\S>C=V[418R'>X$4/X,7=Y4W>8VE>YXU>Z9W>
M!UM&P(E;J#$2S$VQZCV6OU"6Z<%;TLW;)Z&1SIU/Y/T+YX#=Q-W6XTW4N<T[
MT5"()X#>[BC1BNA5,'&$Z=E>45(74<VE]9U/[)5;]#T6/KB472U@4>)?W#W@
MXV7?8DG@[G!@M77@JFT6LKC>PA6?RQB2U-5@US.6$@5!"S86^BI1Y"V\$_X,
MS5@QTBW^X;"EX/&=7F3AL66$".)U! W@@^WQ,A;#B&.9$P:F/B]SS\#5N[52
M$.W+70 BN,Y51E5#%K9M6\I(%9@(L&A5%C[8@+8@JD_U+60UE<(M(R\PJK6R
M"Q\>5\3-P6,YXV,QA#)B,7+!7<4MEIU9%H<#"2Q6VSKN@@5<EB/A"2]6,7B!
MF6##8G0+I5A#X1>""0\^EIJJQA5F,5I-NV&IY&91R$]!OK"%8R2VX=P-%P/3
M"W6!(1*I@YUHU6M:IR>)"TA(X(P;*9P"/O+C0;"*94M%Y5>^7YS:X%.V1!B;
M)U4>)YN4Y9>"K*Q)9#4"B5XNEGD:*5TN-!AE''MY,/ 18/#^T@NRT.6%H@T4
M 9$"<#UL$@H^2).80-)BSM<$+HJ$2(0$CHNGBL1BJ2H?YAB*.#UT=F9T;E54
MAH2N*F9DKN<'LY'8&6&]&$^R0(U@KHA3AN=QBK>N,AYXWHDUV6?GXMM$"&'R
M3 B@RM(A$2=>7N>,%@IETF9HUN98AJR=6&F+J@QLOE\!4>>V0J>7F"=J)A':
M0.EYL@,*62J^Q:F2T(N" .BMQ1!;CHE@-H0(VF>A#@K4<.<^BB ?ON@-#K&R
MT# !J8"Q^"^IGN?O@PE2M!-[CEN&SN> ]N%SAF6<1N5PD9I6;:72*BT?!F@-
MM!$<>C(8>C [:=5Y.ES4*.820=/^BLB3J"&/' FV9\[7)V$KKS:2A+%E9PKJ
M7/J7)WN)JO)II9;F<Z;F;O80OS[E+@V*^[@0>&UEJP8)IA;@M;Z,-!(]@E&7
M0NF#<#E>:PZV!V-J;C9I-/20 9(GJ/9?V[T/5R, &SP?@T,(#?"U[)F> O"U
M'"(V#"B(]\B =.F?TQNV8N.#)P@ ))PJZH"VX"+'"ZB 'PNV\DX,N3(X!1)B
MY/:U3$2)1Z@Q@_N(P?&T 0 =P[FD)G,B(%X=Z^9!F>LM#!BV"JB7VB''CX(;
M@YO)4<$UZC  ZXZEVC$X@O&D#&"PDM ;#'BH B_O?4&/I8DRM0FP D>?18*V
M+>J.@+'^;H8@-+L8-B1ZA &R[C;* #OQ4O.(.#:!MLXY61F?" T( +,=+ $0
MI#[ &VKS#4ZR;H8!"A?+#C 8 $&:*A[&&_Q9)&(CF"71GCARFZWXIHS\#EX-
MM@+O\'TA;E>3)_/F,AA;(.M^D1HGG'':C6'A@Y>A-GNT):(B;QM;HP" BR,R
M.*MX'@/ D;$;E02W@#ZC<M&H@['KG<293_01)GTY$<YA[\V2<?3A@^S!FS49
M-JF!$8^1\&/+'K-EI4PD-D$RLJSI ^E^/T0:MF8KE.Y6HQ9G=!CQ=%9/DS:7
MN@\GBQHK<'E)MFY!)QU/E)[YL1&7NA@ZROY1B2!?-@-PM67^?EDLG^Z3. \H
M\&[ND_ #WXQ[:[+4%98"CZ4D)[9W"9SL.1%7YY*&P9O\2"MI)\=1@9L.AX+Y
M%F^K:(D(K0./<;4I"IS/D;L!$,Q2SW!/*W!Y,@!/ _9PCXD*&  H^(*7X3(#
M6>]HNM_^!B :%^]Z 6_SV \-,!QOT:S=V?/DU:3B(YPP5*E,)!WS8(S\;HLJ
ML@N2V$79O!EW](Y;R1IV^J5=A$!0=R?!< 2IV^CJ>RZ,@(1^(;_6 0HHLHPC
MNA>KL'@OLYR[=7K%="<#02-AHOH0L\Q8KIF(@%?R, "$@#"]BQ>_87*>6E8"
M8SQ"8[.*^HT00Z;"5C+/^.8-@ _^=&'($%ND>P*)]B'DAM$<K#X?7?H(G1*L
MH<(PS8"B!Q2R-W."3FTA8KP,600#)WB$R.& MP*/^9DM"_FA6%DZ=GHCLA@J
MQQL/+]OH[A#.6D(JI >=X!$*9"I[?:P7BK3-_,![&$$7!;(#VQ3]3S&@C0<+
M.Q@  \D]F*@E5WN]_C2@T1<O@X/11\2ELR\-!@VV:.K4=(F:O[>*+A@ R_B^
MT?\I<FQ5M3\B&+TPO#*/7 ,/ :B#^?ZQ[9F($-/AW8%*@+C0)9*&#9 2"?12
MP1 D#!@B04QDH$ZB"@/[&/@",1(8)Y @9>!@: "42!L*)#)DP(Z= G8B?3%@
MR*$A1QG^G$1JHB'2(TA@#(!QQ($/1YE0,/A<6*%DGPI?H!#H8Y/#Q@P:(#G"
MT$1EG8T5NUJXVL?EDPN)(&W8L)&/RTA."A@*>5 @F %=G5S(.G!CP4A]"'2Q
M8R#1A@R.^CS!Z"52'0Y?VL;L(S!213!>"!#-L,&1A<40&^+\8E<H!D>.TO81
M,'##8(Q$(3K) '/ 2PX95&H4_#J2;4<@G?QDN,%"(@L:5=IY(EMG)"\6#AO8
MO7$Z]>K6KV//GKWA$X@<FGP1@"'#!0)U,I0TN<'YHT@7"F3(4 $#% N0-GYY
M[JB+[0%/*O+QB%-=7'"?(Q6 <4%WG&D4R8$:@2%>? 2 L0'^3HAM<,$ ?>0'
MR1,"Q/>>%S)15L%+L.V$ 4Z1"&8(1'4,MI$3#U$VD04#.3(1C!5P8 >,B4!$
M7Q-J"92?(Y'P(5,B_&4P@!=-]2%1';%!Q%5G)78%$1]/9$B (1M0Y1X4S$72
M!8U^%=#'1BKUD19$8_'!00'T[8=!>SHETE87$I;WFB$%O,;!!DFZ^-D%)3WR
MA6T%</#3D2]6X(ARD630'09=" B&!@3$9X$%?60 7Q>/6D?@?4[L=*A$)PH*
MT2,WUIA@>OD)IF8=%?!1V 8_J;F6$\.A]$0!%CAA"*$</;>1<K\Y:!P?%202
MWG@8F*=!$WX18$$&U#ZQXP8OH;?^41\#7#!A=W4$D,%]IC)FP)[E4EMAF +U
M88$!&M1A2+;Q%7 M1%]$&@D&\,EW08N/@*&3 >I>FF,%_*:E5IEG5F1'DKU:
MNY$CBFXJ4G213%I<'5 46"(8&'1'4'>M(FF1EER69XB9,)F8)D0;-$&R=Q(_
M"!')7&E<01V0P'H@&*%VFFQSR=J!:P$/A^J8!>VU>&G0#:(G6"([#M52H9&0
M?%]E5E?6A7UN:>#(!0U"5&ES%?1TZ+\6M*0F<Q4K*YMS1T*101T29D! @YPM
MG,'"5,)DEG&1J+3E0Z@R+O3,VE%>N>67"YPRSH^!X2,8B=!W,P=>%-C0MW5T
M[IS8?"C^Y$@3-]:!<L6O@F%V>Q(=75+/#B+(40%?U%''%XEHX 1G&GSQ$Q]?
M7 "VT,%W;H":>*-(D+\_0M2B@\DAQ7@!=4Q6V6%>A-H%B6(.Z5X78 3\[)<"
MW?JDDBL]0:.5BTE9904;?#'BE_-" 7)E*IGWB ()BU6@#V2"DR'LX 0#<(!=
M'-" 1(ABOCKXZ N/0L[-!B6]Z83.?-W20*.@11D^..H).[F)P#"%( UDP'-U
M<(0AZM"$ JS(.NQQBVQ0EJ,L<2!,#,)2Z&A6*XXD,(!0J(/-'L$2"'ZA"]!*
MA!WJ<X'@()%45$)9)"#AE&<E @P% $/PAJ>![OPI,,*+4A_^R <HM[VI &K\
M@IJZ,  +N(AT[6&?%\:80>(!D(9?V !@#/"$#.Y&CY32@(^"Y[X1/:%"/1R5
M 9S@N3A)["A>,1%&>I4!?X'- $O4S)_4-*D#U<%L8@-*$8N7DYT8@ECZXY__
M9@8&NGV0(!S0)&]XYA2?78"#$1%:)*Z$ROC(\#XT.U+3,')(U"UO:HQ9B-4@
MLCOZW"H1B>A#%T+E/YXDIV2X"]=7V-4$=2VN*CA1)!>-"!>T86DC?5L:W_SV
MNS(6ZE4]LD/G\/(OQ1TG.I/ZE7=LLQ?,(32AEGL"'L?2A+%\ 1)?P,!,\)BD
M_MD)9'@DC!/&$A2=.*<X.+'# (S^EY&*T/%WCH""3$(WQ&:!@7'N0E@PB_>7
MET!! "A<"!.'ULU8&L\+M%&66:08)0U0S"+[N>+W)+60\$VD"4UP!%L ]@1'
MB-$.Z1.(2KS@NC2)DC$#Z()*/K>2GCK""0M97/X8$Y6T#N!_$#G43^PP$P*J
MS0F)LL"M.+02H5B #P:#1!,P\!@^-$4#C4/2&"'A!0P J8L8V$ BDN2%8VU$
M;E:!A$H4:P"OUN\GB5"AP'#RR>+43GJNXT#LI*(9<64)4D#:(A3:&BZ>7&E5
M##7$3#QHJQA94T$;LP!+:\*!J!C6L4 A$?NTV,,%&6<L=OTL3>.RH MPX!%]
MP$#"ILK^ECJ0\%%JFZID,/@[#>Q$J#,LB$I&!3Y#9$Q,7:"@(9:BF<-P=R.*
MW&TB.-!1F7"@0+%\B%9. ]E$9, +,>$#0IHW3"^(U!%,C&G;U(*1#;@&9+(1
M&5N"4MQJ%@02@E(;!OK0!T.  3./<$)<S18M:%V@"50<HP0EQAN* K6MO!N5
M,856'T/T%Y00[2]<8)B2#'PA/)\K3$.:T![O0):D4-":5"'180L\X1'.^<D7
M'F$^^*8M/*DL&:H@H2!EEK8Y%VB/$S8Z6;:X"'+4 QMQ]@:VVRS%$7:X0*]R
M8A;B37DB"'X.!CBP'YT.U"QN78A"&^UHZQ#& AA0T-(N<"7^#,Q'EH.,2(8N
M4.)*8X /YX&$%*W"P@T(S6]EDO3B-H"C#%#8)EFZ)0:(FY,NH$5;&<K7PY9D
M 4OGYM>6W@V,9,R!7W]Z(PFZP!7IS.R8(L]!,12LI:<*/DN7Y DXB;9S/&T6
M*#P,J5"P"=UBZ&R^0B+:H'L-\71] 3XX07.+:?.D;<PB9G<&= QILZ=?0N\+
M4"0#DKX)Z'IE-DM[YDV3M@!Y*3J=]2 Q/B%F'K-98AC^\&8@4"A W^KPB-=-
MF@^ ]?1N"$0JO$&!*J[."E%B>2*0Q!1T=CC-KV]CB&"R* .1S1Z^AU=KS033
M.;7N A\@FW-283R"781U5O"8GUK^EZ0)>Q%LK0U-=>R26HYKP;>Q+P1PH3+[
MT\NV=1,T]X6[7H""V[4T!W:N*;$=F^0S:># "_,(EIZ=/&$Y"[^QNQ$1KV3/
MEO:(LN>#7I%\N@O7LLE+#M[J!O6Q"]INR:\ES0<-E"M#?$A2HPPC>&(Y5F+:
M7A/F][[NOW-@(M%F/& =(AVA.X2&>J=L'5C]Z8TG/"ZL_D+1J<AJ)X-OTAIQ
MO$9NI2T,V.$+.P';M=["-J572&P9DC1O'1Y RF1@-X)I5-J:0Y6QIZQ*PRF7
MBQA::_L +"Q\QGBQ>6?O1\._T=JMR:.VZ2+N\/8^!_F[(:3BE2AUT09%R2,<
M"0V9AC+^559D^88UH=D"6M.)6=.1:%<?$."1I$1$,-C_)8(#5@F0<);_4<<V
M[5P",F!$B,V)(2 $.D@!/ED"'LD'FD8!&L(CC*#(6=.3<>!A,(1OF$8$=E'_
M]>!TB* )5@D _F &=M&)]2 '#B%UZ* R<> *8N!9U!\ 8H44]B!G:9/^ >%G
M]($-K@4'H%E.X,02BLU]?(&Z:$P+<B$(1M;^A: */N$"&DMDO2&I8&$+M@<-
MG6"A!"%EJ. ),40'3H<.$N$*AA0( J(?BM<>FA@.HN!T7.&:N.$4.@@D/ *0
M)6$?*!,,XJ$!.D@@4N)94*$/7F)$&*$C/!GC;* J:A.0 <G^'%K@#CX@(YJB
M%W*B-5%')AX@$7[@SE&B([RAB>F?,(*@%A:B$O:$>/'!("ZB!OZ?,/*$ FX0
MJ60A,'8A99CB60AA*VZC*'Y&_ZUB_YE-$1Y@$%X@0L16_+%C.U9%>KAC/,KC
M/-)C/=KC/>)C=FP>=8#*USBA!E!8/@ID/9(.'@[D02)D0BKD0C+DY1#(*F+'
M+1E&0^:C'?0916)D1FKD1G(D=5CD=831&'8D1S:02([D2:)D2JID.S90Y7"3
M/ZYD1OZA/,ZD0LU?==0D1B[A)QHD0G*6-EJ',W(D-]9C3[J*!9HDYN0D_!DE
M1<)A,%*.!\9B4V8'4>HD5;)C#UK^Y31J!S F% TF) T%95)*(4YB94RB)4:B
M!=NPHT2I"<0]FK"$"9+$5!>\'T,:@A>0VK7 Y;\8A*,Y H0U6A>0E</M8A.L
M(^8$#T(E@E=E!^/5HV3 )$1XP6:H6D(MYNC1$3M*9D<.$IK!",YEQ]R-FN(A
M"5MFQR-<)D8JG3VN!V0JFP9 9$3@6C\ZVM',)CX^ 6I"Q&Y>AQ<L'W6DW'0D
MRD6FY7'NHB16!UDJIW6@F5TEE$E"X>) YV<LIW8<R+AM1!"!#%*()',F)W6
M)W:0#B3TP4NT$T2P2Q==QW>N10+]G7ABQ\U)Q0Q9QWE0I7M"A"M5CC(9R790
M1'PVIW/^RB=U7(QUA$V MN<8KJ(K?>%+-9HR':AXCN> 6J=S5JCM;$1AD8I^
M2AA6/<=YYL1=%NBKL(U(YB9VI*BK7.??<4>+7JB%LN> AHN"4J8TS2BR;*!]
MQJAV*!-[5.A&Y*9^6H<=&%UU")97JB<!H9D #5-B(F=:.M:VX$C](!F+.,&,
M;$ -$5X?.,%9=%."^843V 9BC$>7=8M?<,!DU1&7H R:)<*,X M'D*D/>8$
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M..L2;#RZCM\VCULJB5SL&\J-4(S^"*Q:A !E3-/D5D;P!-%-CG/PD,!0A=I
MP4Y_CX/D;(6_Q,78FBXY,%L0Q4IQDYKT$2?":>\<J-F8B#R=B864B&<$!O $
M]2#A1&Z3D$Q!K\IV@>0^QX$^0:3TN8/\.8GD1U-HQ%G'6EA)1/HFNEJKM#SE
MA9]U--7C2 4L!JDM3U>TA/+AQ(@MCHJ@22IU3U]P1(,T-.,DO:TXS6( MYG<
M1^!SANJ:D"% @<QL8.(_"K.^A$KK>K0F2YNM8JLD?ISA$5#(/HP4.Y4 OJ<]
MRJMTQR.P%B)CT5BDT@:R%!89L-!&]DI]C0'[F=% -PMQ1OB)%D=(5?<H!$:\
M!)SDK&/^<1R)2)=X3\1W:U15 42D/@3LU*G@B(\!0TTR0(KDI4(? W8B)304
M*1(8 XDR.O%BP5$D*!GL$(Q4AX"A#4TB.:K@12"!+TXP.+3CA4^71XDR9&B)
M$:,A WPP?K%@ 0Q0HR%%@HSDY(*A G5:=ND#U6$3#8DJ4 7Z%6Q8L6/)EC5[
M%FU:M6;Y5&C2I(*=+P:<<)@(YF"D+A>R"O"JL8D3 U_L5. X]XE@.Q>Z0-)P
M <J%#(XTL(0$&:B3"D\T5# $)< &P5\N7["# 4JD#9 O8'"T@4.DRZDQ&GP[
MV&52H% *?'E2,U*3#8\RL)X,%**3#18,.;$PTD(B)SY5LW3^=*' 19$&GMCM
MTP5#;0)/&$;"0$!Y="\7'CE_LL%ST*&1["A,;M=.(@,;5#XO;H@#"[IX+!$.
MNO@J@]0DZB,20PC X!&@1 .J,HRZX,ZNG#:#JX\FIA+.P@*<T&  +PRQ8(,G
M*OB"#_0,J2 #S:*S ":NZK HDB\.@J("#BX00+?K,NAB P&Z6"J2WQY9[8D+
M!F P*!2=*.""W&3#3CLH,!SJ0O(B:L* .CC8H#0^GBC@B0P& &.]VMQZPH #
M,6J"M0WJN\B@$S484( OP,.H, TT$("#ZU"[8"O)]B(3(XF:V&L /L;$"(,G
M$K% @S/Y FK2+PJ 0D4#''G"OPS^%@0#I!%%(@"F+P)XXBL=W[.@#Z2(0PU3
MGAC#0(,78S0 ) N^P"A Z#@*L0O!F*L@*:'XT*@N 6#%R)&>2(6BUA2YTX^J
M!0,D,JH,*D7T$=0<"?.Z3 M8=H,NU 2C12?J4"A;.*$0BJ*$H'0$@PRN_2@D
M*##@0T1(^UC)PAXQ"."+/BI(<3.'.8#BN3XPT*ZE"X9MR0##,ML J!-%HQ(2
MS=[SS E"P;3#$0LN@'*MF&6>F>::U^+#"2<H.BEGH@PA32#=^@ :(YSEC201
MH"$!(S"*P& P$2\>Y:B.G9\&:NDFGKB(XF2]POE9HAR1&@JJK8:9OIRI@N0+
MC)%^ E[^K^R@*.HFROX*DCJ<V+JE+[2^B ^OJ@94-]G Z#EH:KOHHJ"3#G>"
MP3Z28EMKF!WY@J.D'<D;\:6W'MONBQSI@@.^]_[*74@TQPB,G9&VP/7!#>_<
M;R=\AGMN:J7^XFI#R*-J;"@0VKL.,):^B&U#5O\9DI^[T,BK!G,&HVKF$T^D
MBR:^^(*I1J>OXW+M["A\Z9P9?*3VVZO.]PD^1M<>#$,,*1SG)HP'"O0N$KD\
MI*0%4AM>DL-((NKP/ PX 6G9TU^#R+- H-1!:W(Q1.Y.<CLG@*%P]*'((Z36
M!3YPCW)ENUPBYE<1JB0""L.2"%&^HK<G,*AM"7Q4_Z P,8[^X.P)Q3N>[D+W
ME?Q],'Q]HYK=X/45%&K/(7T@C_'8ECGNC:YT%\'>U$[2AR8R\()),5KQB.(%
M;'%/($N$Q B1!L8!0@&) DP<!)\@00K.[WG,"J,3@%:_+^P$ VA3S@.CQZ^-
M-2HQ&)2-WUY8$3"@46Z%M-DB&=E(1SX2DC&+3"0I64E++I)Q1L2 Z\3BA>%<
M\I'$V9J*C@5*4UJ2,Y(+TRDA"0D^;$ ##F'E+&E9RZ]H '):<MM8I%-*@41%
M+& XCBV)64QC'E,I"$3F,IF)O[ <DBPE8V$SS5*'XF0@>M34IDHNP!A9:O,L
M=)HF.,D)3CM<,X/1[!YR_OB5');^$Y[QA.<WY5G/4ZXS+/BTYR,V9T]F.D*?
M_I0-/05:4%..D: Q&Z-8 FI0AYHR$8?)IEH@896P%.^1CBBE(1K3S-'MDI==
M"&A$S2(7(_JRDLT#:!= "LG]I<407DBH('$"%D.HSH&U'!T)1;H6D[9PHF,1
MI%D@82(?YG29^_OH)3F:4-FTM)$UC294J:4<C'U! ^E\9!W:N9!"K84P#XV9
M1A5*5:0U@0,H%6LC-S"L)[1S+4T(JE8>B<8'>HR9-D)+?=3ZB*R:A:Z<@@DH
M#7$Q1W  ;9&$1%O3\BBQ+"XCC"J::W!D2V?QH0D-'<MTOF((4Z$%LF<A76?G
MD]<\GBO^J(_42$#!$$M*/H)&9?%D6;I0  <*A0/CA.1OOJ(9+VA6+&]=JUKL
M%K-S:M:WP!UN6!(!AAA.,$)]D*X!FI"(/MR4#S\#P[%B:H?K(L0AB> #).QP
MD9_%D"%R81!"^N %EG%5.\V-(4)^!CY^O<Q-F7.N=LZ+O)NP#%"$<<@CN&J'
M"'663>OEP]  3!\OS"MZANA#'4[HW!MNI$%L&J^C.%)?IF@WL UZ& DEQZ /
MMDUU?/C@SI(6PPQ+U1%UP$E1694( ,>X846;WW;!,C0PA,257ZB#+.4"/@[G
MC44V<5NMY,="A#A"NADK'&]N%"8A?_C*1F2AA!^17=Z%1+K^1?1P4-A$$:'T
MP<:&Q& =.OSE 0JY/$#ISIN?=KZ;\#C*V<4@1USYX/Z9)F3SB;$7]N5<*/GX
M6$,#7]$>C%)'&%HV>OYQK%CU(M[QN(R8ZVP?U-O<23?H"X1NB8J=:QCR8LP1
M<*'(H!/K2D4[XB;:&?2DP\R'V'*Z: )^C06FB62?98#7&*FH3,"<90D7;V?7
M;8F!SZO@\:D.SM1ID&36RU4&N?*#B2!O6"OBWX:Y3\+J[;&;W1>)1[!,P@$L
ML4"$'*%PY]C<-QEO=@<X3OGREW<<8:^0FX<I^4F.*$,S*M(@/26J:!=C)_KL
MHW/L:DTO-V08X!6O$]*VEWQ! +#^RU3++) !&)$71A= CQVB\Q#78 !S_>H,
MS@8@K@+8@6"2*4!/+.":PO;D97V@4@9$E) "#+8.(.E#:X"='UX!^SL6X(!;
M($&QY<"J2?"9EILT@(&7QYSGL+K08P80/2\0X&%\Z%=Q.&T86_>D-QCG-<FK
MG@$2$IT &@ *& ;0%0X4@#M=>-@%U%, B?<F$2J?2*!X3I4 P4=J MA K5CV
MF,[\EN\>=\W<#?"8#8P*4TK7"XK<HG:<70 ^PD.Y.^6.JL-4":T8V6-+,B"
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M47*/#[,'$@.$12HE(3@"?7680E@"?0'3UBC"4VYXN_RE;75.4EKR9(]4-^K
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M/07-[/<Y91B=V?!%+,4H/H,Y#ME$-$,Z"%8ARF4#FFN=C;DWG\15AB.28VP
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M7!A+S55!M1@[\+5+Q[F D$+K" UX39=\X(  [) ].]AV=W54JA<,0=?@-HP
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M6'571%A>49 [-W9AB6?B(7.^E7'4E9M=TXV-,VNRR)J\DVT>P3O+83__HDM
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MP13<$][^<1:BJ14> U(DT3ZDM!(,HE&2@1(551*&,#A3X:(M8=BBG=<.01Y
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MI Q/(O$Q8.B+@3X3^T1*9*'.0C 5-F2PT.>)@ U]#'BT@.$1'PL;-%SH8X=
MA0R)%!JZ@&%#!2^.*GBL@,$12Y<7^"R$U$0 ASX5^-0A<&'^0P&=*1TYRH"!
M@X4O"Q=V(9!! X&N6\U&FJH! T6O7094:&+'@H8-(;$.K/#%RP6%338D,F
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MA<Z\F1B(,Z(L(),O) *FC@K3H^H !0%T]>K-S !+[$V?@RRTT-___A?6\P1
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M2K/6>R6T1V QB!Q(9-P Y(H:@0)>7*PDNMB>HS ;$"F55D%'2! -J4BP+\
MUKH(,/FO]IL+=GN7[ZT)*_P@#4B)B]A>B:RT ) : @"AKM#$TD@3^47-G]D>
MA( +CGP/2<D W7B7#'49]PC1**R8#-#?-PP+Y] -]<L),M7^0^/YB+G0#4_A
MGAPS/PW)"1X5C>VI Q$ABPOT@H;4'TB M E&"F 9"* 3 '6[B0JH/B\H@+H8
M5PDF17GYE*^35+,YQN%K#3ZIBQHS./I@OX>;"S^3WN& -)M -82;D9Q@Q"&9
M&)Y%M>W9(#!XB9K87F3]GR>JR1^$@DKIL-#I H=P @0>(5,!2:?<7I)\0*\
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MAA!0P4U@J:>!!G^>%5I4B6!PP4U0&((!!H9Y$6L&6\&'D0;H5\ PFC>ZY>X
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M?>87I)\&[ MPK,GH$( %91-K&@9-("@&"$![0(%Z:H1ADH1?<<]-S$>->($
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M:XH&*JA  CRU#,\X!4080A@JJT!P;$(:0II>D=*@1^^T1$C^_,9W28:RPDJ
MD,=.N-"Y4B-H[ VE108?2-*YAJ$J?0&8$BP0UJKZ[:Q*H(EPR$R:* 3P1 >\
M8- 3M)"[/!JU@(U2N NH$ 0 [$L%%"H&5-3=%<#]$,_H.,3V*$=<C >2LD\\
MKD8""H %4$4G;13>?!V+*(YYP9"7,@6A.$5!]&L4U6*?8 1$1(3+U8LJ(2G
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M/(P6H2QXVN<"KR(#<*(;H? OT*@$$8)(FL  .I/34.TKNZ#^+7*B "(3"NK
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MT6T *H1]'()[G, A$-.!4T+^<&?J1\\+2N/.X]BLG*(G9.,;6P<XOC$WYG$
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M,'2!GA44D,@7%#K:![+&:0#2!00XL4$%AFS@'B231M+22WF*R$&(?[Y)&T&
M^HH!L!OU44 ?3:"X0:%.!!C3H7L9 %N:QN+:DX^&8&!>(A7^@ &)?EU@$"\&
MA7Z1:YR)@&' 5!@ZDD$&%]]*$!@"9#"?>4WTI-^Y+X$$[ ;S60!)=E TR&L
M6QKP!1AI#N7(!9AB<$'%!#3!00%\5'D4 :*"!$4%91:@%XB1L!R)$W_NZ(AQ
M&$ A8D=8VV4SJI"\[&L&#47BA:D<0%D!E$,*N%JU56?T: 8;A"U U%^0IR>3
MZOZ%M(($9$NL!7VH7%ZO&ER0"&\$5<PCQB%:32(87EQPDQ,:W&F'%R@.21D8
MVHWJ!!12)F)KU?\1#B@'?%P M%60&+?9 *EB\$C<CSE^7?'&'W]\$U/;4;(&
M23EQ@2-V8%U1>9%435L&!EK@95?^.!$PD!,8\,NA'0A[,35!&*#L1 9V$)"7
M </JQ(<%772QJU=U +>@Q'9(>QH"_ 1D=MF*(88#DAU9!5UU&$!2J$(01I$'
M"I&XT?6T%HE'G"81,U)1!6@#JZT)Q1 :T,#[O(>K6ZG($8:P@'D.1::80,\J
MVJH2!:M$&8*L,#B:8I<%-L(D=G$H6_UJ K@8<R<^$"HI@.H.9?@ O\MMJ&A!
M0U4B,J"@)AB"AY$*D:AN!(DQV4$DD8E@ 0P!"5LIY8,0K*#C"+ 5\Q4%1%XX
M8]<P^#[*# E2??@8UN[#!T-$!&%@\ \'ZQ6))FAM \O"BUWZ *R#3&N/<#NC
MK;9X@0K^+5)KZHJ7NJ!@I$0,ZS.?4PH!*',C?GFF._^9VQ@C$BR9>.=ED# $
M'*^7/G5IBBK,*E@?'%'(LMA$=8Z841T@Y30$"?&7P80802[  6,BTUA@ )\7
M^240\WDN:>'1CM<,D1Q#\*$"7L!>US  NZ<(,1$)P99^?.@%GECE/C$15B+L
MTH5QUJ4"?1R..('FM88(RQ'=B2<&K,(M?VJ3("(ZIAT<T:FMQ>N<(!L('[[P
M!1IIH"$!C81\XH:;'S%&CC@Y(S0-88CR5#,ICGJEY0@BS4+685H(\<\7N-D^
MT@&+,ABHCWQ \KA$G"L#_!K+&-^3/R>V+R:CM.5/]GA)'B+^;ZI4K6IV&M('
ML@U@?Q7XE 4"H,(!$*D" =A*!C  !C#4 9$XD1,N5Z0J,&U3+C1M:R@1DAP"
M6 !I]@-4EAJD,<S@!8#\2HJ14%>]+B0093RY:P90-KV44M""4,!@03*@J@$H
M\8,>-8\%:(0!)I%TL2%ID'#,XP@++"XFZ,J2_"86DA\!U;0%Z*'$-K*N+R!-
M8_[2P.&2" ;.W@ADM+DM00"8R"8H]P*1FE$%^)J1I-F%#U@,$8OB.A1&-81'
MH[JBILP'7JA$Y@ETU X4TC=3VH"3#V! V@4T2\("6 U8%!N8 9H$$FC9:UD(
MVYJ$@"<M+S#**OJ4;ZA&A++*AHO^.!O@0&J_0*Z8E')(M+FI'7S'5Q/%ETS&
MK5)O$8*7"J;/$15(#:/T%9/V9A:6=K!9!5G$5^I2L"#NA5]=.5 2&*O*6-JB
M#:#@JJJ)?<YR2RU(C7RGJ@T] 5PX>90%U-F9)+L393W!,4&Z4!60\&%R&!B
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M, X"R# M#"KXK*G&MJJ #SX"C(LM_K8: +6"2H/KM!$OJ*!$ P:XTJ(,8C.
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MIQ*[Q+-%F%JHD^,+,-@-FN$1T3H<)L&  / */YH0:T&)K6CS);U\%/P*2"$
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MF 8\A#A25<8PJ&*ABTIE 13V(7((RE-DA$6 #%P@ YLJ%7TTP*W"<,IG3C!
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MK3D6A25'+DD<57VA,';HIA<B<9[^BU$$EH\P)1U+:]K3HC:U:C%HAYH#"4<
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M#"+/F?HC=+XR@Y*,(&UL2)2J0_,10SJ\59].ROD (3X4+.EY#CD?7&YLF53
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M+FF= @:)0)2AC"27EPVB8=C@;;F(YSP"H9U(2U2,AZ2&C1'8:RV$?VA*YVD
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MJ(F@O$5C[&5FON03B([T-4AC<!*T6.=!82 2/=8ZF5I58DD5K9X?D1_F8(R
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MQ3_*3(S@D=5?AKXDCT&0A$LVE%EP ,7,Q!L+#J?&3,X[0?N$-1P;1M;CA'D
MT=S$)U.T#TD*7F1<DM5 2N-/N$K^-(9&7]!L, >-,#X?5,2'[E9C''%GE4KH
M#U]<-,UQ18KH]#8D= OBD%1,)!_ZA!S<FXKGMP\)G47.-"8 )X]4G+F;GZ_,
MY 3W5U]\U$2C9,CM.T_RC#5CJ$=:-$'?;T!L>;YG <0&0Q7X/-)@ 8,!"XDL
M@(G$D(\3#I$B?0G@A6)&2!<L.'J(X4*3# 3 0-% D4,31Q="8B )A0 &#03[
M5#!DIX*&F78H0FIB@0/02!J>9*3(QT*&# .<]#%@R&F?2$Y.=L$ "0I0"TX<
M8;!PL",&+XXJ7#!$L0L!*'TN9)CID*(A A4V6&@2:8,3BE_H9K!@R%!2#00X
M&#+ QU'^A@L;*MCA4T!#H@P8C4*R (6BHX8/+=CIDW2# ;@4ZQAH:R!#(DA!
M.51H BD#9J1G.4R\0&!#VT10##1AG&$@GTA\;$:J$P"S4>7+F3=W_AQZ].>.
M[$"BF(AG)$/"(]GQ\B61T>T4^TB%5*=+]>'A(?$)KSP1F"Y>I%)_3[Z.^IYV
MMI]E/IXZ2!+A;KP^OMLND?+(.\L1^80#\ LO^"AOP(P&M*X/!A%[2+[L^N@"
M//?.ZP*,\!*)<#M(,LR(C^_>LP/$^R)QI [Z-H01O$@@@1$,CR+YL [WC,JP
M/?;L\'%&,/B3ZD=#J'MDN/G\T_$")\#(<;RX(F32$"^ZX-+^"R\8S*["$Q'[
MH@L^H/H1/#O"HS$]#/US,R-'(IQ0JA-M),NA$[\ 4+XZ/.HCQP4S<U#'#8>4
M,I(JOR@TOC1[0J\Z1_@0T XHA82S#BBC=.P^(0WY\\<#M6-2R J[BU&\/X7L
MSI%'.AQOU"E'5 _&.FZR-+Q'CLQH._F8'!$,3^,BL ]?';DI2"<N6&_&(]?L
MK@(9R6-2N^_Z<&]:!;MTU9 !A8T6RB[%K P]09M<KDLPU*3.$4L]6G/-';NH
MPSH_4Q22T/<:Y$E/;+4S($Q\USW*Q;BT[6-'CQK\4D<[>N1O.34SHK.]>=$4
M6,M[?1S1X!4#/+71)ZYDC]+MX(W^=M *.)8.YIAEGIGFFFV^&>><==Z9YYYG
MOB YGX66V9$N"N!N:.> 3IKIIIU^KHX*0+2@"^<@^2*DI[7>6CG#D.8:[.66
MEAF,"R8*&^VTU5Z;[;9O3L]MGQ/9X ECMX8$[KCU3OMJG;JPSCF)K-V;<.8<
M>6+*PI/..V8H!%(<\L@EGYSRRBV_'//,-=^<\\X]_QSTT$4?G?3233\=]=(I
MKF/PI'UD?>_XGI#4*,>4:W!*0K\C53PHW/WZYO,&IQ%)R(MOKJ3$FV.=1D@,
MJ4/'X^LL_1$HP5#>J$3FZR,[G75=;L?6H[O):8?5I1D[P(VBT>[FN%^._::W
M-6K"FCW^DX[BY_A+Q."FFX=Y7MVS61W6DCK(00(#74@$0;0VMW!5 'IQ0\I7
M,%" JI&'  LQRA<$L(&,-&$ ++&  ;Z@D0Q([0E%T9DC-!!!\;A,<GW8@/2,
M4@?<O.QV&7!,M<"P :Q01CE\X$#[//<(#F0J@<YI@@&>X 4/[FP#);R=!5PH
M,R]<0'U"D^$C^@"<FH&A(\NQ@P'$9Y0NW"6(J6F:$S)@E"9<<&9OE$YLGH/
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M-2DD-U6!T604I_%264;*XX4PBM0_G(QH.FW*4A--"$K C.6PAOI145ZGHI$
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M"+& "HW";>!^^]#3GB%?N\(3XT*%([>!PK&U9^4"1^()NK9L3RA] 3ZH.3P
M9XM7WLP'(#_Q"7=YPI&=8!@!^(Z9=5AS)* 06VI3!(SG_8P ? G:F%46*DAV
M"A@@853O_N4Q5[+):B)#F&T1$M]A4>!A2I/("P!1 WK9B!>RDJ#"9&"(GP%#
MGRV%8Q8=)A&XL5,!#-'G6@+-"S8Q! =D.,/  !$, G#T!H!36QH5P Y-.-I
M@C;L"H"R#FD/CU<?PYWT#CN,2^Q"%YY  +W$A821X( '*X#L.ASM"]A=21,,
M,8 G'*Y:&9BA'3! G#KT,)$8(#S^0W_$%!:VM^TCA_O4$PQVD10], [QFA,(
MH*ME9O<"<Z]6'PJ3$3 \Y3%?>,1"I^2L%0L'"F=7/'4:[].::*\C&>!*%+O3
M7KX,R "=DK&/-M!>.PA@^"=Y@A.<5P$OU$'KS\3 ,TOX=]9OGP\$:(+!H5=Q
MAFR_"UIG"!0V\H3V-.8) W#/5@QCS/3Z/*GCIOBS+ASR+]@!.)Z)M0I@AKZ
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MCXR&K<.RL5&@0"0H0OCJH#;0Q  \0L$L8  P@@-,+?[T@BS^4J\)!, A.&
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M;H5/"*4"FC)C*TZJ"P: 84S1X!R" >55D,J+(Z-F.YZBY_3.+#+I6PTNP0B
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M:"BN"(NMHQ#+EF-],$]D:1%MDDSX11[4X73*XVA#)28DD0'Y]B0/^8TD@65
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M.%@PUA'T-$H2LE>!!2^;97N8M3Q& 4)8]WAS3$FXC;%'15=;@CY05D2[P4
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M9H'J2<J%+X1A#$68(\A1SVZY(1L?OO"%/M2! , [#$H2Y(7^'6X ,SK9846
M8IQ&N>01Z+I,=5P"&S[0R(/%XHFRF@0&EY@G ^="4AU&DKE!]21YS))<(OH
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MK@:UCJ*@3A?R"O%4$D8YK-=TLD4!@PUH3_E<%#Y8FBZ A-!P N!!C+]@"S[
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M:2D7.R#^CK80,$,SLK1J3:J0.(C!# ;9T__8%)C8'MYTA!C[LODAE\YI")^
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MN]:@B_&*N+B ,708,M$0(2&.ZB"3@PH1</Z/0-V5KGBG?U+MA%C4KEG>A2"
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MOB@F/YPO;WF3M4I")"<<V\ /+PA\DR@F'0YWRG *2:*>^#B/G%G-F9JF2;F
MZ/9IDYZ_@4*SIQAUVTB-CTX(0*F/( 4#?!85,#">25JIM4&.S9@G$X\7:6-E
M %O%B3#^#9Q8(WQ+J5W1WK>P%.42"(0PDD<H,S4'YT4J$;PJ"I99_# R$Y>
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M!79X<:A)&*5))'F/-%D'!^W]R"@8FKF%7 7%)=6@%PU" 9(AD3315TU\\!&
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M\UOC.*#"S]TPCHLIX1HUT$8A_1!R3>  8N(&'$B<"F/9*9U$ HDXL,#Q=I#
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M-]'C1P\WX;%!1G.3:3! 5\*A]D'67%^%! 844EW'NL?J.;T*XQES([+&YC-
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M<SV:$Y8*!ZSA \Y@%T#!/D+(DRG^8ZK87_%D5*3\HYF42P(BQZJLU"F.!1@
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M;, %B2 '1)B'&0 &P)]DVAP?;,031!@8] %]N AH<,"&K$32Q8:B&< %E(D
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M2(*DJGUZA(9&!$4D#I$HJHNLB0; '?T9 DVLSJO^1K]N[!MI8(Z<3I 0[6*
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M3@TVY"/TTOE$DN'H3O%DB &MC]OX2'6EBAULT'0112,U4P(Y(U5X3A^,5:1
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M@@%,4X&=,K.PK@)6'5QBAR>8#0H5^ (YO5HW.Z#$:&$$J;*NQ@<!;  ,%\B
M6>YJ 4C4H0)>*.Q3# "&PH*A"0L*V!/ D$BKN?,+B*T#[V"S&Y94X)RQ-4D
M-" =Q<85G&%+G-O28BY//<$"?#B:(PQ@ $=\(:^=NL C-9A3N]F.J1BH$21"
MA]815: ))[D.!@KPA48V(:>;LD!LB:@JR[+V"89 *F,L8+3^L&@M14^X@% O
M\)KUU<$)%NC#_] :X V\\J]+N9H7')Q6**P5 ^9:9'I1R0<,R]8 4$BH1I)8
MAY;F*[XS761T7ID(D#JB !< PS(]\JHOQ-<.4ET=)!;,Q(#Q06M>L,X&1 DK
M0RSW D-LFB$L$,;U&:)T?6"M=-[HWYI>X)5#[:3IF)I4^'H!"@2P@Q<(\(6
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M!4^T]I$C!CAA1QU/"'8;% ;PD0A>? C@!&^.:."$(5\4T <4 GQA1P5/)&(
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(W_]_[0(" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g44361moi005.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi005.gif
M1TE&.#EA/@-O O<   ,# P@'!PP,"P\0#Q /#Q$/$! 0#Q04$Q@7%QP;&Q\@
M'R >'R$?(" @'R0D(R@G)R@H)RPL*R\O,"\P+S$N+S(O,# P+S0T,S<X-CDU
M-SHW.#@X-SP\.PL79@T99P\;:!(>:A4A;!DE;QLG<!XI<B(M="4Q=B<S>"HU
M>BXY?#(\?C] /D$]/D,_0$!!/T1$0TE&1TA)1TQ,2T]03E%-3E-/4%!13U14
M4U=85EE45EQ66%A95UQ<6U]@7F%<7F1?86!A7V1D8V=H96ID9FQF:&AI9VQL
M:V]P;7)K;75N<7!Q;W1T<W=X=7IS=7UV>7AY=GQ\>@  EP$!F0P,G1 0GQ45
MH3,_@"\OJS=&AC))BSY)ACQ2D$!*AT-.BDA3C4I9DE-=E$='M5I:O$UAFEED
MF5QNHF-LGG]_@&9NI&MVI7)YIG1[J')]J79VR'^ ?6^ KG6"K'N#K7J)LH)[
M?H9^@8""?H2$@X>(A8J"A8Z&B8F*AHR-BH^0C9"&B9**C9:.D9B/DI&2CI25
MDI>8E)N2E9Z6F9F:EIR=FX"&KX.+LX6,LXJ5N9&6NI2;O9F>OY^@G*"7FJ.:
MG:>>H:B?HJ&BGJ2EHJ>HI*NBI:^EJ*FJIJRMJJ^PK*Z\O+"GJK2JK;>ML+FN
MLK&RKK2ULK>XM+RRM;^TN+F[MKR]NH6%S8Z.T929S)JDPZ6KQZBHVJ6RS*RS
MS:VYT;&VSK:\T[2TX;_ O+W*RKO$V,&VNL2YO<B]P<'#OL3%PL?(P\_$R,G+
MQLS-RLS!Q<'$V<3,W<K-WL_0R]'&RM7)S=?,T-G.TM'3SM35TM?8T]W1UM_4
MV-G;UMS=VLG6W<K*ZL3%Y<C5X\W2XM38YMO>Z=O;\-_@V]7B[-SC[-WJ\>+5
MVN;9WNC;W^?<X.K=XN+CWN3EXN/E[>?HX^[AYNCGZ^KKYNSMZN/L\N?H]>OM
M\^_QZ^7R]NOT^._^_O#BY_+EZO;I[OCJ[_?L\?WN\_+T[O3V\?/T^?;X\_+^
M_O[P]?[T^?CZ]O[^_LS,S"'Y! $  /\ +      ^ V\"  C^ /T)'$BPH,&#
M"!,J7,BPH<.'$"-*G$BQHL6+&#-JW,BQH\>/($.*'$FRI,F3*%.J7,FRI<N7
M,&/*G$FSILV;.'/JW,FSI\^?0(,*'4JTJ-&C2),J7<JTJ=.G4*-*G4JUJM6K
M6+-JW<JUJ]>O8,.*'4NVK-FS:-.J7<NVK=NW<./*G4NWKMV[>//JW<NWK]^_
M@ ,+'DRXL.'#B!,K7LRXL>/'D"-+GDRYLN7+F#-KWLRYL^?/H$.+'DVZM.G3
MJ%.K7LVZM>O7L&/+GDV[MNW;N'/KWLV[M^_?P(,+'TZ\N/'CR),K7\Z\N?/G
MT*-+GTZ]NO7KV+-KW\Z]N_?OX,/^BQ]/OF _=>;41<2WSMPZ?.6K!U-#O[[]
M^_05K6.+CU_!5?6M0M-\]*U1#4*QU!?'. -9LT:!UEQ$H!KZ-<2/(_6Q0A K
M]3ER$3Z,U!?+1/")](H55H!A3D/CO**&%URHP$479CCR#4,EFK1//RJ-PT:!
MPW@T(7YJ(**(([)$R%$_.0HT(2(K[J0.(O4%8ULC'X"0Y0=<9JEEEUQVH$*4
M:063!C0$]4-&!VR"P:-,CG ) @@C'A1'!Q]T4$*03HK 90BR7,0(GF)JTQ ^
M7A!JQD#]F,%F!UXT*=$Z7#R*2$0.:B@2&QYX0,:;"?7S"A8A;"FG!R"HP,@]
M")FSR"+^_I44#!H'IC1,"7B"\(I'<<K9Y9=>@H""&DIBE&E!C'2)@J$[68-"
MEXU<.>>TU(9 [;16,(B6-7&4( *? JG9@99@Q!J3(].&4*=!B'BYYT#!C#"G
M"(%:U,BT*FB[T#U>;+GH0&9L"8:D$:VCQ9P?7.K0.HU8 8*'(>'3Q9R*,+0*
M"=0&F^X:DN+S2A<?J%&2-6J44 (U*E%3PIPA[-H1NM?&3&T7Q5*TSBI8@! M
M0??.N2Q/SDX+,6TP@Q#"T=4:36VV: V3,PCO#L3/FGF"05/1ZB(4A[NU^B.+
MGQ\ >E'/J3*[4#U@;)D&HX[F&:E%!F^I,$/FD"&T2-68  +^O0L-@\*T'Y2@
M A8JR#OM")H*Q,\:7XH\DC!69&E"UR<-0X*<+G,$L[4L9YQQ&N9.:O><.P_4
M")X?H'!CLW_/.?1LUK#"RBNROP+&X8K$4CLKL1 LUBN<1ST0*W$4G_BY2HNP
M;D%;SUE"U]8D@D@<B-0\$=DJK+X0/FEK^:\_HA8?QRJ@DJB%EW,O%+3K(K4B
M0JKZ(L3XM&H(,\XZX\ARN[4?>+&?0!+SDN-$PHIIF0!E*1E'(JB'",III&@@
M8,,K:$<[5BAB8M,Z6476I[."!&-Z<6"$>EAW-]ZTRWD.Q$GH6@(\YX%K)T53
M'D(0D4$$>H01^(I?0A"%L.]A)'3^<9M3^A1BC11,2T AH4.6W*20>V 0!&20
MU#BXD$$K 1!D6EK#"CW"BO>!X 0I-,@683@M&1ID'%Z@%A(G,@XCSHD11^'@
MZW)#0^?9D%'4&(8>^R,+12PB%B,4R#IRX8@%(H(1L;">/_"AQV%0@T?TD 4C
M#BD+,A4$'\*P8!P2@4BS'>0;KYAD'!2QBF#\[R#\L$8L%H&(1)2R2>:@AB(X
MA[@]"L0:>@R&-?1Q$',$HQ&M;$0N+"FU1E+C'OS QR^-% MB*@2"RR/(":'6
MM7LT<ABG9%0U6)&(1+""6=5HY"FQQR!QO$(1KAQ&^<#7O0^LK4&-M,86UQ&,
M23(B&/#^64<CJ\%+?P0Q8?[8QS <@8A%O,*2C'Q%ZR*H1TM:<Q72XV0BU].]
M1"S$'%CPTCN1-0(2E  %]:*&+ XV)S,,0QA*4D<\_3$.B#J"&CGJAS5>P<I1
MEI(>!#'',!*105;HD54$48<D#\F*:JRS("U2!")6P:=Q!&,8P=">-4^*S8/H
MLY!Q,*@B$P)-A!00814KB#ED 4Q$(*(1L8A?0O5FK37H45OF$$8CC[K(87#S
MD*_0(3SENJ)4<M.;811D,"!*/40J4HX'&4<L)FE0H[IFF@<\(Q9&,((4#$,1
MES.:&M[$BBZ\+TNH"H$*$I'-8:2 !"30@E._@+$YC< +]2+^2## L+(OS2D%
M:]"K.M9@1##M#;:)C8,*$!:VUZ[K%24PG-%$, (46 D?9A!!"4A@!DG=3 N?
MG1<7')%-EFH!M2F@1C7,4-LY8>%X"EG%M$@0S8$T#VHV#,8)4%L"*PYD'''X
MFY=4T AS?$&Z)5@7]K9I!<Y!30UJ[9?WS*4&CT)14K+XKYQ& (9AQ"*Y(AB8
M( ]FK>JAH;99TD+FK*$"+\XKN:7+!6U!@*IIH2 .GE2?&]M[R2>BH'=(?:IX
M\^D%$1@8:B)PG",H&V1J3"Q+*+"%0,:Q!OW^J@1?B"TKO$4M\(*K'YW-[A=I
M=1!\L(**6H):;C$[W3@,Q+0=#7#^0?@1"R^L+%@J6%!#8DAC?\3"BQ\(*P!Q
M]EDOB0 +C"B1-E30VN5V%([^< 0)*(L%'?9#?V_>+QNLUZ@1))<5YLAOF+^(
MB.[:N<=S&I?/$!%(?R"6(/=@1,[D! (KL$%[JH'L'9?LQA*DP<0@0'0793:M
M-8#J5G-2U0E8C3 4"(,@LEBH;:>E(H*L(V :HY8)HEF-?H5MTUHJ 1*_FJXY
MD<!*:D(8&4(W#C-@^UIF\.2@LU0"52.,6B7(W#.I5><Z0@U<P3!Q;%DZ.J.Q
M6@WGFY. 78P&L*$[1]SKDAGZZ0]S:^EM WF%W@ W)RO$ 6%=*)'!F TR8@?.
M9=8H[[7^$"T+*XC:MW-J=D/N#((4;+4@:V@QU,# 5$\/A%(R<Z= DE4J,*01
M7S<R1_=RCH)<" 2"\)8& !5A8E9_  OV#9<B1A!M$(#!X2$[<WF/AX]%X/I:
M8-"K02"X;X)<?%J)XX<BKA7ML%ICXDH#JT#(]K.!X$,1(K^6%J+>\%S%(6W$
MGI.9-P3BP(,@#4 U]4)?MXXT\!H$7@@L:61]1C>&(+L?F)P_H+%0$F"A"U8P
M,0EL".R]88P$7'C:M,P0*W,\405D0 ,9ACLM/?L#AR[N@A:4S<0E?P%P); "
M"@R,@B"]HG. ^S;X1O<!J]D]8/ 6^0?,<,IQT!YJ>\."%FK^6RK_,01K9F"$
M^,<O_I]3$UZM%8%]^Z$&P(E "UTXP7*GE3FR62L$*>B"ZN>4.7Q\P5\$ 7U6
M9R[#H +!<@*ZYSP8!U3H &9EI'UPUS_[$7*\!D?JT 4M9@5DD 9FX##38E$-
MD0A9\@6^4Q!^$S,FT 5JP K6L$[XH'H_]B_)(C,=\$X\Y6):H 7RUT.\I%XR
M$S6.8&(ED(-^,B>JM2'*%0)6T 5NA&=K,! JPS+RQ@J%)BR%0RU/N!";HSS\
MP"3X4 _XT%+EA0)=8PMP-X2@1RTJ$"%O%S.EL@ASYV*PQ@@_YE%5J )=TRA>
M,G$RHFS"8PT>N#=:X 6A5T:Q=6K^_L /-S@G)L %@6AUSE0:TZ1!2'5]4),&
MC& &:0 ?(I@G*A +[S$.C&!BB5-Z<^(%N; .ZS!EV*(M7V->CI5*9) E&?8_
MZJ %J&,&U4 /ZU -MU-Q^H)[1V-2YF -4]=#_* -'(([LJ,>X:8EXS80JV!@
M5K *U4 -7T8M<+ADEJ@%@+0.LG!]PL-5W88PJ!-MSP,O7L0W3E)>5O *ZJ!/
M9O!C U=&<6 -[7&,6<0H"C9]4H-U&I:([<<R:/ ,^,,*"_4!&2=(5,0YWF@.
M^2 ,3_0NZQ!*Y64&LG,@LH Q'Y %U> ?_' -W4,"8&!SE]0]@_=]54AQ*6 &
MP0 J_1#^"ZMP?5\@.U:$)0:F!4H%7.,0.5EB!M; 'M30CUBP(K'C>,ZC"+.S
M(H,V+5U@2A79.@#%D.NE".. #\987A^0A?Y0>BTS$-^@>BG @D[U<X%S;/,V
M+U@ !FS)EEU08M2""+&B#VFP)5"GBN)P=G,2*!7)")=C+1A95#LW+2E@-B?H
M/'$P#-8@"_WV8.%B!C)G HPP#O= #;_(/H.I)2? "N^A#D$X+8BF>"74E>55
M8?A@#JL =^AE&O9&B0311G[F"/[!'@(Q#"'B!:^#4;6G==A".0,) B: )O[
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M"*]"N(O ".:7C@)A"_(2 LG:M08(L;(EL::3093##VK@)0NY2("G<P"#*A]
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M+EC=SP>QB"#P!8Q@"]I@#F(, HG03Y83-B'@"OZ@#_T$"Z7BN,=&V0+A#K8
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MQTZ7..O^!>W@ZS_7 640\>_ RZ';Z[#@)]:B[P./[#SN;UV0#I2]#0S^ 7)
M[M,@Q^-.V3![;?J.[$@_\M N[:3"/\Q=\P:O#_?R 5K0#@2/]/9^]<@^32 P
M](V.[.XP!G*2X[Z.18?W]5+O8ME \"/_WE_$[/K@,6K?Z-@.-=-@[^U@ENA-
M[GRO#R)H+?4%]?=^Q^=M[_[+,L8>]CA;]>2^"&:0"*YP]U<O^)1--B-0\8T.
M"U7X!KVN#].P4(IP\COOJ%Z?#12N,Q%/V6E<*F3O^0NEY6R_\SW^ 63@[.]
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M8L0#'^A OSPR#"VI)KNOPNW['#I?\NG*G05.0X,'@@58V"*RD&):V.R5V8/
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MV8.%TFN<:LNE"-PE;;/ "P0F>=D&")3 QM' #7PRHFB';4"9'_G $,0_$H3
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M!G:&/SR##PC"0$"! !##0(B+$S@%G47'O^"!RY#"";X'S5"CU)C+674&XK1
M"[!+M55)3=!!*?$#'A3</K0B$M2##QB:/UP=X7"$T$"3/-1 %+T+R@1,'@"
M#R11JDF;2E1;$BS0 M! PDB"#A0#SR .#.0 _Y!C"SA  HD+'4@,\G''O0DD
M/?@  * *U$A-$G6#!%S JI%C+NY#57&'P=$ !X##&VG %';^0@ TP2?Z&%S2
M7PO( Q1& #218_IY2==8U!P(0"&XS"4$ #%B0@#,0<(4 @ \8#E$H#S$0W!U
MAD9PEQ1E0 9492G0 ('MQ#?,22 "P$0:RNFQP#> PP,40,[D8&%P"%XD(T@D
MD0_N9F)(0RTA2Q3<4D*PY.=!#CBTP*!@2;.=84KX#C@@Y4A $3+PPY!\H+\
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MX0P;EE2;7D+1H6T,H>:))$@9[24!M_@G)3*HM#GHTB+!E"G^5P(4@&S6A%D
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MD=H3PZCN)7B$='($; +L'F; ,S_S@6K !62I,1R SJ%F%N;)4\@#/M0#(1!
M!% S*-Q;FC9O;A*?!A"!']Q"]>T1 T0 )*#;-Y/"#JI&'LQ  @! $)R(0P+*
M:26G2E F&F=  LBSOEV"/6NF!D"/HV2 /.1" ,1J222C2C"#)/Q !0! !:SM
MG40")U8)[> "'<! 32?EDD:+E!1 5]$S0T>3[7B&!7,$Y$+^Q3=@0A)D@  <
M0'6,13SXP/>5<RDDEP\1 <YBH0K/40OWP@%<GU-0Z_D"P!!PWM1-0B?\3@&$
MKG+L0]/\@1 G@ [L P9'[GO<D#P(XG8R\0$$P9P-2A37$$?$60XPP.,,T 4
M[&6V@/&."UK/LR1 E3\DK1/ \ZG\1&>+Q%GMBG_"(6PRI5-HS1VC#9F1Q [N
M,7031(G,@C14MW5;-V4()T(809= #CUHEPZ@[KU!HW3\0"$,+&4O:<LT 0$H
MVADPFJ.=2A?J)4<,,7X8B219\!YNXT>(2QQ&EV/2,>2(BS+S0WCJ !UX8#7A
M28'ALG^Z))9L6RY\0SYI1&D  $;^_MPG% J-(O/W8$E0CB-K@L(H@L0>LL!:
M\@._8;-RO!L_J"Z<N$PO&,R4Z(#DU -/4M %''54_(N7W"A<:@0I/!SH"L53
M""DE<X<_'^FAJ&[(I(38&O0# &QXUJ'+Q+7,SA4- K'.\9RI<#4 .0$=,(,B
MREE-B&J:?EYW_*P,5"4_Z$ !](*<DHG!>8(QJ(8[BX0S@)LSA*\ Z'37F/F+
M:V$]W$#+S,Z0-XHLTB\\Y*H,H XA_( 5@<.VU@0XO'>,@R*"(X CT<,MQ)2$
M]4(%(.M8RYD8SO&[?$,G+ F>,B<]^'5-0"PQ@L,G.%*CW D29D73^,#!D.,+
MN#%@CRW^/Z3P[=Q  F3Q/D F6>)U!LSPZ\2JRQR#)[ I X0R1SAE,URV9S0#
M M!GCQCQ9RLU4L(%CCQ0U_3".\.:1T!A'>[5J5T= LAV%Q=# >C NWPB)N00
M*"AY/'R"5=%F)_.AC F /%F<UX!#[!:6S\ 2P%_))(%%=$-W-%2!%$R!Q5_\
MQ?^-=AO$,SA :#8'/W1"\N%")VH$E\C'T1[(Z1F:K(ZEH6 =S\KWSSHBE@RQ
MI:6K*"=K 8!>/7Q"33^;<L2#RCE!VZ3/SV7 K38+ L2N>YP7@V-)$^OEE,0.
M:R; \S7-:M*P?$?"(*I$-[S VR;S1QBV+W&$,3C \^'.A/_^<"^ TP[NPRY(
M&2ICB1%^SS$X  3,8S-$;[9'\+N P@&4[SZ@3"]K0(TVI@_(CF6[_1ZFMW)8
MG&M39\OT])$&M !PD"H;FD$G?#V(BQ\X13W^T9T4E\'IP#GR'*X^@"FV2;GN
MX=8:BC%4=<BH:=6\*Q)JQ"T<0'L_..GO0Q8^D ]XH*'@ TUCP^ *0"P$BM>8
M[I&>[A#T>M,>XCO?:SQP0 ;  V\= (#J[D/?#61N)990YK(C 0(\0 X@%"XF
M &>6PZLEJX+S%H.3HSCGR<^=(1!9<$UP.S$6@V9'BA*B#T#PNP3 "3]^]3 )
M2-!L'Q$$Q_CMXP<( "A^A0+@J<?^K]P- '\.;JQ7+YZ&"MWJ?9/ ()?!;S .
MY-KWH\"G??O <8@ #E0 D#>;(?"QCUD"'R/KR<N@(=ZW%@N &01'HT"L>D@*
M%..7)P"=C?L(!7!2+]<!&MSJ@1L"0$:]<A1>R(L'@X!-?O%^"  %K@('< :/
M):!!;U^S7/%N)BY\X,=-3P1^Q(M(RJR\;@]HC#RXKYYBSS<[?Q8]FG3BT*4]
M;_2WFG5KUZ]AQY8]FW9MUZFH2-&]F[=N5+(/ 9CS6>6!8O6<"(!!QR&,O[D<
M.*!#)T* !,;V%6/ .(D&"0$D\?ODDU^N 70XURO:6&4+>4AI,/A[3 ,!&#0<
M, AP*Z3^2'['7@ @ A]^T"" "' ):9]<" !@DL0F"0"2B/;I18 D.*-#@!;H
M:.*!!&SJ2  =\$@B@0J8X8>9" CPH8D,*A" D'UB$8 ."NO1L (ZG(#@@ ?Y
M^4. GQ2+1P8!?OBCB0JJ"R\]@W*Q\29""JB@"3HT*. /G#@X((D_DHC@ 0%(
MX>>;+I.@@X,$ZN)'GA\"X-!$!V0Z!H'&4N-,AX7V28( F0R2Q$$*;^)'T$LH
M_.$ 8SH#YP$8.F.FOA_H\"'.;_:)1P<DZ: A 0#Z^ \!(CJ3Y( +Z$C"@0>,
MH><' 'SX@XX**@@@#WXF 4 2SYP2 (D_D&!2@$_XX>:% $C^I$F#%&])X($F
M\KA! "=6"RZ")_ QXCK-( &@$XYR"& Y(A*00*9Z7FVAD'B6@H>L"I[%\H!=
M%9N*4Q,S:":T&L&C$),#(I@.!BGYH0. '=]E+ \:1OSKCP!*N4D>&!C E"BC
MZJ$GB0!HZ-"!!&12[)@*$/CRAP<>&* E(@XXAK @ P ETTU]P".&! 3PHS^D
M> " A4CJN00!!JYLH:O.BJD@@31;F)>?GK8$RJC"&/!!GIOBX>"">.KY) $'
MFL"#!0'FH(<?)!8UDV$=\NB! !:8&0F/ 23(X0(' J@AK0I:0 RZI>FH(8 ?
M".MCP^FR?'"FF CEC!D$AJ G*23^E,.CB:\3O&RPTTP3C?/20OL<M=$X_UPU
MVU!/7?758>NGE3!@%P/V,&2?O179]J"AE]3J(00&3-PLI(4(*DB"F<1RT2$"
M5&EXZ*9;:%B>#E)TD"D7&H@])H="0/OFASXRI;2SD>CX 1R)FNE4!TF<""!!
MI)#B!QP\7HA.@R;B%LFM#![@!GD:(G:38ZRO,_*0! R(]X.0U8,;+X+ !8C
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MS1^L1CI+CSK1J1;V9Q8\.M,I^LSM=O>[5^-F4Z-&41 Y-^D4,PD&)( #&CA
M!7;A:H'K;Q]..$  MEEK96.ZV9AUM:V_$4;2--S1FK%UZ4A,;'+?&M05%O.R
MO;SPT5VVTZ23=6Q>?'&SVIH?A Y $IQK;H[?N]0K_SBE*8S^;W6ON\H8;W:L
MQ_T9</A  'QS  & .6Q1C^08X9RNP&F^ZI"SN>:8UA^\L9YUUJE:Y*,I12&.
M*F?0J)LSQN#BK[X!Z,X&^K*E&,(>8 OL4%?ZLLU>M,[G+G!HUYCO40?YV/W>
M\<"+_<L.;[A!'NS>V:2<[(-7+BB&\ >G=UOJ?V^\S0DO\]$P7N6F!G:R"UKJ
M>&#""3]P0BEBWO4AZP_Q)O>/O#/-YJ</GNKB/IW6<9][V,A[V=,UR-R#C6RV
M;V3MFE$[Y[U,<<,K/]>U3_[ _:-YVN,=\]3O>^!5;_VQ0C_V9)ZUQ06/?<\=
M7N[W[G+LJZ_T8)>[V("7?IM3#>C^YGOFY\Y/->OE/N['=EWDV7__F$-"]P1P
M "L/_<Q/_<2*Y!K-U>KNZ1:.[A1P^&@NTXC//RHM_!#PYMSO_S;0\M8/ X//
MT?[L_$YN]VI-_)[OX2S/TQ[0\>ROZDBLM:;/_YX$LS0O^S2MY$JMT7BO ],/
M!:_O_FYO (D0ZUZ,!L?L!#//]?"OH(SO D%P\RJ.[A[M!>=M]2RM<\#/!P_P
M!9%P!85-"3FP .=,_APN?F9CR#20ZGC. ROO#4^-]EHP [FPU2Q0XX"/#MUP
M#0ME"ZV.SJYPY3!.V,*LZF:/TXHP$>&MV7(A#RZ,_KHM- RBVW),(B91T<80
MT1A0_R#^D+;X,*PZS0QKZ-P<T.&,3=RB\!-'S@JGC_[B@0XF;>*LD/*J;/OB
M1Q3]8_'$L YA4.;P,!/_S@"#$/"Z;^IB< HOS^.D[A"!\/+8[]"0#P[]C_^T
M3^R&4!&QT:WXH1>6Y !J0!(Z#!P^(0_^@,J,*Q?^( ]  ;SFS!@*(0\^@1T[
MXQLD(0\DP8T\HQ#^@-AR@1#2#OHB\!F52QK[L +5#@HUD"3B3_^&[1,L:N;T
MT#1 01+ ZPO7T)\H)>QN ARDB  T )SRY!,D01@Y8R+332)Z@1#"K@+IX1)6
M2O[V 1<(H1S\X1<*01S\P1D$P1G\ 1T*099P$ Z-,0Q)T0?^R\\BAS$.U>H6
MD;(74ZL:A3(0I;#\M$BJNO#ZDJ(5C:LJL[$KW<H8?.0I8L0K).(8:(  '  !
M#H .@"@>B(  %F !D$0C34,2]LT!"H &&.(F<N$"#N !"* "(ND;/I(6;\()
M"J E>+"SCN_2S(_[D*\-@>('2&'G))#ZYF(G6-'Q<H!/4M'6XH$& & !:$ C
M-65#%H #[(,N<V$!=& @VRP73H0="X4;.*  >@%'D")KF,(4_<08_$$/!& 7
M_$$3 B 3_$$9#@ )-J,ID_(J/U KG3(J_Q A>=$YB7(Z"T_4*(\&)9,Z@3$9
M2<TKR7-UBF!80$$&F&%-("(><H#^ /RQ@X8E(NC@Y9JA&9P  &Z$_GHA 5[
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M=&5; Q]>H&+VJ<.2  $L2S/ H4DGP5AU"2>Z=7Q*H@+BSE#^=*4A_H1">J$
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M$,Q$ X@F#W0  (+ ;/+3/^> Z#) P9QB5/+ 1 J@%/YC :*#!6J@'$PE LX
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M(D  +D$B'%4#FK1#.V%*ND(B]@$0AF1!!( !BD$>RJ$8#@ !^(,?C"%!3<M
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M"*JL&)!.*20@:/E" ZXF"?JF/ 2  S"!&;(+O.; 6R8Q5\(#''H!,7PU0IJ
M'Y#!/U^F$\1"5LNX(@A%Q$D%D  @"0H& !!%- P&'%>L'&H@ 9"A'(CGJ.IA
MJ<Y'K;=,!D"F'.(A'HXA01=J<#0#KW] $H<  0X#7M*.,Q"H',A7>XTAPS*,
M'YH@ #HARP&+8OP'A" Y[2*L,>2A&)KA(,J!/AZ@LUFY"3#UE0=E8Y(ZR[^!
M!2 @JOG^\D*J#,<+HAAB&]E XQCP@$T H 7^7#%86 >NA@<A(0'Z2!Y8X *R
MK#P6H DDPM ]V3/*@0-L]R8$A1!:K@!^@9P/]IS]X1@&0,@)00 F)-92G*!@
MX"$H!"MBO?8\\?P"&/#8^PWO68*5\H!)8]K3>Y\+NBCG6V-!3K^#S:']NX(C
MXE!EX!;&QA/D00-^NMF*X@7HP:?W$\ HYHYNHBB8F2]?3AY>( +B+BT>@ 7H
M(1Y88,:1:@X*  !:^ \L)CF2>]H  (>OB1!^X-\_I2#LY"@^E>%IA58^!=>K
M#!,^XC1..@<*)@ B23%>Q71)2 (.0 !PP5'B C3V]B\PXEO^^.)@AHA6 H![
M;\%&).=Q"P /-F,K8B8>^@*\Y)E[ZY<!C)1#/#D' ""9/OX 7+G*P@)1AAUX
M,N83DH &,F ! B"25_G/0?O<8;F/:$!Y*>#M*8  :+;'<P40",48#F HCK8@
M? ]Z/2$_T;4V&2 'L-"&'L 'G P<6" "PKL<8&!9LIQR<J$02\(]"B5*9CRZ
MW9<XC1-+E;,)ZJ$)9/[H<\4/ZF&PT^EL"@";K;V?S?2^HQ*"%5@+#=C;([+:
MKWU-]SF@:Q_S-E3J1*O<658?-$L\,B/H8>X%MJ4S2D+5\[/(;X(FRJA1'@6W
M:#H/Z&%/T&(CN$$PZJ$7%H!8;.K^%N:@:>+DS^=  "*^$P:E&#1  #2@9AY&
MR.T$3[9BIZ<C__$@N0N%VHADDP B@8YZ3@3DXK<OH<)]/P DH0.1#AX_W, ]
MH$$O83T8#\#Q*P0 $[]O$1*<B0@1DKQ; O#PJ\>OV($\+V'F 0 J'H46\A+2
MX^AQG[$_-1( 6 "J'HT #R/B^0-N(<QF#'3(@U$!7#UY20I H-%DDH8'W^KE
M8-",GY,"!_=]!#!I'PP!32%.+*N0WR0 A! F/'; !S]C!9SXK9>0'[AF]<#!
MZ!6O0H2HB;DMR+&OGF;$,.< >* A0P4! BC,\00@@8;0!P(\^$%983P.-'HF
MO!7 <%?^8_[N"-CEKU* 2OY^#4C"KXG!EVY1_]DX66&2 [T69K:.76IV[=N[
M>_^.'?%W\>"OES^/7B'Y\=[7K^?^/GQZ[MWC7[>_T/9\C> Y[S>_G3\"#DA@
M@08>B&"""B[(8(,."OA,!D/L\PE&O1 P(1("X%(3. ZT4(\D /Q1DU()I+40
M/31TI- ? 8A$QX8*Y2( '?P0\@ W"'V32SS\Q'-,0WVME4MBG0!0"#\_!#")
M/##AAMPQ"4SH5B0 T,1/EMQ MA _N3 E7CTT(G<& 47&EP1.669YC#'R=!-!
M;1H!M0\D+_(C#P<.?)-E0KBDQ9)+,!530!+\$7% CQ6T$,_^G&3%D\LWF7US
MDP_[$,'6FO48<TQ&UM5#A .=(#"'6Y\$D -C^]## @.2GI46'0'D@A@_>3#)
MCP\" +/F8,=HEM>8>>%F&&&&?3I$!<TXUHL\+9"5%S<,T)"99EG"- D-VFI[
M  $P^(%+#C3(H*T# +2 1*/\S5:!NGHAR<]TO/E6BS^7#.>/,@<@YP< ER!D
M$USUM!"=6T@48 Q^_*E'GWR?]O<?>Q$[#*#"[C6<G<+;^;?QQ._%]['$##\\
M<<8: W@>R!AGQ\^#+K\,<\PR"[A.!@L80TIM_0+"SR<"$$%/EI'4N ]5''CD
M90(8[1//-XWRXP>3;GU#,)^Q$)#^!$ST)$' +?SHD(.3>AV09):0  ")6LNY
M=20D Q]P3)9;.\0/,@G\D)B4&C3C5CPTW&P=.&,=XQ8]/PB R3XQ%HD=/Z0$
MH(./_!Q3 0OE@ ,!#+:IV!$_9TOR$AU7NM7SOONP9*-FA$80]S['.*!Y9#QE
M=E56S##P TR#!;;/7C_(DZ4Q#\!0SLC\@'* !@@4^58>_KA%2@&N[@,KU'QE
M^0T,</$C20!$ ,]/+P[$$,]ZWUP 0=QX+OF)EP0X,?(^3@1 2/;%](* G I1
ME<-F/S93#CQE1![TB <+LH(8>?0$,5QCW'IF(X!.9 D<-$B ,>(E@%[TYC?^
MR 2^E$'^@"7P QCY"R _NF$S9D G-O("%L561K+VP# ]Y+$/?FQ8,I3MYV(Y
MM%@.YW.R_ZA,A_4IX@\[MJJ6S6R)3&SBRPXA@ P0(0--.  'TD*/(0C !Y>@
M0P(D0+A] $( +8C$'RJ0@%+P@QZ%2$!?]O$-#22 #I.H 0&>LP]Y_(  2)A$
M$@0P!'F0A$130:,=.I$'!U0@;D0RTO9$IX-.7.('#(!</8Z!@" L! \!8$$A
MLD473^5E$@>X "$F<;C?\>,,:\..'@- @TA @@4"( 0<,T</S@#E> '0 !WB
MT0P-%&H2=&   P["$CM42R;GDD0AE >*?8"C B_8'$>^H4?^ ?Q@$I!H00'^
M%0\=0.X2?[A  20!GW)H  !R&F$"'  )3]"A @BP8#UTD !)Y2(!<R0$#2H)
M.K\%@(MG/, EXC.) F3@DS[P'O!R\3Z_Y*47#T! $BK0! H<X!/6D=8-_(>)
M.0*L)O)@ 07*<;$&2E0C\5AG!?(P"7'203/RVF"]A$,<?2'A)?.KP20BT0(!
M^&%5,9@,0C!XP2,N3&1$!&)Y@HB>DTG5J5"=856;NM09:K6&*3-B5V-(L3#)
M,#L]<:)9SXI6 =&#$!DH0  $8@R-E&,.$.!G#GKA%WI 0HX): %'$R*)!Z S
M,\70 0.^^ ?;U.,;2%A  AC0!(_^Y*("' )6+F3 3P;4@'F X$!23R<!"8(C
M"0Y(P -T<(L?Y "8+RB50N1!"+Y6  _JP@XF6N#8"M"!,FRM#LO 00<))& !
M'(A$+LM1 R0HE@@T\ @X?K" "W!#*#]X  ,60 /&]4(#;LN23') 20:T()I,
M ^_FB%"#1GV#" ]X+ <DD9'%.J$DXI6$#:$6@4D K!Z7D*,#6  )2&2@%/MH
M @PH(XD,/-8'D^! ^Z39A/:*-W'VF01N$Z!;I!V# R3ZE)@J&( ":* 3V/F&
M#)JPF7I\(@)^>$F)Z!&$L,4G#RU@1GCB\8,?T*&]+RW?/OK0 F7X0Q(:^(4_
M2K$!4OC^XQD<R -,XI&'"_"3 Y/():AR$)L^<"",8,W8"[7Z5"$BT97RJ>I4
MNZ,?B'5YK&+V\IA]R.;X?15E4+VJG-NCQ+3J><\N>TD\ -$"6I6X%\P 7I?*
MP:G:YA$<N50(/9AAC-BHAQO%P(LT.U4B/#6C&,P(FF8$21YZ,%HAWS!&,P:H
M%7J4HWR'X4<YCG&, "I,'FV2M#Q&[1UP&(,9*(7)/E:]D'*@U"??8#1GOE&,
M4ZL''+:)R;[HT8QCU+8>P&:II>%8#&F_1]?,4'1V1)WF7[>I48OM23PD#:1"
MBUJ4<#Q&MU>*G7A 6M*+]=3'Y &,"US"VW)5M#S*(39K::;^VJ[$]:?B4;YF
M&*,L,*E'T^KACWN80T#X0$<_!+3J%+_:&#Y&S+G)<VZ2A8P^5]68G;^\YJR&
M!X=,3?F=O:K4/))YS#!7<Q%/'C&5F?S-G\HSGW\.= .YN!=T8+=ZF$/GFL1<
M*@(7>(G<\O+ZN,?I+B09O-.#=(V<N4OMD4G6H/X=B=:J.U='.;  5C+_>6QC
M/VJ",X"8XLV$V<LNKE;#?6Z@IB?&+9S!^=I;[M2E8W7.2O5[U<'L=Y4K/B'A
M%KP.=[YXQX,,[T&O/)^!58]&NYGFG#]/34ID+:47WL5J;S/@<[Z=7.S+SHF/
M.L=L[OCQ*+WQ@[=[Z%\?>1N&*=/^"LITP\$.YH>-'#XK1R+M-V\Q. L^B/$Y
M_O#O8]6.<=7E<6;8R5O/0_.(%>5S%R+$+0]^/F?=R[Z.?7M23/K#!][#_E-_
M[<W__NU\PPF?N&$/YU/VZG/?\-7ZO/X;#H#N!T3C]WF]%W=Q1W@U%U6QIWPO
M9&8I-T3PUWD_U'JG5WL5V%6TYT-517GAYX%,-'XQ]WQR]C'M%X ">($FHSMR
M5V?DAWIK9G_!MWD)J'_45X-1UW-W5WYA=X(IEE6)%W<=." NE'\2^'@O6'@V
M"'U'E'W=!WN<!WG<]X375V;FQWQ/&!XU\8%;Z$0H.'C\%U77$H3CAX%(5WI8
MA8%42('^.[0R&,B&;ZB"!_A4[>=B(9A#Z2>$ F*'">B&:TAS#1A_@)@0\V!Z
M5FB$#@.&,_AW;0B'4J@>_L.%D3@S\==4(UB!!RB',NAYUA)6<-B'FKA^H$A\
MBZB$4F<=Z<>"VF<RH"=WA?B(*6: COB%\?-Z7JB BCB!:OAWK'=$QX>#)-B(
ME'A^+XA[8W6)3@B DJB,+[.'N.B,%@B >%AU,?A_K>B*6+B$HHB-P1>!H?B+
M#3."4D>'FVB"6?> VP%Z>>@/S4A#3+B-WN&+W_B,PCB/(H-S4B6(%BB/;]B-
M-QB,D:=XD+B, \D@3Y>#K-B*NO=Y/@B07[9UX=AW![B0UBC^9DTGC=Z!D'67
M@J4(@UJ'B12I<B#SD?[GD!.H$:*7,IB8?EW2@^BW@PNC&088A+4GC? F'D58
M@F>H=:^H@U%U=Q98D^B(@ [#BAT3E&$VD3M$A^'(DE<89E2'A(FA=[*HD+\7
M9S%)D%F)('VW<BY)DBS3DNQ(CX[W>1/IDB$IA1_)D%*'D$D8,65Y>R^)=50'
M>C2(? FY5!Q3*W%9ETQ'EYG(,@I"=5Y80X#I8?LGAAJ#B@)X0R Y=YBX,4YW
M?C\YF6OYBV>I@#KH@U&HDU HCH[9D"(I<-LH5B>HB+NGE:E9()+9E(EID$0D
MD0"(B#;8CSA8F";HE2%3FT>'D%;^*91FB4-,Z8AZR9--!YKO%X1+.8_3]XA2
M*99=:9S7TI43B9)>)I-[67;Q490Z1'K]89GUL9#[N((+>(IZ1XCL]YIY:9R1
MEY34UYT3XWM.^9XRN'U'QXF=9S'SR82&*7NJZ9_KZ)BQV9D>!IQV69LL!XZ+
M6: FF9/1*)N?.8[D.8H<"9Q?>8$UU)O'&7B_]YVRIY;:Z9(A>E_7:7=;=7LD
MIZ%:5X=SF)XS^)T\U)BC"981VCA>N7B8*7-=UJ$!.9V$"9W&R&8R6A[QZ)%;
MAYP+683R\9^J28:/V)MXIIDO>G^$]S&9=I+\:785@WY2^:#:-Y+NQYPF.8 ,
MF9Q)FH7^*XBD,-2$(8F ,'JFU%E^50J8-Z2.^EF?GZERZ2B7'MF6E6ESOM>D
M4.B;[#>4#2JE!.J4MJ>?-)2BT/F>O&B?VWFCTJ><C1BE9J:.2[J%9IB#T5F9
M?_F.E2BAA.I"N;FFY=&>.)H7?+FC##HRK'>6B_E\A@J9]4AVT?B<6FJ<K1JB
MK29R==JH=S:>*EB7HCF58&6A,+BK.2=Z59JF&2.&&@FE=@:<)F<?BQIULDJ!
ME1J*!5J,9Y:;/ZBDFIJ5S3B8TBI\T5JKXV&+S3F'\A&>V'EV][F3/ME^=I>L
M7QJLV3B,*4.2?9>.8?BE9KJ %MFNY=F2>WJE?8F"6(D@+<K^']LW=>H7)B$:
MDM2IBG26HA+;@T=XISP9F28(DT4JFQ];I.Q1L9+J'Z=J>T#:?VVJH].ZEF%J
M1+LJG$>8&6U)LT='KEF)>3OYH:4)?6KY='JYLB5JM%[*E1&IM*H8D4NKEK;W
ML\1Y'S;;L1%KED5)G"N;BA);M9B7M%P+M@*ZM4L8D1G:G$)[M%,KM3#[LT/;
MMA9K?5*K=$L;L3"A('D4M'O+MRS8MW^;8@OT:7$+N(4+F?-@N(F;D%M!LHH+
MN(HEN(Z[&8H5M7K[MQY)N9*;N9*[KF75LP.))V,[N(';LDXBAX5KNGS;$PL4
MN9-K=ZQ+N*X;N$';N@FTM[5KN[G^*[J8B+MJF;JS*[NY^[N\V[:6:[RF:[FT
M*[7).[G-^Y&M*[BIF[K,J[QR-[RR"[MRB+RI"ZQH>JEP&HU[YZ#7XIHU*:O@
M"Y>DQQP&BZO>6Y.W1[Z<Z+V:6;?TZZ  :Y%XJ+X<.K_QZ[[\B[[PVY/YV[_[
M:\  S+[IJX,'?*7MJ\ '_*CDF[,$O+].BK>?JY4^I\$%TH'\@ ][EJD$$L)Z
M&'YYUL$+LL$.,L(S8\('LL(<S,()4J<@*'X8;,,WC,,YK,,[O"#*0 =G  5V
M  5T8 >!$ KD\('H8 @\< ,]H NX,,3)0"#WL X\;,57C,59K,5;S,5=[,66
MIPD (,;^8RS& 9 !KQ!^_; $8QP =1 '8DP<_H /NZ #H_#%=XS'>:S'>\S'
M?>S'313& /!6"U!: B#&%R .X"<.YB( 1N &R: ' G  FB @E- :E/S'F:S)
MF\S)G>S)GPS&8@P#UD .S_ ,HA !8IP)X.<,"   *X /%T<.OT ,$^</2B#&
MF S*N\S+O>S+OPS,6QS(,W!Q [+&2$(@OV '09 $E8#$ M(/FA (FC#'4! $
M=B!D!"(.AF $1K 'Q# @I\ $A@P!>V )^- +@B (SH /FL "8AP$A& -Z^@+
M>E $/> $F6#+P<S/_>S/_PS0 >T@PUS,_F .+P  '.0/_2#^"*X\QAS@"Q3'
M 0!  4]@R&*< *(P(+N  63L1A=W V0, !& #J(# )F #ZG,QAJ]!P<@TC$P
MSP(MTS--TS5MTW@<R D0!$,0!$'0T0' !,6L"060&CUP X;, 1-W#RL@Q@+P
M D:@TC'PP>*P 0D= T&@   P '8,!0_0U!*0 ^CPQ@!0"?C  RY]%!FP"[_@
MRA@0!W:@/0"P!#=-UW5MUW>-UY(8R"(MQAB0S?>@/0- R?U@!V)\"'(\T0 P
M!%6\"R[- !,7"&*\!!\<"T:1 _V #[[@TB]@#A_\!'#L#_90!'!\#\$AQG7
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M ,JP#*Z\ 9V-#^;@#)TMY !P +YP#_80#E6= ,G #C(@R*%P#N00#K_@#-C
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M=Y 3\Z(1K]89''B"Q,BQ 0R0(R_YH 0 W#VY&$  G3AY0@%0D^4)N*!C-N
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M"FP(A4<(A;BC-)WK!W+0A4?(!%^ ,YS AU[0!%% !W1(AK3"!LN;BW 8!4K
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M!:"%FL &#) !<NB!"-@N=KB#6TN "9@!1,.('!L !$  "*"$B3@'-WA.!1B
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M!5.X4T- ,\^%&&Y:!O"=@5$8!0X(  =X A^.3?7*LU!(!EJPVA&48]4,!#W
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MM*WD0T]\NH=8;("UK@$TH (U2S2N@(I4I*(5JD#H0E41!KSHI2U\J16AB!(
MMN7C-I"AEMOH$ZTZ(( )U%(D%.W^F9(E>#(?/1 =VLY1!T.P(Q1N",=NV%&$
ME(I'#[B14D\P=PY(M28E08J/F/30$K/A9P@"\,7"@E 6?ZS#!?=A0LWR@8-X
M.BD4$$!D;83@JI;J81"]FXRE-O<$I]GC"$[!3T=DT -]G8JL!:K>-/,A"",%
MQ1E.<E"O K32[F#H'(/#HR;NI(RT]*-$[C-216_&*"=-)Q U8DF.8"**_PUM
M2&*RYD8NDDK]) ,T-@J0+@10J=W<0P;<$=Q#>./9?ER6#_E8PMQXHPM1W6\
M/0#+/:IU W/<@$EG48<=1&0* 4"KAH#J01H#%*1#I20Z%+W'HAAS Z?M9A,
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M&8Z\Q'?^?4?AU08VD-PFA ,QG,L%?-_.:$2U", @A <QB)Y'9<( Q)J*;-D
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M'@    R *0[  "3 '*8$:#R/3?16U$' !FP& J12 D&)-NW(9<W0T!Q*4D#
MLD5=MUQ2<S&CC,W.EJU #UC/#.B(K7C5"MB  U! _UP6!U7C#?3 W4U :_G"
M!0Q #,0  F3 ,O@#/J!4!.P !PB #J"#/_2('3B)G[@'D63+;M7&,B2 #B *
M #A/2O3 8VT">NP #D2B L0'RVU$/X2#!'" KV +5J2B %@ &C;<IM"/;&Q4
M;9##"@" RN2#).U'^VA>K;"#$)R&'H0#!+Q C*1$#B2 .:@%/CR! $  #FS
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M'DA%'23J_1R!$(0,+2S!#.R 'D2L/?R"&^"H*;SI%\Z.A=Y ($R1M^6)$=@
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M;'-.&X-%B>CJ6WB<IA\TK;?IJL]/18FL[40YG/\M8=#Z%XYP31Q(A%04,5P
M#H@#/@@,'[R 7MF#K=N$[7A</EU C\KP,DM[]Y9%/P3!$E3O-\DTM;3Z.?"
M$K0ZN:M[;=A.M6P%#A=[8]EZ.%2"KH@ZH=R[;^NJ)7" ,[0%/^3[NMM$,FQ
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MA$:1P0(6 .'9'T&>X#2"(9X1) ,*C@!NKSHRB."%2JQ:A@=-=H!Q#WRZB2$
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MV$\_5N" )17B +X81@+H0)!\,&$!SC#% 5[H#V4DP <N@R=!@O""H2'$"!#
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MIFH+B<$+^E&$]Q)$%-D] P3,\3@87"0($5C''"*PH%ITM@<6Z(L^*$'6?L2
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M#H$'9D#^"-P('W;&1-'!$*!6":I$'T[!"&9 !\2F+W_ "4X7'S0A">B@%B0
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ML,$;NS,Z)<[;I,V;O(D['T)! F+ %[Q[O=4;N^D;KLN[I:F;OFW:'W3!!R3
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M,=RP]&,7!\" ,PY*C @DP!?J? $G5776TTU/ >7%!@80$+ZWL*,' V@U+1
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MP@1 +9HZ;$ />DV :^7D"QQ,_0 KR,1(#3&!GR>@!^.VQQ,VX Q*?#+34(8
M)"-\]I];0!!\$PXRT .<5TDRP'U]-H!?LP,X,'9,YW1A,0CWQP$Y%P!*,&("
MD !Z(%SK8 <.<  )0 &'$!SY4$O;%!]GU4?)@  Q &>JX@8!T$L28G_ZLPD
M( 0(00R44$%V<(.%M0(*T&J^% ""L (#$$WV@%G&%!;G '[^",!T&* )JO((
M%F (+H   J!_R$$,/H< $; $!R!:%6$.+] #!I</@Y  9G0/[* $E14.;L
M/^=VY\"&/7 #X#< !] #R5 $MZ< ?( <34AVEZ<]^?!J-C!V=><"3G15'L<$
MJ.=V>19C"N "1H!Z.!!_]I )JW8 "O \!$$)JW9T$6 (?--5AH -+Q   :
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M!VC4K/DZ &\D" % "1Y[#MF#-:Y)#/T0>8%D7)+7#UVE!)SD#/2H-[XI3/E
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M"J $O2G@3V#.!67?6)2LN9P,"8 #=-.KY16A2/=S1S?;^5#;B_/%P]MG/7
MOL<!F9= LD73 Y&LX9!2&8CI"+"40;,)-R"4/\=85,M3]@ #$\ 3!Y<!,.</
MTIRV$I(,!!D?4HM.]O#$-B AL"EUH10 #/R\T'S*?QP 3I0/B\:MBS6'/Q<
M)+:"1C 0M<>*GXA5>0+96R'9*DS^V>AX$3UH" :W&;ZP F[ I Q<$*&>#+.J
M!*+]UP.1K5+U"*@]%]FJ80_%OI,:"ILPH**P.IQN#X0IX+D]Q:NK!*(PDS.)
MRV#D )LF(?^MD /P:P*A@SW@ +)4+(4G4H5Z ,10W9P]$"^N81/YW]C4PS9(
M1XOCH']\GNRP >G]8V,2#J'P!&^% *F=4=A "4>  0   ?JSMI.LWV0KRQ+R
M3)2K #?0*_T RO;=10JN\Y7<QR$>9V*K:D*L$](<KOU,"45@ 0!P 9MVO0IT
MQ]M8XH#-\@4UVBO^\N;WM\:CD6SU G),$$84NHNS4]N4#[>[?R8W *)E<WIP
M"J<P"J3^(/E[&Q9G)=YO\4MFY.1U>&^VY_ UY=TU55K],*M"H!,K)@ WG*
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M7C@,$<+1/9(WGR  E/I9M*' 63Y* /@(#F=A!3M= YC8J\RD7S[2M YA\ZL
M6]YE"&X\[,=S4+]- ):,OM>/UB/4-AQ,]OA$@$U= =QT-/6(7=5E0(EY?00@
MD#]V$%T>(,8NAH)E'9M:L!".5@".A@(8$FRO#H!-='MX?+AC^$T!INSU.. +
MMJX8E-([,R29?.XYAP\ F*CJH7M\&00;TL+9ZQ':+,NGG\H&P:N'F@1S*8%D
M0,*!'87P<>$"?)0Y( B%^F%'/EW^TO-HB0!&\<X]=G# +L%P7%!-%T/N:JH'
M]O+I 8' QN,H'U,"N".?.@+()#T@:@KG@A4P>@@'[F ,9P(7SF''!<-D,F(
M7Q*4:9, ]B#-$@#0>X@N)?PI! !!NHI%$W'0M&=!!2P 3J9D)E! P&00B.&<
M 3T"":9E%(#S'FPP." 4TOJLL#@A*LJ'%@%ZJ ZB?/0(0!/O)CU  >S2R\<7
M1($D,@!:\@DD $L]&@6 /6X*P)3'%CS "+!^0< (!0)Q$H$>$O"%,@IE6H^2
M>UZ**9]D$MBA.F<EY.D)TDC3A3=V(G/0(R8VM"X4_SI*1@(& F54 1E"'5>!
M<)**@1W^TOI99I!D,F- P KUZ*D?30) EAT8+%C'GWL.LH<K(080L*)P(L"
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M[CP>"0</H!0."(2'-,2P@'1H@[".R, !I5O'01JF$"$<H&(5.8( 'O$0;*P
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MDW02CO_%@ DR&, 3K.*\ +Q@"<NZ0$\5A V@V( ).SCK7>C2SF3(1C#G4((
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MUK6#%X"!/*C)=5@"#I"!4^"*4[@!<F@:?-"#7MJ%@NN!"X" #%B";F#;9^"
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M DT(!Q\(@ O  R'?9W\0A_ UK!/W!U*H U,(@A78N!4YA2!X 1=0@F2XV!C
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M#0&#GMI(P*1O "5$A]L3,L""G3H.;H2SMX+'O6<O($#1$V, I7R5$@0)U&-
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MP%M3A%47B+4RJ0J:B0 H(,]+@\#@&/T54X\+5)F0886AE5&E&6$H^?C%#B
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MK1$3$* G@-G0 F94A@/T<(058(T',6#@=I3AB0%HPC^//(#<W)H,2LA  )U
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M.>3"54#'3O0<(ZU-+I:%#.U 7%V; NC!$?) ;646-NC.S=W#YL46!XSB>SF
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MDG\8@0#H!P9>DA$4';OL6BB,FM_(0'^PPX(M T9:3N*X@.<P&JA(3 VMF3,
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MG5]J]L<R6( A),,&9%N-<-$*"(+^'DS !9@06278/0S"13Q!'600?!A;#BG
MH!42# #?#^:#'0@ 8QT! M 4,4#E(#R""Y2030Z &_"!1>@<8@D54>R!-CV"
MCNX H:9+$5 "!A9!+ 7 HF*@^44+J@Z"2<:,+T9 (%""I-&"<.W MPQ 7(:#
M!9Q-B53:(<0  IC"YR# L# @DD*!N6H"% #98$%+9CJ#!%S M,[ 9O!*2RK
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MT'Q<33FA<S*A53710AD 5)M1&JUED\;*B65T'[YX76(R(9#^X8:3+BB<")3
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M=5$W0&_^JX8B')E0 !/"<=@Z,/"TD*NE(9SA[TO%VP;\T343PH: "AWA (_
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M3,+A]00B'%R Q#)B:I8@'R*F![I%% ;@?M1O(2BAUEA@!3!'4" @B^9I(6Q
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M %,5GD%2<L,,3\DU>N<?$1(;W' &6*!S*&893"&8>J .W&\0# 7B^M 4B$$
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MJD0)OJ]0F !?V($TDW. ^(5C#B$%568DM.D%^ $HA"  ]*3^38X &[!!#P[
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M-D?\]F_+:R_R 1>2Y  DN:D>@37<X,U,@AU"S0+2:@?H(RW/S:M*#8;.; /
M5[:<X?A,.=4&P@6H2HF=@1V<];44H C.P2145P9@8%9I$P(N ,Z8@!TMBPG2
MT@0;MS>;! %D0*O0Q118LY[FB3["(9@O(*T6-Q^6X$O5: =B*89F$(:,P+8X
M"QB;=0.R* (4*I=VB;.. )[L@0\0  -BP*L4H'+OT(#"QHV?R*[DE ,T ("N
MD1U.)0+^G$D&5B<&,."$QFD"OL>V," "((#IR.',EM52"@T;T'DA>BH\0+F:
M+:#[EL&H7("S!"$UG@$"H*!B*S 6%6!QDB$"!F!YTI*3&0M_"((81!IAF ZC
M$>4>FN%?(<(B*<$?\&$.$H"3TX0^C@!]FO:B9,#93(4E5T (%J(H3\BZ:LD%
M)F %W)DW,6!^4DJK6YJH6$ !ROI/0I<HW\D9)F!WOO&SLB\"ROH&E@%XM"]S
ML4JZF.Z)S!("-& %0,X<'D /B-H.$J "[,F7-B$""!H"+*#P^#8W/F)O(SLK
M?F.1&1F3OM"[R$$4\ ,_:*$8D\$4^%$75L5B/,<0!,$43N3^0&#(% (A$QS,
M\<)!% *AA C"0 3(8B9H54B[(V#5'VI/'_SB<TZ('4R!#P8!>BC$'IQA$RR!
M@$:!A0*E7+HH$$XG8$XD$);;-I)A%#J'!_EMM+N%'6B!NZ$G'W2!%A"D>DY$
M$ 0!>@[BO0WAABB$E*#G'D(D'-#&'#3!$'C!&G@A0E;"%PR!#_@--5-$O[V(
M!U: & :A8 B"'#8A$!YA&<C!@MAA%&9'M\?'$ ;!8"@G% )!P@_B'$Q!05:$
M0.KG=8@!M^W!%QXA$$*AAU*CW_;@$=P[Q54&'6JA&R#B'DY!'*SQ%P9AM5N$
M&%@;+C5HM'4AWA#ENZ'%%&A%R0O^15ZP#1MP %RE)A.:1HTV@0\H(44$@@?W
MH&DZ D,(0C(WQ!0ZW+75VQ!HG#XRA44\+Q/X0,<'8H6Q@19$P1R@P%UA)!RL
MT1<$(1!^VWHHX;:-\R#F1E"-I;L(TRB,9$<@/37X)K,U/4L&.5V0YF/:96>L
MQM-)_6-2YFQZ9#!&W5N\YFS<L"NDY%_F5692HM9=QM;#!6Q _35$W356(W]T
M0AS3Y6TP6&4</ 9Q'5S61=EM1B-0J5%]/=J7W6Q7G4A"/1)U(F3 A@\TX!=$
M0X_OZVW@4F78Y>HP@.GZP1>J,FABQB4<)M2[Q=3;G=F5AC6600/VP![\81PT
MX ;ZXMG^Q07::TY1AH6R-P(?+OTD?@/AM6+3';ZR X-#-&.S*R(O8IU*(1XE
M#+Y8".+8,WXQ)-T@?"$"+" (;""L\#8APL&J>L 5-R#JRH)4BD+Z$. &@B #
M(H 7;L(L$KXP,GWG/SXP?M[A#Y7B 8.0P6LE@ILJL")7 V'^@OXH<L+H>T0F
MH%M1HWXCWA/H&Z(.@\ J4[Y3*.$(>H /U@?B:<82C* (]$!&N#[KVV+CX5YO
MB5[3*W[N*1W8R0(V>CXQ$$/AD;Y/TT+N3?UH?B7P%4,@"']8,)CC(STG^A[O
M%Z7NBU[RV:(W[L;R^90Y1L4*$1\J/D3SZ7[O&7^[A,7R/W_^V?6>\@\5ZT4?
M*I;>"RT[LI\#\U\?+!;_]H<B]Q/Y+(:>),2B+2*_*(J&]?D2[A&?.+;^D)&?
M+0QY(J@>+61>]PWB[Z%#]*6#]V<_, )?^R6;X!^C+( %LXW_.J+?T:F?(6Q?
MX=,_(79B^M&__4\C)UQ?_EGB^2?"_AN>]/5?* JU_ '"G\"!! L:/(@PH;]^
M]AHZ? @QHL2'^29:O(@QH\:-_10RM'=OH\B1)$N:G-@QX<>3+%NZS%@1I4)_
M+VO:O"E3(<Z=/%VF3-@SJ%".,XL:/8HTJ=*9&$,*C3G4)KNB4:M:;5B4W=6M
M+YU"I-J5ZU6O]MC]1"C6)MFK9P_^IE4KMNW2N73KVAVX\JW>DW()YFVY=N_)
MP!'[$A2,F*3A@3NA)MZY6.!CC82Y1O;G>&CER1DOW_T,.C3GT1)G_B7->:K'
MFXXSHR:)#NQK>ZXCUNYYF>?MV0YWVT-W&1WOU)Y#&S^.M)_PX9,CGV:>UJES
MD[ZA\V5J'3%P[%LWZZWN,+=U[SAO%T>./KU!WN!)MI^H6N=&\I01T[<H._O[
MW@WW3\R_E7_-<0>32?=!MYU\40F(6H+J/0@A6AGA<R!$%>[UWG1173@2@RR9
MM5IVB(DGXD8>8D2B2">6*%&*'?+$H8DVG1=AC7<]Q^)5IET4(VND9<5C3RON
M!:!$/4K^-.1.,;HHV)$..:D1DSFR96.5#YY679;U->15ET]^R:618((TII=A
MGAD>4Q7YI^5(9I*)YIM.A41?FS$!29B';;JGHDNU%7E1>W*626B8^^TY46WY
M."AAG(7""6E+B"*)D:*5IBD?AY-&FNBE)6V:&:-6CAK:<@Z9^EM$J*+:T*H2
MF0KKJ;*V*BNKL=**:ZJYWDJK:<NQJBM$O#XT[*S$&LMKLL:6E>NRP/[:4'!E
MW:/5KJ]>VRRRV J[;+>V/E1MM\&F&A]0P([;[+G*6LLNNN%Z>RRWXGX;+7?K
M!ALKJN\RVU"X]&8[[K/RP@LPOO;D5BS! +O:[[SQ/KRPJA#^9RL<JS22BK%I
M_6S,<<<>?PQRR"*/3'+))I_<<5$HK\QRRRCGX[+(*L><#\PQWTRSS3?/C'//
M)=NLL\\[>R0TR$$7C;3+/"<M\M%,/^UQQE)/37755E^-==9:;WW0Q5Q_#7;8
M8H]-=MEFGXUVVFJOS7;;;K\-=]QRSTUWW7;?C7?>>N_-=]]^_PUXX((/3GCA
MAA^.>.**+\YXXXX_#GGDDD].>>667XYYYIIOSGGGGG\.>NBBCTYZZ::?CGKJ
MJJ_.>NNNOPY[[++/;C6-7M/5T>UXA::[2@OY[G7NP"LE/$+%FUX10QL?S'QX
MS-?<7\W]U)Q\M-0WGSS,S3,$O3W^^&2O/&W4WW//]=.'_WQ,WQ^L/??CEP_S
M]52YSSW[X9>/3[3I1Q\_]!]-;S[O56]Y^Q.@_9A'O@3"+WS2H\T!/_*]\+F/
M-N2;'_/.Q[^:P8]Z#-0>^"[XD Z*KX'T<R &__>__5&O?]5CG__T]Q'I>4:$
M"@1@"VV(O0?JKWOK.^$.U\3"[040A W\8 F-N$, YH8\IB)/M<BBKHG,B23A
M6DL4.T6FD$C)0FCB(J>:TL6'3%$D8XQ(&472.[.M8Q:M:*,;W]@*:5R&(<LY
MTA4G<BXSCJM:^PI)'KG(*CXN:T?Q\N-)[@B1?04IC]12I*X,B4?"E LA# .7
M0QPY*TC^;@23CT071ORUK8R(:CT70:08/2FF/XH+E1(CD\!<>4I<;7%*+U&D
MJ69)RZ",DF[1N((8?@G,8%Z!"JH@I#W"L8QSD(^3+6&',\*1)(A$DR*NB<U,
MT#%-D80#&^>PT#F221V*X&8@^! '/A9"#N#DR#'8"(=5+D,8*&5$GE4)%2Y1
M0T^6W#.7.P%1WJ(1!G5L['<_2844J- *[#AC!0HX1$7R*4U=1& /V6R(+D1Q
M$VQ0@AP6TE" 'J$ 4TA3$Q#(!)O(D0EG5(0=IM %3WYRB@=HPA_/R  4_+$.
M%BVC$NS(!S9<T .>.,,2W70(H/@I%(0Y$*E#V2=3:U(^O0'^])P(,:@44+&:
M?!QB  -P@3*%I L!0"&;^5A&!(S )OCTX +N_$J( L0' 82B-90(P",XM <$
MZ*)FIE" ("J*E8&((@"'\$<W.* 'FI0H'#%P@5:PH0 9,+,DZ+A!!CB**: 4
MR$UBN0^4G#H4#QT(H@<CT%-A5)8TE@V@ZTB(5;&J$W;,X )&&( IUG*]S*Q0
MFD!T2%B9 )7=]J:W&8Q)/GPQ "7D1;C#O5Y$V.$""T"3/T41$'/%-T+74&\/
M 9@K12@!@$>,SS;8[0\3!N"+FFD" (98R0I;D]WAKN4G@RVL/M:Q,?AM$+=K
MXM%[@\O< $-JN?D@QP1BT%-L0$#^LM>E9GG%![]+<F #YX!*;@![VL*8EHP9
MUL@N#]/AI$HU#*VMJA2NNAI?', (NAA $<CW$&<\H@YUH$6XV#$*&E,"&P])
MAB"84(>]TB:L4$A@.#+Q!#=D(APA80<M3$&,.NP!&_D(QR;J\(0ZC$(KSM"#
M &)0"6C> QN/R/*68W(.4V Y$"Z%R#DH,0$%&,(7(,%&**  !4V88R"_&(4Y
M-"'E78PD&8]PPQ("00R'T&(4X:!$EMO<D'/DV VZT$-WZ4I86M!X%$6E#9F7
M4(=00),=NHB! &KL"R, H >9($=%?N$'4.M"*U7.1#*2L8<G;-0>M'!#'4SQ
MKI3HH[[^_L"'*'[ACW.$0A?8^/$>?/'$<VAZ"8/@\43"48E'+T,33/9%)IH=
M9(OJ80EZ<*E/*9&,!.JB$L]H\B@V,0@%0. 1R5"P#98Q"";H@<X22<8FL#&(
M(.>#U..& B6@>8Y*0, !@^ W.41AASSO>2#*( 2-1='I$-\$M-DAK885I/'&
MC)BJ!WDM4^H0@$U 5P'),.XH+#  "RA  &Y(< \&H( )=)48-:.$ @X@<P34
MH:<M?D(^[I&,& P  A 8P R6,7 96& % 0C CF>P= L<( !UL$<H% "  5Q@
MK[30>01^W@-WLN,)2[\  A3P"(K\M.H*H.@R;B  "$3@ !?^\(5 E)  &RR
M PY(@"$TDH],0  !$X"  !0PBH%'5P8*4,  #A#W*A<!YS+?0,HQ[0(%G%T
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M4XD0^E";;*8+M+"!WJ4$ B!DO=&%F:&:649C=2!OV%!TL0@ -J '-+8'-@
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MLK3!#DN0=J%@ ZS9#[U)4>#B GJJ8CR@%0*1LYF)! $P4P)!D2T;FA0QDI0
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MU\VF,  R@)"7'=:.<88(8 G8\+>.& Y_E@ 94(F7N &_L Z^< $.\ N^480
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M@\.K38VSS@70%+^OYRT8>\5^E1$3VY$  0((==CM9L];=7\ ><.GL<O&^\[
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MM7=HRG+^^L&QB!"ZS;W1!1.2 12/#%C"]KB)*0(@B)OH@S"^T2MU[D$.#BB
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M?F""8.V'&$B 9J (?2B" U@&?, \<8A(90#8'+$ &;")9TB 'J"()"!5-=V
M!7@$3,2'7Y-5O,U;O=U;OO6'0JS5J[NR+[T)2P  .M!8#.4 #M  #1  !R"'
M#T5/=(B M/6'71B .WC3 4#79""  U!<#.  "P" MFU$3J@(502 SX4"K!2+
M/:U/G%"& C#4BEB'R ,\ "B$BO#:C%#39O4')D@ :[!9"5B!=8"!Q%5<#2B
M!1 '8B@ !CVPA^T'&9@ 'D6 9:B(GXT%=G@ &?";A;77F_", /6'&WC<!BV
M8]!3 #A=?S '23 "&[@ !   F?W^A0BS6>^E5]T5"SX0@%A(TDJ0WPLX@'KU
MA\C53@'(SMTEU3TPQ\557 4 @$S0AQB(@-FC""7X#')8  '( ,7E@ L( !?
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M)FC8A\6'&8@ #AF"3*:(1HR%?' !JZX(4S#<SCB 4C[?<6A0!)"N8V/9'1@
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MKT\ "+ #$PV"&=!L/=B \N4%&["/!:"!]+X'&P@"/'^!/Y51Z*8!?-"^!4"
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M\H<9@0C^%^6#1CJ(H8)FCBDADR&NR2"8#3:YHH'\8<CDE2,J::*;.=()88H
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MD&8#8;<>1("H(<*(.1Y@6K:0.%1K<A V)+S@!;&#"9Q-,)/ER> GEQA;/3A
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MWL#3"0G.XI6*?(5.]/Q4XZE&0,T*.5S!%$R>%%B>!9'#^VW> *R A-5! ,C
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M5 _T@/!M%P800S(DP[D=@!"PRBA8@ #H'TD122$AGC\@4Z3I"B9B)M)PHFJ
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M9G)F\.@0))%19\9'OYA#&$P!%6AJ*9[1*:;F 91?@FY"; Z *>2#$N1F46Z
M1]F "]B#'@# [$4 !"@ ,_; 9*5*#!1!/BSC[87#'L@ !E@ >D5G-=(9+LXJ
M!$#  ,A /RB6251" N@",!(EJB0#ZUV !0S ?PZ@6![(&Y98B/)@/H0"G\YJ
M!"@ V_7G?]K#$^3F[RF +V"#:^7#(_ I!'!IK0(7JIP#!O# /6@6;%KDDJ**
M9@G"EQP("89#@F8"0;C@'+!#:?6#"\Q L@3H0E9H?ZSAP?K^(#D,PG NV%0E
MPPP8*M:))X \P@'L7&OQ@3-@J*D$X@ZPZ^^I[":@:^=A PFN92P^ 1- P 0<
M5AT  &H:) #$ #G8@T8"@)?M7P H@3*AV1EH0B5HPBE<!$'$F0)(6%=EY-Q!
MP"-00M@*J:ATE3)!&"W@0 #L*R!IIJ,RSV5XFMXH$3R!#:6>1LT,@RU(0RX$
M ]+>4JF<I@QD%JBVI@"$ H+(IBGT@Q)@J3WPP*KV1ZN^Z@ (PBB$0BB,PBAT
MY+M"F LHXVS*%@(4@2&<&P(D0S\ P86!&@N$@BCHPNO^0C=RF#E$0+LQ@"_8
M33[PX@0\ 27XP@RP #N JT6>P_#^CF4R'(# QN$3C((H9.XHW)LS]@<3@!:^
MN5;[(5IO*EW!C8(I5&32PAC 4JZ#")@O%JP V!BJX)BU99E$8,,"V*("E-P+
M?&>I*($#^$($("" M)8@]* %D(,A]$:I$"F_GIL," !DR<H@0">") ,"M*P"
M+ ',5JPSSBD:ONX1&($2'"-4KFV";>%08, $N $3N($;R,"17F@,E#"\28 #
MQ B:Q0)EJ(Y4FNY!!2+")E@FV,!8)=B\FJ^C+<XWM:W;V@H(N>T)5:;=<L;N
M*!.'7)"GOAKAOMH A * )&X_' $&A)91LJJKRF;Y]4,F/$$X?.SM]<.%[FJ?
MO6Y],HG^$JBL=%(6#T# 6_@#.M"!)FPGA_G#$FR #7Q9L)B?X1)(OZY 31YN
M/H0#UO59(H?##) 4-CJP!#.)+B@!BTEN/[BKJQD!ZD%69M7G?O3#*"S!]_9K
MC(4#!/AB@$S=DB689O%!VMP#QX5#,B3 $1"$;&K".J"H/RC! BA%/I #W9'#
M#7"QE/+D_YY#@L[AJNR  J^*'1PL@I!@10K7#=O# _,!(+(KSTFP/4AOF;XG
MH:B8!6P HC%).,3 #XZ";R*L9OV5'LPF.C$EC5(" 9P"H])I2U:(@W SH@)(
M)@B 4C+)A=YD(15Q)J(2-!&>]KC5]TP:$S.:!<FEZ;1+X&[^'N'F0X(>KCTD
M;CX< 9:F)08PXH#^YR)#0#T&X9=AI_/I A  P.=.JP+L0#(L0R#4ZNTQ 3UB
M@T/R@"XHPQ/ WG9> $]4AQRVRE0)=!TLP[4* - >X@:,@@ B0"B$ PM(-55G
M C%0L59266)>U[V18+)U*X",P@%@Y7CB0"(F0RA$0)XAB^>%0O&**#&,@NLY
MW%3!LBS3,645 0(80C.8P@5PP$K )"\@P WPZ!'(83Z,@OII0B! 0#(+ 0"?
MPY:&0C+L 3WZ**@F)@9T<X(]@NDBR(7N03X( M41@RZ<UV YH]U-:7"% GK5
MP>7J@0L(0!%H)#^;2FOO'ICE S#^N@ YU&%EH,L3" "K!<)R!P(ED .>M<P]
MG,,-#( 04,(H# (BDJ$]F4U"XX\J>?=\+;3Z;,T22[278-#57+8O$H,%)+(N
M., H  @2WEX=U%U_%($-1 M@$DDRW( "T&H/1"=O;8 #0, ,Q,!KA8(%#!9.
M1T"H[<$%:-DHH"MP'<(%*&L$"()@0($-;%M:N  $^+"L7%D"2$ O/@$&.)PN
MI)\"1$ @$ F+<VD$[$$V7\#:0A]ZR<!@P:L"T()]4Y8BM^K1.0,)HI<-X*ZM
M"$("0,#S42^M.M_8Z$)*VXT1Y-D]/$,1&+@#V, P^,,ZO$ @#(0FG* #6( ?
M7# &0,#^"AS! /#@$\3 81'#?P.X+:)*SLZ> L3 =OL')5R 'PKJC>=#\=+J
MZ6T"?N/ !5] DMN*+GS6_R& "U#".5Q=$;S+[T' $DQ ^J**N_J"6Z>=-IWI
M ?1IG_[Y=-\ XH#$$>!6 B3 "LCW(H5W(,6- :5-90[0!4521$NT)^X-<*Z*
M(8[G,JC*=9Y*.*SE+QX=-KC:H/N"TS%B@@G<M#([A!&[QKXN93E#:#G#\V7I
M*?@"8V@$.;S..FQH "7FUOHC@)B;+GRE1;YNLL-BT-'"\Z6-,Q #G27[+^[[
MJJRV+TPFQLRG1R6FD-X/.ZS[G5][LRR#+RB#/>2$.+!$/V#^ RW0 K#UAR[D
M.RS2 @)HV9Z=BG3[@KOSRZ#_>[1WEK&GRKSW1[?;NT4>G<ICRS+H BT,&H(@
M_,DF[3(L S'X[535\CFL S84AB]9I$TCYF$2P[4#N]: E"Z8 C&@?#S%#Z[+
M[1C1#*09\02=]VBL%>1$4V<YV3@AV(%-U9%Y&'WL S880@*8JO6(D]R)V(B)
M/=G[2N[>?:+-F(>-]Q0IV!%,0$"28'0*\MX+V07-?7YYTY-U$(*%&,2/$#D;
M/C E?M[$;7<WM K=@X1P4-#,.OE<)C,U3=KPND1O?=-0AC)HJQ+LU>EC2P]E
MU@HP  <H:U:Z_A%G_M5</D3G_NW^XSZDRHZK<+Y[$7_0G$[7*Y+OL]!DX,,F
MU)JB>I%*Q9&NA,,F#$(][CXEZ1$59?_=7V+O1^KV?+[;EK[=^KKR PLLH7\=
MG4_>3_[6.U)";$_WC_<J 3\F_<KIWX/5K[^\;"+R X0_@0,)%BS8SUY"A0L9
M-G3X$&)$B1,I5F1HT" ZB?<L=O3X$>1$C 5#1F1WCZ/$?"59EAQ)4&-+F3-I
M0D37[Z7 F@OQI=P9T2?-H EQYOQY%&G(HCF9-G7Z%&K4J#$MKDQZU6K5ADM'
M7@69U2M(=DVI"KW'+FQ-L!&Y8DS[]FU;@W#I7I5+TN'0B&M_\J6H5^9=J8,)
M%S;L=J'^7X6 *RJNVY(IPL>3&3J6*%B@9,J;*PY%UY1S:)"8=7JT_)&Q:(>D
M_:EV39'U8=FS:0_4O/'L:\JLT>KV?9'I;[4_60M/FYIM<.-#F==E5]SX[^>U
MJ5>OWCOZQ*RG(2O/KM4KZ=N5OS_D[M)[PY6 D8?<OO=A^\#IRT_4>[XB]+?X
MH\>V_A] @\:K;[/I7AJ00(KXJZ@I[!)<L";]]DMP-?ITDZ^NFRP$BL+.%HM(
MPP!%''$D!#ND2[P3.4M100X_5%$DIC"$L2/N)*01KAMKP@?'A_PC$4C:'.RQ
MQH] &^Y$_'0DTJX-F3PJQ)>.>W+)F684*JT?@]RRL"&?1(K^Q2^].E+,)HTJ
MDZ$K)ZJR+C7;7(A--.?CDD[KRI*SILC*A+"C,,7D,TV'R'0-4(_<5"C.CPK]
M*[0H1SKT19H6C:O.2FM[C*\%)V7)SS130FDFJU92+!^_3-V40::\-!3/K9QL
ME=-7CX(TOLE80XY6.;6TE%<!(6*/)7:P"2>Q<+!)R%B3L#E'+&S( 6G801D*
MA]ASEHV(6H7\$M:9;IT95KUP=-$E&0>%)3:AE9P9]]B'DIVS1+'(.8><>E<M
M\S-9$P(6U@K/[+>CU!(%B5\:T<FGUX2E,M&>DQ9RF*5E5J@CL3I8<,8>)79
M5SU=+- %I&4N> 1"=G X0D^'V.G^X8A[=(E@%,=ZZ(&=?'0)13U1%% @@ITC
M8*&.<$8-)Y -=D; !9R1=8%B>_+QI8>C(0B:+R5HAA<CAB'*YY$+-L  @PTV
M0;6\@0&VZ-:S9S*[UN5"0FY7A7O5.M!%\TGF@#K 8@*!9.PQI(Y[;1Y E//
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M.?$*C-6[?.QAR^IQR V2EY %,Z$?CT" $85 \%@[K@<7H-8%F/ ,!VS@#G?
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M]SQJ7, K5X"_PJ$($& %C,80=($N(^ .",P(PT$($& #." !EB#&U"EG,T
MC"",[B:'MDD!;BVB;H!9&'84@LT%,, &5*FGV*'F34NTB(4<TL\%M)X/?,$%
M " "W( =1H&67  "5H#+ZGX%+@#^ 1C=E)1  *1K&;"AH;*K84^"<B@A ##
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M _ @HK@9N8 =R\!1/Q1E Q 5I5UIC%R1WO<2_O6##Z_DW"!:YAX8!0T\#(
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M;4*M3 T'T.9I#Q?0L21?NP<Q#F"'DX8# SLHR6%>R3H++,,"+@A%*-#J"5^
M)47K8)$#0M./E!'.1ZC$D;UPZ0L9/#9-AK :D4@(D?UUA@^U>0@Q<&0Y-_Q3
M.CLKPF@1ZPSMS%5-RD3*$6+PB @XHP<ST(,@=2<;#$35'MRE&'N<\\T#C.(I
M>0G'#!+^4(1!Z )HV#@7,09Q,[]"P+@0.8+K2L(['#CK,^%P0T/?-8#5_?,
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M$(Y-KC0E.   P&- &FT]0"%S*NPR"_\IG<;(_A1@+N91T>Q4?[&LN Q8+[4
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M"0GPQ57PF(D?F:(?3M*#'<-AA"3^Y<,4 5  )9)!C&5 8 *TX(@;;FD/&P!
M!\Y@1S(LH(!6/J4?IS!9%2>TS'LLPP$!N(,SE*$F??0  =3T!0)> "NU2"
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M"CYX40@HX(!8=?#''0)0; 1)(@#^]ST$ $31CQ<H&D%$$, OPI'M ^%C QE
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M9] -2Z"T6("E R&T8L,'4? %?L@!!TC&D%M&/N0!!!A*KNBO9% ^'<@37!
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MM3R03&!<7KC9 5BNQ40'&#B 0(!9H+D]IJH 47#: Y@O7D@ !\@$9S@%#AB
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+'S_ZTZ_^ 0<$ #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g44361moi006.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi006.gif
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MKK2QKKJRKK&PM+6TM+>XMKNULKRYM;JZNY6:V:FKQ+6YRK2ZT+_ N[W"T[_
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M2#,[Z8GKBR19API P$D0<($?$<E%"#@Y2A!@@8P%V44I.ZF"<8B$%:S\1DC
M089<..0+(!@E"U"IDUQT<@2R+.-_2L,>BI4'DP*QT&_>Z#U"^O @2**;<_RA
ML-YH<''7\0T-C>0\)=EH9-K[H@H/<4CW32QK$&F=(TL32=^0IW\-R8?+>(@3
M48PR!/C^',$T0HG/?H9@!+LPR"=RZ4\5@$,DOARE03_B#E%@ 02BV" 7"*H"
M*^I$E?@T*#*%.17K6&U)16*2,A_80I?%D4N-M-J [N$T:RYR(?';)HV*V;4U
MILALWJ.G0\;)0K)9$DTI==!B2E@U/CKD@#L4DI]B$H^)^C,$9 CE"/*)3Q"
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MD8M/K&$-H<@%."B$CV]0@QK?Z(?^/78!BE#L(A[^8$4_^7M$-)_9JT\"!RY
M\0DWSZ,@^OC&+F0[53*8&<\%X4=:(XQHA>@#'+D !9AWT62#O&,7H?#R)T2Q
MBW6(Z(BB^ 0H.NT/__Y3&P;!QS1P\8E/Y((:!?83..PL16ID.A>-QK!/%A2;
MGG:X:M\-,1S;>Y 5%U.ZO4DQ0F+ZX_.)T%'G]3%%$,N^TY5MV.E,8W93*+%#
M*B1/.H1-?'OI5E]\8L['>,AM64"&?JYA(/S0 B=50 8 =S655U[E/^GMU06/
MX 180.((.#F"3^CCR7#-A0I&P' L$'<@M&1P/K' "C@+!!PLV.H_&3X"!Q_$
MJ2  KD/^(M[)?VI!%!:G$3\<.M62CP +N !E0<#1A8&34@NY>/*%G[0++;1\
MWEQ(-T'T<>4 YWR3G.1"I77MD^ZAK\B%$YV.80AMF-%0PW/;,04EAHAF,Q9'
MU>P-U1\27H*,MSUQW/K$$E&.@H3-/31."%&3JA-^3)236GB':?M)!ID[><[Y
MQ:<6+!Y;P;-BX+BM;7\E3DI_*AWB+:?W/?]I2X0OOKXJF+) OB'OJC9^!&2P
MXH)GV\]0+ 3D$@X1YTE9<A" /N5/^@3B.TG?$9B>(-] \E-5D.]_PG7EIRWE
MG'5!D'CG<@1="#X(^LYTH4130./&") 'Q,QDE^QUVT0C8*_^J?9U#D0?SO8V
M0A[;ZT;MM'3M"[<B%\A([++8'^H/=FC%(QO_X<2TG00%/XR/S]16.*/4@&2Y
M%7@AT 7^%6!PM0Y1ED\LH 58H'$A8$L7=UH,MTJ[U ^X,&<'%8!SIGG^\ X+
M&&%:('$A$ J@-'JM58*GETLAMW0' 8*-UX D>%4#T0LVAUM8,(+]%'*\Y Z=
M-THOYW.[=V&#)EPYJ'$J\'#^$ ^=5X&D!%#-%Q201#_'I!$>]G0Y)F)I1SWN
MMQCV(#<3PWU<&(9>!S. )%F&]'[GQSX09$GI-%A7ASTB%ED'<6VQH6PPT0\#
M!8 "$0KU%0*L@%_]=$J+%H$"467^@&AJ_'5@*B *[Q /[Z!P[C80L450 09F
M7/!N<::!X/"#(R"! ^&'^?0)X, /M,2"*B!+]) +H2!Q79!S.W<07U!5+.""
M!A$*ECA&\4!+596* J%HI80%O? ._/ .]29E R%G^:0%E'9I(>A[ @&#_=>,
M/==/72!S3"A<R!<*9/!X40@4*44>4!="P39>YS0Z[6$(V[0K8)ALA>(/*T8C
MW51'<5>'].=,%(1^9N>&K(-=YQ C-$5.B((CHD5W."&-GE1@A3=*7 !["?%D
M[V!/H]1W]( %^21H]L9+X" *9* %GV :_+ %!-4% \$-2$=Y H$/5O1DNW!W
M*$DCT@C^5;'V#B!'@_ZP6_@4B V!>KE&$#!8:'[75/UDDYC6D1ZXD(;H#W9'
M44KH#WO'AZ7F5KO@=T6(6\$4;U1%!E?2#[;XC3G!:^YA4Q3A8>0#)D7#5_6(
M$"L6(V&W?ME&AG[B8L^V0<KT'L!"EH?@:XF$AP;!; /Q*"LR8K.C?OM39!UQ
M@( (;VF52RJP3W_':-30<GE7B2"0=VW%F(BF#_P0(ZN79#*WD)49:Z61@<LH
M7*% (9&)C 1A3P.G!9*!@B'@<0G!DPR!?__D@?X@D2&P!102#Z9Q:0PV CJY
M#BS =^;!#U6&8,&T!H,(>_KP@Q+XG',6BU[Y$Y6S=OIQ5_O^$AO!=I:*0W;I
MN(Y/$G9:1SVVTVSG%2EI62)A)XX106UAV8;OPV-K9S>NT2S-]1#F"!MH<Q/]
M4(CW-A"FMGRK%7GK\ X6J9RBP(+7>( !6A!ZEPMKP 4+UW)=(!F@J8D%(4H0
MF$^@.! $V'&]T N[,**RQV@3N%6RB1 0AF ]":+")0HCN@N[, V@L%6I5QKO
M< P<*83])('?H'$ZN9H:J)1E-4K,. TT6J(+2* ?&():0 _5.113^#SK*4>&
M%!R2 9:'<#T/$4W+04/"D3V&,'9;XWX%43C<U3%U^1P=8V-9"D'A5I[0AAWH
M0"XBUE-<LI^'$'TU 9OT]F5K\ G^QZA+6780C$A&A2@*B\H/B@A7E7$,9( %
M#-9X^/0%DL$-6P4"M[>A*=A_>(:+VLAQ%1A6 C$.$K>B'W*DIM25H5A[I J!
MOJAEN9!\FTI?$;@8TR"5!G%;P^4/^/",%4BJ5462_D /499T?C>E/_$P+M,B
M&U49X>@V>A(M*](@%P2>V,%BO)9';^J7,P4RXG<0DN%9[KE!Y**/)35:WSI8
M6%,)T<9<8AE:8.A&>((G,"&*3U5R3S6D#VF@*\>"7"" Q*6(O!0/H(!TQP=E
M%LF0E%BI_IJ,PD5Z-MF'QR=\M,>")Q!,J,I;:,6"(I<0_0 *KN=/K/=YP;0.
M5U9[6%#^=)2GJV[UH?TUG1_8L";+@K3'!8O!?R#P!:+)K#\Q1T]CESWT$)6S
M8;DS6&7YGM$FIMC38W0:(N"Z6,QQAMI20DW[+#92=NLZ,5YZ,='&(LB&.4!#
M;&97.U<3"<2R#,50"6L[&AY1&7([MW1;&=GXJ2G8D/Y3MXMQ8*?4#S8X6Z8$
M9[JP7ZY4&2&*!6NP"^ @#X5XH9L7G+F@#_J KZ1IC36743NGKRH 9J'PN: +
MNK45#A*'"_?*MY6A52[J#_)0N7SK#Z**6YX;NJ$[#OK@N"PX EP@H^, #@T+
M KCP)+8Y J8[M_Z@<[=KLUA N[2["_(@#TS(@F3@NGM[NL;^:QFHF[W9VT?:
MV[UT6[UU"[YR*[[>N[WEB[VG2[[G&[[?RQ;@QASDTRHOTAKCDW7+H4#HB!_<
M>A])(H9UZGV+!3OSNE08!+65<"5K&)\M5%E,"S+PNS:1\D@.,60+4\'WDBW2
M][P:O,$<K,&!2U4 QG%/-0*]T,$<3( &)0_C8+,6^KPH_ W/&[T,:;NWB[M)
MU@^MVPN2:\+*.,,H" )=H,$'YU;4L,&4V[HU_+Q(&0HF;,*H9[M-K,&F-EQ(
M',5+O,&H>GRYH,2G!0)KT,'M!H#0VP55Q06M^[PX7+EG',.=MWQ1_,9P',=R
M/,=T7,=V?,=XG,=O;$9- S K0B#^&&$J/>8Z:BN_W2=M6^K'40M3:#I3V10R
M+/-V+&(Q6P*G[).%\TE!@XP(G#P>5',ALX.V%GPU5U,.19;&E)O*JGS$&DS&
M&;4&N; +.3?+$KJI7US%J:S!C#@..%R(_<0*_: /&)5XS]NQ4\7$J2S#0(S$
M3PE0X_"\K/QDL"8/)+MQNY#*A3=P:Q#,&AP*:X +O?#,7+Q5H7"[JHS+1PQR
M+,#+1KS&7%QZT/R\WLP*O="X!]>+,'S$-@A@DPN]/X@%O(S-+/P-E"N*RAG,
ME#L.9 #+X<S&TFO.2&S.YSS1N1S1$"W1%4W1%ZW1J]S1'MW1T(S1%HW11WS.
M(QW2'[W^RE4\TBE]TBK]TAR-QFZ!,?"[4NPW8>GP*(;T#)5"$6"JCOL;F'Q9
M$(S3+.IB&>%WI758.V*CA@CQ=K\AO^;DCMFV7,OP#%@]+/0WKB3T&E7KMLOP
MML6P# /$$3!=TKG<L1'V#B$M#S@L#Z"I N&0Q"LM#X&GG 7]APCF"Y4[S*E8
MS(16@&Y-N:(P>T'LU@OYB4)\Q,J(U_JPPIW$!5 L#[XEC/H<?(<M#^+PNV00
M#_% PQ]-V:B("TL:R[(LR[D PTU%4;YPQKYPDF3PO(?GH:W;#_'@RJX'S/*\
M@UWPS(_MRAG5"Y3[E 5(P_(P4(QYS?[L>LO,TF>,UBD-W='^3=(L'=-GG<LB
MS='7K=W<+='//=T6_=TU?-8HC=W5_;SN^Y<],S&]$U(UEB7J-3& /&&1Y$BF
M09Z%]1"8Y3UNBM0AM*;OO2U02X<$\3&!,C;+8C5;^+_21B/.D*5[&C&A8R>V
M?;T;\=;2[=V$[4_E'-J%:'M"O-+WW']0_,$D?KL.*@ZW.PZ>N 8D2@9=7)E(
M7(GX=,WF?;E_W;H$& *X ,U5*;NXL 8/17 V_MBZI[O+6]XE+=K^%,(AC$^W
MO,^OS I"3E'*K<-J%0J]D ME=7R<BL2^6U4O)T0-ZU9I=KN(^'*AP)&;J@7B
M'+V<%-O53=(@'=H9CMT>'='GW=W^T]W2>*[A?][G=2[=<S[H@A[3:0$C+:4D
MK")]]@(;!K,RA1*/ W$.@2-V\!.O^S,9^=!2+\8D 5Q7MH(BC!,;@ED9XU2F
M$>&7,9)27$VN4^,;RV /OLFZPF&8_I#G'CT.OI6$&MVZ RK92OZ\N+!?<VWD
M]-4%1_S"-1P*;E5?\V9SIU2Y-)ZK*MW#*J -9\SBS(T%QRX/:_#L&N=Z7YS+
MOASG;:W2OB5\K<5)MZP/X>YYK1<"Y0Z]3H5XI:JP<GZ[DKA*!*>#5HG-\E:R
MPL=P*L#7#HWNVTW=AN[G"V_G?J[G("WQA^[PV4WH%2_2<T[Q%/_2.!,74I..
M+((MH,7^,F@+Z<A$Z05,-4-M)&>)"-,2UN,S2%]$GO.=$.%1-<P5UO#*()-4
M*.:U=CU=&JZ>+'198FP;UDH/MQ=^YQ4M#S88V4J>UD/N>KV RJH,1+%4PXN6
M2[I]S_,6#AH<#^&>L<@W:$1.N4%*2EY4UQE(< 2=RI?I[O'<BNR>4: @WFC/
M>F;LTK?KDAG;>)VT!N8<#W;/KPBV!O' RIPW[@CVN9T$T&NL<&;?!?AG]4C<
M#^%0<P15<I9]Q/%0];'M] L?W@T/\:<?Z.3MW.;]YWN>\;#?\:H?W;)?PW(1
M/A(N((FP#!<TOD8[-2C?1T?RR-OFZ0RC+-+J,MY3TX;@:^_^2'YAJECD.C.;
M8SECZZ5<$E._<EC=-L!]6?V!*;87S!%8G^<>[$1"Y+SBO=*[T 5?1@;"C>>M
M2PWHOP:3W0M#M 8$K<1.]&63#;T D8L+%H)==L4;%XK,&C*[].D;MZ;+FC7?
M'NJ3EU%>KS04UXR[J"^>0H:@QLG#*._;FH%86&A9TRLD1HR[OKC$PB67QID/
MY;$BLY"A4(D3@Y+)Y1/CRI8P8%J\J#&B%IQK?*D<6C&CSY54L739&8\A19 A
MX^TB0Y @EU GH\I3&#1I3YIU>Z*DJY0N7KPA^_;U>S?O8,*# <_\&_4M8L5V
M"^N%?)AQ2G^5+5_&G%GS9LZ=/7_^!AVZ<S]_]Y9%0F3(T*%#B2@]NT?:G^S/
M]R@=6FVH$FW1EYFE9ITHW>5TD52K9A::]')TJ%>S?FX(4:)EL7MG1I<Z]S+>
MFOOU<X::-6[5Y".A6]X[^W/AE9<_0S0^TG#1^9PEDCY>/W1TUS\#3NRQ "6;
M#++'[B)0GG$6U*>?E @\<"\)MQ)IP7'B*4S!<=Z)AZ_ #H30K'<6Q%#""B],
MT$"$WO&P0)\00G&K  UKS+$(/Q3L1@!KK#'$QF8,T4<<>8Q0,B'O\B]))9=D
M4K3E^DF'F4@2H7+*2)9)1[;N-KNG&"H3N7++WIZ9$LSYB"L33&>4S.>992CY
M$LQ*L/S^KDE[*"E/-S$SZ^<>9BJQLLIEGK%GS]&:J_),R_I!E$I*[IG-4,R@
M/"W.+ZWLK\G+'+0QKR-O!-4P"@GCJ5-/0QWL.Q<7&Y5&4#\ED--7??H4,91D
M=;%6('E,\=3(BA202& AG'%('/\BUL2Z#I-'4V>?A?8SWKZ[I]ITJH7GGD)G
M4ZY:;R&--,D^L[U6R]F^U9;)/M&M\]EEHDL$7#Z]L_:><B7U;-ULX<F'6_>P
MK;;=^OK)!]UOX<'WNGZ,5*S6 AU&55AE1]TU8II0*I9(>7"%&&-79R5U56,M
MECC87PU$^=B2,_YX1Q _5G9B87V$%:-H;\;9V6DY2SA??YO^Q%=@A><-E]N>
M.X./O$0RY7GGT8864S9^CM:L0?<F-3I:EC/DE6O'*K;+XY!)SK%3B%-^\-2S
M3<W50&9?+COEK54^&=5>=1W[:QU[A'EKE^T>.>RW,LJY<,,/1SSQH0U/)Y'Q
M$'F&ZL0E5UQ<F$7&/'"2YQ:<[[I]7?5OK]$>T.28XRZYX=3S9GMTL$/U6W/4
M9\_<]-,_1WMU6BOGO7???P>^LW,<9PWRX(]77.S6>S75;[ YIYOLZ -/UG/0
MX3Y[;H9U=[OSEJV'W7.\OY<X=M+U/C]W(=]._VODWX<_?OE!0X?X0XR?/_\E
M%PZ9>?]O?Y[J<B<]\)4O<S2['NW^FM>ZV@T0>K@KV^L(N+($8LY\"]P;W"YG
M.P3ISX,?!"'BLC,>X5 NA/+C6.K6-[H)1O!A=7L@\S8(P?\!D'SIJUZ&:C;
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M^,="1G*2E;SD)!^9R13V\2>J.(T/=,#*&^@ EK-\92MON<M:YO*6L<R!#G"
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M2.3:EO-:$"I3L9W H"/;FQU86UO^5XE#QRO%6G>E0T7]!,MD@19D1']0 @U
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M5'?8S:IWF'4GW^4Z,?$$M8$=H+\>ZA4L]NS:MUZ/?6P?^'K[JNX3OV_>%N)
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M_( 30,$1'($KF&'S"1R-F=D?.($Y_-_XH6$",F )CHXI_, ?'IOH 2+J5>'
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MF/Y I1[DZ/ K)&KL(3K!--[D=^0DAK8I;N+!/AR#'"JE*W3KS/Y *= E'EP
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M(JMFH7K^H((?<XRP1@I/^*D&B3^Y(Q?6;W$%UBDD>5784/^*5%+;@U,]V%M
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MU4*(4S ?D>1H1:"P\"2A,\P-8U*4!0;J&$B0A2?P@ =72($OMS,%%.AA#2.
M@X+U<$42;E1%E2WOA"8LH?$2!C.(24N&2_K1^%082HWAC)-*XYOV=#@R'LJ%
M5IZJB->*Z)+-Y2PJ3W/%OIQ@JA5NT51]*07\DG=%4^)DBJ[8!SF<X,QY!/,H
MW/B!+';"#3Q\L"GTF (>*I>VV9CD#U!8""[UILIT3N@/TA!C2!AEF 6"9AY2
M^ $&<F<.*$#A4O,PAQ2@@ 046<,) :V%&#OI,EB-[VUG Q[^*PGXLY_Q$92>
MVV0J&PK#AEWK,(",RRQCF260PD5I1Z,''LQ9#U/\Q7N'<:DY[C6YPW@OIA?Q
MYQ[+=R^#'$&:3G"C!$_B3_-%AA,#T2E!RM>1D.2T*CFMZ;K,0::Q"%4E$BP)
M3'7ZN7K4]*@=D9\U?M#3/S QJR?AQA$V"-.2*-4CZ;L7%'XZ#Z4.1JW=*XA<
M@0I H.ZC(R3A2SD74HH?E,]%NZP01D4XQHO<AC'IJHF;**,N>IBB"N;@!S\F
M C9_;%4:U6"(0\!Q%Q)^R4YY=.'"$'J\Q'PF*5XZ&JHLQJH]QBF)''O?#!<V
MKX4PT:5P[!%88 L=CY(,EB$UUDC^=V-#DGCM!U.PABGN,X6"@FT@QY!N,,$A
M)6Z4LZ"< (PY/.6$*5!W'H\LJ"GHH<T;^/1IF7*"3X?#1/-.P15;_<,/KF:.
M4J"H'MN%@A/P0-U@[).]7'$%'M[KW7UH\\#BK6\7__!>VDGU&!&& AZX,9#M
MOC=1A=.)-A5E7=3PXQAX(,<?@,&-*=R@4]-T+WOY<U9.6)@3%5&Q% ?L8 S7
M8PI3* 6'/ZB2#4.A%#7:AS!J)%YSF(.[4*C%@@-,$!%WL8T_:"XWO&8*Z4(!
M;/.1:,2\DJBQ)'==GVC7F3IZTW(IC4JN#6&3W'S X@2(6J?DWA&;=Z317HBA
M^RN0X9+^^4(=T4,+)U!"&'*1X67A-K)X?M-47FG<OR'7+6PN2#6@P%-SF&*]
MIG!%IK-KFC\$PQ7BW:U-_XN0^V*"B7BX3S#N"S97W$<8GKA/>2.E$/O@X9 W
MN,32CE"*"H=U'K,>;];P4#Y7FR(8>#@"-XYQ-6',VHTHB38GA '=L5KS!YP8
M-C:M.85@-!M""RZH*V1A:FZ\UQ6QD.Z9]?0T8?[! C\MI[QQG:BGW0 /K?#$
M#=S(E Y&ZA9_N %^3(.:8$2J%IPXPFGJ@8<;T%?;4KW(TZ+Y:8#O8]8^Y00Y
ME@UK8ON4()RH]]*@((S_NF+3/W""IS,=7[*95IPS(\BY%E7^Z9#P8Y"*\= ;
MJ=3;SCGZM:=MC<TV-Q76;D?IT[FL^_81Y]$\9NEQJYEK"S5*Y@%WG7CL26]8
M<((-@,#0B*9&3>MD6%<-3I=<&>Y;*"UI'&(I,'E!.3WX =T-&N0T^YA"2OF.
M38O0!,2'N? ^9-'W@GQJBDYP%$06?!\F%O1&$9Y'[ B$+R?XDYI9 U7"-3S>
M67OVR \^"71[5_IY6+/:\T"I03!,1LE[XME=G (W2O%L,4*SVF$VYQ:/\/N7
M$S7RL6#B/BNB^9@2!%)X0.J%ZQ$[L#&>)K'F<>U7\A>40'?$L1NK*PY.$&%<
M,S#2G>+O,XW^4NP#I1WAQ&G$:)K^,\I6T"ADVV'\F/.VL'F>A'M-1X4NZ%*K
M7 8C5YB"2HA'ZC1#ZNXD<<H"<AQC/Z#N6[(.>"HP--Z)<;;N,@;"(?Y@"3I@
M SB@ UC@&!"JZI!B "G$2ZHBZ+P%2])#[F2IN'JH6RQO'[PFN^H!&R D,J#
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MEUO2PB"SN^0+OF&[Q7N\TV*KX9K^!;0 ']Z!!4!!";:@2M9!";@A#+Q %U(
MJK$DK3]A"4Y  SP@!;8@%*BAMLG[>HI;A@^\P),ZL15\9-S!'2R;/?IA'=R!
MP1O\;\* GMO#GN'XPCV<LW7AGOMA"P!:H+GA"SY@L_V!&I;@'8X!O;_ 'N #
M'\#!@EG  S3@ U@ T?#[P_TFP2L5R'U\R(F\R.4NP^OYJ2W<R)G\>@11%#XA
M%V+"POLAJZD!!:PG#$Z@T#9@!;1;%-[;'[Y!%Z9[/=YA&CYA"\2N VSV$Z:A
MKIL\(2]UJH4\SNW\SO&\+;J[J>\YS_V\/<"!#)3@!%+@ SY RD-\H66B'[X
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M*_46#( 7SN+LT_XL5EUDUK[MV4/^&EHZ[ET@"4A9 &CA+53A ')9'<*!L\5
MPR7\"SJ<\)N<&CY!NWO= T0!)@#"W;IY_D!U6+'E1 I1_/J!$P7.G\1XK::]
MDX@QH\:,[G9]6G)"0X<46T)1H[<QI<J5U$)T> DSILR9-&MRJ(GS):N5/'NF
MG!;&I]"A1%<"+;JQG[]^3/VU0W*):;]NJD9)PZ>T'SYHJ4;QRB<5WJU1T'A=
MN,84'J]1J\)EE19.6BIO_;)5Y16/J:4DYUY9;9HM6S]XT-Q!.T4+GM2F_GA5
M*.L)FCU_^>*&2X4,:[A1;-4Q/2=-G2<JF,)A7#=:%30,TIA2'=4+WE)_#9LN
MKML55CO^INVDY5L[2_'2WV219>"U-&L[%YZNC9+5#BR\7NYFJ;+7KQVM4;,\
M]P,;;M4H56[[U:NKJFT2,_GRX;-[ZJI4=>)IN>NGKHJ )K<TVE.5S36GO**8
M5.%4U<L]X$5S("^\&)$$+])P<H$G@O5SF5=@^:-*!MWT<\TU8%6FBB>Q297<
M8K39EI6*#2678FTKLHBBC)]0HV)/_31DSR<1-27C;2W"""2-M('EHI&UT5@D
MD36RF&*1644YHY,^?=<>EOR,V%Z77&:))9AB8L6E5E)UR91[2)Z9#S_P+*'!
M$NM\]\4)VC@DBA=*4!/-!V&XHPL0'831CBXDL,(45F>::2;^/OPHRA0_X+#R
MQ0H?</ !"V'DHDU>PTD%::1J?CEBF%CV \T'.<GDP:HU>7"3JS/M5*J7C>+3
M'E(9[3*&KK[^NM%1O_)C3['%XB,:+/:T,PLFXV5RBCKXA.-))U5=,HHZE55;
MHB=F=&,/M9F4B DRRU;;R27(((/)*:IDDBT^LV#+F1FKM&./N_"$8X8GGJS2
MB2?AX(./L?9(8P:\JF#BR3EJF=&)L^JD,NZ[F'R(C"=(9(#$ 1FHXX\Z1DB
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M=>S8 8@TTM>)P!8AN0M6F1F.,Q/^O-CP,/\>V9A92^QD+WM:.YF-M9A!C-+
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M8"SILP*"80]?\ '1  H>H OQ18D-&%\.62D?L $>,%2LD TX"),K9Y+YV M
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MKAWS.L4HN :(<[ (??:PVF"R9H]SG*)*\UH%7%010"#1Z!K^9)G7)3+1B<U
M1"VF' 4@1B% KI@A$YKQ1'[:H4E/S$L5H('1<:[!RG!! U1B6MH*)8+$UPC2
M)80SYJ8PZ!MYJ$EQE[L+;)KY,GB0!APH.($22+"$=^ #'. HYDG^$HY>?&()
M)[#)-VV7']: 4#<EP0<K5G!/?.93G_OD)PONZ4]^!C2@*?@C()E'JCMB;V=[
M3-7S6N5!:<Z*D(:DJ$N4HLQ$&D\=R(#%E=HAC7,PC3.8O$9([=$.9%00I;/@
MQ34\U V7-N0<"SQI.ZZ!C'#P8GT/28L9;CH+FCKD&N4ZX%:D\0I>!/4:HX07
M+Y"J.@O2)G+79)BF$D<;JF8U'[?^2%-#3$@<P5P3HEUJ7%%TT1$OB (<+GG<
M1."1C5:$@04%0JLHKK&.W'V)K*#P&8/\.I_YL JPK/JK8/M:V,#J$;%^)6Q@
M.0"*5YV$CM2[7D(MFQ-7G69H%T)D18_660["ZB\!.F: AG+$L8R6ISI,5CM&
M<9@)>D)OV_+I1%3+I7+BB*<2N:V]^O6RL685'QAM25:S.KG8$)<E!A.'/(W[
MII6 0Q?K$.14\2(R4,2'52D; WY2ZR_GCH6O0%D0JA;TO/)6-J'G?>SV\M$+
M]5X6>G8,6DK@H=RF@-:SMM)O4U98E]?.ZT:JK*T*B<>FYS[WJE0I4W !9LV8
MM**KPW/^BH? JKL$)\?!$<&O.T &)&_D E(?V,"D*A4-AD36<"#<AR@8BB#
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M"0CY?O"&IJ< K9^"NE\)=SAY?F@""L"$4^J$#$""?+@$#+#XBU\)6BC\:*@
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M\LB\R=9O.+^'[F"0BC^T5, O02X?)!L7H,\4$H"$E_4C"0"0E$"D40%SU>:
M_7!!GD RA0)0 1-),$&@F%8[!.B/(/P C#_L48(LP>,"7+,;$C Q!1,8T% &
M<-7O^'%!,;WB !FPA!0.((4C@4$ 1I@9NW16A709X1WA8,!K8E.WRWEB"ABX
MG#]&4;E^5,$ 2; $$@P00H(<1UF>*( 1+)$$85E.+53(@ 3^7& /?.1F"L<1
M@.G6800?@F& ,TM7E0Y"IP-H@T  N$"5VD&[=E0  55(C^ZB4H'>*:HH-KP;
MT'1HAAY*P3]CFH  Q$2_#HUA%Q+BQ_0^:<I3"F1A[LN122;BRHXQ)&(W*9^)
M5@G+AJSO)S;2GBTQ$C^2_0B5$K)?A]0AA>+,H@J0Y PGECD0;U2A+9QXF4"@
M486"588*=,$$OT;QQ79@8IO>\,325E$4=F#B> 5)!>?Z04Z!\*,3=^G'*I(@
MGFS,HA/VL(8E7@9.(JKC#$OS1S2FT!9/:.<<9O0-NZIP%DQ4RQWI'(@JBA(9
M>U+A&K-8BS0NT4>SJ8()1I#"+4+^4A!9>.)(_;B%%$:J"JC,PIY3@,8M,*$L
M>'2"+N;T)#CM685 $JB9'W$G)_Q#CTMP#A^<H(5 9@$%,+3#$TSE#":6Z0Y+
M %2@U31H$D:AG;U!2Y@2HI# 2BG6LX9,E0Q[R/?0YY")2$1'W]/(^&I"RUXR
M9'OAPT@N/]*^F)P@#%L  4-.8",2K&"7'?  "?9ZD5^&C)AH_0F1A&32?IB4
M9)EER:P0MED+^>2S-K%5341;VH.8EDT'Z>QD/R+:=5S@$JWM"5DM](5OD':V
MX)C&-'31B]\>@[>]F,8N@KN+7?"6M\B=1G")JPO>&A>ZRB4N=9?;W.(J%[F*
MN\E(+ ;^D^RUU6(BDH@K7XD169(/KQF9ZTDXT%><*+8B&5E!+HHKBA H9 7'
M8 $'E) +5K!B!20* RL<ZQ"0D4RRLRV(@A?LX =#.,(<DJ@1*/ S"1LDE*/$
MD(0_H9$/>. #(/8 B4,<8A"C^,0F%C&*6[QB%HM8Q2UF\8E%>1.URF2\>5U(
M*WEL$5?&2$3HM>N-PK?7[JED)W]-R1A$X84M_$$%'/@ *\#!@@Z(X@L? (6'
M-: $:N@BR">!;,(:_& S8SC-:E[S@M5AA S<A<T#J2V$!H;-!X^!O2XBB9YW
MS.<<R>[&ZD6)@8?,DKL.>K$O>J]!J!%?&''@"[GX@Q(&_(G^72BA RCXP E
M088.D$ 4G\B%@1M"9H2A><&IEC.K6^WJ@]D#;G+6<(3B8=:>Y!9A8TATQ3P0
M:)LDQ&,4Z;/WLN?66-;UT+RN&*,9_&A%7X0$G_C&+K;0 26P(@6Z8,$&.( "
M5I!#"QWX QFT0.H2G?I@JV[MNE_-O%R[6YCPCG?(YET3.B/IUC=QAR>J$([#
M92,;/,/'-7[6#WA(PW\0RK-\EYUC&P/[?3E"'XDH0MZ&D!C)W&N8H3^"Z")3
M[&)*?C:?OP"*8YC[#UHXAI8WX(' YF(+U1[#-&" [J&6K+)J;O=J/>(1?LSJ
MYT%GD\\[$A(S'1WI0R^Z1^K1V:7^\^/H'3%3T(<.=*:K%K-&ESK5JX[UHM_$
MZT6_>J^$#A6H<]U,^2#[UT'R=*9'O>Q=[Q7;MU[VI$]=ZU"?>J]&F_>ZG]WG
M1T\[U>D>=* ;G>]ZI_K@[ZYXI"=>\(]7/-X7'W103&/H88^Z&%1$=LHGWAU2
M2,L0X3$%;4FA':*W9U'"D80F&&&J>H_\W&?%<(>WR-?]D):T^(&/W7<]V"TB
MMG<7RX'C'SLC'XB&VH'/>][W ]&E!OG%F@_]?$C+3$M&R9.W  16C $7K,C%
M.G*Q@B^@0 /Z#<-_=;&.,4Q?(:QPOMJQ;W]^V']#O=!YFGE^IV(!(#P$(  .
M( $6BP#^V@,"$B \*. ;&6 "/B $+N $/F #%@L^*& &%J !6F"QV)L_:* $
M$F ^;* (%F 'AF $4F $=N !JF #*B ^5* )VH.]]<,"IJ ,BB "\F )4F *
MJJ +KN ,#N$*6B "]H+ 8: FU40 MH(W& D\+"$'7B R& $O9,(H\$),G4,[
M(,$IG$(2G(,T&$$WF($9P,,H)$$[%,L]!*$)@@'N-5Q,Z$(_N(,.EF!W"9N>
M:=S&L-<'W$(1 B I3(S#A1=*@ (5/J ND-Q%1-HQ<-DN7!D(D, Q9)HHB((6
MB!I%;($LX)=,L((;LN .?B!ER9G_B= ;JJ(JAL,JA ,&MD/^.^!#*W;#*MIB
M!?(",MRB/;0#+WB"*K#A*A*$.BS3#:YB+.YB,KXA-/!""RJC,L*#.JC@!]IB
M.\S"-3SC ^)A-G)C-]*"P $@-1Y@*XB##FYC!%[#MUP"]IU#..2#%YX"%73"
M.R)!/:U"/H2#"UP#"3JC-HY!(=I2_,&2K^V# ZH@/NBA^<AA+/6",09A/H "
M0*8/QP@D]Y""*#XD-#3BQGC!,>2"N*'(%Z0 !YQ DX4!"2S$^57D_!VD01;+
M5T$(*@J33+))-XYBL80#(.QC.'A"-^ C($@#"1Y@/R8C//SB+O*"&6AA,*HB
M5$!#$=#-0#AD$+;#*.BB33[C*F3^ E%BI0J>PBP 8#Y@I+WQPPC.(#B!95>J
MY5JN8BN 8['<A!.^XB[:0H69P2MBH!F(81,@%#QTU17:0S@4@32<XRK^XT+F
MF"X(Y4,F9(DD7XCH&<6=Q ?HPBKF R$BIDR PF(>)".V"!"D@ :PU_&Y#RN\
MX3G"I$_0Y"FM9@EIHSV08&&^$6KN8!?B S*8@4_"0SC 8 /*H&R2(&<:8#@P
M93X8B9%$H"H 0CLP8%@&X4!XP@%$94T:(/818#B8 2\()P$BISD*X4O"IBI:
M)SM(HUH>YP/&YF^>PR7 PF*2X W:X&SB V<*I0#:9EANIW7:HFRRI5KF@C;@
MH3@F8"O^S*4M"F!2)@$@X$,[:-,^2L$\P@,2J (2(,,]A(,18&,RXL-A"ELO
MZ5X0RF ^L *Q&9C&]6%>6=P<-L0'] )&JB!$$EK%(-EC.J(H3&4$XH-G*B1&
M$!],A \K\&<$IM:0G"+_(4D%(D,W7,,J\$*&XB0MJ (OG , A@,O,.DU2.$Y
M2&DXJ((9G,(UM ,RG /VA2DL-"D"7L,UA,,LK (R\" RP$*;HJ T8&,OG@,R
MJ,(LA ,'(D,F9&<WP(.6K@*3GH, (APLP (T*$XVU$45S P_W((9G($RM(-Q
M$APO1&DM]J)22H,%YL,U\,(K7$,W=*J65JF4SB*F\@*@PD/^DAX@,F1HJX;#
M-4A# D;#.2PI+&#I 4H#HBKI-<1#!*XI++CI 8(JD]9BJYI!)RBJ/=SI*LS"
MKPP$-%@"%<R"-+S4#7;#+$3IG@8F,ISJ&,XE/"RIG (@J'9K?UZ@NK:E-DA@
M7(YC@8HG,E !+XQ")Z2>%$B!.^8#()@!/AH!-$B!@Y#AE"9C/W#HCB(F9=ZH
M-HY$159$G]&HG_49BUHF*. 5Q&($*+AH!.:#CD);9F8$*VSG0VI(,+'9:C9L
M.W1"DYR")YA!K=I#4G;"*5S")73#+&9")IQ")V0G/ICAJ/II)H"K&4#'.7@"
M((P"S*Z" -IL)WB"SS8M/*R"TH[^@E(>8<W:PS68P7J, B!<@K<>8%)VK31T
MP\Z>PM5F AO2@B6,PBAD@A.H RT@A0LL#28<P$A=@B>< \$!0LWZJ9J. A5D
M)U,6"VYFX<UBPFZ:@9]>0IHV[BGX*2_8P](*(-=ZPN7FIBJL[3DL:R? K1E@
M(]5V[==Z*6KB)N@" M_:PRIT[2GX*S*T0Y<"PBIH2B8H;<OR@D"L3@8D005,
M .KX \V.PB5D@CMR[=!>0^UBH.MZPM6> CSD0U)Z@N1F0BVR:_:^:"XHH0Q^
MH [" X$&J0'"A13$ABKPAA2<(3*082=,P0^M@A&HX25D8\*&;(?>R$0HIBKR
M0V/ZZ'?^E828D00@EFR @D*/>DS%2=Q";  HC"]L:J3(P@3)[J(S\41K?I+*
M/F [!"XO%J^F>"D;AD,F= (\).4KSF[38N<UW.9=^BUT="F6MJJC5F[,)F"7
MMF-VDB R>(+8'F GJ,+6AK 0V\(VPH/DLB$6>FM2=D,[(!7VP<5F1&>B0(,!
MK&,^>&X0PRX;5J5V8B?E&F [ ,(IL&'R@G#8=F$FL&X[V*R6FD$2G^&88N'L
M;N4Y ,+Q!N88"W$SSNSICB!V N/6 H*4#K)]9B$O L(K)"#<3BG5NL VK(/1
M* LT'("ZJ -2B?#>DNNRGD,7 @(LM'"%[K%1>H(LAD,G(,/^ VOO6N:#++RE
M/0QI8<A@^);C+DK#Z,&""3?))6!"4"+#W[HC/,""4AKN+>9#&$CD26ALD>UO
M$-[AB [?_]X((#:L =X#QB[;L-620CBP>(*L!).$:>YB*?J5D4J8!H<QSW*%
M$(/J70KE">.F*H I S(N=$B#Z.*CT7)P$!>+&)]"Y:XM;.(F<:ZNF,)#,2>@
MUG(M=/#B):S" W*N &K*05>IZ++L)?!".+C#.X1$=!9'%6@&.! G(R?EJL:B
M]'HN& ,@/D0#/A?+*6 ""&OGIQKM;W*M-'BNF[XM(+AI)CRTY!ZT&;R"4/9L
MZR[G >KQ"$)#;O)C.!0J<0;J-1S^LA.W)W:N0B>/X7N,C2?YPVG0PRQ8@CO"
MY@ESK7;R8B:TI\V&@U./<.:>0G;R9G.N\EP#X#?^YN_91 )B(#FJ<EC>:7#:
MGU#:'WZ6["IN:#(CII'5X4$:23U <Z^9%X\VS(E:K'AB<XD05E[-%7@A\$68
MP@/CPS$LL\.U0F%'(#GCA#E'V#1\P8;TPSERL%D'IM$F)5-R+9:ZKAD @BJ\
M(G8B0S_<,PMCIS2T0W8&X'H<<0G;PST,-,+YZ;(6*P&RK"K$PVV3H!,_M $"
M-2_ZXL[Z*S9> \Q&+FE$9X;4!07,!<QF0B>_=>/"0F\#)7V>\$O.PB7 @QGR
M@I'<,_;^SG8S K$=(X,6!FT^ +4=YW>QW&L:*G<"5F]U\L)1@Z<]=(,JM*R?
MC@(B-R/7-J[Q>LEZ& !0^8.7N$/QCFFQ!/=-]_,GX]2&&V_7[N;5-JZ4]F=?
MSSCW3J& AB\XX.@;"C9=AX%)C/:@^9IIMZ$>TJBQO0CQ<<P'0(,JXL,]B((&
M*.Q"8-L?G(!"I, 6I !#A, *0(0'L, 27+E,<  H5/,(?C,X8T0HCK.&8##]
MH'-8BK%*^_8)!R=N[J.SXBDGFR%T<&W.#G=Q-^T!/F\:CH( YL,][VE48V',
M&C$0LW,_^S1$;Z4]#+,J@&MP]_,UT((G2("D1*<W=/4#W +^K6:#4Q]@E5[M
MH7^Q<,[W<L/"VGZQD>!YB+8Z%O;I.6CE@_=M1,^Y4%KN=C/X/R]@4AKL0;>#
M&79"D_*D)YPU+.QQ-W3#6E_#.XS1A8$!!:3A)1ALHN?F;4LZM'M")JCIM$^[
M1'>#+YH!/]/U*L>#7<\RO YH>;;[,^:#_:J7QC*L>#[VE.<>C\UAQ3;S0<)H
M3'" %NA"?8G"!R \*.C"%K02P+P$^XE"+IS 7(6/>W4L>M["1JX51;X(!1MH
M:O;$FUM/:VZP&B.ZL=]S4";@,(>I[1;+"9NA+[OS0N?#>K A%G^R/;RL .*#
MHG/I7'XQ!ZJS=9]U=A.@KX^Q_27^)7%_*3L:C3]X])\4P//8@RW,0B]2KI$H
M9PXS- &6M:0S2I\;)W:",O8EY3XN;]1N<B8$,3X4^" #>PDS,11[Z0/>-/89
M)9/FYGR*L;,;N+-BK;1< Q5D S48P,V H NH2T?EN3W@,-([,>7:>0*^ B^T
M0YO>H%&N+8W7^VN^H5L&:%['*^AG(^J/(+[G&*\-_(OZ;TGDN^P#O$-LQ)FO
MM"E(>4Q\PA]\@19HV1]LP09\P4AHP,KM0@B@@"X P0>( AD@-DF8N7CV@L?O
MV<,(\$64]BWB]3"I-H2M9EFFLQF\]X.KPD%W E!6]$.7M+2/>SOL/=?RMF_G
M0SS/:M+^[JGE2B%N=H,=C\*H @0O,\CRV3-H#UZF4_FNF;EFL-TE50</GLH$
M#YZG3-?"(0,T,./&CA,R^5,EP-*V<!<PS,IFJ\HL>+#,\ IWK9,G>.',G'I(
M$9ZJFLA.F;FTTXRT?/B"UCSG<52[?.TRU;1WSLS @A;A8>55T)XGG>TZ7>+%
MJY,95? HYCNG$5DXFM>0.;U6M-/43!OAK:IYLQ,2</ZF'+"4*HD "N["7I)V
MCI;5AM?PV6NGUEY#3QS](K-W"A#'AA,IEC9]&G5JU:LKF\Z7+U<V>0?]U;9]
MN_9!>*W"X6N]&GAPX0;OC=G0 7ERY<N9-W?^'+H'7?U6YV/^Y=P#\NS0N7?8
M'KWYAUM@4=.K!XI#=^5==(E2<AS$!Q:LQG XP2K,K@]+<GW8$$84]9+C )3?
M4,OGE@_4^T[ !J%C93A[\L&-P@IKZR4,"S7<D,,./9PF0P\KI*XMJCP9!1!
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MR-U!$(J;WA44@1XU"#"GV$YZ"HB8^&II-A>F!%Q\@XT;2($H<@$*%FP "*+
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M ?\IZ\COZCA/EB30V@S.^RS0H[Q%-L2%=X0(<#1OEN;+>KY %_Y@!+Q#"[Y
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M3P)%T';$#O6JL,<@J!NBA*+Z@2W^ZG?Z 0R0[SG&0!=: 0B.PP5!X \"1$%
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M5,1P[,$OZM=\(>*=-8-R!((@!$*$SL$OI $>.B%0.+8?NIE%_&$6"F!SD2
MSN 6MF$5*( 7SF&)'>* \(&4D:$K3@$\LZ4A+D%H@ODQZP)P+F-++&)JK@$0
M+GLG$Z+^)@+X$L9"(WPF'/C$'CBV*T[$'H*Y@=]B%!X('[#",\2BN $!&@R&
MD&H#'US  #Q!';(! VY@453E'"07$'2")PCZ'!JB2DJC'9Z['8)9A/:"BP%A
MNWDBH>\&181&1\#3:2X(LZ=&*"CC%*B C.O7ALZO,LJ;=Y2:%>)X.!;%%!4H
MQ^*QJTNN'GBK-L?R6A]YWT@.%$H\@B3T_GR0%?A0J3.Y-LH5)/6)'XQ K@\@
M@S/V\J A*^+"N#MA:ZG:@ #;,LZB;$\A2O34MH^.A/+VL2-;;O!!*,[APPU"
M**0BF#=X('Q#N#/"R"%"3,@"1Y)&G(5ZM&?A ':A'Y!@,5S^*0DR0%86>RT.
MHB&N^&GZ!H%"""Q4X6#K0LNOXIWMP5#P-+[MX9)DQ;/;<14N(;'5D='-X!PP
M6VZQA(,R_>AX0J/0Y(3%V6MLX[R+ !]J Q 00!V"62EXN:]YXBL,0DP0#2$(
MES(,0AHD2IC_>B=#J$6L@BTX-H(ZVQ.DAD_PH2C@U^* XU11<==DUR:MKJ/H
MP?VXC5KE!_^^Z,0K.9 4=#48=,2M2)(C5)Z05"+-BLW<+!II9AK=ND/\R1+D
MN@36P4+0=:6D@0K.]S5("+"A2\G++DG.(9@%?1"'&1"4'1_J0F@.W43_O8#,
M)"D0?110.8Z%.[(/8A0N(IB?A(S^N;S,_>$63#O.1R>"*X "</M$!)Q/>R27
M;8*$;[W2!7XGER*#X-FXC4(53KC1.WM4C.3@!<)K<^(C##PK7CEIEJ7H1>A0
MP_P:G$0B3A@Q=^>\D\ V,$'5_YTADJ+F%>5$9D(LQJ3?+P_K&T)2M2+AGT4L
M/"$M)+:G"44W1L'(X1ZJ?RDVTB_U=EC&\ &K_87DYJE \R_<?:\7 "U;%?+<
MY6=]+A(9BG;(6&&0)*2MW;WZ'A >4@$3MH%#VP+0)60R)N,@+NEG\&%9HF04
M'E-(L&85#O[")Z,=W-Y$ZX+MXWD4'H+G,X@@R!9/?"0B5.$W3L'(W8(70,,J
M5N%@@47^%DP['S(:B/"A EJ %Z !&:+?KU?*?7G!$YYDEU?*\Y/<#.:VKR'"
M*J8B^)VD2G:^$TCC<@&!1JC@%:#A+*)?*MR7^/T5?MT7%JJB$[ F8L.8*$+I
M-$@=('Y(\4?P$H)PO,R$L\>PFQEDX0!!R\?0TRAXL$9I1)9P(4-X\#HRS'?-
MS+5P9GC9(VE&E31>O* A.\>PILU\YP#!LCG*$[Q3G>#9'$JTZ$U9V2@R),BT
M*=.:\%JI,TJUJM6:^*XRO!>F@]>O8,.*'4NVK-D.'G3ULYJ/U=FW83W _2JW
M[(=;6:G2ZP=J;EVZ<P./!76/;:\/9/\*7GR6E=::_9Q*GDS^<%H8RI@S:][,
MV3)GS$/SL3,#"Q^^?!W/I53JR9--?-<RG8/7B1=)0!YK)KQ&$5_'=IE6*66(
MS]TE3^VR9E5EDF)"7I?"P3;3S;1J7O \91)J#_BI=KS"43R7R>>J2^W@^?,D
M )H_)$?X$432HEV^?/"0=>-N#V%Z>\@\-)P]T]EF#SRC;!>-0BN5I!(OO.73
M3B>9@ ?(;)VHHE1"[90483[A( //-=AUMQN)!()G4EX,H80=A/G@ ]QV1$7F
M#SY%#$20)0>5)(UR'46$#$6TC?(1/*?YF-<JK_!"!6\K)=2-0T/:XV",_?A7
M59%"W=/.):? DTI0CVE%2S8VV0C^VD>MY%;FFP3""5D8&S!F)V-I#5A4/J3<
MZ6=@'T##XI[U>/(G7(H)Q@$H>A*5SV%V)HKG6ZRLI14\^7PFF6>:=NKI9]-\
M\2E3E@[UBAG2P!-.>4*=DDDX^3UD4SNC&#C**O9(4R%__5TR"JS7 *)*=YFH
M M)-O%1QRC7GA'.JL2T"TM)* 79#43N 8!<@+^VT<ZHTP'D23CO="&O/<^T@
M<T%[_AB!A(VC4,#+.2KRPJ*#W>XVZ'2OIFL&+2RMTDXXITBA4H*PKGI10K,5
MJQ1S\'R)R;BK!I40,MW!HM#%$4O)(CXH8:P=Q9E<!%56-N*HHS^8(*"..YF\
M.N)QJ@K^>*!%1$W8":S2I#3CN"7YA)(T#-$*R#6J>G+).8W:A&X[JZP(%*]R
MOG9F/#5M9E.;3<=9-9R#OA8&!X>:59>D;^7)EEMIE\W8![UT71.?;M^)]E<<
MD"+W2+?<7;??E.X]E)J><CKJX8C[8_BH5'>7BAF9 "(N1>%T DCD F.%S.3V
M0),)+)WL--0]NEYNQBDT :=24;Q@8H:T9F1.((+-68E;T9FHU([&EUR2+::Q
M77[<0NUX8D8G1DA!@7M)),%4/)X <DDF9LC"*SS,Q4P:U?B4JS3UJB1G#W.]
MIY*[/=U0'WDFUO(B6_&X1@E(._VI#WEU[9QR>>0J8;]_2KS^ MDEAA0;R%VB
M$]7!RE((PH_D,:43%)A*-UQ'/7'A(R<8.] H3D$4V&1B>L*R3_ B]RMX=&.
M2@G'*([7NVM<!6J P 0@LF6/>*C")U_K8"Z2 AG-0*5-.0RB5O QACH)!G!U
M0XLN]F&5?K MB8EYFRX$EP]0D.TL2/1*%J,XF,)4)1^ZD-06H4@65GC1*OB
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M 4X0#?Z0"A<  !5PADT1#YV0 14 !5+P (%H#YY0 AN)":3TD9[P Q0P"U6
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M:0!GZ T', K1B 1&8 ^I< #WN0XNX *K( M&, &GI*/^L [^+U !GI *)@
M4P"@+G !GK *29  P.D4T'  HID*&KD-VC % I 2A(,)-#H+4B  5,DR!B"C
MEA"CI80 !Y $4A -2."CJ0"CQ*D*:8J?WC !\8FF F LF"  4A W4F  ?S +
M5%  5> /V6  HWD+"& $JH"4%= -1WD 4O *56   H ,_N "SC,+,4H+G'
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M>0#R*04'D*6>4 #2L ZN6)A(D #!R!30( !V:P\N8 3]@)O;P ]5P G1^ ?
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M  6 !$=Z!!F+ 4^,! -QI^Z"!$F !%/0C02A#A,PR 21! 5KJE@<G'W,%*E
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M4'B@Q!),-[QZS(*\40:#SB #TKD;1?$<U9320I [Q4>+RQ_;.HM,(U<DMW"
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MM[$<*_$/&[$8LW$;S[$9&_(;2S'^&*_Q'G- '=MQ'R^R(T]R',MQ%B_R#W?
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M:W58E[5^?S5M.[=GRW9Z-SAG.SA*U[=,US<'C+==QW9_][9H[S99%SAN(_A
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MDX3E+\KB4)BE(?V!;OHL!8QJ+IL%-7>B*UFD>7B&*.$B.MLBA0*3.A8*!F!
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MJ*-[NJ$6=JG[N5/[NK5[NVFZM?DANN>:F6D:MYT;K<^:NS>;NN_!F+M;A+V
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MH88*JC&_[&BI'7&X(001/O#@@Q!NJ$P'WX _0DSGA]I((S&4,!)!P0RKW;
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M"$'LH:LGV\$.=#"#$1^R#6Y@F>:>^@A(> YTG6-$ ^J:R4X28'6@-  I1WF
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M>E '^UC^-"+X-&! =CM4-03IGB551%S34C7E1.5JGU6T!E"2EWFWGT,7  7
M !@95$/P X;G S[0!OF:A'5@!W8@8=XI1U&8891G>8/S"U@X!VZP S00DQ9Z
MH11D;CQP.9GC!ZBW*&ME(R$*!PB$HG:U.JK#8[M#2L8#/ @P6$SIAS,*E7]8
MB$M62U&IHXK(H\GAHUY@#9\*6M_7"2UP#3U["11P#>%@!%*0"2Z ET:@-$&P
M"E7:"4=A#YG0 I<@!48@#6:0 &:PKNV !*/ @Z^0!*/ #T@P"_X@#2Y0!9>
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MWZN?[=K^6\B6;!&  S>0 T?0 SI0 ^O;ON_[OF\$*(]G89T#(S 2*(!D!SY
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MD/K5DLH&WS"+X4<=G(N*:'U:X/)^Y('(;\U:J.HJ_^&JIQL@>*9GK1M ,S9
M!\3)]*1 !5#8^32.BNUHJ)R.<3!IS[6 PYH'>3!"%>6=BP!#:QY>BM S%G4'
M)W('9A>]T"N]TUO:+HB]M3:#-[C:5"1%Z>K:]A"^[?JNQ)5L-V !"V8#7:@#
MZI:O!IIX2M4WD-!XG?-6+N(B)=D'7:7<_ML H:X #; Q\YS;/O &>\ (5,A'
MF X)=H Q%H-L>=7=+KJ4 8?K0]:4?FC>B46(B]4\3-8!D571[ T&UG-]&ZW6
MZB(=^9#^"4;@I/< "Q*@"LIP 9W "TT@!=?0 MB>:KQPEV("#U*0!+S@"17
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MU6>[4W<=^M ]370E)J'U(FQMJ)I L:-2I"(:1*H4^U[1*27=8K'5D-)1 5C
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ME;&#I\M!.^2ZI[53H3)I(1?:FAR(NU*K(>JB$S<QM3B8 SOH"%[9MEASB<\
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MP 1+0)DFF\!>,@]\2! C3<8&J00,2<P%#"TKD"9^$-<"B5)TA5AQ;;+QL-B
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MQ"5Z&KID,0<39<2$4*5%U.T@]:AO](X[[-%>>"1A 1#@(P[\>(,(V. &%K"
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M@%S8)-PT&%_D(Z7<HR'VSHQD&U_P3N2)6X;M *F(QFJ4&(0L9.! R!02#N+
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M92#M@E3B#L0<5?9F73VR#LA9JGH(_G*#+]BO)MOOPESM($0 71! K48 ^S#
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M3A59D9S^@B4$G.B,#NS58>JP$47^>P=VTA'U D",P)*54O9% 0 30YE,ZJQ
M]FI8AJ58O:<-<%1'U>?V:1^^=&(-?)_\IE\;E!+#Z"_$_+0?=&PD/ '[",:7
M0:JG!%VM#@$.:.4"X( %,##*6+5"3%8 .IV&:A8%> !%,*M&+*"(]C(\G'4T
MXF6*[B5APS4\O&LXWE<#Y34$;9>N*>;3-"[C)D6Z6KB$AUU<VU>%RT0W+UN
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M\0,5N%#Y!95A?@'FTF::849RRBMGQA52/!F%E,[5Z!STT$7O?!70:>F\E5U
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M%$HA)U%3&2#-0SU!%9:I"@#@ DCA%3 !$#QAH#PT%?;O%5CK<D<A0DGA ))
M%4;!$R@  *0@%4@ABCK'$ZI.<I$ BDP  ,# U1;J?%?A7E?A?+^MHTB-HZ*A
M'8[D*F>40D!686^*29G*P.ZA$H#* T7&&-"A'_C!%RPV9I118R5,AM:A8W,&
M80M8PWIQ9"&B9$T6:"*/2K=Q!\,*OF3,^:9H2R^@BE0!"<I7BJJ@3 X@ RSA
MC#P!)0[^P @"@ (\P00HP#%5X0>"N*!,@0$$X!+0*1:2QA6HU@D8P  >8 H"
M#A >( J"(%2G(!A8A0$N01@NX08.P  R0&J!X8B_MA0LX B"80HD( D8X (
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M%3P!.D'5$TYU)0J@05]AAJ4@%N;>$H3!KG^=O.0MS.L5K@_@$N*MO)\;GBU
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M$ &<(@P" E"!1P("29->>.7U8K,TO*S'7B_N]2P??>WTHM^TLCPD@114\):
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MD D(WP[V$ 4,+^5 ?@[]P N6T T8, OV</&D$ 1,G@F(@^_PT-?V< [F'[\
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M-,BAPSZ*_/"IXZ=.G3UU\N01&"?.FS=P1A(9,J1'C@@1(#1@$,$&3!PY9N:
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MC>,<YS@H&FCU)9&)C UN< ,?!('%/:!!(,.Z@ (L8 $*J''^C6]LX[ BTG(
M\'%0&)"-?KBCR%ZX ?U4]15,XN8WFOS*;S?9*KCDJE>CW%4I>067P<[%-K=1
M)08D\#MC"B^6S@I,\@PP 0E<( C"M*:U"E  Z 5!#H1 A;?,, 1KSGD":W9!
M,LV0A"=PIIG4DR;Z2-.9&O@R"O*#2^SRE4YQ_LI7Q,F?P913&X)YI049 *!T
M]CF?\MBC'?2T9W4K]MP/B;="J08/RUXM,86Z>F/W!*\%+;9"\M!:10P]+[!9
MY(6('@V'-DP:TG"T(T(,J:-76T9^HQWMD&(M25OS&MC"U@B6MG1+"9[I@M4T
MAP\'S@UQN$,8$Q(GNS4D(10A*D?^W!B'D8!8Q#ZH 0ZT*@.5X/$E,PF"27S0
M \-!J@$+.)3!$7XH'.]X4@$ RL-_[!/+&2 ;(,3'%(BC\:XXN7Z^"LN425<6
M5ZE%=K-"B^U0N2L3Y,O+P*% 8AL+ 9D[9I:[3 !EB\*\XAV/ 040S!"V=1IP
MW6$($6  + -#@?A% 3.;R4PA8'L:0@@B"G_,P1.R20';N*ZP^4N.;Y*\%:P8
M1V #&Z[^IN*5J?P!*BKKM74R.,]ZRKKN;K</W+-C:PRQ,-<=PK7+6GT=NU<7
M\.IQH M_'>S%5Z=%24@"$IBPM!O%Z*(R>D$2@OB(7SB)H_MM!K3S&WK0?Q2)
M2EPBM@G^;.!%:'&+"E:P1^H0DG*_H2 'X4.<6-\0NMU)#W68 _#G+3@?")Q0
M)#84O_6XJ!R<Y.HRL,&^9;#O!D2_ 3$X5"!Q[-5)3;Q2DN,) [JS5BK$556C
MDRM=[VH63MXJ5W1AG2>UC.76E84NJ^+D!3BPDC(+CS",L8%B/$^S$(^*J5AC
M',\"J(0OX4$I>$L@W,$3U,!G! ' -9/3H0\A$$(#XAF>9: >9%/6/: 3U$M;
MW,H+\(9QB-,-F Y7:!QMW _"6$5M:-P%G(X)@!H]/$6*,!<]X4,\$!X0HH>H
MU5H0VMT*Y9T_&%X10@6JW1,2CHCB,5ZP!4WD)0$3,($5/M[^>N6012%;%- 7
MMAD)2$D;&4X;?YG>$C6)E%0)MUG)G+S;@GD)W,!14@E!2 "?'O"!F\2)(@B"
M0^CA3NG!'-R!',C!G\!!20C<#D"5#5R? _1;59G$2>3 #:18)2H*3*A$#$3
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MYJ<ASALB"LI_$NM4M42-)0Y,'&@/!(&O^I$// $<N'!6!6@$/.)6YE@H/EP
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MSAX Y9\UZ##Y0!R7IBP@+0000%J@!94:V" (W8!')^U!A<AH"W\!Y(M]!"A
MO^RE,9/AB[H:V)F-'F:C#5Q!8RCC&':%IF4L[9<%5M.:UNP&!V7N8%A@:H%8
MV2 '1QC"</#0,>]X)Q!WN$H/2@Q#Z!#"AH7(3B.<ZE3I$,(()IM/"Q#=@K\$
M<3TY<T]B$A.9)MK,,"U[(J7W\H,,6.*P5#+0T 1WR7R$XQK3O5$^VJJ@'H6#
M DC(T M6P;8DF$$"26A''RDP 5C^!Q(?O$@"!2J0!%Y< P, 2  5EDO93&#
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MB"< (A!!4/2A6_#:%HAG95D5#\]R5C,E[F5G-BO,I+/UAY\1CK)JW:,J)G"
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MHNT:KL$ V.BOS  K TD5_(87HD!L^B$<)D *KHV.X"'8W &U4@$KHZ$ /"%
MLL$3UL'^!GM- %AK"L0R'T9! 'CAL,[(#!#)0\(A""9 &HP&'HS ;0+)$YH
MN##@K7CA ,P 'ZI2NI3F"]NA BZ@1N[AUTBD!9  '^ZA"0I@:P2S-<,P->\A
M'U2A-0FK$V8S&C+A#RVKN0SQ-V'IE!!Q2G9A#!CQ.*\D2WH)$L5D2Y@ #TS1
M%!FB&3*QZ9!)ZN2KF41Q3XIIZP8E%1>!=C9"P,8.%A]%)+SI=X GG-J.4]X.
MPG""[N! G;0BPS3L57#%!N!)>F0,*FB@!P1O\)X1)7R */ 3'*$B+A:/\12@
M?1**!GH,R-Z!"G9F6Y:,H@0C\S0O,M ETTZJ,7X@,ZB,+T#^BC&R##/443 F
M( $2X #Z!:8TB,,*DJ9T /=ZHS5<8S9RH/C@  ]&)F0"03D*E%>.[SGZ0! B
MAA &(8<B!@<L( DNP/KF P,2[;6NBH>,B/SZHB69*( B:-) (W\"0_T69#C]
MP5J\H 0IRPB \K2.!!_,P "$\D":X #T3P3-  $4)!\\S@S, ! L 0.($ E>
M $CJRAZ0P0 \ <AZA!;ZL0D\84_MH1VD014N(0H$@"T]04ZCX0",P$_-P.,Z
MP1U<X "0 !.B8;,"Y)(RD[6DX+3R818*P(P>9 B!,!^DH04D8&L8)!PDP PP
M!!ZN03/A2!PNP-:*P-5VQ O!L +^FD#4S* "3C,)2B0*$"D>!!,K">M3 >$2
MID  HB8#!  )+J$PZV)'XI+]7(00]>;4#.>48*F2S-1)%!$YD1-+FL ,?FGH
MQ(1S'J$8[DL3-5%/"$*93 <4T0%AG4E/2+$AHE-V&*%0#F41_HL\1\518E$6
M4>)2GJ=53**H.*4.T$ED?9$^?6((WFG'H,<H:&#'X"E:XB(":F#%XF X4&5[
M"J\'5@*@QL(:858I9HP;":  <BP<Q]$NRE$OM@5# \/)%F,O.J,O0D_*,(,Q
M0 _T.(HQ&LA=4$_)4C1F7@\!ODP@-<@W"K+,G'0W M("&& A"[('A&,//)(0
M.H$BA>K^(G=%..Y@#P(!2?T6246F^BQ /4IRJEK !5[@6Z9T)>GC!R*M2YOH
M/DB#2W?&ATS $AA$59MD)XG&0/*!%XP@ U2A<.!43A>D'6;PUB()U1(@D9)
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M"@9["UAF3.V0*Y1QH17J&/2G?@]K61,*%.7GE!3K9MRB/[WPE2+:<_P0#='
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M3<G) -#_# SF2[X[K-2SN[G!>PML++^C/+_=7<IZ?**A6[O^</,M!ZP]&3O
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M;$PA %-0QA$$8+,+( ,SRFB=$4X##.<B(1FGN(  [)P$5R#F !4HP'./4(
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M=;@$U!, 6!B)7K 6?Z@"_AL)3C" ;>@'^?(OF8"'68B?(XJPK3@^_\JJ)$@
MN1*N#X++DJ '%S "%0($*5"'HI0^3]#)E@P_DJ, =VB'!! [ZJG+5G&[D3 "
MT.-*!@"'=1 -JLB$ _"&63B [Z(%M*2C7M * _S,JN"':.@%AN@%:( &T^R%
M:( &M:@,AWG-OCBDB,&8":3-;@B'#A0 (TB"([@!+&N,6DC^A4O(M2 (,P"0
M@C([Q);)C)@I  ;(&PSHA&1P!72;@DOXJ>V3@ #(A%KXJ2B(AF!S@5@(G5+
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M/ "X9' "&URS!\># U#IW@ $!H" 3N"N QB ZEN%5+@ "1@%6*@6/$@&3X
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BIC&5:8I&@4:?*7*F.=7I3C?D4J"]8YT\%>I0B5K&@   .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g44361moi007.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi007.gif
M1TE&.#EA/@-O O<   0$! <'"0L+"PX.$A$0#Q,3%!86&AL;&PL=*1P<)!8M
M-"$>&R(@'R0D(R4E*2PL*RLK-C P,#0S,S4U.3P\.PH+3@X/40\04A(35!H;
M6@P99P\;:!(>:ADU3A<C;1TH<1(R8R$B7RL\2S@X1R<H8R(M="XQ:"HU>C O
M:3,T;#H]=3] /Q]!32E#3"I(5#-,6#E27#))<4<\.$9#/7!:.41$0T='1TQ,
M2T5&6$]04%144UA85UQ<6T9'>4I'>DM39U14:5I:=E=F;V-=66=C6F1D8VAH
M9VQL:V-E>FYQ<71T<W=X=WQ\?#)%B3A&AC)1C"-BGDM3B4M5CU97A%EEE%EQ
MI&1EB6EJCFEKE'!TCG5WF7=XF6MTHW5[J'Q]H7^ ?E*2LGR#BGB'KD>US5VG
MRU"MUK4X,IYG+YIS58=]=X%_@KJC(X:#>JV28=VA->>5&>J5&N68)^*<-,JF
M6]6U<^:I2^:Z;^#14^3">X.$@X>(B(R,BXV/D9&2CI24DY>8EYN<FX2%I(B)
MJXJ,LXR4M)*3K)N=I):8MYZAG9NBIIZ@M9FBNJN;DJ.<L:.CG;>KCZ.DI*>H
MIZNLK*FJN*^PKJZQM+*NKK*RK;.TL[:YM;BXM[N\NX^<P)N;Q9JFPZJ=RJ6F
MR*JJV*^PP*NTR[*NRK:WQ[FPQKJZR[BZT[.SY+>WZ+R\[[V]\)_/B+;-L[[
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M(<J@E/J=ERJIDXJIFNJ@E=JI(YJI'XJ7G-JIF H/:9$:!Z(Y ND;0[(DHF.
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MG9W?T-[?H+><ZM^>0 B<@ K?,->)W-QX3-P"G=",3.)DK=;.C<]O7>*?>MP
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M";,3 N\K 9L@-Q#X-OK>,;!-2(_;3IS>/D#&'VP.Z<2;4;@0 REV2!&#BRY
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MATW<LR]"[O,$-HQ@K>C"2_<XH76N>H_(5+,^Q-S2":@"T4?]D2>V1($+0M*
ME0;!(LU$810VU5LPZ;,1=HC-"5(81#1H=PA-H8(4TJJ5APC2B0>!R0,? $D<
M!4$7 ]UT1<KBB#=H&1:Y8(%D!2$$IIP@!BJH95&QJHY<3H#^"D'@QQ,$PAI:
MN;"^\0P"4RK@ D8U8Y9HJ 8X75#-"1@:(B<4XF;,,># -B N;O5%JQ/AA'M*
M0 4J@(4#&5(0!SYP IGB!U&&.L$@/#%47/KC';3<ES_F@46!Z))&=-WG5[$
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M$Y8IC3_JK3^YTFBH%4RSPGG AU!HD/YPR+'ZQ'48A$#X!,-D"9"#EQ$[N_9
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MFUA;4V" 00;H9Y ^^^>SGS[Z\:_O?OOPSR\__N^[G[_Z^]??/__JIS\!^B^
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M8,<I5(V*%* B&U)--S,^'L$9CZ**RJVNO .1#7RL Q7FN\ 4M*&(0* W&UC
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M%Z3#:JT4.PC"%H2#/WBAJN'#(6#!BQT:">B7.'B!%OA@(%C >0&B%\S8+5:
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MP:(L3H(7#$*3G5T*I$,_H-,%H"4X-E,V@-:%=F-L+AW%%<(3J9B?-:/)-5%
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MK;):Y_DLWB\V)84U+BF^YG%BP!ZBIP50+-*E@TYEP!ZR&,>F#ZXB'L>-6 7
MIFS>[LG.44!6:!;.6('!'G1EP*?-FO<5 F_F&,ZZZ452V,Y6ZN*Q9PZ^F)GR
MF&)E0^^% "GVV!ZR8@:HF'!BP"P$&09 )_(%'6UM00J\72+F:UP)Z-<N1JSJ
M*[*Q S^0PJ@=POS=H@4L7CIX@17^S!@SH  ZEL(4> $7'AKZ5*>3%64.H<#\
M:4,A>$%-XD.,H0 T5* 5""4_="2P9NM%KF@&^T,T7 '6Z>(@3,$\]@!)^@,T
M1,$4B"-DK0.2GD\G3&X4\(,XN&NF84$%=!@['((@A!GFHBXMG5:_,EA".-B!
MB:@V+-U>":\A;@$_O(/+-EF&@:^3"0(I<./6!>^-N1=^K9B\U:0+IQ\['*Z(
M'MK[(=X:%@(6L%R&?2X_7&\5-9,XD%A$\<,Z"$(@Z&B,(5T43D*3;<$%$*:B
MAH,)]' D,EJEJH X'L*+29^CRMLK'T+ZG4/BQ:(_) ,RI.6Y4J=-8@$F"X(@
M2'"\$IW^*6"!%Z 7F06HJS:P43RPK%H 6AY&3J9/"!Q""@YA%&C@O/8#YGD8
M!^A0#,D:*H&/$E8C"UY %! =4>!#)X0 !28##Z_>X>(RO6+ ,!?%.31A%/C@
M-U8G#:F H)$1859 B;II@O7C;.6Q/[A#'D>Q&.\K+BP+5"VS8X%O/41J!$W!
M.6A#W!V"5J9#(6"#]'FD_@%Q(:##NO5 .D3#TG&TF/6 %^R#GYD7*61S-/A7
M4+'#NIED-H1#=;W@_OEA(8L3.TCR#4T!.R0#QIUJF%5C('1?[#SL(*0/-L<H
M[ VEMR$#)-J0((3:^?C 2>/#,&PS/DOD^?2 *=PA/B #JW[^5S2X0_BEPTQB
M@"F\P]+N;YCQPSE$]9;B@K(EG2"$K5<QL#,C1E&-L=CRUFO55MA%4 9$02 <
M@A:071!-7R'@'!9TTI:J5X7)EN *PHFA7@2A !84@B!,00W=ZG"QC]ZUIQ4,
M0B"88 \$P@N?K@\(\Q2DP&;+6VT=XG3UP&S5%OPHEV:1@,]A00_T0#S(9L >
M&+]^E!G3PUM!=PJ,%B-!5@R 5M/!W+0)%LI- 0EX0">B3V2YCPI,@<IA%L(E
M6 QXUFVUF\U!%K:ASWN[W'6#UG4?(BAY';:ED<_M]B=Q%LR1);6A]Z!=&^4=
MN Z]G7H?XL'=4'=_5@1%@86K0 C^=&J'7MLSGD^ KYW,S9V SUDS'S8J1C0O
M)9)FZA&KE9D?(?<DX$,R .B:M?@3?5%?E9&OC5$9T5$$5< 3 7D2K?@?W7B.
M6QTM4EN'$2Z*2S1%C ]BA$7K>E=A75J.L]I>65$9Y9 9L9F9;9&905$;6[F5
MY>MAZ9 "MUD>T=J:#5D$%<(L4IVJS3B9^Q$I$3DSF[@#$W:3>],A-!D^'!]6
M[5F3:5\_X ,+]CDH42=H7&;[*3JD"U.ZE5,YG<-;][EAZWE10'.D5Y,5F((H
M!)A79< 4' (IX,(D,&:GYQ!;E7&4Z\24K[JLSQ'6>8$@!%VG9[JFG_BL@Q/\
M/#=&V=#^_  [D9$QE!_&5\1ZK_?Z7Q&[8Y7AKA\&IR^[,CD[M9-4@DWT96@)
MZY;MM7^[K.NZID\[N)>[84U51SU<8FB%19N[NZ.NN.LY#062(<$16/T1O><[
MO>-[O>M[(/$[O^^[O^M[P ^\P1\\PB-\6(%5("U\PA?\P$-\PB=2PR^\P_<[
M($F\O0.2K?I[P6N\K4W\P>,[R .6ZKHZLDO$6X75Q8N\R[^\OC>1%64Y6+4\
MS-_\QF,\SN^\P?.[%-G\Q+=1RXLYSC?1K0&66=&[Q?/\P0,]SH-\P%= B1^V
MYVV<U5\]UL-=%, =UV&]UW\]V(>]V(\]V9>]V9\]VJ>]VJ_^/=NW/=9O/=>[
MO=EOO=Q[?<K5/=Y' 32H7T$5A!?@/> 'ON //N$7ON$?_L;=/>(O/N/?6+0?
M!C[T@S[HXN1'?JI>_GI=_CS$P^;'@^=_/NB'ONB//NF7ONF?/NJG/NAW_N>S
M/N>K/NJ[ON?/P^;+_NN'ONW3/NSOONG;?NSS/O#[/O //_$//W84XR:-ONPO
M/^ZOOO*?OO#/?O/?ONBS/NWG?O%3/^E'O_/W_N]G/_B'O_COONZW_O17?^_[
M/O:C__.O?N17?N4?NCX<.C[$_^4_?JZ 29*\2J>HBJ?T/T#PHT=O7T&#!Q$F
M5%A0X$"' ALZ',@O(CV*$B%:G"C^<6-#A/P^+A0Y4F3%C!4')@194"/$C!8;
MODQ)\F#+EA#WM3RXTJ#-BR<[2F1HD&=-H"XUVDSZ<"/!ET;]194Z52;'IDPQ
M!L7*,2+*JUZ7-JT*%FA*@?M69MQ)$&U(EC83*M4Z5FG)F0KE*I7YTB/-A7S#
M"O7[UBK@HD9UZEU:<3!ADTGW/IPZF7)ERY<Q9]:\F?-EL%87@\XJ.O#5L#7C
MTF3;,^ACKRA?9_5:<W7.VH-OYQRY%:-:VJQ)@W;9V#9!A\5UW]5-^WCPCB";
M*R><,KISG,E9L^S)#S-7R(5'6P\?/C;OS]YYBQ4L^"WA[&@YQL7Z.:;0W*AW
MUS]O_#C^<9&DD3JKL9M*ZT\^XXH33;_[_EM00=DZBU#""2FL4"KHP'-.J_&$
M$\] W$9RT#0-NQJM+ &UTX[!U%3[ZRO1WD,PQ?D*W TAMF;J3[KFEDN.QM)Z
MO ]'Y-#;S[:>4DR..\_L(S&X_4;,$, G-9RH/M#P6Q%)AF[#\2*Q8BK1*1RU
M[/'&(L/4J*V<H#.3N!%? [&\*Y.<T3@QJYJ(N#G5X\K"/P&MD)UM"-UF4$(/
M+7300\\IE%!Q'"54&W$@W:;22B,M5)M',XT44TX=Q50<+85<:,K0^'HL2O3,
MS*TV&=DL$Z_IPN)K3PX9:Y5%A52]-;U<9\7K+)C((Q9%60G^PBRB?>+I---/
M"X4VVF>WF112:+'UM%-I025TG@*_0W'7+6F5IIEBHB&S2H[DD2:<=%AJLTYR
MR82RR0^7>[5.MDR"C;U\D43//%?M^O5?@H'S=V"' FW88<SPJ6855BBN>)6+
M,;Z8XHPU9F5BCC\&6>2,/1[9Y)$WKF8>4X-U,T&!)8I''M-*S!/&(%M$C;K_
MLM0KSQEO5!%<R/P#.-^=C=Z2O_-B4IIG6@L4<TP,]UW2LF6W.5EKCBW66.22
MMP[[:X^['K7#$<<->CF!PID$$D-P.94IE)J)1)-T^<.7W+6I-%#-(_U;K=;>
M])8//AH?2SI(J3,4=UY:12P-HH?^*:_<'WRNJ5CSC3?7O&//,?:\:XM%G[AS
MSKWN/.3/5<9/[:?[I$>>=,*!IAE<,(D$DDAN:2:<P<'3K^FG'W=YW_S$.XPD
MK@#C45?CF3OI3<*OE(Y%P>&#W&8]G8_+ZLI>RKKDTD,W'77S3R<Y??3)3QUT
M]D$?]<LO^=MN1>SE*T820PSY_2@.-Y*.8O O&@):BNOPTJ?$L69X",,>=8I4
M&*>I"#K5(PUN"M,\ZQWO</:RH.5 V+#,G8Z$78-?"4F'PA1N[H0JO$;Q6&8J
MA\@C&KJXA24@@8@__($/>LA#&IB0ABSDX0^W2,>Z++@C&^T+?\2#&LTV:)>7
MF8A>:4/^3'P&M#VBQ9!E&YEBN&QSEF')ISM)$9\*2]A"%K)O=6A$H?G8>#&S
M@>=([-%7RRP2#DQ P@^8^%:54#*/79CB7*;XG97T]+@NS8UP2*N?<N[2Q,78
M*Y)[ZQN=7N<]IB5R2'O[XI54-9$0CK)"F$,C_$+'0C>N,GVLK)@U5J:V)B+0
M(>G A2/ZL ==YD$/>]!#&I9PA"(,80A%,,(1E@"(8\SC?^"J3PQE%:\N%6]I
MB$2;))/$R.\4#H% TY&:L!DD$YE&<55\BVN"@QR7>4E9$CFC*U5'-A*V4(WP
M7-\JV.$3[V3/BMBYD?X, 0B\@7*;&4G'(]I@"61$ UY@:1G^DI*XP$P637*0
M&9YJYA?*OZU3:.,,3#\M.I[8?(^4)=5,Q.8)SWIRSIXMM=@T<@0X8UEE7]$P
MA!KRD(<LZ &G/ TF#W2P Z'NH A%X $2\G"+>)Q*53SIY.NF*4TVQ6N"7_2.
MXY9'4X<^%7KRT<_T-NK0;C[U5>KYR<"&5:!V-N2=HG.I*E=XRK>B3QS2;.J_
M,#J3=$S"$'R0Q%+3<S9</&(-;2A&/%2"UZJ&*R]<=5.I/&*1,&X32T'K2]X>
MY!L6T:>Q,:4EY&3C3)..=C,C3*-<55A/>KYU8]=8ZE"LVA2\-,,/:5!#%M*0
MAR#F00UJT(-1BR#4(@!A!\<LJAK^XA8[ ';U?JX;$H(8E"9]'DR6'1S+13TY
M2W71-+L4/&<CE4=12AYPLHPDZ60X\LZ5IK:EZWUC/.59URF2!5;9Y%LXY!&/
M:$!"#WK@@S 4%#EZQ",3F7C$,X242!@"IV^9+)7.ZO@@8DGVL4HJC@;C0U;H
M)A&\#Z7-L/8#&]*.V#(H7:5[SY=2UKHU?=40'")!NY+Z1<,/2UB"&I; !"8L
M(0ML4(-2,6&$(2C!"#LXPA%T<(0T"),-" ZM;+"KN"CJ"U;-%=ALYN6JSC)E
MP5G%<M"T;#-,1A5V9]N>C[9R7JJX<Z5PE.>*7>EF%'M,OFGRE^-F69!PX.(/
MAI!$(7;^K = A"/$E)V')BIA"6C(T+.*9-/VHMSEU$ 7RAGJHH_$C)))1S9O
M\Z,C_NH+G]<HK"(D-O543&S/SZ408]-H+UQ9'$^,M4YI=_HH:^(!B24D 9A
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ML*WUD]LM)!J^W0C8( L8><>&W#+F85"+(2-U05WU@-U!/N?^CQK 1W[40SW
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M%,,9TD '.G;,4*))UI1#GJB&B^@.=:A@TJI21[[=L8YPH>K^2 K9CVI&>H^
MH\I5"U_XJ1I^+(#[.^(0?[C#":7PDAWLXH3R-\?]U'!CY\JC@%H/MO()'Z/\
M#I*?KILWAAV9:!@BUJL^]1[\H&I:UWIRM^XY(@R!B%R_8.@PX#7!U!WL>Q]K
M4/@0:A3%)%=+SO17:46FUDB7JF8[&R<C)$J(HRV_3KOG&E%GFC0 <>MO>QOM
M6^TY(" A"4E<XA;%@,8XT*$''OAXATHP@F25$ TB*]V"X+)"(49Z["25?>D;
M9*D?%9:,[HX\TX):[SU7[NDLOA=G7G_Y]+@6\RP( 0E"*+WI3?^#TO,@"$$X
MO>M/GX0?N. %<PE#!#=QBV,L?H/^MKQE:5F$^!.I"*1/'SY' 7K+C)ZT4B]Z
MT8E0['P9T7+X:T)QZHX$TC-]%$7-'Y02HR0H>ZP(H!##1SVF-+:MB] P+ 1F
M>\7.>;#OQ'BVLUTX -$'/[A][6I'N[<1\7.0$ D?$BF8H$.;< 1&@ M"%GB6
M-7@6E Z[9RA/]X"%Y X^L 6 E%[?X@Z<%C^9-V(AB'GZY'7GH#45Y@_ID AA
M( 0P0'LL (,LT $Q*(,B,(,T"(,,Y"\NP(.S5WL.)@RZH P2^$=,A RRT%WW
M8 [#( O$( NR8 Z"$@W"\(2SD SR "CKD S(P(7(H T<P85,* Q1^"W94(7"
M0%I9F S^3\B$T2 HZ<"$8DB&]2 -LC +N" +R!!L:_B$LA -I94.1TB%4"@H
MW="'N)"&@,*'PR ,S% HZL"$>"@+P 4HW2")LS ,Z@ QT' *3"@+R^ F^, ,
M78@,YY 0[-"%V:!UZJ<0T!8W(Z@M\ >"UV!)6+,)8;0'^:=_:==S/->+_K=V
MC1!&EJ &3' +29 $@6=O%5A!P\9+YH-X]8=9U=,#69 LSZ@-[D-,>()%[O.*
MC+$W1&@V_I!PZT )_?(%+*  Z\B.,\B."J".\*B.\8@ _L(""E9[F_ *PE ,
MRW!6C_=2DT "&1 (X)(/E4 " YF0V 4H6A "#QD"/6 .8F+^#CV0 1#I!0DQ
M#"00 AQ) I70*V( D1'Y7/> #CXPDM9X?L)@ A!) I-P2X'PD!RI B6I#D$P
MDE=@2\C0DA"I"#E6"".9 M" (^XP!3.9 58P<,R0 AX D8=W?H<PDB; #"JR
M#E:0 1P9 D&P#@B1#2K0D0-9" DA"AV9E</ BG'BBO)#;;+HC6''$_17-NX0
M6)# !OFR57W0B[ZXEWUI"&L7"7F@!I7%C,)V@DBD$@Y8F!NT#C&@!1U$5*M#
M*#J!5SW5?O+W@2?7%/0E-I%Q#\_E"BT(!C0HC^PXC_"XCC&H  @P /=XC[17
M>YGP"K*@"\T@CN>3#Y#@ 9/@A@K^8XBG )R$""C14 JR )QI6#W#$(;#D VG
MR(6E4 JG,(?0$)V;4 K"D"K#< JR )V.!BCC$)W;>0J42(?%"9VRT">H<@SA
M>0K+("CH8)S!^6:($IS;&6SK:9Z.B$E/&)R2QPW<:9RRL(?1R9W#@"3X@ S#
M, RXX(4)<0Y<> @I@ QI&1,R\W7S S\[]8I$079KHX1IL -*0!'[TXN[V)<G
MNG^8$ XNHDZ+N2K<,(=,!$+]<)LNVC7JX -:0 _&0G*;)HOQ=2W%5$*KX'DF
MHS7^H [=< ^5T()?4#DX6)HX2(,=@  "X)HL )MTP0>R*0S"X Q%B)N*0 *
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M*P( 8()0()A E6K"@Q0':P810 M"(=CBNDVWJ,:\3KS#P8!!/H&/T.(&$54
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M&72H $9B"6M@,U$ !A@!$<HX2R;^'L  Q&?B$@( Q#WZ$ !*.., 1'#'#0Y
M@7OG(1]_H*X2).&,E%.  N@81UG=P8,!,. !KK#! 2+  $>(=T7]T!>_]'@;
M#&%(L?S9#Q(Y*H!!T T"GR@A049@  .,RCH]' !\5L6)52#!  EPP"!4(8(>
M&@ "M^8"*\X& ?6DDDET.8=4HM*.5TQ",,LVQ"V%L ,6*&#:9E"  C2&;7#[
M]G^]]9^WQZ2+9R(1=+B[BN &7%@'V8,WV% '!Z"  ]B#OYN! G@%=> ! F
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M6 0R2(1*V(0QN853$(97* 9SPY&O"K#6@*[40 <'V($9R($O:  C( !B0(0
M8 -NR ,!Z -G*  *> 9'"( ]4(<_@ 1EL#SU6KCR*HM\<$%CT .:RX2;0P=
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M<6U[LM<-P$:!'"R!&%I]HT36$8A)#/8@>;/H#/Y@N$A(@!L[Z(,Q5O %1,P
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MACTB,8(99((;$9B!96[0!RD[*"+CVT@Z>I"%.88>(O[9-MU;4CIKI.)%/'%
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M%+)!$KP1M6D!]JG*]LVA<K0$5 #+Z<A( H#7"'3"5 S"C R"%K@?40!!+XV
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M F2@0V?MW4:HP]P85S?Z'O>MF9-8P0B 0NO@  YDA2^1GRIL 01 P _HDA=
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MPQYLFL;U:>*"R!KRF[>!6ZNN0L:R0B<X0 (@B3V.0 '(WP!@@3$YP"%<P0!
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MU.5N5,-">(0EBQZH:3(F7W(F=W(G,\0QY$$:J,&LCO*7Y,'^9>Z FBR!'O#
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MA@6#_)N!_#ZWA,B'2#YHPB3\8ZA?$P@S-*EO]@GS08E+SXF[!WO ^B(X'/?
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M/65N9FU6C8:PNW V9[OIY4(P=F&C&O(4D_@15W%5=WT7&IQA&31%&(QLGOK
MR*KV49 +X?11%GGD&(@O*'"D&"K!%J'+%Y>!6Q4XDB8)AT/N;<?W(=<05X1F
M83=J),IO<)EA$;RA&[1A%I(@"R3U!_S YH0E$O3K42'!8_E +^YK>O(#"5P
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M#%0S;! QBLFX((C8C"6U<V/(;P'G%] XD1ET)M60C5M2',7  W]@#N,@"8B
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M)UP)2YS"/8S$*YS$'6S!&!S"2<S$(:S!,"S"65S%([S%37S"7&S"-,S$(WS
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M-KY**^D*AQIJAF0P!W8(/J3+CW?(CWE@AX>@0768!W1HAN8CLP?,!$L !['
M('50@>I[$+23JL9#&V0@N,=*.'D#M?'#*@4Y!W.K";FY!UVP!,$3"73H@TBH
M+UK1OC:3-)J(D9BR"_;C/P\).Y2Z![.+M'J(-.L;P_];J%CZ/PVKDS-TAT59
M%#C,0SSQBE,+0%_Q-(FKN/,#+E SH*J8AB_9C=!8AV,HLU+P STPA#\ !$-
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M[6!@K3@@R;M%-$16"$P0 >"$D(9-B 9RD(EBZ(.O@8R.NTM%((%HB-'VBV!
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M]CM#CP,-:0#*S_M/-9$%5Q@&"!" !Q""(Q@!"IB!%J" "8@ ")  (. !(Y
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M5PS775K^=G[P'QUZ_HWVNO:[PJPE0#B%9$B3-!$# A  "D@"'OB!&J" ")"
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MVK)FTZ*-Z-;?6702&G"[=^_/%V<2"N3(<>.+L@)*[+V(@(Z- %?UBAQP=BG
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MTF 2"20<80AH9(-BTDA&"R"0 [I!@ A96,(1.@:RDSC 1PCX@S(RF,$P^$@
M H#1!(2P"&;(HBL0TX,CM 2TH!GC%BT4AM%T 26MY,P2T8C(U(97CTH,0SSN
MX!]$<KB0>ZCC$GK 8$*4X8<_'*/^'NB0A#+JL8E,'.L5?;B$+BZA#FXX(AKW
M,,8>(J$,*#H"@&7DACLRL0='!$Z'"KD'.F*P!;N@Y8?*2HCB5B$KR+7J0'Z$
MG./NAYQSR&99#^%'-([AQ<^5QAW$0 0BI)$F;[E1(?E01 BB\2D@0F197P#
M%QQQA #D0!V.0(2UMAB\<9 #(>.0P ,L(H'&./%8[D#'L7")#G4@A!OCN-7P
M./F6;&PA&\P[)O/PL:KG'><XGS# "+B7BBP(8A6A&$$"1N"%:G@/? 887Q!P
M0+\?^& 505!?)T80""UD3)R!@$ "<-")R'5(8< LE7^:(0E(0,(0D(B& ;DA
MBP<\X C^6<C"#B: @Q9D 0E&6((2;-  !T @ @TX0")N<A-9"*$ "!@  @A
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M;8@;T@]S<,X=% \Q.HKA"$B0SCV?VGAI\%$)*V2C/FFAMUO^EK4$ /R!*>I
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M%Y,%)&)H;7@OI&JQP.8J)\Z'^,YD.@ 1>*B#_TA"YFXLL5R2&@L6>HZ%.M3
M#!A!$<Q #HP#,1A!*]7#5<4'_@XTOB;54B$$K$+#"C11;+#!$<0'JL8'[I%&
M-B\$]'FL(/_HU'U@J"6 @@1" CC A#Q(*!2'*H3")_26%JRFP81"_*B"A&S/
M%01 %F#^B!:DPI!62$F7IDL_"'=]8#6P RCWA_A&PS,8-30\PTPY @J!<.D>
MP1*PP1*$@<OV@>FB;B5 R7CZ8;;D#)3@S"7P$XH8LX0I,^SE:>#):GIR"SE0
M,W@H\34/*JG>0Q6?U3*M;<#RT5+ZV"HT)81.\3AT0S-H0C&(L6F@0SA,Y!=S
M0XJFF"?>PS$40CI$LS;?D5ZLG#LX0P18Z+8X@S*D$IA:2V8KP_MEE3,L0V-S
M@S%<:#3HPCBHQSAL$6ECJ#-P0R;, (E*8#^H@S(L0_>-=F.?ML8UH#K4]GE@
M]&MH0R%H0T;?UC?>CRK 4TF'@G1_ C;E2RJL A(D0#8!@!;^A,($Z$LG.( ^
MIM,Y L%X X !!,(50$ Y.L Y7H$U00 .C,  3$ GW#6/L<(TK$-0!4A1(Z<3
M(J>N9,+VF7(?H+(&&P$3?$$>5/4?D->P8D(FE,)-,9CI28(_E9<:M-1+K5 +
M'XVZDLO\FHXZ7$$A1'"@OL9:QS7PS75=?_._&DCE(B5_YK6-@Z^Q/ ,TD'$S
MK.N5>8<[9"$D:((C- -E_UM%BP>01X0[Y,,E3, X]$,_*(,$$(,2 ((Z?,$-
MW  1<,-KZ4 .),$XO*68%P$WH,,2Y( .&$'@1$)?U, KN ,;W, .Y !9?L$1
M&,$,%,$6&8&=ZP #NA)J.0,/]$7^$4B#.BR!#JS6.*"#$N3 #AQ!;!O!$<Q
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M#6B>#KC^0A&X>69 $06X-A&XPA[H &,#FC)0 "5L.1L@P@I\=KG7LP[T\01
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MC ( X  $$$ 1QN,3<S1@".O800. -I#['"$ %.C# ]@@'OB8!T?T,0( "G"
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M'7:E"7;H^R=[R$,%?5V1,0A A(PH 0"6L*(<== -QO+@L0R(!C=T($>&) $
M7;S$ _*@CAM(H $N<4 .&'  (U"@ !2@<3Z, -O_YF  5YWM.+B!V]S.@ '&
M@ 8EA%T/:1!!C1&XT3AV<( '2""Y27C ,O+!A@84X[X7GIAVDL(PAFEWNT-^
M:83L#5[^(B.40BMZAE)E0 ,BG**_I/R..2*1&6B 9A.74$>FZ]O*?"C";7ZM
MT#T*#B(+<;(F]OB/>#Y^GCXZAI5BW+@]_%J?]5AGPQN'C\4KU&,@SSR@0CZ0
M(_.M;TD2^=X][SE3KK'QAPT]D42)ZP\E+31T]#0:S:#L)>KU"$8<]<Q%<( ,
M(B !"0QA-.,B5Z'!Y1EBC'WLS=$3)#:ABW#54&#%@$Y;\\%H1L^CT8UV]*(3
M[59_Y&,=]K"TA&]"]$L[+#OHZ'3+LW./8A2@ 470 0$<((T]$  1F#@ $\+1
M^'7P@ '2R,,  "&) QQ!%P]H0"9>48 PJ$," OA")M@  "/^7((! T!$[.F8
M6@!$@ (1*, 1W"'; I@^!^_NYAWER,1,W&,) G@)!1C@#$  @ EB D"> _ '
MUM=@QVJ3N4V<EO/NCI_\!_*&@+*3U F$\@BV6,?WM;..8US"=1>\("[<[ACK
MZ#_B*YI$"J !;F2NW?JO  VP,62.66Z*YAC0* A*:L2O_"30?XIE01@#X@1,
M[]A*[Q+-'S;0K=IJT1CM'D(+')SAJ@#!=;@%&J+!#W2  A[  1Z "*)A&49#
M&-) #Q A$X2A$C:![):#&#SC.&B(JH90&*0!!!O-0MR!':SC'N:AK6@B!)LE
M,E;'TO *;MS!\+2 :;3#'91H^"3^8 <.Z_&.( D.H :D@0%XP(H: !IRX(F.
MX !F@!PH0 (Z@@"4 !VTCAON(0\"(!/080+P,!,$8 ^N(W0 @ <H  "*@!P4
M @!N@ V^X \JC2;4808*( _\@ G2$!I@$,'\   <P0@, !KZ00\":1P>( =<
M@0#V8/#@)BD>)ORJ)@(GD+NFQI*V 2<"R&'Z( (BP)DVX6@R;F-^\2;4 1<L
MH1FB(1S2(1W681W,81J/IC%:#M,$)!EK@ALY[CN\L1N&81TV"0-OXOW6JS',
ML1N_\$^\\1R_,?Z^\>\(+VN.\2BB80J8H0'Y46$>$!>;+&H>!2!WT9(61#$4
M[:T4<B'^W^H>X2HA%\WNVNH>]H$$T\%"B"$3B($2+.&HGH$%%\X1OD 'E. 9
MH H:]D#-:F ']B 0PN /^@#M2$.JAC!<J,HY<&@BZ8X=L.,>G) =G' )'TT$
MYRH],"XB&3(IE5(I[^$02F$I\X$AG:$ =F :#>8&"D /^" /(D$:$@"*>* !
MI"$'LG(K(<$=[M =EH$ F& =)J &W,$?5)$8[F$"*, =-D$ ^F"NCH  G,$<
M:D  (,$?9.L/YFHAZZ$&'B N^X$'#*L&)  Z1E$2DJ  H,$?8N\2_&$)#F '
M%@ 5EU*MXB[NR'$A&6TA[W$H%G(;DBP7<Y$@(X0=&#(J%Y+^'\SA",:-!S9!
MK1)P*<M#%RJ/Z10(&IKA%C+& VOS,)6S-OF!-WTS[GRS'YPS.J,3(I62-M^J
M@!:&.N7C.>&..Y-R.J\3/),2.Y?2.JLS.XDG*/JQ/7'J'\OO05PS(!W$(!7D
M&A9P>3KPZ!9MT>I!"O$A'G(*&M+A.C A&MQ!R\YL&1@4&IY!@<CE&'!!-)B@
M -*H 7@@$RHA"11@ IB@&%ZA6\AE&:@*-,Y)*!.4':911==!1:V#'2PD!!6M
M ]T34:"A (K )R8/$##!!@"!L8; 'S@/'?8 ]#"A!@ !'V9  NYA&0: 2B;
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M6:)A?,?!K;AA AS '))6"Y9VNU1!%5(A@ ,X0J#LDE(A%1A$YR;$*.X!$&9
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M!"T:4K4)ZV$>E)4[0A#O# :5#^4>5$#,R7SE 8HUNZL:B'O-0V%3G/L0NF
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M^/SYPU?39C^;/'OZ_ GTIH\M08L:/8HTJ=*E3)LZ5;J-E=2I5%=1965UJI8
M7J1J28!CQ(!!7@(,8C5B@JH@!#[^61,4X J$$:M6 3'P26JG 4%"C0C M=K5
MP819B7L*5)J?'12 I%&C1\\>/GOV,&IT9<B0(TF,%-FA0\>-&S(6+'B >H@2
M-#IDR)#@^D::3<2&,3M6B4\8*&-ZQ]*'&"D^7/=LWB.KQ8L743RS>4F^94LV
MGJ2B1Q]4W-^[0EN4;V%NT[ERY<EXGNKN98N@=3;Y'4*_91)/<8&\>T'&$U5T
M+5L&Q6M_"'3QY71.>NEI@9]-R*07G1CI\-1(=]T=LI,_YP32!8/#\(1,=..%
MT]XG!FYQ"#\VL2.(=UN<$ER++MJ$SS59%4;C8#-.->.--F)%8UTUXE@5*]<L
MM=-.TH#^8TXSMQ03#33-I"/3/?A(V=(\[[CSDCON##10.NJ0=!%)Z0B43C39
MF#3212"=DQ!"W2 DYD%>IM...@/-PXY YD1CSCI2XH13A3?I-.B+/B$SG:&*
M+LIH<,QHLVA4A.E(6%F"L*(*!!"$$H19@02P12HC.!"*%P($\<D/ QR"@P&#
M=.+ "*I(]<D .(1B!0 !:/$CD%2=8V@Q2[1V Q-I +$$&WW\\8<AC4!BB"&
M_.'''GJDL<011?!PPVFHF>8::N+*X <NQ32CC"R&A-$;&&/P1@8\@C9*[U(F
MUHOO4?<6M>^+_>8+L$TR^MAKP0;_2.G!05Z3$U.VW$)/.LG^0(..-,5PD\Z?
M4[9$Y3U:UG//0'ERJ8Y(=-K))3I\HIF--"Y+$\V;#:4S$4GG?-D..^EL60\[
M6LYSSTL>FX.QE#3QTX], 2_-=-.(X3.%%Y%>E;"OK$PCQ@!=6+-*$ 6,,((!
M@71B@ &"3!' ")\ 44 "!ES!2B<0E.U )SA:4?8 (\R52H^3LL*.B_WH8L0,
M#T1 A!Y'S"!!!")TP(((+\0 @Q __""$$$DHP4:V0\C0@ 0/+$   ::=_L -
MC#3#^C.PA.$N;[WY!ARA]>YD8L,]Z=Y>O?_Z-._O1<V;E/ ]Y:ZOT\J_&&-=
M5F5%*?0(*UQUU5)9/U@U('?<4DS^,$V9#T_XV&)).*7@$DXXV>"2C9P#J;-E
M.UVN@X[\**,L\CH"^;R..SZ;DXTMF0-F38(&-([1IWAP:1UVTIG^VA&R>K@#
M:!QK":#N0;-[($TG.\%'/23HC@]^L((<BTD^3GA"F.2C>QMKR?8JV,(*KO![
M'$/*]KQ70GR@,(7=RR$)>TC#'\Z0>S[\81&-&,3NU2,?_<C'$INXQ'6H0 M#
MC,D2[]%$I#CQA)*R6J]",8B^L2(5AQ!$*#KQB55TPHRI&,0@5*&*-7;"1VTT
MXU7B&(@PAB(O!9/>*KR!#W>04(<\O,<'^P&3)=I$%SR0P>@DH 0FZ, (-JB!
M!!3@M@/^*$ !"$@  CX9@1D080@[R %J)," TIGN= VP@26:P8PFZ4(,8'"7
MNV8WAEB$4(2\[&4O=^G+8/+2A;TTY# _N$LI'<68PD3F,9\IR&:*D)G.E.8T
M0TA-:X*,EX*D9C9'&$SB+<]IS2,8]12&SG32Z!KJ !DPJQE"=_!D'8^P!3BJ
M@8ID/&03?,)(-[JAC3=U(TSU,YF:SD1"078S'NZ0QD!2XHQC'*,9!H1&__SW
M,9:X,!X6= F@ !43FKC#'.Z0B=+\ <)J-G.7"GVG!*4906E^K!Y'Z8<]1.A2
MEGK,I2H5)D]_&<R?7M.:/ 7F.]71@RP0\Z4X%:=/@*D-=5+^+4?78X4UI')5
M'EW5G%GE$8^F(56LU.4<047F3L$I0GQ 8P@3:(  &)"#)5!2#8CH P4:H( 7
M0 $*,1!! AJP@ GD@ 9$X)8C)4 Z :SR=#*0Q#.B 3--V!*7N-2E-B][V6].
MLYDP.8HU6R+487H,LZ1EZC9+Z\MUH+:7X1NG:Z_A-Z]Z,:Q!ZM$JJF%.JM%H
M&J,MIB]Y@HYB#,1BV7A&,29Q#)>%PQRSB 4S9H&-6&!CNO_D4YC2T;*,!=*#
M]<!)=^\1P'5 0QB;T,4MFN$R7$@C'?T+VCI>XJ<%MD-^"RRI2?%!DWR@HSA%
MN@DR5;M:F+I#$)-8K3R-TH]@:C;^P P.9CY"VV 1(C4+-VVF#4>HC=S62,.U
MI:U4L;>-!5M3'N-00@0>0  !1, (80C-$0H!B!M P%UEJ/%>7S #:BG!"#NX
M0>,>, #%DNYT$_A#-"#+C590=LEC( .$&2SBS6+6J3V)L)6OC.724MFU &M>
M53T<6W1"#WLUJD8TM5FA>W##'"B!;#%NT0A<4/3(L8P&-F V7>A* Q#69?.>
MI('%CWYT'8">QR,<X0A(Q)D;W&!2.$B"#G5\24QUFE-)$!(X?\RK'^;0G3/M
M\634W@,=*MB"$U&[99L(,\I9;O65U]$#+40YU2@588;)W.$^@CF=.B+K:N]A
M#T0X<@'^ 3B #3IG R0H@0MA4((0H&!C&[_@"GTX0FAV,(,(2*   2C=Z4Z3
M!LBVS!5,7K)E78WN>M :LZR.<+L-V>YT]Y++R_/RKG-],#+CME<WFD:H/\@3
M>33C&<TH!BYP88E(_ $3F*C$)3(A"UDD@QD4;]*1CZS<;' #9NB5QP=KDC1^
MJ ,B_6#'(RZ!BT9\8AA$$P8T%)*.?\I\NC6#$SI,LHX!L@=&.C%'<7)BS%T"
M.,OI&,JI2UM3G\K;R@^6MSM$,0QKTIJEV^ PC:S!M=GB>GKWEHJO4>N.9YCR
M 04 0 .&L <>\" +8(!"+:D [3*, 0Q5J$(4JF $'NB !T/^H$ $%@   7S;
M-#RXV$"9,?=R5_;?2[^L.]9]Y7@WOL&2/R2]ER>C#^.[ZYOOE;\S6R%[Z.+-
MFKA$PAO1K&I-Y@^)B 0E-N$*611#HL=(!D4-6,!CZ$(7NQCX,\#!C0,"VA_I
M8,0NXE&0B83C%,=H64*BRPSI2A\;L^B&)(@!IY&X;!TSJ5 ^AL^3HVM3_)@E
MM:E):TS(^Y+QDU__J<G_66TF4IH7!MFM93L856 !"4% @A="P0J'8 5B-%OJ
M% H$2!BJ< 674C!?AW[KX ?B(@ ", &<DP-A( ;0YBY?L%=[504U]BY54 1
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MH9  /W#^(U7C#>_$73(E#3L0 6U5;#>@!T9@!(% !C!82T@@!7 G!&U78V4
M!4)P!$)@. 0  *:S6 Z0!MD0#A,1"S)(6;& #CG88#L(% C)D/+&.SR8+_@
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MN@H.B%G2P ,S< ,3   +\)X\L >:0+.7H 8[T *-TP /, ,Y< (?H#F:LSB
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M#,4@"Z^@"6F<"$&ZDGF0!GN@!-H:  Q@&L!\ !(@"8RF#MC@NK[A"L7P"J_
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MQQ$^'>H'R( ",I X!2Q> PK,@ (AI#@%)B"!:3+  +CND "&P&M-Z&(&&UI
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M?- %Q-T#NYT!;OB"T&H 1"A1 HB &N"&%7@  E "60TM!M"#?5 &"2B &CH
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M46?8<!OX@\;\R]\N:=%2Q&@8@@)0AGY@ P%P!1YH "=W! W5 P"XA'ZP:T>
MT"/X@\3<A 68 #_H STHAE))AT*8B\ &G8PMWZ),;(ZE#\;64]KJ!W-P!F:%
M!FYHK)5427-@![AT61;[;&KV;$-O9A8K]!;+;&,XAD#?9FZ6!IG][6AK#5V1
MAT#H@1[^" 2?& 8?X/0>\(%30)-"B %1MP*+?0<L&'5.%P3FO(=C"'51KX0]
MN8=#$/4>F()K I8LT/4PV,-DF )=KX2%F 1=GP*DJ8=UV )=UX+AB 9B%_5)
M\ E02/9D2 AW<'9.CX$L0 <ND89IY_1#0#= /5];KMK"5NQTMV>Z2CAOI UW
ML 41'H@<5N]*I0"RE0"#)@@'N"&7*Z&1(0)=V 3=K&'^3GB+GH&,V"%T\VA2
MKM<9"(!(R(0!X %)L($CJ)HB ( ', <+-^F,20))V'#HM8$#4-<#R(%+$!!N
M8 ,>H!LS=@8=   >((;1E09)O00>N %I8 -0W@/0VO$ H.K^':@';64#8^!W
M23""&G &1\@!9>"2<1@(?HV&!.^#CM\!0'B ". &1 " '?"#&G(&5V#=)7B
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M9#!X\(" @  %'DB@,$%&3 H2)$2(H/*!@P8,&C0X('1! 0)$BQK1A:N8K@@
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M.DD.3=(]T4PRZL]7-^EC5D+R[<@K?.,GI5:,.RQE)I'@5X0#TH#)MS,2O%1
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MNB&\$;W#',+01'S)ZH@^( (1:"UA.F*P!<;IYZX<)' ](;:.840#I.1Y4?L
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MR$$W*: #(MP;J%D)L':Z,PR3E[R6#OZAW/OI/O:SOSY^ZQLZ\/R*5\CB%<+
M__WW+XO_KXC_Y5\ YEP 7A(R2<I_ ,C(/ /&;-.!E%<W14LW34A[I<.R1(,F
M8((&WH(D](&^,4+8.4,)E8\6D!WYP17;J:#;G90[0$0N[5K3K%\.^9)Q[54?
MR5PT$,%!-8">"$#@)=(A[00C+1*)(<H1&D 1X,**Z0+D:=(2_)&GG-*87=YE
M2$!8#)ED<(.KN$,1' $Z$(,C9$)5&$$$L($RS  WZ$$1C,,,7(([W, >] ,W
ML$$TV$#^$K@#-ZR +AC!%Z(#$>R!)*1A/7P!!62*5]@ .D1")JB#,MB;*TR
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MDQ$QB/59B5JH,8(C&((C3+=OS4,/M#6 \W@-;?=GUU34RH<X_,LZ,,+9)!8
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M@@]H0\3S/(>&@+3W=XAZMB[!CBJP0O4._=.HNJWMM"Q%0XDSK"X,-6RW-@U
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M]$/2$X8)0/)Y;*$!"?0#@ 9F: " )0+[PP9I%"+)GW[N*>*(>W(Z9@8*" "
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MESV<A?C^R08;U['I4<XVZ_R:*=;P0@ 2  0O?$(5J0#-(!(P@E!L(0"#Z,0
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MPQG"$%SAM,0E"11A#Y=XQCAZB$I3FO.7DQO&%*0A)F[X( ,D($$&O% V49A
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M=[@C&,  Q[EU_(<7M&%5K.H%'8A!&VK59A.2J$0;'&%;3&3B"_I@MP0.$/0
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M+:N00)/N+)/B"C-L'(Q@ GHR B:@07L2+-!J+%;,ZJS"2- 0#8?@&)SAQ28
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M81[B 1RH#SF P;F;6[GO0+G=X ZB01H^G1NXKQZ.X0:((+4."QCD[1&:P1D
M"[ 0%Y$,6!(201S[X+SY5 ^RP*=W,PO.\<C3R1Y$&;Z+BQM:UJG] 1,TR1RB
MX0&D@=EUP4)T00_4X1[L01EVH &R.A*.( DNX5V6X3BSNA[^=&$)E. 2,(\;
M], (^KL\5? (_.!=R/T+'*$%TTA<_, (_*@>,D$)E, 5T"8:V, ( $$=I($"
M=$$=_F 3O-*Q/Q;%/36,(=YZG1!!U?$S.6<<H $7'"$/EH (=,"N;USD]YJ&
M>Q("AJ 9?)PX)&$JT6%W(%LLV3-&E9PA)!;F>^S)H1PQI/PHJL$+   +4H,5
M1B !4D$0"L !S&H .D$0"(CH#Z 3I@ .[[Q51V  W!("!H M 2 (5@$(#N 3
M?&"S1^"M5H$3$J"!$B""5H/$>Z(:J!V$#MH96MW0EV$7GN74\8 ()F (X@$?
M2&(?Q@%-+X$(B, RG5O3[P /LH'^&\9A'-8!B/@!$D:@#5CHL'RAD6WA<[X;
ML&2!3BD9$M1 #108O?_ @;MH-]D@4+U23"9!%I3+'EZ! HI #_QA'4Q+!_"!
M$BC@'O#!""2@#WAN<IQA!H:@8V8 $?Y  G0A&FP J"7@$ERA!OK $6S@WQUG
M'(B@""[!"'; '=C@ ?3@#R) %Y1A!O*@#V)%#]T!Y/V #2@@!5< /VQ &<;A
M!I* WAU!%V; &92 !S 7(.JYJT>PH$%WA289%+BPG[^'$"/Z&UCOGK95K#)J
MW(AQHT>-JSI^Y#BR)$B3'U=5$\D*X[9^"V/*))C/'[Y[]]:E"P<M$R ]3)(4
MV6%CQ 3^"1$B2%B*-&F$"4J71A@"+9JT9I(P22HV3IT[BC/#BAU+MNQ,AQ(E
MFEW+MJW;MV/1IIU+MZ[=NWCSTKW&LN5'+P"T:!R1(!60 9U4X0C0:1  (*NN
M ! 4*@&.558";/DT D(H" D^51ZQZG H(  &J2(<*LB 0:4#<&H9<N0T=SCO
MK>7FC!FSWM".V?K5B]>O7[SFS!B1!Y]S?/WZ\>.W9 $#"!)6[/F&Z=(C.KN>
M<0N7[AYTYTQLT.GERQ>P][6$00L^'UJR8YLDZ9=$2?^?)7OPX<<??PSX1Q]+
M,/$%$PJR\448862B&UQCZ8:;6?G\<4,?1_CC1Q%**.$/$T7^/#3.'S-(X A8
MZM@@R3VO9 *-*Q1<P@8/[N1SR2LZ*%$5$5_ E(\ZDBCC3!XUH+.#$?UP0T$F
M22A!4 Y*Y$/0.!+\D8\N%"AC QO/1*/#@3N@DX\KNOAA0Q%%C+/0A#.YTP,6
M<,J$ET$7H7221WWIB=)*)/E9&RN TN971N=06--#SN&4CC30;(+('FHLD801
M0^E@PPPR4'"45-B!2E4TV32SAR.W1*...A2V6H^5;]4IZUVNUEJ//;;F*I9<
M>O7JZZ_ ,LJ7GX!=,9@#H1"6BC56(#9( %=8XT4 @:1B  ZLH ;!" Y \ D$
M$*222@*D'?:)N=:PAD,"H4R3V2'^UO2IT6UUEA4-,\LL@V\RRN1R'"\ \]+&
M#2- \E _C?:3SA%+U3##!)5TDPD?C-"B##KFN -==/B8PX,.M;#7'C"]U'),
M,LDX8]]]RF2RWWZ1[,&$@'[43. ?>2BH\X(0LI&)KK7FD\01F>P0C0W"Z "(
M/SKLT8\QZ]R#CAX-Z&)E/LYTJ<X7.Q#!0P/*Y(!(/E9RXT .11"AP]@$Z<+#
M#@P7P<T,FMQC# 7&U'!)/NZ(;:4]7$:3#R(YZ-+ #FGG( D/>]PST#U',"#!
M$?6.I<Z<<=%*D$6#^NEYH"AA%)*\+(DT^NDEK>*-HOX@;%,^.+GS*#3"7 +(
M'GFD$6+^$D(!\;$.-]Q@0PW$S[""$;<DG\D?F$"#SE= VPJK6[AI+GWTV+NZ
M:+#<=^^]3</^"5@6UF3$;2H_O)8L8H( D$4U@ 52V669;9:%&*F *ZX#Y1IP
MF@&?6,6Z3A, 0:1B,;,YE )9<9NVJ",:*OO-,J"ABUP8YSC$X04=YE"+7>PB
M&,\@1U?0H8M+2 )G>E &,X[!!TJX0AGJN ?"SN./8MR "+SH!3!&QHM'+*,9
MSD#9,I(!#5E48C^4Z \BF) &FA6H9GY8D,X8% 8VL"$,K\A>02H7EGNHXP9_
MB :5F& ."A1C'12XA30F4(Q\]$,:$=C;JRYA R)1P!GU0!'^-VP0":RQ01<2
M((8[H-$'<Q2$!TM0!SHVI(P52.,>CKB!-&;@BJ=)0!<T(1Q!E+ $0$:C'LKX
MPSAR (A\C",,S["!'FCDC.E5Z')9X&)![D00=^3I<[CT7.ERJ9+3=8Y/B8(+
MKQC5J'N88QS/: 8N, $)0/2!#6E@PA)"%*(C6-.:1CA"$IB@!"9$(A/+0(=7
MM*=%85JOG.A,YT&&^;UVNK,N?/FE1Z0% &.UY'R',( !(&  9]7S&EL(@!=4
M 8$!!.$0"8  #@R:"@E,0!7C*M< _A?  79"G_P4 +SD.:]Y[(,MZ(#&;WKC
MC&7LXH+_PF![?-&+XN008+WP(##^FO&,9]3G&-!0AT/XP3%\\ ,0-6C#<=P#
M'UN@C(C-6(8SCH$+$[Y,$@@*D(%J=KL$,4A!6?C"%_*0ARQFSQV3D(4L8W*/
M:%S2'36@@#2$,8%T'","W,@'#VS@!T#H( ?<T,T]V%"$>V1" I1P! 5TX(XE
M[. 2.U"".KHF";BQBB!&(,(KV'  V]T@1THX0CV\UM@(N(D@25@"WV[@B!8E
M(1(W^$(]V)"#2Q#A"%G#8P[TX$JQ>%$%L813O=BIELUI8X'RTE-?@IO+SP$J
MN*O8QE@S)Y$9Y@,?ZE@'.M#!#4@=0QB;N$0D'%$@/NQ!#WE@ Q/"P%4]Z $0
MCMA$--#^L0[HJ?.] N%M1-A26_AFK[YDN<<[]\O?B. CGL1E12>  *^,;.$*
MJ0B%%X*@A<-THC6'$' 0/L$*0># "JHX!!!>@.#(8$$5JK""%E81B"F$0@Q(
M2,4JMF %<2U8"T$0P"!2LA%ZL84;S!"I;_+EKW_UXCCOV04P@O&>':[TQRX%
M6"Z6[$$0@B,<N/&I.Y*  Z&.[#UTT,5\)DC$^V2B/R^#!!N6P <!/;&N5]6J
M5AUT13;(HD)P08<*MK!<@]R#&WL81S_^8 E_0&-IT/@#/OR!#CYX30_2,,@W
M=?,'(NPA$H"H!S?R8(0^L,H92BC"']!A$&AD-A)]((8K'*'^&T>\(A^>5H(C
M  $61)Q:'7V 1CZ4(11$D*,>X]B#$?+\C#VHPQ[+8XL\K! (G(1%OA"9$.<Z
M$N#4@6Y/T"9NLT&R2XX$\RV#K@M,W"&/52GRF-R(!@2/40QAW&(3F<B$)2YQ
M"4QD A?%< 8W5N6.=60/5Z["=UMD>$[[^EM7V>ZOP-OYW]$5EU!82$ 0O  !
M9!%*(_'JB"I*U\N03*,C*ZGX*B[NA00 01"@"86>;+P;(ZFL-Q54*7&"#(UT
MN/R8ZB '., 1#"(;N3W$2;(%><'D6BBA#3DD*LEJ48PAVF=EQ]!$)"*1Q/X
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M1?A@6]UMF+JNWQ*YI%O@I.3MCXO^*)D*9#IWN9>BPVQ]B3I^Z4M@?Y=WN3K
MKA.KL@X!YQPZ^0Z#IH/BU/8&X6U7"B=X[W)PX@ZK8@[I\'E76J:/11#R4/>K
MLD5XOX&.$UW>QB**Y'*%+Q#3I4B/-1"05V\7,N7W(-;0 1'XP [T<(44#GGI
M<!"KHJ:G7Q"$CP[R )&-WWGL-2'N@/AMJ8/>=H$%80^I[W+H_?BK;_CH$ _>
M9A#BU&T;*! 9N YH\1PXD:_X, _XL ^#.O&M1Y(!QJ"%"-K Q4N8NI^IR]J:
M*6X11/*]/0S*0 S$P- 8[MN]G?Z_/0S+, S'8 RY??(G<Q^_'?_&, SE5FX
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M[1)(G\H'72" '"A, BB">M"%"3"  R@" UR" SB !7@C    "G@%"2""EF$
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MJ-6\KOV+S1P5$1>ZP+VDFI^#R9A$4)9 A_@ZDF1X!>%D(T0PA.*4M4BXA$K
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M?6R*4!B$01"$3O@$\^HY8[U J>"$3[A C%T)Z.%8Z+HN=]@! !  3:B/'3@
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M@!W /F6X 09H "* RSYH@ 60@$BHAS\X  EXACY@ +ZC@#YP!SUX  >(@"\
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M*P  (!B! '#VP?\!' B *T"" !!= P ":V#OQH?\R1^ 3IB"^#: \!8$RQ<
M' @%@P9X$\F&N?#[W-=]HW $ / #Y]@$<_"'R<2$!D@"?_@" B@&?S"" Y &
M'1" &K#^ 0>X@64X ![PAWN(<J(Y@@/(!G-H "/0@P* AKX/Q=U'?]WO!VF
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M^N>I9TYYI$KUT\UWRS!S#+*,,#*?L^V=@<8-.HS@7QJTS-'&!!( D82R243
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M+&6)RQJ"29<Q%$=FKN;*H0"! 'W^",DZPJ:#?BB! <>H 0 (L =H3( !#9@
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M*MA  L@IEP !  3!!7G#CEZE%43!578E1H)E1!:IHSXJI/+H*B61'TB#)1S
M!*Q#&!1 #CR !$1#&$9"<#0F;>1 !$B +N0  !R ^@1 )FR" !S  [!!?-T
M!0C <QQ !$A#+8[# SS 'RR4 !"!.S15$N3!%V2"+=Z#+A" $D0" ;!! :P$
M &A"'P   T@ (CQ'/5#F#-R  .A />@! 2#"##2 +CC# 1Q!/2A! >C  U
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MW*V:=(EA6 ,0Z$5*8L$ LH(U2,:/W&TG"$ 6D&T!9 &:-&7^5Z#%WZV"(/S
M)QQQ HP%! 0 FDY#"OS(7U19 OR F]SEH0ZN+19N4-"C#,,P'!?MXAH!\%4*
M-!B :9RK0K%*<!3!=++AN>[!,:Q&/^Q! %BL 'P!I<V !*B#, S %]S#$A
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MND>6%#S^J)>$270J) .%8TCQ'G6"2%A?*X)*)H5]0U DJ7X*J5??%):)29V
MZ_6 BB?ST5C?>0OI!Z9#Z/4@A!2.0<@=*VRN=XH$ZXE&!9$S*&2_[:(4]$(?
M1R6R:2%'_;1I)5?QAKM X#6I4:75Y2X?=6YH@)L^ .BC'R4 \$,=)0)PA8T
M_E#G;3\N"2 /=_: TY4"C.#&B (VF>$!91PI( ^GNH9R+)W2+8RPQ"&/W.M)
ML\$B&TLQS]PLJ9\N<DC..W?ZKFD.=2<:Q919AAA+)('$$&8EFY76V#HCC=?;
M<<55F-$\\XQ8UXC!Q!+;*F$V-TN@C?:W2!#QHSAND5,N.3[^GML6$DD0J6X7
M=$]Z_%!T5+ "&0L14F<89(9)W\5ZI#E_F&2RX8>E;+!!!IMHLADIG6.*21^9
M<48B#?2E+QGJ<,<!HY&^]$5#9^I(AO^& 4"$9$.!R$B&B :DP&)$0T3K.,8
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M=D  CJH (N 2@J*+^L H=*$&^B 2#D '=*'Z7"$)E( <E&  _J /"* /7H$
M&H --J$>RG KNB(#-U #Q4I4T)#T0/!I<NX:WJ%T$LB3CJ$2<./H6# T7- %
M]<I6>J=7GHY71J,U6,,D+V,3/ ,3;(/,(L'J@K"7(F'L\J#-O&7LOF5;%"OM
M=H$<LO!0Y"$0)F$44:(@_8$++3$I46+0"DU'\,X=?"3(W&(:W) 3K($5<*
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M$5<!%)0W8GDH%3JA$_R)%:BW>8/K>!L1DXQ(.ZY@"F8,[PZE"OL@ M W A[
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M:WJDB9NX+X9:2N_"J)7"H=*EIR'GB98  &: ![A;XB*  ')  @+@ 7+  "@
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MO..= C>>8M'=]N '8AA4/ICA7NA.HF^36*YP;^N.+?@@"L3UPE>TD3[B]F#
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M" F0 &4W $MW@J$P @(P D%P"*RP!2_(@?(8"JSP P80"ITP "/@!4 0 %Z
M ^]H#3\P %>%5=,0<EHU&)Y#&+GRA,=0#*3S&)0A#,."&:GS&4*2":VS":+@
M"G%E&F]U:5"".TY"+;ZS5Y$P><-3><.!";"H,>D0 UM0%N%8$-QP% \  #N
M#CEP (3^1@ \4 ]Z( "9X Z9T <[$&O+4  Y$"!?D(G'1@#+ ""<J RO$ !L
MD _*0 !&( D"D ?W, X/0 &%Q8#4X7_9]S[_4T (A)?_<S /T3<1M)=[24)_
MV3=]B1U_N2 B9)=^V8H& 90).([6H8!)M#B8\IB528'FB)E@(4,"$Q*IX
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M3VI9,WJD%80Q_D&D3:I ,CH_^"%!.8JE]C.D8 JD"M1 ;X&E6VI!/IH?4:I
M0XJC< JE8+H?%5JC.KJE8OJD4%JF%B1!41H@91JG.MISF8FH$X&!>B&"0" (
M@J %!:F0@V"#KXD#.:B.D/J"@X#^ X)0J:$ ! ,@")W =J%P!5$5!*39"6XG
MG*^2.6>1(M!PG%\%5HM118PA.L? #)%A(Z]P#([&.EPT::?!G;WCG4KR&I7
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M"67GR*]R#=*S/['*.83Q52XBA30B#(QQ&(_!&#F",YN@1;%3"5J8"9- K)I
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MT$D9/B(:LE"2UNDCI1'/T]+8C;UXCJ<&W^L'<%0\@  )<7BB_U?-=WB^C%)
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M!IP+R<?H[F' ?084G.B<C$!7^3EZ&C2<(LJG#QWZ4(CNB3-M"LUH4G9$54#
M :FP!A &P D(0("CQ!&$%@)@@!%<834&P($U.K'$EP(!-[[Q0@!TYM%/G)$3
M+@T $.;H!6L0)X]?PPY ,V>V\122&<I0#WN.48Q$#N-N\;'/*V2A"ZS*0I(
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MAG@:DQ<LLS1LK9GSRX=2!U),*F>(!F=8FZ:"&V6HA5K8!5UP!5AXA34X@S;
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M1-B#6\CA@*Q2O_;(A%23ZE@.PT9JUQ+LRYB'=TAMGY $ 2#^P'7@ :G. P*
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M[=,R;='F[,=:K=+^;,P^[=>R;,JJA(#(0FN"K4V,+<[J1$]TK=IJQ&1&2#\
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;*%\9RUG6,HOK<6$%;W/+81;SF,E<9M@&!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g44361moi008.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi008.gif
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M"AO!0[%%D8P%3)UHVN&"CNVA'7-J$Z8.T@](]/%EQ%K#&06B#TC 2E:(ZJ)
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M6%3HTV3M]DD,L9+?F1#MX(X>V84=\P4T^(4"L9Y;**$LZJ++X(WD-I,&T0S
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MGYM0B7# V90*-SM20JJ+EN@-3RG^B"B54BHU&B(I"R7YC!DQ&BX]E2G=#=O
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M1("&UDB&)+ !Y?;@$;<! M=@9&B""Y_-0E!Q'=YM (=J:/@! TCN^?8'3I@
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M]W:<CP!"P.]RAPIVP($ ( !"<.-&'VZ9(/QW0(0(Z($(:&W^9X@ '$"$0F
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M2+,*<9V[3[4) [EA/Q"AR0C0X#CL2$(GFB"TP7<.$Q2Q#DXZH2:_ZZ,)$!#
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M<$(-;D4.?04FF,DWUIM(+&2%+MH^L (,5  7E)\Z54 ,-(0LK  S" $:^$,
M:417J<$%B ''>41G?B;$52@HCH0\F,OBE$J$[&CTU25XM,SKD,L$O!&>N) 3
M3%($06#^2+J.@G3",NEBX' )#"&"L, E#>W'/7;#*QVE0K00SQ#1S/09J:"B
M +"? 4X 82P,^3V--X(C*]J)8<RF7<!C:0B DM )?)+,,N)HBK #_1 >H2C&
MOP%H=43%QG0,>]C,.<9B#ODHN9@+3;#1JX8$A5[JG<U""@1!"72J/X19$*Q
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M5P7"-W>.,%=DC-)J6[&=*STS/?6#.XSS1@0Q.\L9-J2 +.L#+=MR$,C#,ZR
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M&&)CVU3#R-"I(%&H,E)$8[WA:UI4!_, WOS*F5EG=G0UFA"LP H( 2O B2S
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M)$ %GPE2%4SY8%AQK_AQZ8,0E ##L0(V*[$*#)<0[+0U@&RDJ=,C](.0GRH
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M?90AMEAEGO''&A8TF&4\L5^"ENR7OO&-MSUE;=6Z!T^Z=YYY3&-N5.E')GI
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M_LAP*N[^X0P_1#&@P0F<(1F48(C6 @<U: ZYH@=7"+*.)QF0QX3H2Q]*JJ3
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M4$_?@!$YUPLQS9//<@P#%*)G?FS^&"XA& "A$HY )9!@,X?M' "!!HY@!Q*
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M<5S'&<9V D;6*P<X?S<"$2#@+225 7@8'B.6@ W @!7@2LLB8Q@X< E  "<
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M 0-..-DK2H7@4$@$$2102*5)VC ! 4X<U$EF$> I':E)]%#R!,@(1(\3#.!
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MU D!SK;IH*S<$\?0L7KH%WGX7_9\%8E,B7%P"]) #;N@!_&;MR\<R4GWS[Q
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MGT%C-C AR; [+/-<A) ,2G N4<(.EVX#U;,H%F,#/^#2Q70(-%,FW*($"I
M/\ UMW0R)H0)G:!8,9,,/X!6P%((R8(#@^0AR:!F2? #P84).$ #/1#H3C!?
M[^ $(Y%H-F #,OA+/T #2> C'LY8JL8M3> ,A$ #.%#IT!'GTS5(O</1I]X>
MF= $_M0C1R+I2(/N#2)A"I $>?'74][L\!-I8;3K0-,$M1?^%=?X=KJV:[.!
MXSX<<4RER@1A#SJ>*5QM%<+,DM/<JK_XJDOHY/29CW>P*.S-,2UT:.7.#FHA
M:8#V:OWP6\X @YB D2\/2:,V.^]"9[,##9U0/;/C)LX0,W.>62/Q"YCP#H2
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M),F1',F2/,F/1$EI4,F1G 9>V+IG!$*9U ]]@ 9G\#A=<@CM@L)W< 9W&$=
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MR+D(=O R)4 S):A.3 BSS>D$>8B* (@ )>B'3D@"YK$!-E&>,+.!M6"7 ("
M67L(&Y U/LF$"8" "6@,3 0)^:102QG'58L(9.@!3N@!"&  +3F,)'@+9_@!
M*SNUW)#^3G6Q./;!%W1I3U*IBQB-@ F8@,%@A_U<T29XC"Z3JT-( H=P1T)+
M@ $P#@L5,R$U/T\T.XW("XG(H>Q9B2:$#WTPAW2HAW0HTS$M4S)%4S,]4S9=
MTS8]4S(]Q)_HS,,Z!^<KR$WP 04X@F 0!P=AS0$Q33\-!AHHPP$)F=J\36/S
M18Z<AN$$3D@E3N$,3N-4SDBU5.9L3@X;/?LHG";(26BA1E;[@5_HA.1:#$]J
M@G?#@=T "DM4@",Y! /8'60P%YQTCJGP)!0M(VK)IQ]H#UM++F?Y ;7 BC-K
M KV)EMF(EKPX#9QL@@3@!)_(! 7P)7HX#85K*1RXR4+PBF3^8!MS<09G4)ZI
M0(8$4(*\Z &W,#D;,*/ZK*IR.0A&J8M.(( )>*%NK0M]\"IZL $(33!M' TG
MV$=H<8G\TE'N&+,E R[E^AH%B(CR/)),,"YC#4_$G*YS^P$&Z(1]Y*W1RBC^
M@$RS.Q.3FHF?S!Y]. 24R(1M%(IZ") ) 9F8C5F8G1";A5F<53&;O=EPL ?'
MJS[0;#L6) 9B" 8D (0C$!#6!! 'J00?")!@J %BD)!P2%0"@4&1R<T9ZP='
M!<Y)O=1'Y4VQI52P%4)-12<[,5NB@ 9,L)P>. *$P($$F"J,*)4?L)5M6:4!
M"T\_R1>AP@H6[:0QR@T!> L,JXO^5\&-U:J.9=E6A%""?8$IB>@$A[!&Z-"-
M)EB,BN@U:BW7S4",FZI80Q(TY\%$FF(-3<.WMV2EC< ?DM('&S@7<#D7U;@(
M1T0&MKT*LN@JA)6(4L,-61T>Q/@!?2B+JW &&%I=.!,8=W0()X"DN HXG^$/
M*CP[,7&"0O@;)#G'G@B:='R/EPW(G_-9H<@'.BVGSR2*R8O!8&!-A60"I?7"
M;R!#B:3(A#R08[!:VP,GK?6PC@1; %9.Y(34KRW)7<C4LWVLM-T/?8@3)8@*
M7>$=M:HE-CK0ZPG/8)F35V&'=.G00CB$XJD63[(4MB& 7QBT!-@(U6F5/EJ6
M\R&$14G^@#;*A%ZSW"P#EA(R"-?0#(_PI.2]5Q .X7VE)-_%Q/V4C4+TI]7=
MGM;E)/&HCGVM#G9!8FQ8(P=.@@3X%OT*BG29'P/XX ^F 0B0AV[M@>R5#:%L
M#5N1E;-X7IXDLB; A)*CWBL5N\>@X:71GE5:D(FP./BH!_%]MF\@7Z$XWW(*
M6G\0S0 AADJH@55LQ4I@ AHHS4O8@4KX!D#8 23P 8H\D$3%6@D*&4;53904
M8 #>!:^-U$DMX))$X 3N*TZMCRY3@!]XFPB(8+ ;*KQ@AP0@*=']"=CY"&OT
M&@.8@% Z9I=("[KUX4$[@$Q(JY^P#3:YEH\@!!H8CDXH- +^,( D< >VN$;5
M< _0L0'L30(#L!2]\ E>,68E: )W;EO>0I? _8G3.,1Q9.+NF9,>J([9A0P(
ML.="J^7L-(P<Y6(%> OV,8!V;N<FD!9&LP$"8P"72./FG2[GA220>!P"(( >
MX$3(JN.PXP1.L A$J$Z=X$F@8=FQVHKZ>-GJ(^2@((?J6SL3@[YQ$ 9 $) Q
M# :>)@8P% <NM(1AV,(:5+K^[;#_3654!EM6;NH"YDVU?>4">D[\*)Z_&8_=
MO9_VD(=X'C0#P&",$  -)A=S$8I.F-O 8(U4VH@>"%V_Q1M5JN:;&HMS(P0"
M. C=N=QSUAX#:(*KR 2T9N9;\F7^B$J?W\'$\D3BTXI7D*B,>N63?4:?=4$5
M,9F(3RHA'"#H">!+B3AH9!*8PQ"H56T/QGY<2*KHYYVXDR4 PL:/ZC6[H'$"
M3/ (=K B@7@4F:(A*[K'I'!II8-IA3+D;?J&+&Q ")G: _'3<#@'Y7X0_>7%
M"/F&H^ZLL2CE &;J5/;-I1;@Y93JQXIE^$ALOA87\;$+O.B30\*(5OV)[2F/
M?K5;O&4'!>TDM%[6I\@JML@P:+ D7L860IB53"B4A*V.O,XR3'(E2-0'R?$(
M<UT+Q/A;^8988,V-  C'W+CL3F( U9775MJJR([BAZB,L6* 49D /QXP@KX7
M+I[G^GG^"D,IZ2;X&]5 !GV( )+:;X&1%8?X[\= AB-MB+8&Q?=X[;-#!C]:
MDX8:))F34Z+P[:(#[M 4[FT:R'-L[F6#0 BJOE'>6I"\[D?-;NPFSFT0<N^>
MJ)J\#]4H!#C16-LI[]DX;[U(@E] A GP"E=M@FM!AL>A507H 9@(+TL98:2Z
M[[@@#"'M!.X:4>RIYEGA!(6&%&%:UA=Z!V@9GM52KF1P HB&(749KEKU\VR.
M@!VBY3.!:$Q\!_04Z7!18GG5EGK59][5I:""B%RI" )0<T[06+3:8I-C<7:X
MT($XE?5Y',KDA M]##2R".<X;4@JV.R@94[XD2\.69 N04#^IL##@O*/.""E
M0V1%3C$:'*= EAA0#A!Q8+JFZW(O7_=+G=2H+G/ 0<$@*X0@Y4-,\.NY"L]Q
M=2(QMH&J@,1YJQ4;YX0?GPU6HY8EZBWM20+%=13MT5B$YX[YSC(G6(Q,X*XK
MDZG#R$Y,T_,_00;N(F<]'QX-C8"#0'0K2X)>.\\QRP0GZ,-!2P(K4X*I> <E
M\"'1RFCW*(2OZ <GX(W92GF/Z =Z3RZ4J'B?!VOWZ</9DC5(_)0PVVQ+MXT.
M=7F'N'>'T ?%I $5"J\K.P0H#+QJ)T$G']_VDSLJ#\UREZ#G7GMR#Y M]U^/
M_-KMME0O7V6P/6!XYZOPXP\V"?O^B',XCO,Z+M9)@N+@P/\((?\CPR>L?EJ3
M0V23>(%*#BZA>>.XF4!\RC\+4/PC/[9\T#\,A>JZ=VB'0F(3W7T/FV/\R-=\
MQ:]\A2JD+XF7=U ')A?[>3S :__MG^WV.RVZY\:\N.\P $S.N__RZ_Y:5][[
M @+ =V\8,F=^Z4<(D?W!LB^GVZN'KAN'<3>VM&\[MT>@X"](Z>[^ 0&'"AQ^
M#NO(N@]@5F;WN5_^Z3<9\)Y_^^?[L?_ W7]RHI!%UUL@@!@7;B#!@@8-BCNH
MD. W<_X>0H1X+V%"AA6_B<,X4%S%<!4%%NSH,=PX?!%/HDRI<B7+E?VD]8HI
M<Z9,7C3^:]JDR2MGKYV\MK4,*G0HT:)&CR(UNH\7MZ1.GT*-*G4JU:I6KZ*<
MUPL>UJY>4=9;*!;AV(/V5/8;)[(L6['?QJW4MW9CV[H$RZVL=VPOW[['OOWU
M*WCP8)-?H;Z\J5@QS\4X?QZ.+'DRRJ5-*6/.K'DS9ZSPMG8.W3*LW=('OYU5
M"=(T:Y+]5/*;V[KLMX8KI]')K5M.;MZ]Y^BFX[MW\.*]Y=31)KKERUTTG>NL
MN7CGS5T^@2[/KCWBO&F7MX,/+W[\4*U<R7<F/;NTN-0IR:TW/>YURMCQ2SM4
MR0L*E"=/^OL7H(#_$=@??P?R]Y^!3T01!8/3H.=/8HY1>%/^8XIA%Z&&7LTC
MS7<;@ABBB%UU>-Z(D=7SS7UVU;/2:BN6!1=LLL%X4'XI[=<@@E!$<86"!O(7
MQ8$-"AGDC@PZ& 6$Z$TX7847SG1AAB=2>91E56*9I98I?6;BEE6I5^-8+=;W
MXD''B#G?C&*.99M^.L))I)S_$1FDCG;R&*>#;2Q)7I-02@===(/2-.67AT)T
M)53L.$/?2<XX$U<R[UCU3C*.=D9/,O0@VJD_YGDZ58ILBB4.F>^%E&HEQ!0D
MS# '$2,,JV*5@VE$_)A):D$WHK1+GG("*^05P?X:K)#!]CE><Q96V"R&H7:J
MZ%.$T, I2C_@L)(S"F!B%2(1L+/^'#(,) /MEUV:"U689+%YZDFXBC4,( P<
ML4DXPR#A@P^6%&0)#_\&(Y:,*<FEZVENXFBLPG(6NS"P?$;8Y'/2$4IA8X:F
M6Z6T3CD1@;4G=<+)2N]@ DU1SB!B\DJ(*!!N:/UT0@ R&6<)CS1>TES4N@9O
MY!Y*N0[T#2" \#!T.( @08PE-[QZS# [K&J(#[,>I&9]-.K*ZTF].&RLG<!^
M#7:#R8HGL;-0VN2<38!^F/.))2;%3B:<O-,QI>] TP\RG?C#CLG0J/P0-.ST
M PVE^CBC#S29=/*Q/^]TPC@.-I1[TCN<9,+.(2U#M'@F@=/3J#.95+XX,OI
MU,_HF)S^#I$S[US.B<L/T1,Y-)T8,+/;;X.VN\XJMH;U0NZ>!'0XWS !R!&O
M$K.#)0+Y4,E PM# ZC T!*P0.2O%!CS/06L=42\-,TQLGN37&2>/9(=G=F/O
M.^L8QKYON#%1R$0 @0T]X! !ZH7\@! &^$$_DD# ).# 6N_ 0>88D E_)","
MA[!!!!30 TKY QD3F( -#& ##$;$&39@@ UP\ /.]>,0^J-@MS)H@PE.P "8
MZ,0$(F  )[SF'4J P.02D 1.L6,"A>A!!6T0J;Z=T 8V2$+NZ"<B4#E1*#OC
M67M<))9@'"$!/+#$]80Q$"0 XASA.(8/ !$,0"1@$T CAZW^(&*?[^UJ);Y:
M6-B\1BR%L0\\9G,,VOBHD_E%D3P=:IM0WC$!'+!#'YD@P 0H50@/9H)2V/('
M)@A0N4Y$ ' RA" !(L")VB7@$(^;0 \2R3+=080>/9A XCJA ,YQP@"'H(<^
M-E>NF/W &?)00@)^@(QW%,*2E&0 ,OK1CUCRC1T*8  BWN&,""CA(4U0P.F<
M08,!H#*0Z$&7-EDR18.9"BW&.QXQC@"('0CC!I<8R!$,01!A(,&<V%N(U5#R
M1C@>+WP0V0^>NM8P].$Q0ON "6,H5E G]4(:.P%D-\%C/Z%P@@ B>\@//.8/
M0@3@@13-%C040 AI_L ?T-@D,@3^\-&']"":T"! "]G!@$*<)!D$0 1$G-"R
M?O3 !JA[7 2<X(^83;03 J"I2 WP0$89DQXNA2D[!D@?)]"@'RYM D0J6;F&
MCH>;6 6+]^!81=6(A0F6.((E:B",Y(UC&#4(QC!>=8E76<(':%+(P.R9*^&M
M1Y\/X86>CM77]-W1K\"Z0AZWL\<G3<QB.R'D5K<#-Z,(,'!V\\<C9S=)?R1A
M OHP9+=&^D!D2!0B/P@I.R+0A-> 5J-5%<!5-\<.92H@";)E8@]^:H#*R91O
M(N760Y+1A)Q.0 !,50!,'U((S29# "W\J<P:*QXH.A<BWS08\2("'X6(8ZP,
M@%HX@K'^ R:8\VA(. ;1 '$#?M$S+GC%+FL0AA*^ K1\@17LP@JKG67U)":
M.EM^H[30Z#Z7*4=Q@@%F-UE", "$V'I-+/<&KJ)V*[<0,>!##D& )#2! 3\
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M9K$9B[ 1(VB4*L;?YS#4U)G91R\8VY)D&."DVXH I1"L8!S0)\,,F.A((TR
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MY$, ]GEP0UW'=!2='%+K(T*;VNK>!]O=H981I3O#<[;JR3\%LDG;\U<7<V-
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M97!#,TL#4'##-% #4'PKQL\#=F\)L"/%.T0  /@44CA!$J".";4$SZ,$)]B
MR10"YQ!"$KP&)NA\5"0! \S0_2'^0@*8#-"G+@#Z_$G$X!$%!2+@0+5CR9_?
M)+N?Q#S0P16T0=F;_=F[P=FK?=E'P=J[?138P9N?!"[C72M.@RW80I+@PF9&
M01Q0@W(F2"/*@31@-9'4(C S2Z+2]U=C_-#V.'4"0Z)Z:3]H@]R?A,W@-UY_
M85.\A%]O@S3T S5P SQ0 UXGV\L'DIT_!"<P@,L%13^\ V'VPTY5O3_H RU%
M!.U)B.Q;R] ?SDX1P@3H.4O@?BKU5%QP"LN83#\XCCZ,-3VTT6:U._1+2$3
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M$Q .Z5#N-<B%@PB!\EALE-2E8IR@$'I >#*AS.C*ESH!9#[CYW!%"_VC!QC
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MZK&A5HB%1D0<(BK4NC*&[D'":FAH<@@:.6J'XL $W<O4SA*'S.[6TNYM=FK
MN+'OLH39)"$'AD ,EJT($H$D)*$!0$$:/ $%= &,X/$EMJ*KZ!$K!P4M\/$Q
MS8(EE4#D1FS,?FHR"_ J-S.%A#$<8,@K/P0L=48<OF$K92A%CI&'KJ"E+.)H
M9 IIO@89':(9W: M9PW5-K!*WD0N=8HG NP:Z[( NY'9X 9.7 $-/D$,&&$(
M0D(:_G+^&G8!,5L!!5XAV'( .\](,ETBPAJS.SV3+(A0/"?$S6Q L[HK$WJ@
M*,O3,PG0/>E&*V/H&$H$-<-A*TD3/T]3'([A&V#H/\.A/O]S*XNQHAJP1=I
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M(6[S19FTFX1L&AL=UJADS7**S9$L3?AWN?V'I%JRP)M'$MF;M22A"D2P $"
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M@$.:Z"$) I2@*Q,"/"I\@K C2 97UR%X%70#?C#;AM[HB<#^;!JT?B<)!9J
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M0>HX.152O9EY- /KM#U!B[]X$\#*KP-IB]P#% .Y.+_BM+B0N1N$->*;C61
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MM2;@!$@$1@$(%V.[M9V0626@@;1$!AZ*")Y]-0Z_">V-#G]V#,^%\$ Q=.9
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M'Z5 PS@6HCM%@!C>4>@9QQLV!-VI7S72X):-AL?PGU7\HS[^T,!M]L,U6HP
M>%6[$&9N) $-_$+.%> ?L4ED2HN@](!/BN4G2L0O.%\T?F9HEJ:!'BB".MQ?
ML 4-8A #7 P#K,-]), S-I/Q-* _[*1$ *.U>8UP'$(F'N-DZ8-(Y(82$,
M<H43" !58>@Q!HQ/I&!J=A)-?,@/) %BVL#40,/TJ 0#% =;4LBX< @IIM\[
M#N)82H3TL$,!"46,EB=,E 016N$'&4^2DLD/$ !A6DHHOEE.-.A$.$@_Y"<"
M>=4BZDEFDE^5O@,-&, 1CF1))JB<SBF=ML5ICH4^R =PF9X($L >Q)Y\^&*[
MT([TB&*&WB:'%J'J=<(A)(!_^(3^11P.)A8,)[0EL>!C>;C=26"CT& " = .
MTT4AGCE!S?"$/W1" A"?9TP E27 #S J:\P94B""]'2-^D$ F( HP#"(?W1?
M$@"806SEN'B<=!HA?=' 9W!%1A3"V[@'0B)3!,SAG%A(ZC =0XRI?;#)4AP"
M<EE<#:6I1YX? %3I78!FG-;I%*&KNJ+(/IQ/9K6%WW!<$FP)(M! 169" ?$#
M.AD=:@2,9%S%<IC)P!$"Q^U9,O2 $58/VD ; VSE4$Q T3% #Q0,CZ9-/\R<
M$4[0E/B>L1Y()_0 !/P$H72"T>' R! 2 CT'L^J.[^0("G'=T@F'378-@]U*
M)^  4:K^6 \\AA)T@Z^QA]^]#6?<'Z$@PH"X"L$:89-Q!-2] ]#*WY4I@<L@
MT#AU@@+L&%V8Z[/TPSQT;=?"P]>&K==Z+=B*;=F6[=BFK=C.P]F:[=JZ+=O&
MK=JV;=RB[=R2+=RJ;=JB+=_BK=S:K=ZN+=C2[>#J+>'*;>#^[=OZK>(B;N(B
M[N$VKM^V+> N[N,*;MX^;M]BKN1J+MX>;N4Z[N4V+MWN[>1:KN&>+NF:KN*&
M[CQD[8)"BSE9Q;D@&F&1&E>\GI34T*H,2;9P@D@:9P2D2CO@KCX,(U?H0SM<
M&F$E+_(>R^P^"+$<+[KQKEA0[YPT+UE8+^Y:FV>)Q;GL"?;^%$)LY@4\%*BI
ML!DOK*\T2,/Z\D(O2,,TK&\O],+Z3D/]QF_^UF_[UN_[OJ__\L+\WB_\YJ_\
M_N\!%W "LR\O)/#^+G #-_#\[L+^,C !(_  "_#_!C#^\J\!?_ #2T, ;[#]
M:C !0[#[.K !#_ NS*_[#G %OV_[8C#]EG &=[ !B[#]9G !7[ &/S /JS *
M2W -\R\/^W ,X[ .Y_ ( [ -O^\-@S 3/W$-^S#^#K$*&_'_(G'^TK ,PS 5
M"_#^QN\2ZV\O4' 8\_ NH# 88S$,TV\#=^]9L)DK/HL^@"1:,&H$N.-62.6Z
MAE0F$ (#V%FYHN^,?,48VV\B+[+^_S*R(S^R(B]R >]" 4OR_E(R)#^R$V<R
M)S>R(Z,Q)&,R(U?R&9-R_8)R#&_R&)MR!7=R)[.R)XNR)>>O+'>Q)\-R)+NR
M(L,O+N-R*??P&2]R+:_R)?OR*I-P(ONR,;]R!/?R*2]S%T^#')O%G<Z(8A$R
M:OI&+>7,-/^Q1,B#$MC \^S%NYZ*MZ!R*Q,S)Z.S+MOR,;OS*%?R,K-R$5^R
M*T-S.Y<P/$NR/&LR+/]S/M-R.]-S/SMR$=-S.N>S,>-S%T/S0?OS/MMS/4>T
M)P>T0:MR+C<T19^R_4I#-Y-%-6=/FGDSI?'%^9ZKBWP%,,]R)O,".UMT,NNS
M.MOR1 _^=$+#-$['<$RW<DWC-#Z[=$X;M$S?]"[W,D,G,BH?M22S\TOK]$PW
M<D_#]$\W=4LO]%!#<@.WJUSLPR[4,4FOJ]::,PNW,SLKM297] @3=4.3,BRC
M,QJ;M3V/L"[ =%+7LU&S]3VC-5+O]">_LEZK\ET[]4J7,"_,M4U',BN7=4 #
M=CSCM5]G]%X_-56W]%_;]2A+\US$X%=O=D.<]+.H-$M#]BWKM2Y3\D1;]5.K
MM5"+MD^3MC _MFJS=FRC]F#GLVF;,FK/=ER/LFM3]BS7ME3S=6H+=VR/MFQS
MLC.OMB1[]%R$-&<GZ/J@=(OXQ4HG]VK#]48/-VOC<E+#-G+^>S=XNS9VGS5Y
MC_=Q;S1 ^[9Z1W5VNS-<I[=VMW9Y!S5Y[W8 ,[=<M.)S?_4*Q@B)L+=Y+S9O
MQW=HT[>!!_515_)DRS9<+_B $_=Y$WA.][-Y.SB$*[=Z2_B!,_B%$S9F;W7L
MODP'+5Z*8!>)O\F1")4S$*!5X%I1]3>,4#=K*S9:&[.%V_<Z%[=R.W8FOW1!
M]S9.=W=.4_6/1SA9'WE[[SA1_W1%\_B!"SDC6SB1[S,^W_B-\W,<9_:WM$4R
M\!S2R8@SG&%:_&,2M1WN]L.N72\.D&4^)96I@*:3LS0ZY[9"8[1%7_F&&[B3
M*S6>=WB>/_B=_[F.YS6&YS)#!SC^D%LT;L<S,T^#5L>%<ZOH27RT7A#0?8[%
M-XY3N,CQ0YQX:XT%MA:59YMS?2LZDB<S+P"#H,,SHB=TJQ/ZJD^XJL>Z?!LY
M@1<YK3-ZKKORE2LS3U<P?D-ZB*,%/1@&#1"/=-(#>T%;!SW;?=!#[_CA'='7
M^'Q)[Z1<!P76@]$)G62"<"$(<'W(-V)"-^"KID@GI/"/LW5[1'23;JU*]0$.
MI'22%U6A\-A:LTO5ES I)ZC1[#PHA6V>/M 6@O2(LF-"OT])?B((BX-26+_Y
M86.UQ'?R6^.ZGQ>XGM,Z,+^ZCG/\J2>Z0F=\DI?Z:ONX)?-RK>\ZR;-ZL-/(
ML)\%?A#^  %$R31*#@%(R6EXC0(0 GQ$1NX9P#&M1FM,DH4= @VDBT(:H0!>
MU;9M!%9,9JR2; 0 ?64D@!*8'@.\'7>6+S(P@%9\QW1H'FQ<W"'.(FR0BWCD
MS=(9'5YFPL7=_(9&  T(X&'>D="M1O*A!'\*P,"MR61,H7_8(H+L++^:&0UD
MZ]/?TZBG+PXW=5,#]\4SL\I_?$#C>9_S^CL'^N1O?F2C.LB_MBX#L,=S/NAC
M?'9G>7ZW66_M)/):" YT@K,IP.3\3&V2WP1\X?0%GK)#IU5LV\#1^R&F!.AM
MQ+AC(\H=AP&\ZI"Y)C2@*/,Y0P24H3,JZ1Z>J@%,P&,E0P+^Z(Q(#>CT88<0
M7:T"+H<\)('J'<DY'M\AJLKP(X@!, 7X0("(' <#G-M6G*,-<$)*[!K3]>/9
M4 9 ])N@Q!\T&TWZ^5.XD&%#AP\A1I0XD6+#>=+@5=2X$>*\7;U AA0Y4B0O
MDB-YI2QY$J7*DBE-]H(9<^3'DRY9@J1)$F=.ECM?QDQI4V9.FD"!^OPIK2=/
MF"B51I6J4^C*J4:E]IQY,VG(IEF?7A4;->S5KUZ5=DT[;1_'B/MX<7.K$,>/
MA4D((%,(2$$WA?IPX/#W3H$3A>P4_$BH[V!#PC;>*6S"@)W"?CUZ%#2 R1\R
M ID4)B-0Z+ "1 4)&%:(B$ R?S_^!"OL9$!OIP"J11]*Z(^=/L8]=K-C0)K3
M@$X*.0G@[,^9 4[^)D.SC%ESDH5-<"0D!"%R0T(!0"ND[D2!,X7O*O>CH>0=
MCA[TYL:7/]\AO%X9Z>=GN(]GT;$Z92JK*+6H(@F8E(#1:9>M #3J*+)V.NN_
MH'32Y:63%IR)J F=TBJF:799T#^T.+SJ(Y=P(K FL+ **41>I+G)P0U)_$G
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M( $B?&0:,/*>2'*! B \4"1,D8;^ !V! $=XA1?M"T#Q!%  1_0N1O 3B;!
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MH0SZ1>UR80P"  U0X0$DX!-RD!'2@!$R4 UTH14\X1- (0$< *J&(($P$ @
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M#%'!Y/ -CDS ! @@!VS"%1#  1RA('-A%Q@A!Q[@ (3S$18@  A !T#ATG3
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M&8F@%7(@\E @.GE!SHB@G("SY69S +JU 73A%13@!)8V "3@! 9.L3SN $X
M#=1):*3A!$^@&O^G%_14!8<@J,X@)%APX4P",Z_T#!A  !QA" S :*.S@ P
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M1,(5EN#AAF [QP6DC0"F'>&;76$2=* !<N 14%,,*#J(MH?^$70T!SPAOG0
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M2'G*9/S@'1?LQS%9N,ID0NR4\KCE%?OA0WK0 Y4X\^ '37A,>#83&KW\ 2>
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M6@ +].#^"7P@C2814;3#1&L'2_[&4)W 6"Z%<DX%?UE5;5\#42*!#!.0#._
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M( 6><&FT@ KER1+],'4QH63.4&<+A F8!1.(H$<N4V^<45^=(92&-4ES&J\
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M^:M"_X'%,#$^E(=76WS"8?R:S>J].(.]NLB<).$.I'MZ4K 'L8+ 6L P,\/
M:[ ,WXH*(;$/Y>0+SKH*T @+V L2.).L:W!7.$%3U'='4L)5NYH3+!-+XE=D
M)_%","K"(@%?'OMJ,@%9AVP2!WA,)^$,3X4S>.82A:#"[8H,L_M!-E@2KGP2
MB !86)0)F?"^G#$^[K!QW8#)B(;)B4I*M5Q&F!S*/9'),L$)ERS&RWQ FO:_
MJ.BK_L#^!ZUXQZW8#?NP#_"0K-%8R.X #_! #W>LK-< ,>X "<#X"OVPS:W@
M#A#3#15L!4A,!;$ "ZB("NJZ#\9:NN/CS"\!#>&E!,H,(*!%"'^%$W,:0L[
M %DF,DV0 )D',W55:\J,"%7,E DPRRTARTAY/;8,39A0S##3 Q%00)F0 !;]
MR=/GC4ET$O],IG25DBI<=ZD\>NQ&45%VNSRA#[D+1AEM$H@ "(K5#RU6"*:U
MH(00?3/5!()U:3/M2CB)$Q'H$ID\T3*QRLR,U>^#>2_!PKZJSE3@BJ@@BUJP
M!FO0!:AHNO#\!40<!E] G=1;UE\PC'X@0=W BG!=Q,&X!K3^D+[ZD*Q4$ 9\
M$ :RF,:K6P@"/1(W"T$<^ -$I$: =X!UE4\2AY/OT()O! %5QF(XL$VB]0.@
M65QJBDS!UM@'B$PI^'&<0 B.)U0;B47H*1(_>@CZY'[)4&B)-&$QV+#!AELV
M0%6G^5#<!@UJI)?(]&" =5^ RF*K'5"<@ F8]T>(1@^9D$=B&P&SK=I0K0^V
M*C),9&[L('%?U&L5K4C@G98WI%85:$QO!*_3#:!DN-JT]$8XF46V:T+!!H$,
M0&W--0&)I _L_4,75&S_Q'ZDZ0]3B8!"YP[6)A*=V(6'T%')0 -4U0^J#:_0
M@ F%8&&J3405OMHX:9\KA]K-E4?^OP6H!\BZVI6HJTU1U#V[4V4#."G;J%3;
M66WCW!.T_RO 7IVL?B RL3#8P6@%8; *( '/J#B,SVH,03Z,7X *M"<2[VS$
M0OX%GM -U] %5J +_> -?F#$PF@%?$#.+O&-M/-5'_E'C,584DA688EPQ98,
MR,  J"Q$'P>(#>528$I9;G1O5(8($7":MT:FG !BV=5]1GA)$\BBS*7F4VF0
MG(@,-/">3B#IL,10G(!>'5<_,<A0821X"BE!/C7%I)VR2L )_*8/-L!E2A9(
M<_IA62E$H[QAEQ1K\H!O3T67@^YOG0 !U3>$"(<)1IF&?TKH5O9AL 0-PP5?
MQYX,D,G^"=K451#F6-:&"*8%:Q.0"7/J18U-$MM]"%X7$E.L<'V.DT+'#H P
MRR3I!(#Z5YH.@5YD6H<P 8>GZCUZ@(8N2#9]7S/';E0UCT@F8!A7H!% >-!&
M7:?>;X<]6M+'HG"$V#<.\=D3SKM'$M?@"[[J#LO F[Z N?ZP#>&[#"#/\4NU
M#*\0"[70SB:1#;FP\9C[>LM >Q!S#;0 "[%0#8^+/N]&".(V?TADHP;)6]+'
M#PE)72+C!'I$?TV@76X$1Q/P5E)HDYT8@S[U,81%@(A ELUE6L'E#\!59DL'
M6*P&,8UMA&I$;U[4B4+%"5+-28 '1D??!#X5B1+Y<JQI/X7^  $H!PT3\&U:
M9)^:3ADGAT5., %S^NT8EY'P-9>!IG]6)VT-> BRG-XR)WU,90-.\&W*%D4K
MJ&2?EDA4/!)B;^X$^)6C9W,1F(/B;7>*-':QDH(Y2$1'^ /R\%4%1VT<M7+W
M)HD<"&;_9+ V8)"9,*NTY&54/&_(X X5QE!3544OEY(MU*F!A.%4%?'5+SN\
M!AJ5)A0:)&K###N(R&WSELR-B9/!AG]3M5Z&I ]'8.=4!PU(^D>K?7*M%(&U
M-8%KO\A6]U65&!+TD%I7!A ]V.'H!*V?OWZ<;'3#Y*0?.X'L?K!3<@C:.W^=
ME/C3]\-9$TS^1+)+0DBD$TS.</S^0(8L"30<[Z#9<*91I)(F/]YUZN&,'<<?
MR42JS"0RTX]^_9+]T*>D$R(G_J )5,+)'Z%#F)KXR]2C'TJ1($5V2N+O7<]"
MA?PEPY$,VMH>^D0FL9KD$,="2)L4-;H5&=)^/SJ)I$>(D#Q_A4PF$^AR\,"?
M3>Z*O)GI+#N([&RJ1,:NWSN/_CAMY-0$,CL;+9,<=$+HHLBIF"!B=)+)V1%]
M2_NYG"J3IK,?],X6E)O0QEO*R94O9][<^7/HT:5/IU[=^G7LV;5OY][=N_7.
MW\6/=]X)(WGTRIW<Q;0Z22%.R/39J-@#&C(<F904ZBB4'HY#,-*-DP0ZZ2<)
M9'CBQ#+^3G! Q 9 .JK)!DP0@:B0)B9@!Q.3N%I-*AR@>2\^9S#!9")$>M)-
MMT*<LBH3')!QI@=Z#OG!Q$Q*NZN_=R+8"A%"W@%0"1O>*>0N>3R2C*A,H-$'
M0&@PX42PD7!H A$E #D+&DYZR"0)1/ZKZ =H.G'0AB8"\Z\'9(;"02N'G )1
M2I]L0,0B)_:+H!-D,L'P0--$2M$M"IUHHC@E&"C$P@9/Q"09!NSJ1)\DG,AK
MI\GTZ<FEM7[@*D:(Z(0FN,34.H2_'C"<X!T@13HDB4XLDY*NF2SS*).M&O('
M*B%;M"$W&S@!#3X939PH/62357999IMU]EEHHY5VVNN0>4O^,ZD..<2M'C Y
MQ!F$.BG$P'XZH6<L1#!BITUV.$G*7'TX*203??0QT5I]X,UDV[4.Z62P9,#U
M1T:1$I+I$$2<8?5;?]C9=MV&VWS'V\'>\7<GLQ!)&)E#.#DW7WK*_2G@@0]I
M:>"WZ)FTS-VR^NFI=_8=C+(-YWU'97T2\K>??#EA6)],,)$Q7XSB/7>LCD,V
M3Z1D$/X)&?@>ZAB9@V7K]Z>&^>78,I'BK1"3=W0>S!E$*FP3&I>;LHHC3O2Y
M+^*, 7::'6$.LG:MMYKF<RV!Z?%S4I_)#7HG?9P1BF22.3[9WJ+03IC5A*F5
M?'+**[?\\NB2P1KS9I$YFG/M.DEN$W322S<=/$P.RD[UTUMW_7788W\V)=F_
MZ^>0S6MO3B;=>_?=V9Q_%WYXXHLW_GCDDU=^>>:;=_YYZ*=]1Z[HE0N[>NRS
KUWY[[KOW?CQ^M>^G$.2^-_]\]--7?_W8I^?>,_;CEW]^^NNW_WYE P( .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g44361moi009.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi009.gif
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M1BX&H8.%?IKL0X\E2;PP089PJ'M0+FO<X/<$+_@PA^0"(:A@UE9[8FX%?U,
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MAXY.@BD!A-(4!%2YCU6TB4E.( @];-E%,;% <JQ3@.L40H4>+L '7B.(.%X
MINS18P>7G&%!E.@F?=VB F!B()$H(+R!_$]6/@@G#<#A!%5A:Q$&P04$B'0#
M^@BJ3UK^&MZ9PNFD'*D!8P)Y@I,FD,]([FE< V$3M2#Y2#6 :0>4B"@E)F$)
MB5I"<OFPY(HP:;4%GLI'$O !$L Y28)(@Z38"EP2;O#+%?G I!00$_I\T$HP
M\6X@#@43!6Y @WD^B03[<\4O%?"F@50"5 VH@1-\0((P04)G/&-(/<[(+X9D
M]%0!1!DDP"3 @5#!20S0)CAH *8)^$ ))."3 M;I/U.M* %UXB:+D*"TG*YH
M08KSZ (DL*Q\A.%+#K!!$FR0IQ4Y0)NKXQ,#5%F[<%)R'W!@8CD9*C8OK0I5
MEPTK0>ZQSP5PM$P[V),3FB&O:(3V231(QT",V*(G@.,>^:#^!R40MB(2J.L;
MK>13 ]+ ,O&Q %LLZFHN?!JE,$B#'NT(!5F)%*U]W&,5M"5JRN"X@ = (AWY
MR$<YJ&#*Q[(N5 PI!PR^1(>&7$%%)2R"IP+YI KL;Q_1(.E:RR$0=ZWH!KG(
MEPY!U=Q(Z@D"5)A$&VZP(WHL:4X0$"4ZEKL "KA14$Z"@!OW,5PG28 2](CM
M)"( W!H,2QHQ91$EV0LF&W1HJDYZ@3@HVS^)N15,\1,( 9WT "S""DRS)(@M
MB$L!=36C#ECPP0ZZ01 (KT@"$P:Q*:5P/R,2B0<6"P-7[\=-!D# "1WRI9L
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M0$W':0,EN0]L>X6 :0UZY<8/\,?^IN($5ZN!</@D\4J#J8"W-? &CX %[;D
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MT% !;R?^ 4?KA[QLL[@,R\0<JR^MSXP9H3,<T[2JLMLXTX79PSPMPSZ[(@@
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M!MFU]'/!![0C<&- _G,L'-L4V$/!'%21D-LV"/D+W,L55C$YI&&K3[,5(73
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MMOB&,K@ #$!-]CC,Q!P/,^" U#P/<M@ .[@+8LB  K" :^".5\@ 8-@'/=
MX\2.;_B&X"P'[;"##9C.,]B >1B1/TS*K=P'+?#&M!3/\51+\E3+F6S+MS1%
MEH&]=! "4IB&^)2&^)P&9$ !$+@$Z,B'"P"  [" _RP  +" UZR.:QB #;"/
M,R  Y00/.P" UF30M@@$ <  #C#- ,#-<L   <@ #1B  W!.6BB  MB "P@
M#A"M?.@ "M4  C@ T?R&"Q@ #=C0#0A+[O@& M  \M"  YA.]" & >" N]B
M -  ,_A1[4"# )C,,A" "*T.8#C^ #VPBT(P@%K0#@X@@.C< !_=SCQCQ?L
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M"("@W8, @$K! F)Q\%4+Z 9ZV(6NW4P.P-"M959&?HMO"- R4*HR<.=]  0
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M-@++/<##KO3*X4EA' *!,X0%*9B ,);//C'"/DS#_QRB"9C#/G2!0UWAL(
M%TQ#,'H $"B%$"S+/5YA066A#4)C]>6#'IR( &05&F"C$KZ" 4Q<.F*/S%C2
M <#;A-%#(7!C6%S#8Y&%4^W0KW2#(#!>^'00L5%?/FQ &TE8/<")<H3DKQ"@
M.'#D :ZB!YS /*8#(PS!%I""0%P""/330QVBS0VD5$YE7@3!(7!!5.;%77B
M"3R0%U0E5C;40&(E1%6E"OQ<0KJB(9Q LD 45;)B60Z48@#^ B#4PN:9!D52
MWSUHA+2)UP&T1U^"8'=8#U#BRAO-AI8DX<FA 0' )(E@@!J9A4:($:[<0P9<
M %'B"F\<%\K5# =*V+U<@![P8&+.Q1FV13[09 9.H5\@ G%LP4.-@%,Z@STV
M% B@P/Z< "/J)@J@  B(@ H(@7!:Y0@ P1 $@7#F10F@@&]^Y0CH3PF80&:,
MI6X69Q 8(UZ @ FH@"(&@0I$Y6X*P1  00DTE AL@5(8@G#N)@KT(UXDYQ#\
M@'Q^0 FH@ E\@ GP3RV6CV+\05YN'N-]H_IU1P:LAPH13)F)X6&>7&$&8:+,
MANY5GT90VM*5R5EH!&K62FA<B(3^16B&68 !N,.$/6AJPI,\G2((:E@;B@ R
M[ ,R_,]#J< 0^"9>J, H?(8Y,$(M>H *F(,Y<(%3$@<C,*('8,9GU ,F_"@B
MU(,ST*@0.(-2]*A8.M0)8,)G3,,6D"<IU ,C."4ZJ( (-$( 38-=#,&23L-W
MHD.VW 4(=,$T*$4](,,0L"(C,*D7/!"4!@& B@)>ZB448J ]G AJ!EHA$$,'
ME%GNV0$:E(,9%,(K; "5R D]  *E;L!C,4>FZL&$#-5;T,,1[D,YE$$AR!U8
MY .C8  'M&3(]%@&E $Q7$MWH,$=9$ &/.KE0 0&;  @S(2F]4V1*04L=  &
M:( >F,;^*W" =-C!1Y$%+90!+6S !DQ/EN"JK"Z)&1""<119D!"#M,[81]##
M?5")O<W#'41'JYH&N!XK&DP(N +#K1;9:]1"8%W &11'&;S&'=@!,!CK!A2(
M&^ED&=2"&31HM]':L=[!X>V! 02 !MC9;I0!!G@KX93! !  !R@$/>@!I1;9
M>G#HTNF!!ICKG=W!+W  JU**J Z I]@0+0"LIQ:7&4QKM0*"O#!K!]A0L-I!
MD5V#J;H(1!39J2P)'U J!^150^QL@C35M7R#CBUL5: )5=C#&5@/.92!P"YK
MK_ZJ9I LJY:9'P06!NQKBM;*:@[>![+A0*% .NR#(\QE0Z'^P#S6 RE0Z3Y@
MPO^L93VD S)<0F;40S"B@#G4PR@80B.\+2(PHC[RHP<0[CZ@ R9\J4",I0@X
M93I,[L_9!8P21SW(X@C()I-B0F9,0PD( 38(A#G4XT+N0T-^@"$HA2P"9#TT
MI =< G&8PRCLZ#X4PWT>XEWF91HRGHA.V(%PYM+=4-+XS@:(PWS]!L$<@%/D
M T(\1Y08F:%8P$Z\4-Y,R-<<2-<$13Z QWF<UTT:".!$ATZ=2G,P#@8\K,?5
M0@+A*I=01#DDDLOVTAT, +TQUTP 0E9I ,%LP#L6BI1D+"&LDP <:U'91)LP
M#G0L<'6X$ FJ"#W<B05H &SMSCW^^,NQ1@FMO,*E9,",S!TZ%=$%\(10N((!
M")9P2==3%-4!G(AA@50C)1*\,(0)<5)$D%6?<,D!Z 8LS.^,6$ WM(-,A91-
MY$N'6("#O:W(:D^^9/ &ET: _-^,$  MU$.^A%1J[&__*D=5H,$!$P!P^<8%
M.%IJW.^E% 1N9,<O0/",^!7A^(OU#H ?< 0P> K8#,!_<,-+'2MR9$<]I' ^
M7$S2B8Q[D/%Y%!/"+,D4:W 7H4$+-Q)IG*UJKFC7=: A JE2(,(5ZN-E#*?H
MVL5:]FXM2A0B>( 0[$.V/.(0> $0X$7CUJ+H!B,(Z.,^C*6:"BY!X2XIB  (
MQ&@];$'^"?BF%EP"%S34%A!'N B!4FS!_[3NX +D*)@ "*C /,[H!S3";#XB
M)D0N7"8&H YH\;J<F/1,6&C%?*!+*[2) .P!T<426'0'!T0*D0D +*C6#Y$J
M"?L:B;ZM"CE,DAA6Z\&" &#<!0^ O;5$NNQ! >P.(3B'0HC#9W'%:L2"0 !#
M09#JP]Y!TQTOT.2#1NQ.1#A%3QX -93%&0  !A!#--"#Z]R!4@"#F]3#T2B*
MB.C&1!M +3P>NI2!4EP#B98#)7' M1!#C43N 12 &.VTG &  7#LC"@$4C7-
MOV0  )1!5;C0%*V94ZP3 *0:@TS<-RT(1US!1D , 1!:3FW^0#XP22^Q5P=4
MQ047#.F@9E KA8 90'6PDWO!T'] S*KXC@5PA3Z4=$5P"#$00SUP   0\&XT
MR3A^=#=\@X-DAT80&AH4P)_$1EWO@T4K$D/4PTD+!'A0"AG3RC*YAFA6-L;L
M0V8'$R]5ATSK,T>("%<OZ   PSU<-29G\CR10P%/8">?,BA+Y7S.XR@@J77N
MPR5X<D ZU ADQBJC@%*D0S$@@A#(9^,*LU,&\UV<\ECJ(SH 07#&&#KX9HS.
MJ,TEH@HT)7$ @2?[LD(RI <T<^T^5!?,]^WNXX_V]WH+5(@%ZN89Z/R]RP>-
M!2%TT1,=0#LTD"]I5R%ICAOM'UO^@[0]H,-KW$,*>Z_#'$ALNXX(M0,]E,<C
MHTNUE@-.5T5S$!MXV 0P$-KA%(#A% !:H\%$T(.)[[%0R-09( [3F45+SP8Y
M-(DXQ /OF4V;D)-J7<B@N =%$4-]W,P97<4!  )ID$/<$ 455/DW($4^O,)6
M%PI>)XH,90Z?S,A\M GEH M(@@Y9&P@M &LW!(C6Z0,,(S3";,GCS;!2E(,I
M5$=<JQ0:J11FEL:6 $.5Z_CN_-%77<>F?&@J <!&TH,\^/AB6T^^V!N'M@E:
MSW:&= "CYX/:-A&C\YZ(M!].>0?$(.\UP$*W?,.6. 6)\KB;O(4BKU4 [$&5
M4]"""T3^K2]$=VQ7=^1Q<&<R6X!#A7Y@)Y_  V%"/^4G(_[C/JRR;L8H*>RF
M4NA3=5\[0>WI0D!I0M:R"!C#/C3W74#[=(>S*Z=#.M#I>,;H*#047IA (\QI
M/? I?9]R0K9N0ZHW7#I4*^_#G3K"/D0I,T<N"O@3(HJ"@ HJW@C@B[A66*##
MJ-B#@VR7I(/-"]UZMQ' IH 2 / 2&I"&@NQ-PTS1?SV%5!L S$N$Q8N#5NL4
M!Y19<UB/H1!:S&9 4P= 4ES,9PS(?,%\"U-.+;3P %B &6!HG\2,@0B E, \
M"<9,F[C6 I&$2=RO>1@] 5AZ10A  (C\'0R.-165T0=  :#^ U&LDD7\R82V
MS@ ( ZHLR90<Q'IM]&;I,404D=KG^87B%.HPA.O4 C^_!3F@P0:DB=A_Q&5J
MS\,:/6R!?9I\5,-LBE2L"M%+/H<LML VBKG$1FVYB=MH5G9\ SOIU,[F'D](
MOD0\L@7N T*O4C PG-\7P#=0+6S?TZ[;4M$GTC4QA#TT20")C%!TA\0F>URH
M!:]$!8+CWRJ>.X!/)2.D0SU^>R,,I @PMW0GY+>O,D&=0!>,PISNHSU^]S#O
MP[8?HU*,)>ZB0Q=HP19H@18,P0AT+B9$Y<WM8Q?8*'%P!D"HJ+=OB </008*
M\=!E7ST5!CUH:1C$PZ5]SD08W++^#]T)#Q] A@3I <0H0(!JD:.WCV5+ER]A
MQI0YDR;+<@4.K'3Y30,:EF4&_#(S -@^<@0TM*P5H,P^"SE;?B.0@:4W-!D(
M +A KMX%J/ND;MA';$"'EA@$E#FS]@P:6##I >IP0(" ._L !=#3\HR 6OO0
M""B@H8P> Q;HJ2M E24' !W0L$5#:-^]<'8V% !0H.C,OG_W 1-@@6U;--]N
MFF69+T,!=(7TLB17H$!I-&@Z_SJ#84  #?;L -A@.X\^6 %\LCP3X&W>O?LX
M" BVKW4YENH,7-C704#GT +,O-1#@ "&PA<*D(-91@"Q?7H //\IX!>] Q?N
MC:5[@8/^G0X!*&/O%Y=N*L",R$P#)I\+#-!I-JKRL<""?+8+ #+)*$,C %I:
MRDRG?>X( !!Z%FM)M*;VF4</#@X(8 !"ZCE@ -O0 ,TE#@BXI@,"W-N'$/(P
MH"(/# CP1I^G$C, @_R^:TH#IB1#HQ"7Z#EL();(X@"O /:HR<LOP0Q3S#')
MM$D/0(!1J<PUV:10BX]$$FDAEAC)" 0AT-D'F1% (&6?:3SR8(B!#/% (((,
M&L&9?1CQ  4NNLA(!$0:>HB1/T?PH)$_43"("Y:Z\, +CE(P"(@M5  !!&/V
MN62D0[<P2*)]@#!TH#<] "*A7 D%@:11]C''HTV1">$##S[^3:?3.$4"0923
M:OGF2C:I_9*#V%Q"XS&6:AF@# LPH/!!I<#;1X,!>MRG%@'"R">0 8WJ(+Y]
M&+1NGV $$(LLU: 38)>6R@'DFI> (83">@H90#M  +A+N0"BQ6G@?6Y"#)T2
M'Y:/'D*(J<>56&S2$$69/I.M@ LH9.F70NJY"8.6JK3 QP <CC"]EH@AI)R
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M#X6$ %CU8,061D$HD%@$&2 XUD8Z B=FD404?T#)-^BA-I;<(V7)8Q,Q"%"
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M$@V]A2P"T$ YU.F>UG .'=FAD!X&,  +%,   ,B:2]AV@0YHP "6G1M+0D2
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M#A,QSI"!"YBGC\2H+>'*4,9O=$!V4;L#!BR@ 4"D+!]WT "XSL YO&1 QK5
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MH@8=4J9EM$\[6X@ *= F7-(;!D#^2S;J)91,G:Z!%C  \#K .N[!#P4@ #
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M591%]<$& 50#[P&%Z.$;@(YJ\:)F64(?W+(I%B==/N,F+N!*N,-&I*(J!VD
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MTQ0-=E  !  ,)=. !R  _/<0>C  !U  )L<09P  9E +;D@(&P  &< I]&
M!> *<1B'2;<' , !N1@+K] !+IAT:!  &Y TQ' & F !<S<NIB8.1\<;4. !
MW_B-'R".XAB.Y#B.'O !Z)B.YKB.X^B.ZUB.Z:B.YSB/\JB.]VB.^,B.Z*B/
M_/B.[\B/\QB/Y%B/X+B/^;B/(% ,0Q,.#_1:N2<$9?@0]7#^AD'@AV"( 03
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MZF&LGJH",%,  23FH)P+IA.))'K^G'22@ '*$"M$ 0@ ^0RQT "Y@$]=O";
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M4YWZ5*A2#3*_^(8HHTI3G&95JP_^E6ALR%%1#4;U,/<X@QEB*E:T&O45%LB
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M&5[DT$-!P8%AIS:PN?#ELD,]4-CY_E2\/,K  0HT0X&\H@ %(%(!B R3F1W
M BV+B;@R-CK&E$-N&C"12J89YSEGP)\X_$92#2  G^5E8KY+,8\.H $H+T9M
M*RI$T,1JOG0>ABQ[$."?>,9IA02#8L);\YKS,!(+O$DA?QH5[]C"X"%MCV(
MF)&4;9VNQT0F'%9U*F:[O.5?1_#+KLE#:,E1#OI>=T(8H(?^!@"QD<WI^0#*
M(HA^I (+%2E71B_)1X%BD8]RU*W&B($V,2YP.0)$8Q^P:,]^<N(SA>@C# -0
M73GZX[B@1*86M0 D3\*7Z<7(BGJ>",#FQ,I+\O*$+,G[GXP8OKI/B8,<$H='
M./)1CPX @';,(XYV,41K!N>#E_O^Q:N8?6N4EXN @I!,PH'J7@<"F\LRE^"P
MI]O;9#^U'NG@.3IX;9E?1,79]  $8"JM+52]>1]K&U_'ZA+NC<M(=8M!52VB
M@8$+%<(N3)^*!2S047(T961GR@#7"I,/8.B)GL<,<C\5LB9Z%$+K5XP%SWZ1
MCU)8Y1N  $2 KT&(/P#CY[%BX2O^"M&UO?.AF-,,QK$+T?=Q[D(/0X')-PH!
M&3_.22!>$J0>FFC(5VB1$ $ ]58\8<G=?8,:X  $IZ3R]\E3YDM6(<; B"$
MZDG%.P(@UQDNM0]"F.P" 6#P7,*7XI0G'S'HT(-=79[2',*\R]//:E>I$>;:
MU)>IC#@!"KS/"'3UY=S.A@FW7'STN7!4(5RW!Q+M41*E&V8C9@ &UGEW@*$*
MA.N!.5.L3%0/H@ 5R,@T:G 4 "" A(B;YP$4&D&# F +4T&C (&P7WB% ,"
MKA"  2 I!RR9 =@ [W) "-P)_5E W8F51[L3#;R##C"<=A,(!S29DC&X#C"
M.<J "]C^ )JY0#"*FY*9%=(3"$(0%Y#!@/'9  O @ ,,!IZP@Z@Q'"-<.@$
M@/Q ,-PKC.-A-F  "W':!SO #M\K/ICPO?M1/C,TC'N !X*J(GHPKZ:2/NKC
MK#@LC=JBH(GR+:CJ M[@#4-(%T<K #,X"OT3@!\*NHT3"'1HBO(C/H68ASOH
MCRMXOF,:/@LP@%FP(T4\E0 H'H4(!$L;)QFJAQ2!G@ H@*FCL#QQ,W+H!@4I
MND+H"N8P RH1,3_"(DTI)E,P$P CA#6SDI%H*V]XE;-1B+<H %K<B/I(L*@(
MN[+XA> +  OPA%K(D(Q@MPSPA6LHA#4+":Y30@PH!&#(N(C^T#,"*#H[&
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M[3,JE>0,EHP7JN"S %!'';3)).J_G)P5U72Q>E ';]@2[%F=>D0#-$ ^N#D
M'30 ;@@[I10(WWLSLB"IJ*0B4M$# ,#)?; 'K;0+'?RA:+& ?> 6T(R5!RS+
M3\P)6@B[K.F ,KB""P" CE#- $V1 NB ,." ,H ?6F@'GI$(0A2(5O")0"*&
M+BI*PVS/?0B?KI$5JPF*7; (4_$<!.7/-GF)FL@T63D1A:BTA) 1T!0U"^ [
M0" $0E#^MWL, &N3B\\LEJ(0RM<\PURSC[N*JKRB3;\Z#2,5-B2M%Y&DKHJ2
M1),RA(5IR73ACX,$BWNX @$(!M,2D^CTOU "BL;A"7T(N_P3"#V8GX*[BV#
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M,O@%3R#^'$9<&W]M7?\[$:I M%@(BB21R*8AV &P@)#X6;F@!7;\@U?0T@W
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MTA!L)[6-BUILS=YLSGY-Y/IH=OYKRK87T6Y6,>MLU$YMU1:OY:VJV=PLT?Z
MV/:LW2(VPG96\6J'PPZH?&@'R%YMX YNE'JM ]IMCRK2T6;2VC3M>6A>\1(Y
M#1@QJ;B'QD(,ON4)ZC[LN-L48Q(2Q1C2AX'2B\-8(;$'>J@'\XZIZ[ZBP:MN
MX7[OWYJLRMK(HO*UY+[O?7&-P=YJ-!:N:] >"#O%?$"J \B 0.AOJ4 ##7"B
M02@S#$"#L9:+M:J8C_VA<[T "^  ZW2U^V&3#/APRDDG<RO<PT #.3MQ&=J
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MD)X># $"$+BS[QL!#0C1!("E\" P 64.QC+ X5J\718"%$K8\6,A !\-FA%
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M!4%6O*$4BLD9E,$W[<,P=( >Y ,:H $@9, %<( <%8(&6 #^!MA!F)0#&F#
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M0!DPS 5 CC@1@"<8A!U<YUT2P&LHA!1AIWF6@0\JR@4XI/6LQ1D( 'XZQ&\
M@@$ @ 7^))08'5%^_D8M6,]!N(( H$%'C-,%!, %F$EW!N !#(!$W,,2[9\%
MA(-\NF?&%(_!&%$ 6@#\&<3[9<!=<HE"U,(*"<?^O4(\=  !>&>!?H,%5,1=
M D#J0(D *$4'&  !Z!-%[!\'\- %%,3IK!#<>8-YKJAR2$0Y+-%,P *@T ,L
MU)^^&, !$-$0&4 X+J@Y]1 ':-.^E,$ ')$^W8$ B(1V9H"9Z P](-,(>4,1
M)0J7;, R;D08PD9':$!5WH'*(<0W)$68G@0*78!V[L0^Z,N:'&!L#,#)J!!/
M%,( %("9]M"C4 >9 ."$IMXXW(0UE6@YY .^A,S!7,#NY G^S+P1,91##*TH
MANY!% G ,";@ .A31TA>%;66;J%%I(D;1BVB;1IKL1[5*#QB+7Q#N.WA5E@B
M)HJ5)AJ?0QR !6 KM@H@/1@1(4"'>-0#+[8,+:PE, P !H@==-1JOYS!4[R=
M151/I>1)I72#S]3#I90.B0( G](0A9(H 8P#(7!'YB@*()RJ!1#L!8@#Z 4
M:1[$P?R,VW  G'R) 70,!Q@GKV8)&P6 /F%$E\1J ="&N)9#.40#??!$.;A&
M!^B#P.I'O]#)/J##QA!#.-30/H@#!OCH&CTGHI#K!5@=$74,0K3I#-$#!A
M;:SL6A #,M&#.!2  /S+/O#!G)C^TX 2 Z31WPSEJ'':SKD. \*<S"O47QA>
M $]HJ:ZR);X$+13MPRY 3O!A  X9J@5\#GN*1[_\2Y[,3![@($*\R4,8P!G
M%C'$T\GL@4V@W#91 ;<=1#A$K2O<0SEP8QGL)THX:@#<4QW&1M+NP\>4K-@:
MA$]8!'440);4@Z)DWY\(@.0RK'B0A_E!WT7NH  TYSY KG-\JT&$ [XLR$.&
MC, V)Z_6 CI876U1E L*S8H9:],U;Z4UKR-"HB128E18(G BA%]TB/)Z"08
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M/L"" 03 =5Z!1-*0Y?R! /R!%U4'U0* 'HP)1#3I ,!GZ$2JP/AA2]Q!/1P
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M/@2#'4 ,?^^&P+:,/KSP1[BLQDQJD:2[+-]!&J$#GB^RZ* .0J 194^X P_
MS-AZ\RAY"M_UI,)X!HA&SXBE/!N,%?]ZOZR)4^$WZC".L(L'*%N*5 NQ6F)
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M8$('RP/:%. ,E"XXP%%3"AC S0/^5",$*'HX"$!3/N_91R8]+1"  ]Z ,6"
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M'\@!'!R%^B B' S.->HA',*AI';L&TXP^WK0!X7-.[1&'%10[,3O_'()!8)
M!3;L")LP[]C/K%;PK?*! P2 50!A8[X'+RP@8V ! ]#@+28#&+KE .Q @/1
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M@I*\C-$H:],VZ:[V;B\I3<JS^G*+<N4A:*$G]@  U&*2"@ 08$$Y.X L:B$
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M>R#T+[IR $8# T %-*3U->SR(^J$5"C&9\G! @#  +X!\PPF PZ ]^:W)#(
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M5\X=+)434['$.B?>L]!&^RQXTE:[77GGO9(>>_.HLRQP\$TSWP\>! $C;_G
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M%R0+7$U2TP$+7(88%J"T#O/LLV)CH "?HL<9"J!K 1A :1;[N$P($5T!!&
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M'#B&DG2$8T@(&I<!C/%IKG-99F.$I4&*P@(,?H8!1H1VG@@A67$ 5B@0'4
M#E*,SOB,SW8L@O +/8)ZIG@=JHB*VJA@??14O,,>:WB']= NKVAZM= !&: !
M9Y",H4,/=[ !&< !.T8ZQ% &&I#^ 8GQC->P 1P@.6"A!Y+W@] XD 3)1NB@
M!V^4'.6H7_IPC=OXD!^0C=_!5-E2>W98D!B9D1JYD1S9D6IT#_!P'+5 #@+9
M; X)D2BYBMT(;@VV'A[YDC 9DS(YDS 9;< @#KXH8">9DMPFD7K$BG_$'E-%
MDT19E$9YE$C94Z (8 ]FDA*61SZYC5&IDA49E.R1>^F0E>F #NBPE5TY'#%Q
M(?9@#U-H>@N9E-5VEOWU+6KI;&V)EG>XE$)E>CO)DW9).[A#A^IQD<!1#UH@
M!$, F$,PF(.I HP '/=@!OBVF!AP :/F.L3 CK9Q#1F@-@BR@?M%#QLP2\L!
M#"5I&Q?^Z(]R1)F6R14:()EM00]Z4@YZ]ROBL %C\0T9(%&GIYH70IFT^2OY
M@)EP*4=+^0UOJ5-%-95P^)1U5!UX9)SC@9S,&3O)&1Y/"93<,@]-R1N$9 R\
M-PW3L'O3X PH  *-\!OI$A<*A&^31'@"L8>_L@L(]QLG,DNU-C#[%3*^]"MH
M\'F^T0'RV5.]8HF@LE?H H\(H@$:D)/#$0W$= _#X#!BR %$)"0RQQQFX'6]
MZ9LN T<&RE]U"2W*F6UVU*'9\:$B2AT@&I$C6D?@X9RI&)U]I#M[Z8K"@0Y#
M@ WC\E6]030'E ]32):OJ)[,T26_U1N],DN2U%#Z)0[_AF'^O*%>[+4;^_>9
MPJ%9PO&>;$$% C ,NZ$F(/0\KF$ ]1DL\;,R%,A]SH86#15LP6)$%U6AT)8Z
M)&F-% 8")OH<VE&G)GJG=UJG$B:G<ZJG$9FG>FJ<%/:GSP$"='JG<GJHA4JH
M?YJHC.JHAPJIC:JHBSJGAFJI(4H>W;@[O?,>0B NPG-(XCD@3B@3]0 +A0 C
MZM *) :&WX &9D (U/8-=_!2P/""OP"K>N 7W] !(B$I^4 + 4,(\2 3WV '
M9J 'MH(Q^7!T"'=QUU"K:.!T;4$,M6H&@.!/Q "K=X!]^> +L)JM,Q$+ 0,(
M[?!R2?IR>O!2U-H-A7"L:, 0DQC^,&AP)+4070>!('H ,"4'%H5 /7J /-%:
M!F>P"^%5".) "&7P% 'X"FA L+"P+(K1#OL:K\9:JX!@*Y:H#WOS"GM0!G=P
M4O2PKF<0L3L$"#,6L(  9>)*-0]KL1GS"N@ """[%K5P!F= K0Y$3*Y1" Q1
M#H5@@__B"K[C&0&SJ[>QK690"$"[),1@"MV !FAP&9.H&8,@@H5 K<GV*.A
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M@<(?!N"S-TP]S,@!37D&!% V4B->4&8 )AP1_$$ B 5V;C=%9A 3T0 :U",
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M$',QZZGP(*1>3)[[[&$@\*WG/C0 !,!BJ<\"!I=E! 3C ,#^0@8,5#.8*7?
MPCV8? +HV4=L  &J53-H^(4F %*6UP:8>4G/@@5Z^38,N-8RGP4#]%KJFW=E
M[ $-' *<V8>A0+FX!BYP=2F6  ;*&<[^*E<@P[XR4BM;+K,/3X!"+6$=$&
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MTA\5!RU=S7(@TK><R99$RJGT4S\-AZ84A\#TTZ%<U*F\HY%KR4B](:Z\H6N
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MOC,!G'880(Q@O@L6?@*S(,!  0L!.NRK): J()DBBYZYMZ^<!@$%=,X]:4H
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MW3QY3SM=C99E06J]8I5:A/QNAJ9FS!K= -\@3\Q+O_QR#W@%B :N '46E <
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MN ]8"$!ZAS% '#E@ 3,,(!KD!(0W]$2//KT$4%145@D+LH'VD<@59^# !01
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M\4"4=9-\#(\<:JE=QZ #N[F$0[]$.L.]U- -1<_(!0!:*(5$^4$  !M!%%D
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MEMR!4!C 6\Q8&'%5T$S8(15?=0""'5P 6'0$3\'%A_V$6FC ';2% -5#!AS
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M!2%80(W0PWF!A"M6A3=<@/_ @@6(&+C,1 %P0!EHP%C< R% 3%[807[XC%0
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MLWH<:$\+$AKF>"*5HQTE*0NI!RP:-*) Y2A(A/C&QFQ$CP-<H%<34@G9!$(
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M]YUNH,R>*$/+J@((#5C@ F4XY82Z@?D+=(!-:&#DD^S>>!_^+G[G:-C3'CJ
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M'&!A-+Y"+&&B*X"!0D$R.]G2#:7G-[^S1+N31/?28%C3/&,.0+]"Y+2 "[J
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MLQP$E6W!HE#Y%GO<AU_ 8HD*@&J/1 .6R4@=HA" H0#H^ P>38X-HATFDD4
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M(GZ7/^0$&'ZZ,YE**:BB5"R@).]!M>/.E1"K=F)Q'^:C';IAO'T+TJI"(@J
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M^S(<H"=PGYT KKX1Z!!Q'X8"]/0$T"/PVP -&6$%,",P'P8 '"*V"H!&8@!
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M7*J2 :^9 8 9IKA2B">O_#)D .#)1(@9 ^29$C$LJID!<6N-5:) ]&@0@
M@D9MM7"A<T>K=MUC;;>@ ::88>$R-JYDYIZ+KKGEIBL8999A1HXZG,WS&6CI
M '$)*?J2,HJ^HYS@@1!\V7-! >+ %L!4^]!C@ 40'1D +&'^&?0:@R )1,P
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MX "'RD$/0)CG8:\00'TN= $![($>]0 <1D1'MZ/=@QZ &T W[J%$,Q"C%A<
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MM=JA<HR$;,D^"F$&<&R%2<VBA?/J 8P"6 "$ FSI6\JA!T#\XAL<=*E-":C
MG"8FI^O2J;G<=9D'<D8=P^0+,DZ0&,5L<"_Z*!A+B^B*B)3^XU -&\ !>#4Q
MX^T#$ A9W@#*@!?E=*R*RJ+%R)QE,G*$T0+OD="E,O*=(S*$'*@TP $&!2/
M22L^!!#I-WAI5ZOFJ6H <%Q$?G%7J662)R9IUAT$4  ,'.  J)08.30@@*9@
MP'EX<44!K&J =+X&4XX=@.<LD"$!2(P6 Z@//;[7M\2&E@.CS<@U,!  NPH
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M=:A!?;B'?YB'?ZA!@NB'?3B(A8B(A*A43^:'CHB'ACB(B/B(C<@8(5 9>N!
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MEYI]Z%<7#QB"]I"GD@JJH0JJ?.J$HFJJIXJJJ9JJYKD6]H"JF JKL2JKG+>
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MCWIEVO1A_X)RSQ@6Z)A2N_>)K_58*.I;2/B"#_F/P83()Z^*;_D_>Z],E/>
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M)S3L1&LH0'X)IY[D4DO115)+-17&BO* A;?"?GL)'2&F*:D>%3P0HC27-A
MD)"&+,!2DYHLIR1B@'7IF@&D'*D61<?BLB5(P3Q)@P+$ 8G^&/!^,B. -T>*
MI5F<ZKQSIF=#.B. 5_;1!X,"U+FIV$('D'8E9L_8AQY@3,0,4DE/VH  0"^]
M$"8[-#VKG#L$^>6H-$55T52((\X+58LPXLHW&X<P9]8?/ CB)7H..""T,PRX
M[QM"A@4)F$)*R\  8NXX@Y#(Z'GET'L+.>.,6I[]1F8]N*/'#@$PH#DD<LP
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M G  )-_(@  *4(!D1<83!A@ (PT BV <(  "L #.8%$   P  ^JH!Z0(P$@
ME00- ^!CD;RA#W6$@91$JN2]+/!* @@@ &'H  $($( +D*D6FBS  0I @#GM
MHWOWZL J!Y ![G @  $H@!L+H(&DO,*1!!B ENPP@'_%LE$DH4<Q2WD!O.D*
M  30P&]>@4E-HB,?9R E(\&YCWI<P (7L"4NP:,'1 )/DIX R2@;J4=)8: Y
M "C -=X7!@&4T@+#R,<&!D!0 QA@F058SRL.8$@^.NH,!,#^   "P"N2E,,
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M#+C+#,A+B'RER)A$ZG*HGGP% ?"$S],DK\S+!JD\DJ@SZ@J)7;S$-YFRR]H
M3_/*FX0J3!Q%+N2& 9A#N/PQ \ M0\$_UV,@ [B F,R@.JO%A?1&GGP%<(&G
MO/I%^P,IZ=*DF[S)#* %>@PZD8(^:*,]=*FUYL.I KB D<O&M;NC;9E%0[R&
M5DC D."7)E-&D=@#O\( KR,4WP,_GC. >J!'U>Q,T@246Q0Z 0@&?3"O/0!
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MN,)ZR*,G.A=EI(>DM+ !>*%[R2,->;G7$->J%"U<4IE,R8/^L H0)-&_G#T
M[L#',R04YV.^/UC14,7%0PP)>\@C2:$2 K 0N>S4X%0FD,H'.PH&I%PQO]R'
M5OC0G 6 ".D3K.R  K@/Q1R)>C"\;J$')+$01=V'/9V+2.. UP $ LB.PK6.
MZJ '+O0&MP0)V,R.<YDYO$I+K&,;3>L6Y\. >J@S#7@-(H.T!%S+ =@&O"J
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MZ\@P@PR8FGP@:P=W3FEK;\,UYQ"'C@PHD/6^%\F>,V\$"H19+7AE"Q3Q:+T
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MC0+ 0,1(9X ,'$  ')@@(;B%@=IJCA;!RT<8!,!;C'D.#:_5P %,NY':$G$
M%F#B!@80C7M4D&$7&,  "$J[@T;# @,H8@&>R[L"VVZ8V<4 !@; .(6L40\#
MH.N!#>JY&/+6 KN]R1TRQM^L9B  %F@P;/<18I3%;@"F4,@KO!L[#-Q$O <8
M@  HC%$![$**-]R'% M0 (HZ.,;FI7$9[A  GBY1(=TEP. $D %Z "/%%_A#
M0O+Q*6#^7%%B 0 K,&R+QCS0HAY?O.@^R,$PT=DUS8/J28O"F9X[3C;.J_(
M"K*2-8'4HPN#!:R<"6G)RT)FDQ0QVR<3TED/"*$BL L 15>ZTC($I1P-IH5!
M Y</"V1.(*_0[D9L>,1\L"YR<H7T/FA!  W<0ZZNW$<9 H"&D.RB (23H@&.
M*.D=)F0>(PS*+P9\$WK0D*T(*0?#MDF/^@[C%P8.Q$.#0HX,"  69;UA.087
M%.#M0=,#T(!"ZNL-V&6NH0'@@$)8N \S"*"#UT!94%BW3=@-H(5Z\')"6%>+
M[\JGM850)S%.+9]6A\L. +" H^AQ!E>_A! U-C$ .L GA9/^.X0'*(##AFJZ
M6]80%L0(XD#($;*7L&YW905 4.<=W@ 48%SH,#?KAI$0+1K@W0?7G!,Q()F&
MT .U2!; -B,Z@ TD1 ,$(/,9 "!L-2/],J4YC8L$'33)]CGJ@3U!%RXQBE$@
M @A[E/J$_+PA6@!:DV4;0@,-'4H)@A8# "B  =K>=@W(!QAL)P 7T7@R4X(.
M'0:]@SVTAF6@?S&,^R!$Y#88+B<>(#7TT$<,@?$*5P]DW] 5ZJZUW,9^8R A
MC^<A,;*J[, !K^?[\&D'ZC&P.WPC'^BPTS4&3(_7T^.+^_3V/AI\08_;/"$&
MC=PP7O&2?'SC F9D]0"$V64-I/#^]1<PP$672#I\]7L/L% G/0H11E0& %V<
M0\-D+FV =@A5#P[+(;FD> '-&QC/PB='.B.ND#UD7R#BW<!DG,C\7EK@ /2@
MQ;@'PG*>)P0@D-Q M /#O-X6T=$\Z%8'M(R[#<0X_%Q"@ Z:B<,!)%[286!E
M\(13N0B)P!G7@:"-(%+7R1DE@0V@T8,ZT-%#H(,0E!W'>-8$.40]-!@PP%XY
MO![M ,   (SI$<Z-$</EH(P%&D  7, \F-4$;9 K$0.-6: %$@  %,+C>,)
M>,, 3%[6C-!+U%?%B- %#L3N*81XF8$^+%^E? .3[0,@1"'=H8&0O=83.A?
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M=,/)D(/^.$S1KVT KB7$\MF)>&E >-A#:85E6,G:38": -#""<E5!P3%L06
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M.Q\&[KNX:].\A?_5+;T<NFYW"@VEAQ0]R;#KK[+7"M8]_*?RE7YU'U:@.W'
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MJL>B>AC^DG^A]P>RWYVO]%^(?PC!WT;N\;]^"60B"L%(X!:R#T'5R!XUZL@
MYW<_BFP$?O;KET4P>)&$7) @]-C? =V7$/\Y)( $D5__#F) @J1P(/+38$7>
M(<(8YN>$#8%A_ C80A1V\(8S1&!%_L="(*K0(_=X((UZ>$023J2 ]9,(#1]R
M$/KE)W\<)* +.YA K+A#B Y1X#N$V+\/>I"$(*SA"+'8D/_-L']<?)]%S%A!
M-4;1($4DHT&,(L&.]-&!^["'1P99/KKM2U*)PMLB%9G(2.7M1^B[#P(S4A5+
M8L62&(G@O=X104EE\BM^HX\G%:44DUQ2*91,9;T,A4DHPF_^/O"#I=]"N4I0
MQH>4H,2D?#JYE5L.T2)X4V54<OE)C?"RF*NLI2PE>1!2EH1OI(P*+-M#R6$B
M<)/7;$HR%S7*14'QD=-D"C!Y*<M*?A.8YWPD5KBY(VEJY)V?K$H[O]D40]Y3
M):5TY#X1&<X=_4U]].I1,P/*/DT:5$?QU)%)]/D4A2+T40^%Z$0I6E&+'H2A
M%96/1._&T7Q==#T>W29(0SHD?)XTHR E*$57RL^6_I.?!GTI3/'UCI/,M*$D
M!>A.8\I3G=;SI^N;"C2#JJ]FXK2100TG?22)5*0:!*51%4DDE<HWE?;S/3EE
M5$$_VE.6VN>47O6I4!':TJ<FE9'^B!)K3:T:29L2E:UD+>59K=(H@J+OJ/NB
MJT6EVM<D=B6O5VWK6M?Y*+U!<J>T'&M<>7131C)UL/[4*E:I*ECV@66ODJVL
M5N"*GZQ6%:U*Q2MHA:G7T";*KW[M:DXQRY763O*RL26M:--:6XTX=K:;_:IN
M7YI9H/86MD[I["\U*EN?/M6W0)7I1(VZH]3V5:V?A>BA3DO8Z.8VD:\-KG79
M%]9&*G:IBS6L=#5KW/&NMKR3O2XG_3C5LJH7NV0=;7S)&]3G2M5>XN5J=2WK
M*.JF=Z!R+:I[H#E,^G(WL@FF:7,1J]_\-MBV8.TL;1T98/2N]\!042!_BWN?
ME\SMOC?^N>A\=4O3"!]8N_P%[GDK?%-7>I:RS)7Q=ED,8,;6N*E/F7"&E?M@
M$__XO4/J@S!B#-_T ADJ+LG'&:X18A'K-,44/K&4^WM7!SNW),GM\)1K7-^?
M_A?&\97*CE\\W?T*E,89+O-4LM$.(]OXMPS6L4O"(2@GT\3,/)XQ?;5,VAWK
M&="!%C1L_XSD01^:QWU>Z)WOB6C2*IK#D/9S2G/$7D!+VM&9AJIZ](SIV:YX
M*:>HQIDSK.0]D(/1>!ZPF#O-Y]R..<LC[C)H/6W>'K.:TIHF::WMMHMO9!JR
M+KF'*\J1ZID<>=4W5K.N?3Q)W&*7UU]F-K*76^!IA_G3U\[^MK'+IVUO?YND
MSP;WN,EMMT*7&]U:J48YR/T28L2+VR\)Y34K<DQZQ[0@L:1*O>?=2GSS^RJ_
MU!O Q<DW@L?2P/9NY;T-GO!:UB??_98P29AZ\(>7T^'@+#A@,VY-A4^3X1RO
M^+[I7?*%^WNI%M?XQUDN\99S\-S@W*7)07[RC2-\Y! '>,1ECG/ [CM(*O>X
M04Q!Y'FS5N@[5_J_M;EIEN0##=Z(=TRFO8]TV_?02;GZU@-M=81J_:=>YWJV
M=2KVB<*DO5-7^]K9WG:WOQWN<9?[3>0V]Y3 V^YYU_O>^=YWO_\=\""QPRY,
M8@Y(2 +OJWC$*CI2CUP\0@QB> 3^+@2%"T6D(B3U4 8DQB"&1*P"[_L !RCB
M( 8R0$(9]=@'/3(!"6ET!!VID(/I)?'Z?30#%. (R9*;''C?_Q[XP1?^\(GO
M$K281!DS((+M.T*&%;QA'^9XPPQ:( ,9M& &9##'/N2P C& A!Z*R($+K(]]
M,#!?%4UPP?K7GP-%U,,<1)@!+FYO!1F0__I' $4]0!$):(AD1HI/  >0  O0
M  ^P[7)A!G2 ^?;A#5K@#>J!#%P@!^  %&1/!UJ #.I!$58@#/RH'A+!!6:
M#4!!%!3!"%9 "LYA'XXA Z6@$E8!%<A@!F0@]^0/%\QA"5I@"21A%3C!"EJ
M")1!&5#^H0%C0A\04 F7D F;T D)$!"(P2044 =TSR/(  )1809P0!4^(A7&
M#Q02P0,_0AEP8 8TP8^2@0A:(!+J 0Q:P JVK_$2 0ZA0?Y601%:@ F>P2/
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MU59O%5=SM5#')_C:@5!U%5B#-5@'[U693%B/%5EU-5""CU23U5F?%5J;,"
" #L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g44361moi010.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g44361moi010.gif
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ME6MLEFQNF6]PEVYPFG)TG79XGWEZGF-UIF5WJ&=YJ6M\JW5WH'=YH'I\HF^
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M^/?X^?[^_LS,S
M
M
M
M
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MQ1OB36GGF2&O&,0+(#[[5/>RG(1%""S 0%&!I*(&&TA#(/S^((4,%.&<>L2
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M!/I)CEM*U"WQ"D#'=!@@ DEP9@:AO;SF -)<$.S<6DB@PB(1![<I7?58M44
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M&:#J&G !I^[JIYX!%\#JIZ[JLA[K)R1R]BT0EJ#CFD4!L_P2KR &P"P"_07
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MT,.2;,J2(LA K5 $RU$59XN_&XR<UB.+UQ.,-;.VK\D_@9 $&J0,!^  .(!
M8A*#_SD.$:"$@S# 7?*WW;B=XY#^KRMX/X@*!!<X(H>H@&Y3"$O@P@9L@ G0
M 4;X/ZT A39P@3V*+P;#'O#K/*2K%B-2$R,0H+B(A!(LB\?#P3_,F?D["I9C
MI3/SD"#$FT"C# R@@ABTBDM0@HM2$^D;LI_SB2G<#49@O.28@"*(!-V3BE,8
M _O0N8= @LI;N*7CLIWK #$(!5"<"E@@!3JX@8F;%B<30(@0OZ'(19=["!Q
M0ZUXA4& I@:T04!$QG;10;%(-]]HNQM1JA-#B%.P1 PRPT%(PJE !3IX 5N,
MEWI#"%ZC0#ZZN];A$,X0 3>@0ZEP!48P KHH18<0@;9:"E1( B:) !N  U"
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M6$B$@H%;HJT5!PA8-XW%1*@!B$T3<A4<K9F (V"$9XLIKFL*Y6U9X[VZA\B
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M,&6<9NRIV#B0+=ILX@P5SHK8&PVEME34B&6G0(5$($YD)3G^D%FL7.[F!XB
MW$R#ZESBB#$,R>8(@&&5:[H0!G!4R*X7JU8(5K"$-B@"MNZ,S1CMSQCEKY4N
M=?H"1#B%:?X-5I@$W@X!!JSH/_&/"-  '0"#0>C-JM@6;/H3SBAGJWB%3' #
M).@ Z,80@?8,F8T5#&@!*C@$FV[L^!Z)4- !E:@)^TZ)IDYHK( %.BBI$.B
M#K!O >^ EF@#H58(6 @%11 #)[V ^&H V@[07J47V(B ">  '% ".* $^'X*
MLI$)_!9Q$1?P$;=O$#!Q$1<I_-8!GE4(5) $_KR!E];7V3JCN5RLN=$ %RB"
M,V"$5Q255,B$,^V!%@!M_T!R<:G^E9V+  H( 1U8 CBPA%- <(.8A!JP[Q47
M\27P\*9(A4OP RG0@6,-T'\IVKGLU8G @!"X@2L8A).6[SBG"EBPA$JH<TFP
MA#RWA$G(<SZ?!$KXA"I_"E2P!$K8\SRW\SK7\SV7A+UFQTM(!#@  R2P@18
M 0W( $S/@$S7  WH@!> \C/P@T8XA115#%"8A%0_]%7W<S_?<SY']%BO!%BG
M]3VW\UG'<U8_]%1/]#W/A#UF"E<XA4CX@S-0 AUP@0#?]$Q?=D\7@1M  C"
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MM":O "$3:4(A[IE0+P^=HBE6.*<BX"LPL#.4[ XC2Y[A<#2[VUD/=;DP+4X
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MBXQ $ES!%1C!"$R  LQ9T%0 !N!>*T)8/>X1!G! !4"5G(1 $5#!%2C!#51
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M F0*G,QG?3K !&  24[K0V( !H3FL.T, TQH(W"  J!/B]2!?ORIIDQ !E0
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M;R5C"#Z4U6FMKO:F];$2SWEP+(!4WH0 (SGI#)[4&*U4\33-#;0%$FFC\CJ
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M@U[W1+L"%23-&6B@ E!Z&@#!$1C!$11]5&="!V0HIVPJ![C $K0W+&0"$"A
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M"A#YJ :DD$0&;K 0#N"$<@S  2D4L2&*B(8!=%+$!JLT@DN08@0>XYCW?,(
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M@ 2(=K6:?8/\/IN =C8P90_!R03^VI"*3+CA"G8#H@426J)&B.$*:<@$*^
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MX.H;%E^ )&2:")#_PUU 00=F'>( BB= #K".1%",X  #$$#I"5  R_O%$D>
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M"J" "&_@!G\P":Q@B>G6!.1' $L0"75X  ?9:HQ !*ZG?Q"@ XE03Y9@! ]
M?06@ 70 "Y ( 1!0 8DP$*DP ET) 1=PDW-!AUZY '0P%W1 EA! !3B)"&/9
M@P4  41@@71Q! M0 5YY" (Q!A"P #W8E16@E(KPED: 9)%P!!5 F#J "*FT
M!&0) J;B!B!PE0N0 V4H&*C !B-0AP2P " P!BSIEA" @+ZW %UI 6^G%TG
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M 4?0!$T9@17P"0/!"@H:@AK !%^0 Y=: +.: 1PHHG6AJS [%Z$J "/("B!
M?A#P!8<P"8K0!A?P>_\G?#:Z? (A?DX)GA50 190AM$Z $ Z$&U@K0<P D1P
M WGZ>TL0+$C*?>/9!DT0B1"(@GXA"AGPK1:@ T2@ =9: >E7!Q9P :%9EA8
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MOA*//*'.2VA)BD"(TZM/B!"22(GJ(^ ^A3(22C[!8"%BP0/$("D65MQ 2Z,
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M(H@ H5H+,KE()98,$_!F A:  *T%C4O4HS8('V!"C^CPUJ-1(A *@E% *F^
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M#+L '6#%#20E*<%>D8-\1F 2?H&%(G1@T-@Q0 >,:*@]37M:U*8V8Z?(A"A
MD8F\_N45F7@M;4F9PTP$X@UC>,,A/H'4BU8B#FR 0R1J XN%V2V$^U+$;HM;
MK]ERPK4N2@@K.$%;4&Q5+Z501!S:, 8W' (3@:5K)C(A7?+"(A-T\%D=,I'
M5K0V$Y\HE$M@40I$O.$,;PC$>U^"BMIF@KRM (4HKEO?P[ B$NQM QTB$4&7
MI(*VG #^!743TPI+U($-8FAP)%!1VHODJ7 A8^9\/T%?*;KVO%QYB2D4 8<Q
MM"$0EK#P2V:;WS.P(0Z*8/%+8&$*1+#A#'2P1 )3 8I/M+:%/Z8M;8&;(E$<
M8K<R_JUJK7QE+&=9RX!!;F4*L-PMAWEYL!@A(Q$H9C2G6<UK9C.;NVS1-L?9
M8HGH8 '@(&<\YUG/>^9SF) [3C#W6="$8<4A$I&(,83.=8-F=*,=_6@]_QG.
MD*;T1\(EM)V)H=*;YG2G/<U%6!P*-('^]* #.,<1W+;4JV9UJUWM&%CD(#9?
M?G6CH;>2<1(!A[7F=:]][>M(_$'8?]#NK_-,!QV,H 8Y:$+^(F!J;&A'6]K3
MIG9J8?$*$%=;V]OF=K>]_6UPAUO<XR9WN<U];G2G6]WK9G>[W?UN>,=;WO.F
M=[WM?6]\YUO?^^9WO_W];X '7. #)WC!#7YPA"=<X0MG>,,=_G"(1USB$Z=X
MQ2U^<8QG7.,;YWC'/?YQD(=<Y",G><E-?G*4IUSE*V=YRUW^<IC'7.8SIWG-
M;7YSG.=<YSOG><]]_G.@!UWH0R=ZT8U^=*0G7>E+9WK3G?YTJ$==ZE.G>M6M
M?G6LR]D5J4"%*4R1BJ^C A40_HO8R4Y/5Y""FO\EQ=D!XXJNNSTNID#%DP%(
M"E*^PA6OX/O>]V[WK ?^VYS@0N'^N;"%PQ^^"\_^""JZL(4YG'8.6^@">1%"
M^"W883"NN,/C"S\'4C#3#I[WPB86*X<MR"$AKYA#%US_>M?/(=N"ISVU-V$"
MW.<^]XL'3"FX8 (Y,-Z+D-B"";@@=U=X ?>1#PSK=8_[+JS=^28HOO'77J0[
MX-X+"7Q%%W)?_>)W ?"U)W^T-Q'^1T B_>G'Q/AC88K?JQ[M=]A"^"U/_^(S
M'S#$-T$7((&).< ]S8L%3B@^+\ $^C,!_0.@R=.^U;,#.8C "/2^+;B#\KM
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AG7B-!_@SC[-6^/>-WS@YO_@7#GF5Z_@VLW&3[]N    [

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
